CINXE.COM

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline | The BMJ

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML+RDFa 1.0//EN" "http://www.w3.org/MarkUp/DTD/xhtml-rdfa-1.dtd"> <!--[if lt IE 7]> <html class="no-mqs lt-ie9 lt-ie8 lt-ie7" lang="en" xml:lang="en" dir="ltr" > <![endif]--> <!--[if IE 7]> <html class="no-mqs lt-ie9 lt-ie8" lang="en" xml:lang="en" dir="ltr" > <![endif]--> <!--[if IE 8]> <html class="no-mqs lt-ie9" lang="en" xml:lang="en" dir="ltr" > <![endif]--> <!--[if gt IE 8]><!--> <html xml:lang="en" lang="en" dir="ltr" > <!--<![endif]--> <!--[if IE 9]> <html class="no-mqs" lang="en" xml:lang="en" dir="ltr" > <![endif]--> <!-- <html lang="" dir=""> --> <head profile="http://www.w3.org/1999/xhtml/vocab"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <link rel=”apple-touch-icon-precomposed” href=”/sites/default/themes/bmj/the_bmj/img/icon.png”/> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <!--[if IE]><![endif]--> <link rel="dns-prefetch" href="//static.polldaddy.com" /> <link rel="dns-prefetch" href="//ajax.googleapis.com" /> <link rel="dns-prefetch" href="//crossmark-cdn.crossref.org" /> <link rel="dns-prefetch" href="//d1bxh8uas1mnw7.cloudfront.net" /> <link rel="dns-prefetch" href="//www.google.com" /> <link rel="dns-prefetch" href="//scholar.google.com" /> <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> <link rel="shortcut icon" href="https://www.bmj.com/sites/default/themes/bmj/the_bmj/favicon.ico" type="image/vnd.microsoft.icon" /> <!--[if (gte IE 6)&(lte IE 9)]><script src="/sites/default/themes/bmj/the_bmj/js/respond.min.js" /> </script><![endif]--><link href="//netdna.bootstrapcdn.com/font-awesome/4.0.3/css/font-awesome.css" rel="stylesheet" media="all" type="text/css" /> <link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/387/bmj-2024-080257.full.pdf" /> <meta name="citation_funding_source" content="citation_funder=West China Hospital, Sichuan University;citation_funder_id=http://dx.doi.org/10.13039/501100013365;" /> <meta name="type" content="article" /> <meta name="category" content="other" /> <meta name="HW.identifier" content="/bmj/387/bmj-2024-080257.atom" /> <meta name="HW.pisa" content="bmj;387/oct01_4/e080257" /> <meta name="DC.Format" content="text/html" /> <meta name="DC.Language" content="en" /> <meta name="DC.Title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /> <meta name="DC.Identifier" content="10.1136/bmj-2024-080257" /> <meta name="DC.Date" content="2024-10-01" /> <meta name="DC.Publisher" content="British Medical Journal Publishing Group" /> <meta name="DC.Rights" content="Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions" /> <meta name="DC.AccessRights" content="restricted" /> <meta name="DC.Relation" content="10.1136/bmj.i5191" /> <meta name="DC.Relation" content="10.1136/bmj.39489.470347.AD" /> <meta name="DC.Relation" content="10.1136/bmj.q2269" /> <meta name="DC.Relation" content="10.1136/bmj.q2605" /> <meta name="DC.Relation" content="10.1136/bmj.q2605" /> <meta name="DC.Description" content="Clinical question What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidney outcomes for adults living with chronic kidney disease (CKD)? Current practice Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors have demonstrated cardiovascular and kidney benefits in adults with CKD with and without type 2 diabetes. Existing guidance for SGLT-2 inhibitors does not account for the totality of current best evidence for adults with CKD and does not provide fully stratified treatment effects and recommendations across all risk groups based on risk of CKD progression and complications. Recommendations The guideline panel considered evidence regarding benefits and harms of SGLT-2 inhibitor therapy for adults with CKD over a five year period, along with contextual factors, and provided the following recommendations: 1. For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 2. For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 3. For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour) 4. For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour). Recommendations are applicable to all adults with CKD, irrespective of type 2 diabetes status. How this guideline was created An international panel including patients, clinicians, and methodologists produced these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel identified typical risk strata of adults with CKD (from low to very high risk of CKD progression and related complications) using the classification system developed by Kidney Disease Improving Global Outcomes (KDIGO), and applied an individual patient perspective in moving from evidence to recommendations. Effects of SGLT-2 inhibitors were interpreted in absolute terms applicable to different risk strata with varying baseline risks for outcomes of benefit over a five year period. The panel explicitly considered the balance of benefits, harms, and burdens of starting an SGLT-2 inhibitor, incorporating the values and preferences of adults with different risk profiles. Interactive evidence summaries and decision aids accompany multilayered recommendations, developed in an online authoring and publication platform ([www.magicapp.org][1]) that allows reuse and adaptation. The evidence A linked systematic review and pairwise meta-analysis (13 trials including 29 614 participants) of benefits and harms associated with SGLT-2 inhibitors in adults with CKD with or without type 2 diabetes informed guidance. Among individuals at very high risk of CKD progression and complications, moderate to high certainty evidence shows SGLT-2 inhibitors (relative to placebo or standard care without SGLT-2 inhibitors) decrease all-cause and cardiovascular mortality, hospitalisation for heart failure, kidney failure, non-fatal myocardial infarction, and non-fatal stroke. Among individuals at high risk, moderate to high certainty evidence shows SGLT-2 inhibitors result in similar benefits across outcomes except demonstrating little or no effect on hospitalisation for heart failure and kidney failure. Among individuals at moderate and low risk, moderate to high certainty evidence shows SGLT-2 inhibitors probably reduce all-cause mortality and non-fatal stroke, with little or no effect for other outcomes of benefit. Risk-stratified estimates were unavailable for outcomes of harm; the panel therefore considered absolute effects summarised across risk strata. SGLT-2 inhibitors are associated with little or no effect on acute kidney injury requiring dialysis, bone fractures, lower limb amputations, ketoacidosis, genital infections, or symptomatic hypovolaemia, although a residual possibility of harms at the individual patient level remains. Understanding the recommendation In order to apply recommendations, clinicians must appropriately identify adults with CKD, consider the underlying aetiology, and risk stratify them based on glomerular filtration rate (estimated or measured) and degree of albuminuria. In addition to classifying individuals into risk strata, further estimation of a given patient’s risk based on the extent of their kidney disease and other comorbidities may be warranted to inform individual-level decisions and shared decision making. Available risk calculators may help estimate a given patient’s risk of CKD progression and complications. [1]: http://www.magicapp.org" /> <meta name="DC.Contributor" content="Arnav Agarwal" /> <meta name="DC.Contributor" content="Xiaoxi Zeng" /> <meta name="DC.Contributor" content="Sheyu Li" /> <meta name="DC.Contributor" content="Daniel Rayner" /> <meta name="DC.Contributor" content="Farid Foroutan" /> <meta name="DC.Contributor" content="Bert Aertgeerts" /> <meta name="DC.Contributor" content="Frederic Coyac" /> <meta name="DC.Contributor" content="Pauline Darbellay Farhoumand" /> <meta name="DC.Contributor" content="Andrew Demaine" /> <meta name="DC.Contributor" content="Anja Fog Heen" /> <meta name="DC.Contributor" content="Vivekanand Jha" /> <meta name="DC.Contributor" content="Edward Machuve" /> <meta name="DC.Contributor" content="Evi Nagler" /> <meta name="DC.Contributor" content="David J Tunnicliffe" /> <meta name="DC.Contributor" content="Gordon H Guyatt" /> <meta name="DC.Contributor" content="Per Olav Vandvik" /> <meta name="DC.Contributor" content="Belen Ponte" /> <meta name="DC.Contributor" content="Thomas Agoritsas" /> <meta name="article:published_time" content="2024-10-01" /> <meta name="article:section" content="Practice" /> <meta name="citation_title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /> <meta name="citation_abstract" lang="en" content="&lt;h3&gt;Abstract&lt;/h3&gt; &lt;h3&gt;Clinical question&lt;/h3&gt; &lt;p&gt;What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidneyoutcomes for adults living with chronic kidney disease (CKD)?&lt;/p&gt;&lt;h3&gt;Current practice&lt;/h3&gt; &lt;p&gt;Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors have demonstrated cardiovascular and kidney benefits in adults with CKD with and without type 2 diabetes. Existing guidance for SGLT-2 inhibitors does not account for the totality of current best evidence for adults with CKD and does not provide fully stratified treatment effects and recommendations across all risk groups based on risk of CKD progression and complications.&lt;/p&gt;&lt;h3&gt;Recommendations&lt;/h3&gt; &lt;p&gt;The guideline panel considered evidence regarding benefits and harms of SGLT-2 inhibitor therapy for adults with CKD over a five year period, along with contextual factors, and provided the following recommendations:&lt;/p&gt;&lt;p&gt;1. For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)&lt;/p&gt;&lt;p&gt;2. For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)&lt;/p&gt;&lt;p&gt;3. For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour)&lt;/p&gt;&lt;p&gt;4. For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour).&lt;/p&gt;&lt;p&gt;Recommendations are applicable to all adults with CKD, irrespective of type 2 diabetes status.&lt;/p&gt;&lt;h3&gt;How this guideline was created&lt;/h3&gt; &lt;p&gt;An international panel including patients, clinicians, and methodologists produced these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel identified typical risk strata of adults with CKD (from low to very high risk of CKD progression and related complications) using the classification system developed by Kidney Disease Improving Global Outcomes (KDIGO), and applied an individual patient perspective in moving from evidence to recommendations. Effects of SGLT-2 inhibitors were interpreted in absolute terms applicable to different risk strata with varying baseline risks for outcomes of benefit over a five year period. The panel explicitly considered the balance of benefits, harms, and burdens of starting an SGLT-2 inhibitor, incorporating the values and preferences of adults with different risk profiles. Interactive evidence summaries and decision aids accompany multilayered recommendations, developed in an online authoring and publication platform (www.magicapp.org) that allows reuse and adaptation.&lt;/p&gt;&lt;h3&gt;The evidence&lt;/h3&gt; &lt;p&gt;A linked systematic review and pairwise meta-analysis (13 trials including 29 614 participants) of benefits and harms associated with SGLT-2 inhibitors in adults with CKD with or without type 2 diabetes informed guidance. Among individuals at very high risk of CKD progression and complications, moderate to high certainty evidence shows SGLT-2 inhibitors (relative to placebo or standard care without SGLT-2 inhibitors) decrease all-cause and cardiovascular mortality, hospitalisation for heart failure, kidney failure, non-fatal myocardial infarction, and non-fatal stroke. Among individuals at high risk, moderate to high certainty evidence shows SGLT-2 inhibitors result in similar benefits across outcomes except demonstrating little or no effect on hospitalisation for heart failure and kidney failure. Among individuals at moderate and low risk, moderate to high certainty evidence shows SGLT-2 inhibitors probably reduce all-cause mortality and non-fatal stroke, with little or no effect for other outcomes of benefit. Risk-stratified estimates were unavailable for outcomes of harm; the panel therefore considered absolute effects summarised across risk strata. SGLT-2 inhibitors are associated with little or no effect on acute kidney injury requiring dialysis, bone fractures, lower limb amputations, ketoacidosis, genital infections, or symptomatic hypovolaemia, although a residual possibility of harms at the individual patient level remains.&lt;/p&gt;&lt;h3&gt;Understanding the recommendation&lt;/h3&gt; &lt;p&gt;In order to apply recommendations, clinicians must appropriately identify adults with CKD, consider the underlying aetiology, and risk stratify them based on glomerular filtration rate (estimated or measured) and degree of albuminuria. In addition to classifying individuals into risk strata, further estimation of a given patient’s risk based on the extent of their kidney disease and other comorbidities may be warranted to inform individual-level decisions and shared decision making. Available risk calculators may help estimate a given patient’s risk of CKD progression and complications.&lt;/p&gt;" /> <meta name="citation_journal_title" content="BMJ" /> <meta name="citation_publisher" content="British Medical Journal Publishing Group" /> <meta name="citation_publication_date" content="2024/10/01" /> <meta name="citation_mjid" content="bmj;387/oct01_4/e080257" /> <meta name="citation_id" content="387/oct01_4/e080257" /> <meta name="citation_public_url" content="https://www.bmj.com/content/387/bmj-2024-080257" /> <meta name="citation_abstract_html_url" content="https://www.bmj.com/content/387/bmj-2024-080257.abstract" /> <meta name="citation_full_html_url" content="https://www.bmj.com/content/387/bmj-2024-080257.full" /> <meta name="citation_pdf_url" content="https://www.bmj.com/content/bmj/387/bmj-2024-080257.full.pdf" /> <meta name="citation_issn" content="1756-1833" /> <meta name="citation_journal_abbrev" content="BMJ" /> <meta name="citation_doi" content="10.1136/bmj-2024-080257" /> <meta name="citation_pmid" content="39353639" /> <meta name="citation_volume" content="387" /> <meta name="citation_article_type" content="Other" /> <meta name="citation_section" content="Practice" /> <meta name="citation_author" content="Arnav Agarwal" /> <meta name="citation_author_institution" content="Department of Medicine, McMaster University, Hamilton, Ontario, Canada, L8N 3Z5" /> <meta name="citation_author_institution" content="Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content=". Both authors contributed equally (co-first authors)" /> <meta name="citation_author" content="Xiaoxi Zeng" /> <meta name="citation_author_institution" content="Department of Nephrology, West China Hospital, Sichuan University, Chengdu, China, 610041" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content=". Both authors contributed equally (co-first authors)" /> <meta name="citation_author" content="Sheyu Li" /> <meta name="citation_author_institution" content="Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China, 610041" /> <meta name="citation_author_institution" content="Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, China, 610041" /> <meta name="citation_author" content="Daniel Rayner" /> <meta name="citation_author_institution" content="Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8" /> <meta name="citation_author" content="Farid Foroutan" /> <meta name="citation_author_institution" content="Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content="Ted Rogers Center for Heart Research, Toronto, Ontario, Canada, M5G 1X8" /> <meta name="citation_author" content="Bert Aertgeerts" /> <meta name="citation_author_institution" content="Academic Centre for General Practice, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium, 3000" /> <meta name="citation_author_institution" content="CEBAM, Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, Leuven, Belgium, 3000." /> <meta name="citation_author" content="Frederic Coyac" /> <meta name="citation_author_institution" content="Geneva, Switzerland." /> <meta name="citation_author" content="Pauline Darbellay Farhoumand" /> <meta name="citation_author_institution" content="Division of General Internal Medicine, Department of Medicine, Hôpitaux Universitaire de Genève and University of Geneva, Geneva, Switzerland, 1205" /> <meta name="citation_author" content="Andrew Demaine" /> <meta name="citation_author_institution" content="Plymouth, United Kingdom." /> <meta name="citation_author" content="Anja Fog Heen" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content="Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway, 0456" /> <meta name="citation_author" content="Vivekanand Jha" /> <meta name="citation_author_institution" content="George Institute for Global Health, Elegance Tower, Jasola District Centre, New Delhi, India, 110025." /> <meta name="citation_author_institution" content="School of Public Health, Imperial College London, London, UK, SW7 2AZ" /> <meta name="citation_author_institution" content="Prasanna School of Public Health, Manipal Academy of Higher Education, Madhav Nagar, Eshwar Nagar, Manipal, Karnataka, India, 576104" /> <meta name="citation_author" content="Edward Machuve" /> <meta name="citation_author_institution" content="Geneva, Switzerland." /> <meta name="citation_author" content="Evi Nagler" /> <meta name="citation_author_institution" content="Department of Nephrology, Ghent University Hospital, Ghent, Belgium, 9000" /> <meta name="citation_author" content="David J Tunnicliffe" /> <meta name="citation_author_institution" content="Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia, 2006" /> <meta name="citation_author_institution" content="Centre for Kidney Research, The Children’s Hospital at Westmead, Westmead, New South Wales, Australia, 2145" /> <meta name="citation_author" content="Gordon H Guyatt" /> <meta name="citation_author_institution" content="Department of Medicine, McMaster University, Hamilton, Ontario, Canada, L8N 3Z5" /> <meta name="citation_author_institution" content="Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author" content="Per Olav Vandvik" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content="Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway, 2819" /> <meta name="citation_author" content="Belen Ponte" /> <meta name="citation_author_institution" content="Division of Nephrology and Hypertension, Department of Medicine, University of Geneva, University Hospitals of Geneva, Geneva, Switzerland, 1205" /> <meta name="citation_author_institution" content=". Both authors contributed equally (co-last authors)" /> <meta name="citation_author" content="Thomas Agoritsas" /> <meta name="citation_author_institution" content="Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8" /> <meta name="citation_author_institution" content="MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282" /> <meta name="citation_author_institution" content="Division of General Internal Medicine, Department of Medicine, Hôpitaux Universitaire de Genève and University of Geneva, Geneva, Switzerland, 1205" /> <meta name="citation_author_institution" content=". Both authors contributed equally (co-last authors)" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int Suppl;citation_title=KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;citation_pages=1-150;citation_volume=3;citation_year=2013;citation_doi=10.1038/kisup.2012.73" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int Suppl;citation_author=CP. Kovesdy;citation_title=Epidemiology of chronic kidney disease: an update 2022;citation_pages=7-11;citation_volume=12;citation_year=2022;citation_pmid=35529086;citation_doi=10.1016/j.kisu.2021.11.003" /> <meta name="citation_reference" content="citation_journal_title=Lancet;citation_title=Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021;citation_pages=2204-56;citation_volume=403;citation_year=2024;citation_pmid=38762325;citation_doi=10.1016/S0140-6736(24)00685-8" /> <meta name="citation_reference" content="citation_journal_title=Lancet;citation_author=KJ. Foreman;citation_author=N. Marquez;citation_author=A. Dolgert;citation_title=Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;citation_pages=2052-90;citation_volume=392;citation_year=2018;citation_pmid=30340847;citation_doi=10.1016/S0140-6736(18)31694-5" /> <meta name="citation_reference" content="citation_journal_title=JAMA;citation_journal_abbrev=JAMA;citation_author=HC. Gerstein;citation_author=JF. Mann;citation_author=Q. Yi;citation_title=Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals;citation_pages=421-426;citation_volume=286;citation_year=2001;citation_issue=4;citation_pmid=11466120;citation_doi=10.1001/jama.286.4.421" /> <meta name="citation_reference" content="citation_journal_title=New England Journal of Medicine;citation_journal_abbrev=NEJM;citation_author=AS. Go;citation_author=GM. Chertow;citation_author=D. Fan;citation_author=CE. McCulloch;citation_author=CY. Hsu;citation_title=Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization;citation_pages=1296-1305;citation_volume=351;citation_year=2004;citation_issue=13;citation_pmid=15385656;citation_doi=10.1056/NEJMoa041031" /> <meta name="citation_reference" content="citation_journal_title=N Engl J Med;citation_author=V. Perkovic;citation_author=MJ. Jardine;citation_author=B. Neal;citation_title=Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;citation_volume=380;citation_year=2019;citation_pmid=30990260;citation_doi=10.1056/NEJMoa1811744" /> <meta name="citation_reference" content="citation_journal_title=N Engl J Med;citation_author=HJL. Heerspink;citation_author=BV. Stefánsson;citation_author=R. Correa-Rotter;citation_title=Dapagliflozin in patients with chronic kidney disease;citation_pages=1436-46;citation_volume=383;citation_year=2020;citation_pmid=32970396;citation_doi=10.1056/NEJMoa2024816" /> <meta name="citation_reference" content="citation_journal_title=N Engl J Med;citation_author=WG. Herrington;citation_author=N. Staplin;citation_author=C. Wanner;citation_title=Empagliflozin in patients with chronic kidney disease;citation_pages=117-27;citation_volume=388;citation_year=2023;citation_pmid=36331190;citation_doi=10.1056/NEJMoa2204233" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int;citation_title=KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease;citation_pages=S1-127;citation_volume=102;citation_year=2022;citation_pmid=36272764;citation_doi=10.1016/j.kint.2022.06.008" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int;citation_title=KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease;citation_volume=105;citation_year=2024;citation_pmid=38490803;citation_doi=10.1016/j.kint.2023.10.018" /> <meta name="citation_reference" content="citation_journal_title=Lancet;citation_title=Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials;citation_pages=1788-801;citation_volume=400;citation_year=2022;citation_pmid=36351458;citation_doi=10.1016/S0140-6736(22)02074-8" /> <meta name="citation_reference" content="citation_title=Clinical practice guidelines we can trust.;citation_year=2011" /> <meta name="citation_reference" content="citation_journal_title=BMJ;citation_author=GH. Guyatt;citation_author=AD. Oxman;citation_author=GE. Vist;citation_title=GRADE: an emerging consensus on rating quality of evidence and strength of recommendations;citation_volume=336;citation_year=2008;citation_pmid=18436948;citation_doi=10.1136/bmj.39489.470347.AD" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int Rep;citation_author=G. James;citation_author=JJ. Garcia Sanchez;citation_author=JJ. Carrero;citation_title=Low adherence to Kidney Disease: Improving Global Outcomes 2012 CKD clinical practice guidelines despite clear evidence of utility;citation_pages=2059-70;citation_volume=7;citation_year=2022;citation_pmid=36090504;citation_doi=10.1016/j.ekir.2022.05.033" /> <meta name="citation_reference" content="citation_journal_title=JAMA Intern Med;citation_author=P. Liu;citation_author=RR. Quinn;citation_author=NN. Lam;citation_title=Accounting for age in the definition of chronic kidney disease;citation_pages=1359-66;citation_volume=181;citation_year=2021;citation_pmid=34459844;citation_doi=10.1001/jamainternmed.2021.4813" /> <meta name="citation_reference" content="citation_journal_title=Lancet;citation_author=K. Wong;citation_author=D. Pitcher;citation_author=F. Braddon;citation_title=Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort;citation_pages=1279-89;citation_volume=403;citation_year=2024;citation_pmid=38492578;citation_doi=10.1016/S0140-6736(23)02843-X" /> <meta name="citation_reference" content="citation_journal_title=Ann Rheum Dis;citation_author=M. Säemann;citation_author=A. Kronbichler;citation_title=Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors;citation_volume=81;citation_year=2022;citation_pmid=34844933;citation_doi=10.1136/annrheumdis-2021-221474" /> <meta name="citation_reference" content="BMJ Rapid Recommendations. BMJ 2024. https://www.bmj.com/rapid-recommendations." /> <meta name="citation_reference" content="citation_journal_title=BMJ;citation_author=RA. Siemieniuk;citation_author=T. Agoritsas;citation_author=H. Macdonald;citation_author=GH. Guyatt;citation_author=L. Brandt;citation_author=PO. Vandvik;citation_title=Introduction to BMJ Rapid Recommendations;citation_volume=354;citation_year=2016;citation_pmid=27680768;citation_doi=10.1136/bmj.i5191" /> <meta name="citation_reference" content="citation_journal_title=CMAJ;citation_author=MC. Brouwers;citation_author=ME. Kho;citation_author=GP. Browman;citation_title=AGREE II: advancing guideline development, reporting and evaluation in health care;citation_volume=182;citation_year=2010;citation_pmid=20603348;citation_doi=10.1503/cmaj.090449" /> <meta name="citation_reference" content="citation_journal_title=Lancet;citation_title=Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials;citation_pages=1788-801;citation_volume=400;citation_year=2022;citation_pmid=36351458;citation_doi=10.1016/S0140-6736(22)02074-8" /> <meta name="citation_reference" content="World Health Organization. WHO model list of essential medicines – 23rd list, 2023. 2023. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02." /> <meta name="citation_reference" content="citation_journal_title=Am J Kidney Dis;citation_author=KE. Watson;citation_author=K. Dhaliwal;citation_author=S. Robertshaw;citation_title=Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process;citation_pages=564-74;citation_volume=81;citation_year=2023;citation_pmid=36470530;citation_doi=10.1053/j.ajkd.2022.10.012" /> <meta name="citation_reference" content="citation_journal_title=Kidney Int Rep;citation_author=K. Yau;citation_author=A. Dharia;citation_author=I. Alrowiyti;citation_author=DZI. Cherney;citation_title=Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations;citation_pages=1463-76;citation_volume=7;citation_year=2022;citation_pmid=35812300;citation_doi=10.1016/j.ekir.2022.04.094" /> <meta name="twitter:title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:description" content="Clinical question What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidney outcomes for adults living with chronic kidney disease (CKD)? Current practice Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors have demonstrated cardiovascular and kidney benefits in adults with CKD with and without type 2 diabetes. Existing guidance for SGLT-2 inhibitors does not account for the totality of current best evidence for adults with CKD and does not provide fully stratified treatment effects and recommendations across all risk groups based on risk of CKD progression and complications. Recommendations The guideline panel considered evidence regarding benefits and harms of SGLT-2 inhibitor therapy for adults with CKD over a five year period, along with contextual factors, and provided the following recommendations: 1. For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 2. For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 3. For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour) 4. For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour). Recommendations are applicable to all adults with CKD, irrespective of type 2 diabetes status. How this guideline was created An international panel including patients, clinicians, and methodologists produced these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel identified typical risk strata of adults with CKD (from low to very high risk of CKD progression and related complications) using the classification system developed by Kidney Disease Improving Global Outcomes (KDIGO), and applied an individual patient perspective in moving from evidence to recommendations. Effects of SGLT-2 inhibitors were interpreted in absolute terms applicable to different risk strata with varying baseline risks for outcomes of benefit over a five year period. The panel explicitly considered the balance of benefits, harms, and burdens of starting an SGLT-2 inhibitor, incorporating the values and preferences of adults with different risk profiles. Interactive evidence summaries and decision aids accompany multilayered recommendations, developed in an online authoring and publication platform ([www.magicapp.org][1]) that allows reuse and adaptation. The evidence A linked systematic review and pairwise meta-analysis (13 trials including 29 614 participants) of benefits and harms associated with SGLT-2 inhibitors in adults with CKD with or without type 2 diabetes informed guidance. Among individuals at very high risk of CKD progression and complications, moderate to high certainty evidence shows SGLT-2 inhibitors (relative to placebo or standard care without SGLT-2 inhibitors) decrease all-cause and cardiovascular mortality, hospitalisation for heart failure, kidney failure, non-fatal myocardial infarction, and non-fatal stroke. Among individuals at high risk, moderate to high certainty evidence shows SGLT-2 inhibitors result in similar benefits across outcomes except demonstrating little or no effect on hospitalisation for heart failure and kidney failure. Among individuals at moderate and low risk, moderate to high certainty evidence shows SGLT-2 inhibitors probably reduce all-cause mortality and non-fatal stroke, with little or no effect for other outcomes of benefit. Risk-stratified estimates were unavailable for outcomes of harm; the panel therefore considered absolute effects summarised across risk strata. SGLT-2 inhibitors are associated with little or no effect on acute kidney injury requiring dialysis, bone fractures, lower limb amputations, ketoacidosis, genital infections, or symptomatic hypovolaemia, although a residual possibility of harms at the individual patient level remains. Understanding the recommendation In order to apply recommendations, clinicians must appropriately identify adults with CKD, consider the underlying aetiology, and risk stratify them based on glomerular filtration rate (estimated or measured) and degree of albuminuria. In addition to classifying individuals into risk strata, further estimation of a given patient’s risk based on the extent of their kidney disease and other comorbidities may be warranted to inform individual-level decisions and shared decision making. Available risk calculators may help estimate a given patient’s risk of CKD progression and complications. [1]: http://www.magicapp.org" /> <meta name="og-title" property="og:title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /> <meta name="og-url" property="og:url" content="https://www.bmj.com/content/387/bmj-2024-080257" /> <meta name="og-site-name" property="og:site_name" content="The BMJ" /> <meta name="og-description" property="og:description" content="Clinical question What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidney outcomes for adults living with chronic kidney disease (CKD)? Current practice Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors have demonstrated cardiovascular and kidney benefits in adults with CKD with and without type 2 diabetes. Existing guidance for SGLT-2 inhibitors does not account for the totality of current best evidence for adults with CKD and does not provide fully stratified treatment effects and recommendations across all risk groups based on risk of CKD progression and complications. Recommendations The guideline panel considered evidence regarding benefits and harms of SGLT-2 inhibitor therapy for adults with CKD over a five year period, along with contextual factors, and provided the following recommendations: 1. For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 2. For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour) 3. For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour) 4. For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour). Recommendations are applicable to all adults with CKD, irrespective of type 2 diabetes status. How this guideline was created An international panel including patients, clinicians, and methodologists produced these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel identified typical risk strata of adults with CKD (from low to very high risk of CKD progression and related complications) using the classification system developed by Kidney Disease Improving Global Outcomes (KDIGO), and applied an individual patient perspective in moving from evidence to recommendations. Effects of SGLT-2 inhibitors were interpreted in absolute terms applicable to different risk strata with varying baseline risks for outcomes of benefit over a five year period. The panel explicitly considered the balance of benefits, harms, and burdens of starting an SGLT-2 inhibitor, incorporating the values and preferences of adults with different risk profiles. Interactive evidence summaries and decision aids accompany multilayered recommendations, developed in an online authoring and publication platform ([www.magicapp.org][1]) that allows reuse and adaptation. The evidence A linked systematic review and pairwise meta-analysis (13 trials including 29 614 participants) of benefits and harms associated with SGLT-2 inhibitors in adults with CKD with or without type 2 diabetes informed guidance. Among individuals at very high risk of CKD progression and complications, moderate to high certainty evidence shows SGLT-2 inhibitors (relative to placebo or standard care without SGLT-2 inhibitors) decrease all-cause and cardiovascular mortality, hospitalisation for heart failure, kidney failure, non-fatal myocardial infarction, and non-fatal stroke. Among individuals at high risk, moderate to high certainty evidence shows SGLT-2 inhibitors result in similar benefits across outcomes except demonstrating little or no effect on hospitalisation for heart failure and kidney failure. Among individuals at moderate and low risk, moderate to high certainty evidence shows SGLT-2 inhibitors probably reduce all-cause mortality and non-fatal stroke, with little or no effect for other outcomes of benefit. Risk-stratified estimates were unavailable for outcomes of harm; the panel therefore considered absolute effects summarised across risk strata. SGLT-2 inhibitors are associated with little or no effect on acute kidney injury requiring dialysis, bone fractures, lower limb amputations, ketoacidosis, genital infections, or symptomatic hypovolaemia, although a residual possibility of harms at the individual patient level remains. Understanding the recommendation In order to apply recommendations, clinicians must appropriately identify adults with CKD, consider the underlying aetiology, and risk stratify them based on glomerular filtration rate (estimated or measured) and degree of albuminuria. In addition to classifying individuals into risk strata, further estimation of a given patient’s risk based on the extent of their kidney disease and other comorbidities may be warranted to inform individual-level decisions and shared decision making. Available risk calculators may help estimate a given patient’s risk of CKD progression and complications. [1]: http://www.magicapp.org" /> <meta name="og-type" property="og:type" content="article" /> <meta name="og:image" property="og:image" content="https://www.bmj.com/sites/default/files/highwire/bmj/387/8449.cover-source.jpg"/> <meta name="twitter:card" content="summary_large_image"><meta name="twitter:image" property="twitter:image" content="https://www.bmj.com/sites/default/files/sites/defautl/files/attachments/bmj-article/2024/10/ckdrr-homepage-thumb.png"><meta name="twitter:title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /><link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/387/bmj-2024-080257.full.txt" /> <script>window.dataLayer = window.dataLayer || [];window.dataLayer.push({"page":{"hwTitle":"Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline","hwUrl":"https://www.bmj.com/content/387/bmj-2024-080257","hwPath":"/content/387/bmj-2024-080257","hwType":"journal page"},"user":{"hwMemberID":"","hwLoggedIntoInstitutionID":"","hwLoggedIntoInstitution":"","hwAccessUsageTerms":"guest","hwRegisteredUser":"no","hwHasFullTextAccess":"yes","hwEntitled":"no","mail":"e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855"},"content":{"hwIssueDate":"2024-10-01","hwIssueDateTime":"2024-10-01 13:31:26","hwPublicationDate":"2024-10-01","hwPublicationDateTime":"2024-10-01 13:31:26","hwNlmArticleType":"other","hwDOI":"10.1136/bmj-2024-080257","hwAuthors":"Arnav Agarwal,Xiaoxi Zeng,Sheyu Li,Daniel Rayner,Farid Foroutan,Bert Aertgeerts,Frederic Coyac,Pauline Darbellay Farhoumand,Andrew Demaine,Anja Fog Heen,Vivekanand Jha,Edward Machuve,Evi Nagler,David J Tunnicliffe,Gordon H Guyatt,Per Olav Vandvik,Belen Ponte,Thomas Agoritsas","hwContributors":"","hwIsEarlyRelease":"no","hwEissn":"1756-1833","hwPissn":"","hwVolume":"387","hwIssue":"","hwArticleType":"Practice","hwTabView":"main_tab","hwViewType":"full","hwAccessType":"Free","hwOpenAccess":"no","hwFreeAccess":"yes","hwTaxonomy":"Rapid Recommendation","hwCorpusCode":"bmj","hwType":"article","hwSubtitle":null,"hwOverline":null,"hwPisaId":"bmj;387/oct01_4/e080257","hwFirstPage":null,"hwLastPage":null,"hwIsLatestVersion":"yes","hwIsCurrentIssue":"no","hwIsOpenIssue":"no","hwHasFullText":"yes","hwHasPDF":"yes","hwParentTitle":"BMJ: 387","hwElectronicPubDate":"2024-10-01","hwElectronicPubDateTime":"2024-10-01 13:31:26"}}); //--><!]]></script> <meta name="generator" content="Drupal 7 (http://drupal.org)" /> <link rel="canonical" href="https://www.bmj.com/content/387/bmj-2024-080257" /> <link rel="shortlink" href="https://www.bmj.com/node/1101485" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:url" content="https://www.bmj.com/content/387/bmj-2024-080257" /> <meta name="twitter:title" content="Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline" /> <title>Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline | The BMJ</title> <!--[if lte IE 9]> <link href="/sites/default/themes/bmj/the_bmj/css/ie.css" rel="stylesheet" media="all" type="text/css"> <link href="/sites/default/themes/bmj/the_bmj/css/ie_2.css" rel="stylesheet" media="all" type="text/css"> <link href="/sites/default/themes/bmj/the_bmj/css/ie_3.css" rel="stylesheet" media="all" type="text/css"> <link href="/sites/default/themes/bmj/the_bmj/css/bootstrap-ie7.css" rel="stylesheet” media="all" type="text/css"> <![endif]--> <!--[if IEMobile]> <link href="/sites/default/themes/bmj/the_bmj/css/screen.css" rel="stylesheet" media="all" type="text/css"> <link href="/sites/default/themes/bmj/the_bmj/css/screen_2.css" rel="stylesheet" media="all" type="text/css"> <link href="/sites/default/themes/bmj/the_bmj/css/screen_3.css" rel="stylesheet" media="all" type="text/css"> <![endif]--> <link type="text/css" rel="stylesheet" href="https://www.bmj.com/sites/default/files/advagg_css/css__FiHqHoPUdv6CHw5dUEIfFV7jpYTgBb1JUncssjaxHyo__1sncCi_mkZlnZk1lpMbS0Ko6gldf3d0A0WKzvsoV5h4__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.css" media="all" /> <link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" /> <link type="text/css" rel="stylesheet" href="https://www.bmj.com/sites/default/files/advagg_css/css__HDRm-Ze6A_WM7h5oLdI-Kk_i3NAW4GgOk0HcDQdbWx8__JGOoIKrIXtW-DpIDgx0t-NK4GZPWlQQf493sD2pjl04__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.css" media="all" /> <link type="text/css" rel="stylesheet" href="https://www.bmj.com/sites/default/files/advagg_css/css__hcEfBsSfdZ2na-rT9Jhk7K2mHyy5KBdPKm6ia_F7MYU__4716zpuGoj4DfVIEENbeOWgAOX_pf_t16EI4fvJGo7A__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.css" media="print" /> <link type="text/css" rel="stylesheet" href="https://www.bmj.com/sites/default/files/advagg_css/css__b-tWEqg3_twqP_ufdNXyA5V14StJgBdiIxG1UIi0LYc__3z5eyFP7TvyPE6DkwNj3xM94b3mZNfr4lSWEChDxsvU__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.css" media="screen" /> <link type="text/css" rel="stylesheet" href="https://www.bmj.com/sites/default/files/advagg_css/css__-BkZ71IF4pBXmZfP4vYyswWdIhuaKktrUUQ4i2vtUVo__0i_0YcYkMECNn0z7FdhNoJ8gLWleqnTtjnHRAmLijvc__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.css" media="all" /> <link href="/sites/default/themes/bmj/the_bmj/css/fonts.css" rel="stylesheet" media="all" type="text/css"> <style media="screen" type="text/css"> .page-news #latest-blogs h2.pane-title, .bootstrap-threecol-4-4-4 #latest-blogs h2.pane-title { width: 153px !important; } #navigation-wrapper #navigation .main-navigation .menu.nav>li.last { display: block !important; } </style> <!-- TCF stub --> <script src="https://cdn.cookielaw.org/consent/tcf.stub.js"" type="text/javascript" charset="UTF-8"></script> <!-- OneTrust Cookies Consent Notice start --> <script src="https://cookie-cdn.cookiepro.com/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="565e50dd-f6e9-46d6-91cd-5c40a270264f"></script> <script type="text/javascript"> function OnetrustAdsConsent(){ if(googletag.apiReady){ //console.log("GoogleTag API ready") googletag.pubads().disableInitialLoad(); if(OptanonActiveGroups.match(/,4,/)){ googletag.pubads().setRequestNonPersonalizedAds(0); //googletag.pubads().refresh(); } else{ googletag.pubads().setRequestNonPersonalizedAds(1); // googletag.pubads().refresh(); } } else{ OnetrustAdsConsent(); } } function OptanonWrapper() { OnetrustAdsConsent(); } </script> <!-- OneTrust Cookies Consent Notice end --> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__wQYYWLUWErxls_q7a6fk-aoyATq9qiA4xZWj_nuQWIY__idPe4msTM3VewG9y-TVQn9f3_mIGnqFi2cuHIkTOFDs__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__HyZs0OrVjSQ2wld_eNI0NaK9Vi0-KoFzbichrdHbOI4__RqmGWm3ssuUnq94_aKIHVz-PVgfC9bR1O0FCes3IBFM__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.google.com/recaptcha/api.js?hl=en&amp;render=explicit&amp;onload=drupalRecaptchaOnload"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__DHyRbO-X-s5fZKSfxEJzy40bGNe1i6XGBjGcuM-346M__477kC4pXUrqTTHsMUOJkxSSzafqG5gb1tWaqbVvPjjw__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__UUwMbpErCBHAQQqH_Cxzi20oSmMoxcbKeYV6qoD70qc__skFUSUohWkyaYdPjJ2LSEF0xKVUuQTqmOxG-9og_468__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__7tN13Z_jEtWpAlHc4vWZWrFePCNhuslRS59mkCehpG8__hIhm4v2jj35Ek3jyTBAduhmH_HOFYDYH-VH1JBUELWg__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script>var _prum=[['id', '612e3f1b1733500011000061'], ['mark', 'firstbyte', (new Date()).getTime()]]; (function() { var s=document.getElementsByTagName('script')[0], p=document.createElement('script'); p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();</script> <script>if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };</script> <script async="async" src="https://scholar.google.com/scholar_js/casa.js"></script> <script>jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"the_bmj","theme_token":"FdkiFwecQ3n61R4dGMEf5f3yaF2xVRXxuE0Ua81nGWI"},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"1101485","apath":"\/bmj\/387\/bmj-2024-080257.atom","pisa":"bmj;387\/oct01_4\/e080257","ac":{"\/bmj\/387\/bmj-2024-080257.atom":{"access":{"full":true,"reprint":true},"pisa_id":"","apath":"\/bmj\/387\/bmj-2024-080257.atom","jcode":"bmj"},"bmj;387\/oct01_4\/e080257":{"access":{"full":true},"pisa_id":"bmj;387\/oct01_4\/e080257","apath":"","jcode":"bmj"}},"processed":["highwire_math"],"markup":[{"requested":"long","variant":"full-text","view":"full","pisa":"bmj;387\/oct01_4\/e080257"},{"requested":"index","variant":"index","view":"full","pisa":"bmj;bmj-2024-080257\/DC1"},{"requested":"index","variant":"index","view":"full","pisa":"bmj;bmj-2024-080257\/DC1"}],"trendmd":{"trendmd-suggestions":"{\u0022element\u0022:\u0022#trendmd-suggestions\u0022,\u0022track_id\u0022:\u002224814\u0022}"},"dataLayer":"{\u0022page\u0022:{\u0022hwTitle\u0022:\u0022Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline\u0022,\u0022hwUrl\u0022:\u0022https:\\\/\\\/www.bmj.com\\\/content\\\/387\\\/bmj-2024-080257\u0022,\u0022hwPath\u0022:\u0022\\\/content\\\/387\\\/bmj-2024-080257\u0022,\u0022hwType\u0022:\u0022journal page\u0022},\u0022user\u0022:{\u0022hwMemberID\u0022:\u0022\u0022,\u0022hwLoggedIntoInstitutionID\u0022:\u0022\u0022,\u0022hwLoggedIntoInstitution\u0022:\u0022\u0022,\u0022hwAccessUsageTerms\u0022:\u0022guest\u0022,\u0022hwRegisteredUser\u0022:\u0022no\u0022,\u0022hwHasFullTextAccess\u0022:\u0022yes\u0022,\u0022hwEntitled\u0022:\u0022no\u0022,\u0022mail\u0022:\u0022e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855\u0022},\u0022content\u0022:{\u0022hwIssueDate\u0022:\u00222024-10-01\u0022,\u0022hwIssueDateTime\u0022:\u00222024-10-01 13:31:26\u0022,\u0022hwPublicationDate\u0022:\u00222024-10-01\u0022,\u0022hwPublicationDateTime\u0022:\u00222024-10-01 13:31:26\u0022,\u0022hwNlmArticleType\u0022:\u0022other\u0022,\u0022hwDOI\u0022:\u002210.1136\\\/bmj-2024-080257\u0022,\u0022hwAuthors\u0022:\u0022Arnav Agarwal,Xiaoxi Zeng,Sheyu Li,Daniel Rayner,Farid Foroutan,Bert Aertgeerts,Frederic Coyac,Pauline Darbellay Farhoumand,Andrew Demaine,Anja Fog Heen,Vivekanand Jha,Edward Machuve,Evi Nagler,David J Tunnicliffe,Gordon H Guyatt,Per Olav Vandvik,Belen Ponte,Thomas Agoritsas\u0022,\u0022hwContributors\u0022:\u0022\u0022,\u0022hwIsEarlyRelease\u0022:\u0022no\u0022,\u0022hwEissn\u0022:\u00221756-1833\u0022,\u0022hwPissn\u0022:\u0022\u0022,\u0022hwVolume\u0022:\u0022387\u0022,\u0022hwIssue\u0022:\u0022\u0022,\u0022hwArticleType\u0022:\u0022Practice\u0022,\u0022hwTabView\u0022:\u0022main_tab\u0022,\u0022hwViewType\u0022:\u0022full\u0022,\u0022hwAccessType\u0022:\u0022Free\u0022,\u0022hwOpenAccess\u0022:\u0022no\u0022,\u0022hwFreeAccess\u0022:\u0022yes\u0022,\u0022hwTaxonomy\u0022:\u0022Rapid Recommendation\u0022,\u0022hwCorpusCode\u0022:\u0022bmj\u0022,\u0022hwType\u0022:\u0022article\u0022,\u0022hwSubtitle\u0022:null,\u0022hwOverline\u0022:null,\u0022hwPisaId\u0022:\u0022bmj;387\\\/oct01_4\\\/e080257\u0022,\u0022hwFirstPage\u0022:null,\u0022hwLastPage\u0022:null,\u0022hwIsLatestVersion\u0022:\u0022yes\u0022,\u0022hwIsCurrentIssue\u0022:\u0022no\u0022,\u0022hwIsOpenIssue\u0022:\u0022no\u0022,\u0022hwHasFullText\u0022:\u0022yes\u0022,\u0022hwHasPDF\u0022:\u0022yes\u0022,\u0022hwParentTitle\u0022:\u0022BMJ: 387\u0022,\u0022hwElectronicPubDate\u0022:\u00222024-10-01\u0022,\u0022hwElectronicPubDateTime\u0022:\u00222024-10-01 13:31:26\u0022}}"},"jnl_bmj_infographic":{"infographic_tab":"content\/387\/bmj-2024-080257\/infographic"},"custom_search":{"form_target":"_self","solr":1},"panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","ws_fl":{"width":100,"height":21},"jnl_bmj":{"container_id_share":"article-share-modal","container_id_response":"article-response-modal"},"urlIsAjaxTrusted":{"\/content\/387\/bmj-2024-080257?tab=article-alert":true,"\/content\/387\/bmj-2024-080257":true,"\/login":true},"orcidLogo":{"svg":"\/sites\/default\/themes\/bmj\/the_bmj\/img\/vector_iD_icon.svg"},"bootstrap":{"anchorsFix":"1","anchorsSmoothScrolling":"1","popoverEnabled":"1","popoverOptions":{"animation":1,"html":0,"placement":"right","selector":"","trigger":"click","title":"","content":"","delay":0,"container":"body"},"tooltipEnabled":"1","tooltipOptions":{"animation":1,"html":0,"placement":"auto left","selector":"","trigger":"hover focus","delay":0,"container":"body"}}});</script> <script type="text/javascript"> window.dataLayer = window.dataLayer || []; </script> <!-- GTM custom dimensions --> <script type="text/javascript">var DC = { Date : "", subject : "" };var ga_article_category = "Practice";var ga_article_page_type = "other";var ga_article_pub_year = "2024";var ga_customer_number = "";var ga_user_type = "";DC.Date = "2024-10-01";DC.subject = "";</script> <!-- End GTM custom dimensions --> <!-- Optimize Page Hiding Snippet --> <style>.async-hide { opacity: 0 !important} </style> <script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date; h.end=i=function(){s.className=s.className.replace(RegExp(' ?'+y),'')}; (a[n]=a[n]||[]).hide=h;setTimeout(function(){i();h.end=null},c);h.timeout=c;})(window,document.documentElement,'async-hide','dataLayer',4000,{'GTM-NF7HCLL':true});</script> <!-- end Optimize Page Hiding Snippet --> <!-- Start GPT Tag --> <script>var googletag = window.googletag || {cmd: []};</script> <script async src="//securepubads.g.doubleclick.net/tag/js/gpt.js"></script> <script> var topBottomSizes = [ [970,250],[970,90],[728,90],[468,60],[300,50],[320,100] ]; var mpuSizes = [ [300,250],[300,600],[600,600], ]; //googletag.cmd.push(function() { googletag.display('div-gpt-ad-7326006-1'); }); googletag.cmd.push(function() { googletag.defineSlot('/21798771943/BMJ.com_HomePage_TOPBanner', topBottomSizes,'div-gpt-ad-7326006-1').addService(googletag.pubads()).setTargeting("pgid", "pubgrade_lib_disabled"); googletag.defineSlot('/21798771943/BMJ.com_HomePage_MPU1', mpuSizes, 'div-gpt-ad-7326006-2').addService(googletag.pubads()); googletag.defineSlot('/21798771943/BMJ.com_HomePage_MPU2', mpuSizes, 'div-gpt-ad-7326006-3').addService(googletag.pubads()); googletag.defineSlot('/21798771943/BMJ.com_HomePage_BOTTOM', topBottomSizes, 'div-gpt-ad-7326006-4').addService(googletag.pubads()); googletag.pubads().setTargeting('url', window.parent.location.pathname); // Some examples of ways to enable below. Normally, only one of these // methods should be used. // A) Enable with defaults. //googletag.pubads().enableLazyLoad({ //fetchMarginPercent: 0, // Fetch slots within 1 viewports. //renderMarginPercent: 0, // Render slots within 1 viewports. //mobileScaling: 2.0 // Double the above values on mobile. //}); googletag.enableServices(); }); </script> <script> let cookies = parseCookies(); let bmj_uuid = cookies.bmj_uuid; let bmj_ppid = cookies.bmj_ppid; window.dataLayer = window.dataLayer || []; function checkUserLoginStatus(dataLayer) { const userMail = dataLayer.find((item) => item.user)?.user?.mail; if (!userMail) { return false; } return userMail !== anonMailId; } const anonMailId = 'e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855'; let nonAnonMailId = ((dataLayer.find(item => item.user)?.user)?.mail) === anonMailId ? null : (dataLayer.find(item => item.user)?.user)?.mail; let userId = ((dataLayer.find(item => item.user)?.user)?.['data-ics']) ?? ((dataLayer.find(item => item.user)?.user)?.mail && nonAnonMailId) ?? bmj_ppid ?? bmj_uuid; document.cookie = 'bmj_ppid=' + userId + '; domain=.bmj.com; path=/; max-age=31622400; SameSite=None; Secure'; googletag.cmd.push(function() { googletag.pubads().setPublisherProvidedId(userId); googletag.pubads().setTargeting("islogged", checkUserLoginStatus(dataLayer) ? "true" : "false"); googletag.enableServices(); }); window.dataLayer.push({ 'bmj_uuid': bmj_uuid }); </script> </head> <!-- End GPT Tag --> <!-- Google Tag Manager --> <script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-NF7HCLL');</script> <!-- End Google Tag Manager --> </head> <!--[if IE 6]><div class="ie-warning">Our New BMJ website does not support IE6 please upgrade your browser to the latest version or use alternative browsers suggested below. <ul> <li>- Google Chrome</li> <li>- Safari</li> <li>- Firefox</li> </ul> </div> <![endif]--> <body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-1101485 node-type-highwire-article 1 Practice" > <!-- Google Tag Manager (noscript) --> <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-NF7HCLL" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> <div id="skip-link"> <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a> </div> <div id="wrapper-outer"> <div id="wrapper"> <header> <div class="bmj-disclaimer"> <p>Intended for healthcare professionals</p> </div> <div class="ad-leaderboard"> <div id='div-gpt-ad-7326006-1'> <script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-7326006-1'); }); </script> </div> </div> <!-- NAVIGATION --> <!-- Top Navigation --> <div id="top-nav" role="navigation" class="navbar navbar-static-top"> <div class="container"> <div id="userbar-status"> <ul id="status"> <li class="user-status-link user-status-subscribe phone-menu-item"> <a href="/us/subscribe">Subscribe</a> </li> <li class="user-status-myaccount phone-menu-item"> <div class="btn-group has-submenu"> <a class="btn dropdown-toggle" aria-expanded="false" aria-haspopup="true" data-toggle="dropdown" href="#" > My Account <span class="caret" aria-expanded="true"></span> </a> <ul class="jnl-bmj-user-my-account dropdown-menu"><li class="0 first last"><a href="//myaccount.bmj.com/myaccount/account/hw-registration.html">My email alerts</a></li> </ul></div> </li> <li class="user-status-bma phone-menu-item"> <a href="//bmjverification.bma.org.uk/validate/userdetails?url=https://www.bmj.com/content/387/bmj-2024-080257?sso=">BMA member login</a> </li> <div class="btn-group has-submenu"> <a class="btn dropdown-toggle" aria-expanded="false" aria-haspopup="true" data-toggle="dropdown" href="#" > Login <span class="caret" aria-expanded="true"></span> </a> <ul class="jnl-bmj-user-signin-popup dropdown-menu"><li class="0 first last"><span><form action="/login" method="post" id="jnl-bmj-user-login-form" accept-charset="UTF-8"><div><input type="hidden" name="form_build_id" value="form-zizV77Uidmq1euw5xspkYjxhETZZ_KpbD_TA30I7pR4" /> <input type="hidden" name="form_id" value="jnl_bmj_user_login_form" /> <div class="form-type-textfield form-item-name form-item form-group"> <label for="article-p-name">Username <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="text" id="article-p-name" name="name" value="" size="15" maxlength="60" /> </div> <div class="form-type-password form-item-pass form-item form-group"> <label for="article-p-pass">Password <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="password" id="article-p-pass" name="pass" size="15" maxlength="128" /> </div> <div class="link"><div id="edit-forgot" class="form-type-item form-item form-group"> <label for="edit-forgot"><a href="https://www.bmj.com/user/password" title="Retrieve your credentials.">Forgot your log in details?</a> </label> </div> </div><div class="link"><div id="edit-activate" class="form-type-item form-item form-group"> <label for="edit-activate"><a href="//journals.bmj.com/cgi/activate/basic">Need to activate</a> </label> </div> </div><input class="btn form-submit" type="submit" id="edit-submit--9" name="op" value="Login" /><div id="edit-message--3" class="form-type-item form-item form-group"> </div> <hr /><div id="edit-bma-members" class="form-type-item form-item form-group"> <label for="edit-bma-members"><a href="//bmjverification.bma.org.uk/validate/userdetails?url=https%3A//www.bmj.com/content/387/bmj-2024-080257%3Fsso%3D" title="Log in here if you are a BMA member.">BMA Member Log In</a> </label> </div> <div id="edit-athens" class="form-type-item form-item form-group"> <label for="edit-athens"><a href="https://openathens-sp.highwire.org/session/init?entityID=https%3A//idp.eduserv.org.uk/openathens&amp;subcode=bmjjournals&amp;hw-shib-return-uri=https%253A%252F%252Fwww.bmj.com%252Fcontent%252F387%252Fbmj-2024-080257">Log in via OpenAthens</a> </label> </div> <div id="edit-shibboleth" class="form-type-item form-item form-group"> <label for="edit-shibboleth"><a href="/login/shibboleth?uri=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F387%2Fbmj-2024-080257&amp;subcode=bmjjournals&amp;env=prod">Log in via your institution</a> </label> </div> </div></form></span></li> </ul></div> </ul><!-- /status --> <div id="userbar"> <div class="region region-userbar"> <section id="block-panels-mini-jnl-bmj-country-portal-switcher" class="block block-panels-mini clearfix"> <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_bmj_country_portal_switcher"> <div class="panel-panel panel-col"> <div><div class="panel-pane pane-country-switcher" > <div class="pane-content"> <span class="country-label">Edition: </span> <div class="btn-group has-submenu"> <a class="btn dropdown-toggle" aria-expanded="false" aria-haspopup="true" data-toggle="dropdown" href="#" id=country-switcher> US <span class="caret" aria-expanded="true"></span> </a> <ul class="jnl-bmj-country-portal-country-switcher dropdown-menu"><li class="0 first"><a href="/bmj_countries/switch/uk?destination=node/1101485">UK</a></li> <li class="1"><a href="/bmj_countries/switch/india?destination=node/1101485">South Asia</a></li> <li class="2 last"><a href="/bmj_countries/switch/international?destination=node/1101485">International</a></li> </ul></div> </div> </div> </div> </div> </div> </section> <!-- /.block --> </div> </div><!-- /userbar --> <div id="cmp-link"> <div class="pane-content"> <span class="country-label"><a href="/company?int_source=tbmj&int_medium=header&int_campaign=URLswitch">Our company</a></span> </div> </div> </div><!-- /userbar-status --> </div><!-- /container --> </div><!-- /top-nav --> <!-- Main Navigation --> <div id="main-nav" data-spy="affix" data-offset-top="125"> <div class="primary-navigation-bar"> <div id="navigation-wrapper"> <div class="container"> <!-- Navigation toggle --> <a href="#" id="btn-nav" class=""> <span class="sr-only">Toggle navigation</span> </a> <!-- Logo --> <a class="logo navbar-btn pull-left" href="/" title="Home"> <!-- <img src="https://www.bmj.com/sites/default/themes/bmj/the_bmj/logo.png" alt="Home" /> --> <div class="bmj-logo">The BMJ logo</div> </a> <div class="ie6-site-map"><a href="/sitemap">Site map</a></div> <!-- Search --> <div class="main-nav-search"> <div id="search"> <!--<span class="glyphicon glyphicon-search"></span>--> <a href="#" class="dropdown-toggle" data-toggle="dropdown" title="Search"><div class="search"><em class="fa fa-search" alt="Search"></em><span class="search-label">Search</span></div></a> <div class="dropdown-menu"> <div class="header-search-form container"> <div class="searchbar"> <div class="region region-search-block"> <section id="block-search-form" class="block block-search clearfix"> <form class="search-form form-search content-search" action="/content/387/bmj-2024-080257" method="post" id="search-block-form" accept-charset="UTF-8"><div><div> <h2 class="element-invisible">Search form</h2> <div class="input-group"><input title="Enter the terms you wish to search for." class="container-inline input-append form-control form-text" placeholder="Search The BMJ" type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" /><span class="input-group-btn"><button type="submit" class="btn btn-default">Search</button></span></div><button class="element-invisible btn btn-primary btn btn-primary form-button" type="submit" id="edit-submit--4" name="op" value="Search">Search</button><input type="hidden" name="form_build_id" value="form-Emh6zLFmjtiHUaPLbrwTPlsDnJOUMEaQE0Itp9v9_CE" /> <input type="hidden" name="form_id" value="search_block_form" /> <input type="hidden" name="custom_search_paths" value="search/advanced/[key]" /> </div> </div></form> </section> <!-- /.block --> </div> </div> <div class="advanced-search"> <ul class="list-inline"> <li><a href="/search/advanced" title="Advanced search">Advanced search</a></li> <li><a href="/rapid-responses" title="Search responses">Search responses</a></li> <li><a href="//blogs.bmj.com/bmj/" title="Search blogs">Search blogs</a></li> </ul> </div><!-- /advanced-search --> </div><!-- /header-search-form --> </div><!-- /dropdown-menu --> </div><!-- /search --> </div><!-- /main-nav-search --> <!-- Mobile top nav --> <a href="#" id="toggle-mobile-top-nav"> <span class="fa fa-cog"></span> <span class="sr-only">Toggle top menu</span> </a> <!-- Navigation --> <div id="navigation" class="navigation"> <!-- Main Navigation --> <div class="main-navigation"> <nav role="navigation"> <ul class="menu nav navbar-nav"><li class="first leaf"><a href="/coronavirus">covid-19</a></li> <li class="expanded dropdown"><a href="/us/research" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Research</a><ul class="dropdown-menu"><li class="first leaf"><a href="/us/research">At a glance</a></li> <li class="leaf"><a href="/us/research/research">Research papers</a></li> <li class="leaf"><a href="/us/research/research%20methods%20%26amp%3B%20reporting">Research methods and reporting</a></li> <li class="leaf"><a href="/us/research/minerva">Minerva</a></li> <li class="last leaf"><a href="/us/research/research%20news">Research news</a></li> </ul></li> <li class="expanded dropdown"><a href="/us/education" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Education</a><ul class="dropdown-menu"><li class="first leaf"><a href="/us/education">At a glance</a></li> <li class="leaf"><a href="/us/education/clinical%20review">Clinical reviews</a></li> <li class="leaf"><a href="/us/education/practice">Practice</a></li> <li class="leaf"><a href="/us/education/minerva">Minerva</a></li> <li class="leaf"><a href="/us/education/endgames">Endgames</a></li> <li class="leaf"><a href="/specialties/state-art">State of the art</a></li> <li class="leaf"><a href="/specialties/what-your-patient-thinking">What your patient is thinking</a></li> <li class="leaf"><a href="/rapid-recommendations">Rapid recommendations</a></li> <li class="last leaf"><a href="/student">Student</a></li> </ul></li> <li class="expanded dropdown"><a href="/us/news" data-target="#" class="dropdown-toggle" data-toggle="dropdown">News & Views</a><ul class="dropdown-menu"><li class="first leaf"><a href="/us/news">At a glance</a></li> <li class="leaf"><a href="/us/news/news?category=News">News</a></li> <li class="leaf"><a href="/us/news/feature">Features</a></li> <li class="leaf"><a href="/us/news/editorial">Editorials</a></li> <li class="leaf"><a href="/us/news/analysis">Analysis</a></li> <li class="leaf"><a href="/us/news/observations">Observations</a></li> <li class="leaf"><a href="/news/opinion">Opinion</a></li> <li class="leaf"><a href="/us/news/head%20to%20head">Head to head</a></li> <li class="leaf"><a href="/us/news/editor%27s%20choice">Editor&#039;s choice</a></li> <li class="leaf"><a href="/us/news/letter">Letters</a></li> <li class="leaf"><a href="/us/news/obituary">Obituaries</a></li> <li class="leaf"><a href="/us/news/views%20%26amp%3B%20reviews">Views and reviews</a></li> <li class="leaf"><a href="/careers-articles">Careers</a></li> <li class="last leaf"><a href="/rapid-responses">Rapid responses</a></li> </ul></li> <li class="expanded dropdown"><a href="/campaigns" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Campaigns</a><ul class="dropdown-menu"><li class="first leaf"><a href="/campaigns">At a glance</a></li> <li class="leaf"><a href="/better-evidence">Better evidence</a></li> <li class="leaf"><a href="/campaign/climate-emergency">Climate change</a></li> <li class="leaf"><a href="/divestment">Divestment from fossil fuels</a></li> <li class="leaf"><a href="/campaign/patient-partnership">Patient and public partnership</a></li> <li class="last leaf"><a href="/too-much-medicine">Too much medicine</a></li> </ul></li> <li class="last expanded dropdown"><a href="/careers" data-target="#" class="dropdown-toggle" data-toggle="dropdown">Jobs</a><ul class="dropdown-menu"><li class="first leaf"><a href="/careers">Doctor Jobs UK</a></li> <li class="leaf"><a href="/careers/jobs/hospital/">Hospital Jobs UK</a></li> <li class="leaf"><a href="/careers/jobs/general-practice/">GP Jobs UK</a></li> <li class="last leaf"><a href="/careers/jobs/international/">International Jobs</a></li> </ul></li> </ul> <!-- Second Navigation --> <div class="second-navigation"> <ul class="secondary-nav" id=""> <li class="even"><a href="/archive" class="">Archive</a></li> <li class="odd"><a href="/about-bmj/resources-authors" class="">For authors</a></li> <li class="odd last"><a href="http://hosted.bmj.com" class="">Hosted</a></li> </ul> </div><!-- /second-navigation --> </nav> </div><!-- /main-navigation --> </div><!-- /navigation --> </div><!-- /container --> </div><!-- /navigation-wrapper --> </div><!-- /navbar navbar-default navbar-fixed-top --> </div><!-- Main nav --> </header><!-- /header --> <div class="main-container container" id="page"> <!-- #page is for back to top to work --> <!-- Remove heading --> <div class="row"> <section class="col-sm-12" > <ol class="breadcrumb"><li class="first"><a href="/us/education">Education</a></li> <li>Sodium-glucose...</li> <li class="active last">Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline</li> </ol> <a id="main-content"></a> <div class="region region-content"> <section id="block-system-main" class="block block-system clearfix"> <div class="panel-display" > <div class="hero"> <div class="hero-wrapper"> <div class="hero-content" style="position: relative; left: 0px; top: 35.5px;"> </div> <!-- hero-content --> </div> <!-- hero-wrapper --> </div> <!-- hero --> <div class="row"> <div class="left-content col-xs-12 col-sm-8 col-md-8 col-lg-8"> <article> <div class="panel-pane pane-highwire-article-citation" > <div class="pane-content"> <div class="highwire-article-citation highwire-citation-type-highwire-article node1101485" data-node-nid="1101485" id="node-1101485--2318824931" data-pisa="bmj;387/oct01_4/e080257" data-pisa-master="bmj;bmj-2024-080257" data-apath="/bmj/387/bmj-2024-080257.atom"><cite class='highwire-cite highwire-citation-bmj-article-top'> <span class='highwire-cite-article-type'>Practice</span> <span class='bmj-series-title'>Rapid Recommendations</span> <h1 class="highwire-cite-title" id="page-title">Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline</h1> <span class='highwire-cite-journal'>BMJ</span> <span class='highwire-cite-published-year'>2024</span>; <span class='highwire-cite-volume-issue'>387</span> <span class='highwire-cite-doi'> doi: <a href="https://doi.org/10.1136/bmj-2024-080257">https://doi.org/10.1136/bmj-2024-080257</a></span> <span class='highwire-cite-date'>(Published 01 October 2024)</span> <span class='highwire-cite-article-as'> Cite this as: <span class="italic">BMJ</span> 2024;387:e080257 </span> <span class='sound-cloud'> <style type="text/css"> @font-face { font-family: 'InterFace-Regular'; src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_rg-webfont.ttf') format('truetype'); src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_rg-webfont.woff') format('woff'); /*src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_rg-webfont.eot?#iefix') format('embedded-opentype');*/ font-weight: normal; font-style: normal; } @font-face { font-family: 'InterFace-Bold'; src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_bd-webfont.ttf') format('truetype'); src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_bd-webfont.woff') format('woff'); /*src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_bd-webfont.eot?#iefix') format('embedded-opentype');*/ font-weight: bold; font-style: normal; } @font-face { font-family: 'InterFace-Italic'; src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_it-webfont.ttf') format('truetype'); src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_it-webfont.woff') format('woff'); /*src: url('https://www.bmj.com/sites/default/themes/bmj/the_bmj/fonts/if_std_bd-webfont.eot?#iefix') format('embedded-opentype');*/ font-weight: normal; font-style: normal; } h2 { font-weight: normal; } .accordion-group { padding: 1px; } .graphic-background { background-color: #C1D3E9; margin-bottom: 20px; border: 1px solid #2A6EBB; max-width: 750px; } .graphic-title { background-color: #2A6EBB; color: #FFF; padding: 2px; min-height: 36px; text-align: center; font-family: "InterFace-Regular"; } .dropdown-background { background-color: #C1D3E9; margin-bottom: 20px; border: 1px solid #7C8696; max-width: 750px; } .dropdown-title { background-color: #2A6EBB; color: #FFF; padding: 2px; margin: 0px; text-align: center; } .outcomes-section-end { border-top: 1px solid #999; width: 5px; margin: 0px auto 0px 2%; padding: 0px 1% 0px 1%; } .rr-graphic-title { /*height: 50px; */ font-size: 14px; border-radius: 35px; /*padding-top: 1%;*/ } .rr-graphic-pane { background-color:#FFF; padding: 10px; /*border-radius: 5%/6.48%;*/ cursor: default; } .rr-outcome-pane { background-color:#FFF; padding: 0px; /*border-radius: 5%/6.48%;*/ cursor: default; } .scaling-svg-container { position: relative; height: 0; width: 100%; padding: 0; padding-bottom: 100% } .scaling-svg { position: absolute; height: 100%; width: 100%; left: 0; top: 0; } .magicLink1 { cursor: pointer; } .midWedges:hover .purpleWedge { fill: #4b3b68; } .midWedges:hover .pinkWedge { fill: #791050; } .midWedges:hover .greyWedge { fill: #888888; } .thisisthetooltip {opacity:0; pointer-events: none;} .thishasatooltip:hover .thisisthetooltip {opacity:1; transition: opacity 0.3s;} @media only screen and (max-width: 767px) { .graphic-title { padding: 5px; min-height: 30px; } } svg {font-family: "InterFace";} </style> <div class="graphic-background" id="rrGraphic"> <div class="graphic-title"> <div class="scaling-svg-container" style="padding-bottom: 6.667%; max-width: 750px; margin: 0px auto 0px auto"> <svg class="scaling-svg" version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 750 50" enable-background="new 0 0 750 50" xml:space="preserve"> <g id="visSumTitle" transform="translate(190,0)"> <g> <text transform="matrix(1 0 0 1 58.2085 30.2236)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="20.3891px">Visual summary of recommendation</text> </g> <g> <path fill="#FFFFFF" d="M48.739,23.664c0,0-8.202,10.645-18.32,10.645s-18.32-10.645-18.32-10.645s8.202-10.645,18.32-10.645 S48.739,23.664,48.739,23.664z"></path> <g> <g> <g> <path fill="#407DC0" d="M30.434,23.402l-4.21-7.921c1.351-0.719,2.679-1.05,4.21-1.05V23.402z"></path> </g> </g> <g> <g> <path fill="#799BD1" d="M30.434,23.402l-5.52-7.069c0.414-0.323,0.847-0.605,1.311-0.852L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#628ECA" d="M30.434,23.402l-7.434-5.017c0.562-0.834,1.121-1.434,1.913-2.053L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#006AB3" d="M30.434,23.402l-8.661-2.322c0.26-0.972,0.665-1.861,1.227-2.695L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#4981C2" d="M30.434,23.402l-7.604,4.754c-1.396-2.235-1.739-4.53-1.057-7.076L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#7498CF" d="M30.434,23.402l-5.52,7.069c-0.855-0.668-1.509-1.395-2.084-2.315L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#437FC1" d="M30.434,23.402l4.347,7.846c-3.209,1.78-6.976,1.483-9.868-0.777L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#7297CF" d="M30.434,23.402l8.661,2.322c-0.655,2.446-2.101,4.297-4.314,5.524L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#1E72B9" d="M30.434,23.402l8.933,0.782c-0.047,0.538-0.132,1.018-0.271,1.54L30.434,23.402z"></path> </g> </g> <path fill="#6F95CE" d="M39.379,22.776c-0.01-0.143-0.028-0.325-0.045-0.467l-8.9,1.093l8.933,0.782 C39.413,23.656,39.416,23.305,39.379,22.776z"></path> <g> <g> <path fill="#3A7BBF" d="M30.434,23.402l7.254-5.273c0.926,1.275,1.454,2.616,1.646,4.18L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#006AB3" d="M30.434,23.402l4.071-7.993c1.324,0.675,2.31,1.518,3.183,2.72L30.434,23.402z"></path> </g> </g> <g> <g> <path fill="#006AB3" d="M30.434,23.402v-8.971c1.52,0,2.716,0.287,4.071,0.978L30.434,23.402z"></path> </g> </g> </g> <circle cx="30.419" cy="23.416" r="5.457"></circle> <g> <path fill="#FFFFFF" d="M36.82,14.387c-1.023-0.421-2.085-0.764-3.186-0.999l-2.773,9.319L36.82,14.387z"></path> </g> </g> </g> </svg> </div> </div> <div id="image0"><div class="whiteBox" style="margin:15px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 105.51468005283273%; margin: 0px auto 0px auto;"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="Layer_1" version="1.1" viewBox="0 0 695 733.327"> <!-- Generator: Adobe Illustrator 29.1.0, SVG Export Plug-In . SVG Version: 2.1.0 Build 142) --> <rect x="140.246" y="478.42" width="541.744" height="238.769" rx="6.258" ry="6.258" fill="#ccc"></rect> <rect x="348.102" y="257.716" width="328.195" height="85.017" rx="11.831" ry="11.831" fill="#ccc"></rect> <g> <text transform="translate(55.103 32.917)" fill="#2f6eb5" font-family="InterFace-Bold, InterFace" font-size="21" font-weight="700" isolation="isolate"><tspan x="0" y="0">Population</tspan></text> <g> <g> <path d="M20.755,16.884c0-1.688,1.397-3.055,3.12-3.055s3.12,1.367,3.12,3.055-1.397,3.055-3.12,3.055c-1.723,0-3.12-1.368-3.12-3.055Z" fill="#2f6eb5"></path> <path d="M24.039,20.823h-.328c-2.176,0-3.941.456-3.941,3.859v2.211c0,1.476.532,2.298,1.369,2.74l.603,6.894h4.187l.601-6.863c.884-.44,1.45-1.271,1.45-2.772v-2.211c0-3.457-1.764-3.858-3.941-3.858Z" fill="#2f6eb5"></path> </g> <g> <path d="M30.56,14.027c0-1.933,1.6-3.499,3.573-3.499s3.574,1.566,3.574,3.499-1.6,3.499-3.574,3.499c-1.973,0-3.573-1.567-3.573-3.499Z" fill="#2f6eb5"></path> <path d="M34.321,18.538h-.376c-2.493,0-4.514.522-4.514,4.42v2.533c0,1.691.609,2.632,1.569,3.139l.691,7.897h4.796l.688-7.861c1.013-.504,1.661-1.456,1.661-3.175v-2.533c0-3.959-2.022-4.42-4.515-4.42Z" fill="#2f6eb5"></path> </g> <g> <path d="M41.185,18.622c0-1.538,1.273-2.785,2.844-2.785s2.844,1.246,2.844,2.785-1.273,2.785-2.844,2.785-2.844-1.247-2.844-2.785Z" fill="#2f6eb5"></path> <path d="M44.178,22.213h-.299c-1.984,0-3.592.416-3.592,3.517v2.016c0,1.345.485,2.094,1.248,2.498l.55,6.284h3.816l.547-6.255c.806-.401,1.322-1.159,1.322-2.526v-2.017c0-3.151-1.608-3.517-3.592-3.517Z" fill="#2f6eb5"></path> </g> </g> </g> <text transform="translate(18.804 56.359)" font-family="InterFace-Bold, InterFace" font-size="16" font-weight="700" isolation="isolate"><tspan x="0" y="0">Recommendations apply to:</tspan></text> <g> <path d="M329.576,134.171H31.639c-6.648,0-12.086-6.209-12.086-13.797v-41.883c0-7.589,5.439-13.797,12.086-13.797h297.937c6.648,0,12.086,6.209,12.086,13.797v41.883c0,7.588-5.439,13.797-12.086,13.797Z" fill="#6f4f9b"></path> <g isolation="isolate"> <path d="M36.994,94.022v-12.006h3.744c1.38,0,2.403.306,3.069.918s.999,1.519.999,2.718c0,1.164-.351,2.046-1.053,2.646-.702.6-1.725.899-3.069.899h-2.25v4.824h-1.44ZM38.434,87.938h2.358c.732,0,1.326-.18,1.782-.54s.684-.954.684-1.782-.216-1.428-.648-1.8c-.432-.372-1.044-.558-1.836-.558h-2.34v4.68Z" fill="#fff"></path> <path d="M50.89,94.022l-.072-.738c-.3.301-.645.531-1.035.693-.39.162-.819.243-1.287.243-.372,0-.735-.058-1.089-.171-.354-.114-.666-.282-.936-.504-.27-.223-.489-.501-.657-.838-.168-.335-.252-.726-.252-1.17,0-.611.165-1.115.495-1.512.33-.396.747-.711,1.251-.945.504-.233,1.062-.398,1.674-.494.612-.097,1.206-.145,1.782-.145v-.108c0-.72-.153-1.235-.459-1.548-.306-.312-.747-.468-1.323-.468-.396,0-.759.087-1.089.261-.331.175-.609.405-.837.693l-.972-.684c.348-.469.759-.813,1.233-1.035s1.071-.333,1.791-.333c.96,0,1.707.246,2.241.737.534.492.801,1.314.801,2.467v5.598h-1.26ZM50.764,89.54c-.396.013-.816.043-1.26.091s-.855.141-1.233.278c-.378.139-.69.34-.936.604-.246.264-.369.611-.369,1.044,0,.276.054.51.162.702.108.191.243.351.405.477.162.126.342.216.54.271.198.054.393.081.585.081.42,0,.807-.087,1.161-.262.354-.174.669-.381.945-.621v-2.664Z" fill="#fff"></path> <path d="M56.524,92.061c0,.42.081.699.243.837.162.138.369.207.621.207.228,0,.444-.048.648-.144.204-.097.39-.21.558-.343l.54.937c-.276.204-.549.366-.819.485-.27.12-.651.181-1.143.181-.648,0-1.146-.165-1.494-.495s-.522-.837-.522-1.521v-5.634h-1.476v-1.134h1.476v-2.34h1.386v2.34h2.25v1.134h-2.268v5.49Z" fill="#fff"></path> <path d="M61.186,84.068c-.252,0-.468-.099-.648-.297-.18-.198-.27-.441-.27-.729,0-.275.09-.516.27-.72.18-.204.396-.306.648-.306s.468.102.648.306c.18.204.27.444.27.72,0,.288-.09.531-.27.729-.18.198-.396.297-.648.297ZM60.484,94.022v-8.586h1.404v8.586h-1.404Z" fill="#fff"></path> <path d="M65.325,89.648c0,1.08.246,1.926.738,2.538.492.612,1.206.918,2.142.918.54,0,.996-.132,1.368-.396.372-.264.672-.587.9-.972l.918.612c-.312.54-.717.987-1.215,1.341s-1.167.531-2.007.531c-.648,0-1.23-.1-1.746-.297-.516-.198-.957-.486-1.323-.864-.366-.378-.648-.849-.846-1.413-.198-.563-.297-1.218-.297-1.962,0-.685.093-1.299.279-1.845s.444-1.015.774-1.404.732-.69,1.206-.9.999-.314,1.575-.314c.636,0,1.191.107,1.665.324.474.216.867.519,1.179.908.312.391.546.858.702,1.404.156.546.234,1.143.234,1.791h-6.246ZM70.005,88.551c-.012-.372-.084-.699-.216-.981-.132-.281-.3-.516-.504-.702-.204-.186-.438-.323-.702-.414-.264-.09-.528-.135-.792-.135-.576,0-1.071.171-1.485.513-.414.343-.699.916-.855,1.72h4.554Z" fill="#fff"></path> <path d="M73.516,94.022v-8.586h1.278l.09.684c.348-.264.759-.479,1.233-.647s.969-.252,1.485-.252c1.176,0,2.007.291,2.493.873.486.582.729,1.442.729,2.583v5.346h-1.386v-5.382c0-.72-.162-1.284-.486-1.692-.324-.407-.853-.611-1.584-.611-.457,0-.903.099-1.341.297-.438.197-.813.417-1.125.656v6.732h-1.386Z" fill="#fff"></path> <path d="M85.197,92.061c0,.42.081.699.243.837.162.138.369.207.621.207.228,0,.444-.048.648-.144.204-.097.39-.21.558-.343l.54.937c-.276.204-.549.366-.819.485-.27.12-.651.181-1.143.181-.648,0-1.146-.165-1.494-.495s-.522-.837-.522-1.521v-5.634h-1.476v-1.134h1.476v-2.34h1.386v2.34h2.25v1.134h-2.268v5.49Z" fill="#fff"></path> <path d="M89.625,91.898c.204.384.465.682.783.891.318.211.747.315,1.287.315,1.176,0,1.764-.42,1.764-1.26,0-.252-.039-.465-.117-.64-.078-.174-.204-.329-.378-.468-.174-.138-.399-.27-.675-.396-.276-.126-.612-.262-1.008-.405-.432-.145-.798-.297-1.098-.459-.3-.162-.546-.339-.738-.531-.192-.191-.333-.407-.423-.647s-.135-.522-.135-.847c0-.695.255-1.241.765-1.638.51-.396,1.185-.594,2.025-.594.696,0,1.278.117,1.746.351.468.234.864.567,1.188.999l-.972.774c-.24-.288-.522-.528-.846-.721-.324-.191-.69-.287-1.098-.287-.504,0-.879.099-1.125.297-.246.197-.369.44-.369.729,0,.18.033.339.099.478.066.138.183.264.351.378s.387.228.657.342.615.243,1.035.387c.792.276,1.392.624,1.8,1.044.408.421.612.979.612,1.674,0,.408-.078.771-.234,1.09-.156.317-.369.585-.639.801s-.591.381-.963.495c-.372.113-.78.171-1.224.171-.852,0-1.518-.156-1.998-.468-.48-.312-.864-.708-1.152-1.188l1.08-.666Z" fill="#fff"></path> <path d="M101.775,94.022l-2.844-8.586h1.494l1.944,6.462,2.106-6.462h.792l2.124,6.462,1.944-6.462h1.494l-2.844,8.586h-1.08l-2.034-6.192-2.016,6.192h-1.08Z" fill="#fff"></path> <path d="M112.773,84.068c-.252,0-.468-.099-.648-.297-.18-.198-.27-.441-.27-.729,0-.275.09-.516.27-.72.18-.204.396-.306.648-.306s.468.102.648.306c.18.204.27.444.27.72,0,.288-.09.531-.27.729-.18.198-.396.297-.648.297ZM112.071,94.022v-8.586h1.404v8.586h-1.404Z" fill="#fff"></path> <path d="M117.903,92.061c0,.42.081.699.243.837.162.138.369.207.621.207.228,0,.444-.048.648-.144.204-.097.39-.21.558-.343l.54.937c-.276.204-.549.366-.819.485-.27.12-.651.181-1.143.181-.648,0-1.146-.165-1.494-.495s-.522-.837-.522-1.521v-5.634h-1.476v-1.134h1.476v-2.34h1.386v2.34h2.25v1.134h-2.268v5.49Z" fill="#fff"></path> <path d="M121.863,94.022v-12.006h1.386v4.104c.348-.252.744-.465,1.188-.639s.942-.261,1.494-.261c1.164,0,1.989.294,2.475.882.486.588.729,1.446.729,2.574v5.346h-1.404v-5.364c0-.792-.162-1.377-.486-1.755s-.846-.566-1.566-.566c-.456,0-.897.104-1.323.314s-.795.43-1.107.657v6.714h-1.386Z" fill="#fff"></path> <path d="M141.986,92.187c-.336.696-.795,1.209-1.377,1.539s-1.197.495-1.845.495c-.504,0-.999-.09-1.485-.271-.486-.18-.915-.456-1.287-.828-.372-.371-.672-.837-.9-1.395s-.342-1.215-.342-1.971c0-.804.114-1.494.342-2.07s.528-1.047.9-1.413.792-.633,1.26-.801c.468-.168.936-.252,1.404-.252.48,0,.903.071,1.269.216.366.144.678.324.936.54.258.216.468.444.63.684.162.24.279.456.351.648l-1.026.647c-.252-.575-.57-.989-.954-1.241-.384-.252-.786-.378-1.206-.378-.324,0-.636.074-.936.225s-.57.369-.81.657c-.24.288-.432.642-.576,1.062s-.216.9-.216,1.44.072,1.02.216,1.439c.144.421.339.774.585,1.062.246.288.534.507.864.657.33.149.681.225,1.053.225.42,0,.825-.12,1.215-.36.39-.239.711-.63.963-1.17l.972.612Z" fill="#fff"></path> <path d="M143.696,94.022v-12.006h1.386v4.104c.348-.252.744-.465,1.188-.639s.942-.261,1.494-.261c1.164,0,1.989.294,2.475.882.486.588.729,1.446.729,2.574v5.346h-1.404v-5.364c0-.792-.162-1.377-.486-1.755s-.846-.566-1.566-.566c-.456,0-.897.104-1.323.314s-.795.43-1.107.657v6.714h-1.386Z" fill="#fff"></path> <path d="M153.398,94.022v-8.586h1.26l.108.756c.228-.24.522-.462.882-.666.36-.204.726-.306,1.098-.306.264,0,.507.018.729.054s.393.072.513.108l-.252,1.277c-.3-.132-.678-.197-1.134-.197-.348,0-.681.096-.999.287-.318.192-.591.391-.819.595v6.678h-1.386Z" fill="#fff"></path> <path d="M160.85,93.843c-.492-.264-.906-.609-1.242-1.035s-.588-.912-.756-1.458c-.168-.546-.252-1.101-.252-1.665s.081-1.113.243-1.647c.162-.533.411-1.011.747-1.431s.753-.756,1.251-1.008,1.083-.378,1.755-.378c.66,0,1.242.129,1.746.387.504.258.921.597,1.251,1.017.33.421.579.9.747,1.44s.252,1.092.252,1.656-.084,1.116-.252,1.655c-.168.54-.417,1.021-.747,1.44s-.747.759-1.251,1.017c-.504.259-1.086.388-1.746.388s-1.242-.126-1.746-.378ZM160.616,92.042c.228.312.506.567.837.766.33.198.711.297,1.143.297.443,0,.831-.099,1.161-.297s.606-.456.828-.774c.222-.317.387-.681.495-1.089.108-.407.162-.821.162-1.242s-.054-.834-.162-1.241c-.108-.408-.273-.771-.495-1.09-.222-.317-.498-.572-.828-.765-.33-.191-.717-.288-1.161-.288s-.832.097-1.161.288c-.33.192-.603.447-.819.765-.216.318-.378.679-.486,1.08-.108.402-.162.813-.162,1.233,0,.432.054.853.162,1.26.108.408.27.774.486,1.098Z" fill="#fff"></path> <path d="M168.662,94.022v-8.586h1.278l.09.684c.348-.264.759-.479,1.233-.647s.969-.252,1.485-.252c1.176,0,2.007.291,2.493.873.486.582.729,1.442.729,2.583v5.346h-1.386v-5.382c0-.72-.162-1.284-.486-1.692-.324-.407-.853-.611-1.584-.611-.457,0-.903.099-1.341.297-.438.197-.813.417-1.125.656v6.732h-1.386Z" fill="#fff"></path> <path d="M179.101,84.068c-.252,0-.468-.099-.648-.297-.18-.198-.27-.441-.27-.729,0-.275.09-.516.27-.72.18-.204.396-.306.648-.306s.468.102.648.306c.18.204.27.444.27.72,0,.288-.09.531-.27.729-.18.198-.396.297-.648.297ZM178.399,94.022v-8.586h1.404v8.586h-1.404Z" fill="#fff"></path> <path d="M189.109,92.187c-.336.696-.795,1.209-1.377,1.539s-1.197.495-1.845.495c-.504,0-.999-.09-1.485-.271-.486-.18-.915-.456-1.287-.828-.372-.371-.672-.837-.9-1.395s-.342-1.215-.342-1.971c0-.804.114-1.494.342-2.07s.528-1.047.9-1.413.792-.633,1.26-.801c.468-.168.936-.252,1.404-.252.48,0,.903.071,1.269.216.366.144.678.324.936.54.258.216.468.444.63.684.162.24.279.456.351.648l-1.026.647c-.252-.575-.57-.989-.954-1.241-.384-.252-.786-.378-1.206-.378-.324,0-.636.074-.936.225s-.57.369-.81.657c-.24.288-.432.642-.576,1.062s-.216.9-.216,1.44.072,1.02.216,1.439c.144.421.339.774.585,1.062.246.288.534.507.864.657.33.149.681.225,1.053.225.42,0,.825-.12,1.215-.36.39-.239.711-.63.963-1.17l.972.612Z" fill="#fff"></path> <path d="M60.079,115.622v-12.006h1.386v6.678l3.474-3.258h1.764l-2.934,2.771,3.69,5.814h-1.602l-3.114-4.86-1.278,1.17v3.69h-1.386Z" fill="#fff"></path> <path d="M69.366,105.668c-.252,0-.468-.099-.648-.297-.18-.198-.27-.441-.27-.729,0-.275.09-.516.27-.72.18-.204.396-.306.648-.306s.468.102.648.306c.18.204.27.444.27.72,0,.288-.09.531-.27.729-.18.198-.396.297-.648.297ZM68.665,115.622v-8.586h1.404v8.586h-1.404Z" fill="#fff"></path> <path d="M78.276,115.622l-.108-.702c-.312.324-.651.556-1.017.693s-.765.207-1.197.207c-.612,0-1.155-.117-1.629-.352-.474-.233-.873-.555-1.197-.963-.324-.407-.57-.891-.738-1.449-.168-.558-.252-1.16-.252-1.809,0-.552.087-1.095.261-1.629s.432-1.008.774-1.422c.342-.414.771-.747,1.287-.999s1.116-.378,1.8-.378c.432,0,.804.033,1.116.099.312.066.576.142.792.226v-3.528h1.386v12.006h-1.278ZM78.168,108.35c-.072-.047-.171-.096-.297-.144s-.267-.093-.423-.135c-.156-.042-.318-.075-.486-.1-.168-.023-.33-.035-.486-.035-.504,0-.942.096-1.314.287-.372.192-.681.447-.927.766s-.429.681-.549,1.089c-.12.408-.18.822-.18,1.242,0,.479.054.927.162,1.341s.273.771.495,1.071c.222.3.498.537.828.711.33.174.723.261,1.179.261.36,0,.714-.075,1.062-.225.348-.15.66-.399.936-.747v-5.383Z" fill="#fff"></path> <path d="M81.984,115.622v-8.586h1.278l.09.684c.348-.264.759-.479,1.233-.647s.969-.252,1.485-.252c1.176,0,2.007.291,2.493.873.486.582.729,1.442.729,2.583v5.346h-1.386v-5.382c0-.72-.162-1.284-.486-1.692-.324-.407-.853-.611-1.584-.611-.457,0-.903.099-1.341.297-.438.197-.813.417-1.125.656v6.732h-1.386Z" fill="#fff"></path> <path d="M92.675,111.248c0,1.08.246,1.926.738,2.538.492.612,1.206.918,2.142.918.54,0,.996-.132,1.368-.396.372-.264.672-.587.9-.972l.918.612c-.312.54-.717.987-1.215,1.341s-1.167.531-2.007.531c-.648,0-1.23-.1-1.746-.297-.516-.198-.957-.486-1.323-.864-.366-.378-.648-.849-.846-1.413-.198-.563-.297-1.218-.297-1.962,0-.685.093-1.299.279-1.845s.444-1.015.774-1.404.732-.69,1.206-.9.999-.314,1.575-.314c.636,0,1.191.107,1.665.324.474.216.867.519,1.179.908.312.391.546.858.702,1.404.156.546.234,1.143.234,1.791h-6.246ZM97.355,110.15c-.012-.372-.084-.699-.216-.981-.132-.281-.3-.516-.504-.702-.204-.186-.438-.323-.702-.414-.264-.09-.528-.135-.792-.135-.576,0-1.071.171-1.485.513-.414.343-.699.916-.855,1.72h4.554Z" fill="#fff"></path> <path d="M100.074,117.89c.132.048.297.093.495.136.198.042.399.062.603.062.276,0,.492-.065.648-.198.156-.132.318-.39.486-.773l.702-1.71-3.384-8.37h1.584l2.538,6.605,2.538-6.605h1.494l-4.392,10.854c-.216.528-.52.889-.909,1.08-.39.192-.795.288-1.215.288-.276,0-.567-.039-.873-.117-.306-.078-.543-.152-.711-.225l.396-1.026Z" fill="#fff"></path> <path d="M118.343,115.622l-.108-.702c-.312.324-.651.556-1.017.693s-.765.207-1.197.207c-.612,0-1.155-.117-1.629-.352-.474-.233-.873-.555-1.197-.963-.324-.407-.57-.891-.738-1.449-.168-.558-.252-1.16-.252-1.809,0-.552.087-1.095.261-1.629s.432-1.008.774-1.422c.342-.414.771-.747,1.287-.999s1.116-.378,1.8-.378c.432,0,.804.033,1.116.099.312.066.576.142.792.226v-3.528h1.386v12.006h-1.278ZM118.235,108.35c-.072-.047-.171-.096-.297-.144s-.267-.093-.423-.135c-.156-.042-.318-.075-.486-.1-.168-.023-.33-.035-.486-.035-.504,0-.942.096-1.314.287-.372.192-.681.447-.927.766s-.429.681-.549,1.089c-.12.408-.18.822-.18,1.242,0,.479.054.927.162,1.341s.273.771.495,1.071c.222.3.498.537.828.711.33.174.723.261,1.179.261.36,0,.714-.075,1.062-.225.348-.15.66-.399.936-.747v-5.383Z" fill="#fff"></path> <path d="M122.753,105.668c-.252,0-.468-.099-.648-.297-.18-.198-.27-.441-.27-.729,0-.275.09-.516.27-.72.18-.204.396-.306.648-.306s.468.102.648.306c.18.204.27.444.27.72,0,.288-.09.531-.27.729-.18.198-.396.297-.648.297ZM122.051,115.622v-8.586h1.404v8.586h-1.404Z" fill="#fff"></path> <path d="M126.407,113.498c.204.384.465.682.783.891.318.211.747.315,1.287.315,1.176,0,1.764-.42,1.764-1.26,0-.252-.039-.465-.117-.64-.078-.174-.204-.329-.378-.468-.174-.138-.399-.27-.675-.396-.276-.126-.612-.262-1.008-.405-.432-.145-.798-.297-1.098-.459-.3-.162-.546-.339-.738-.531-.192-.191-.333-.407-.423-.647s-.135-.522-.135-.847c0-.695.255-1.241.765-1.638.51-.396,1.185-.594,2.025-.594.696,0,1.278.117,1.746.351.468.234.864.567,1.188.999l-.972.774c-.24-.288-.522-.528-.846-.721-.324-.191-.69-.287-1.098-.287-.504,0-.879.099-1.125.297-.246.197-.369.44-.369.729,0,.18.033.339.099.478.066.138.183.264.351.378s.387.228.657.342.615.243,1.035.387c.792.276,1.392.624,1.8,1.044.408.421.612.979.612,1.674,0,.408-.078.771-.234,1.09-.156.317-.369.585-.639.801s-.591.381-.963.495c-.372.113-.78.171-1.224.171-.852,0-1.518-.156-1.998-.468-.48-.312-.864-.708-1.152-1.188l1.08-.666Z" fill="#fff"></path> <path d="M134.309,111.248c0,1.08.246,1.926.738,2.538.492.612,1.206.918,2.142.918.54,0,.996-.132,1.368-.396.372-.264.672-.587.9-.972l.918.612c-.312.54-.717.987-1.215,1.341s-1.167.531-2.007.531c-.648,0-1.23-.1-1.746-.297-.516-.198-.957-.486-1.323-.864-.366-.378-.648-.849-.846-1.413-.198-.563-.297-1.218-.297-1.962,0-.685.093-1.299.279-1.845s.444-1.015.774-1.404.732-.69,1.206-.9.999-.314,1.575-.314c.636,0,1.191.107,1.665.324.474.216.867.519,1.179.908.312.391.546.858.702,1.404.156.546.234,1.143.234,1.791h-6.246ZM138.989,110.15c-.012-.372-.084-.699-.216-.981-.132-.281-.3-.516-.504-.702-.204-.186-.438-.323-.702-.414-.264-.09-.528-.135-.792-.135-.576,0-1.071.171-1.485.513-.414.343-.699.916-.855,1.72h4.554Z" fill="#fff"></path> <path d="M147.269,115.622l-.072-.738c-.3.301-.645.531-1.035.693-.39.162-.819.243-1.287.243-.372,0-.735-.058-1.089-.171-.354-.114-.666-.282-.936-.504-.27-.223-.489-.501-.657-.838-.168-.335-.252-.726-.252-1.17,0-.611.165-1.115.495-1.512.33-.396.747-.711,1.251-.945.504-.233,1.062-.398,1.674-.494.612-.097,1.206-.145,1.782-.145v-.108c0-.72-.153-1.235-.459-1.548-.306-.312-.747-.468-1.323-.468-.396,0-.759.087-1.089.261-.331.175-.609.405-.837.693l-.972-.684c.348-.469.759-.813,1.233-1.035s1.071-.333,1.791-.333c.96,0,1.707.246,2.241.737.534.492.801,1.314.801,2.467v5.598h-1.26ZM147.143,111.14c-.396.013-.816.043-1.26.091s-.855.141-1.233.278c-.378.139-.69.34-.936.604-.246.264-.369.611-.369,1.044,0,.276.054.51.162.702.108.191.243.351.405.477.162.126.342.216.54.271.198.054.393.081.585.081.42,0,.807-.087,1.161-.262.354-.174.669-.381.945-.621v-2.664Z" fill="#fff"></path> <path d="M151.427,113.498c.204.384.465.682.783.891.318.211.747.315,1.287.315,1.176,0,1.764-.42,1.764-1.26,0-.252-.039-.465-.117-.64-.078-.174-.204-.329-.378-.468-.174-.138-.399-.27-.675-.396-.276-.126-.612-.262-1.008-.405-.432-.145-.798-.297-1.098-.459-.3-.162-.546-.339-.738-.531-.192-.191-.333-.407-.423-.647s-.135-.522-.135-.847c0-.695.255-1.241.765-1.638.51-.396,1.185-.594,2.025-.594.696,0,1.278.117,1.746.351.468.234.864.567,1.188.999l-.972.774c-.24-.288-.522-.528-.846-.721-.324-.191-.69-.287-1.098-.287-.504,0-.879.099-1.125.297-.246.197-.369.44-.369.729,0,.18.033.339.099.478.066.138.183.264.351.378s.387.228.657.342.615.243,1.035.387c.792.276,1.392.624,1.8,1.044.408.421.612.979.612,1.674,0,.408-.078.771-.234,1.09-.156.317-.369.585-.639.801s-.591.381-.963.495c-.372.113-.78.171-1.224.171-.852,0-1.518-.156-1.998-.468-.48-.312-.864-.708-1.152-1.188l1.08-.666Z" fill="#fff"></path> <path d="M159.328,111.248c0,1.08.246,1.926.738,2.538.492.612,1.206.918,2.142.918.54,0,.996-.132,1.368-.396.372-.264.672-.587.9-.972l.918.612c-.312.54-.717.987-1.215,1.341s-1.167.531-2.007.531c-.648,0-1.23-.1-1.746-.297-.516-.198-.957-.486-1.323-.864-.366-.378-.648-.849-.846-1.413-.198-.563-.297-1.218-.297-1.962,0-.685.093-1.299.279-1.845s.444-1.015.774-1.404.732-.69,1.206-.9.999-.314,1.575-.314c.636,0,1.191.107,1.665.324.474.216.867.519,1.179.908.312.391.546.858.702,1.404.156.546.234,1.143.234,1.791h-6.246ZM164.008,110.15c-.012-.372-.084-.699-.216-.981-.132-.281-.3-.516-.504-.702-.204-.186-.438-.323-.702-.414-.264-.09-.528-.135-.792-.135-.576,0-1.071.171-1.485.513-.414.343-.699.916-.855,1.72h4.554Z" fill="#fff"></path> </g> <rect x="203.903" y="78.008" width="120.742" height="41.445" rx="8.9" ry="8.9" fill="#d1c8e4"></rect> <text transform="translate(217.54 95.205)" font-family="InterFace-Regular, InterFace" font-size="14" isolation="isolate"><tspan x="0" y="0">With or without </tspan><tspan x="19.236" y="16.8">diabetes</tspan></text> <g> <ellipse cx="520.227" cy="113.012" rx="135.129" ry="88.164" fill="#fbdace"></ellipse> <image width="282" height="201" transform="translate(400 30.963) scale(.842)" xlink:href="https://sandpit.bmj.com/site_images/2024/ckd3.png"></image> </g> </g> <text transform="translate(18.804 161.282)" font-family="InterFace-Bold, InterFace" font-size="16" font-weight="700"><tspan x="0" y="0">Recommendations may or may not apply to:</tspan></text> <text transform="translate(18.804 355.977)" font-family="InterFace-Bold, InterFace" font-size="16" font-weight="700"><tspan x="0" y="0">Risk stratification for recommendations:</tspan></text> <g> <path d="M318.679,188.395H48.211c-5.667,0-10.302-4.64-10.302-10.303s4.636-10.301,10.302-10.301h270.467c5.667,0,10.302,4.637,10.302,10.301.001,5.663-4.635,10.303-10.301,10.303Z" fill="#ee7219"></path> <text transform="translate(60.478 182.308)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">People receiving kidney replacement therapy</tspan></text> <g> <path d="M47.53,182.487c0-.268.049-.511.149-.743.099-.243.237-.448.413-.613.176-.193.382-.32.619-.423.236-.09.487-.143.75-.143s.514.053.75.143c.237.103.442.23.619.423.176.165.314.37.413.613.099.233.149.475.149.743,0,.27-.051.513-.149.756-.098.233-.237.45-.413.616-.176.18-.382.308-.619.41s-.487.153-.75.153-.515-.05-.75-.153c-.237-.103-.443-.23-.619-.41-.175-.165-.313-.383-.413-.616-.1-.243-.149-.485-.149-.756Z" fill="#fff"></path> <path d="M48.536,176.774c.297,0,.577-.04.841-.128.264-.078.492-.193.685-.335.192-.14.343-.32.453-.523.109-.205.165-.438.165-.668,0-.333-.11-.613-.331-.858-.22-.243-.517-.358-.891-.358-.341,0-.614.115-.816.333-.123.14-.208.308-.257.501-.061.243-.267.41-.515.41h-2.339c-.249,0-.451-.193-.451-.45,0-.255.168-.793.312-1.089.226-.46.538-.871.94-1.229.401-.333.874-.616,1.419-.796.544-.193,1.135-.295,1.773-.295.649,0,1.24.118,1.773.32.533.218.992.513,1.377.873.385.358.682.768.891,1.254.209.475.313.948.313,1.462,0,1.654-.996,2.818-2.985,3.524v.731c0,.255-.202.448-.451.448h-2.134c-.249,0-.451-.193-.451-.448v-2.23c.001-.255.203-.448.452-.448h.227Z" fill="#fff"></path> </g> </g> <g> <path d="M349.018,214.066H75.55c-5.667,0-10.302-4.64-10.302-10.303s4.636-10.301,10.302-10.301h273.467c5.667,0,10.302,4.637,10.302,10.301.001,5.663-4.635,10.303-10.301,10.303Z" fill="#ee7219"></path> <text transform="translate(87.818 207.979)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">People who have received a kidney transplant</tspan></text> <g> <path d="M74.869,208.158c0-.268.049-.511.149-.743.099-.243.237-.448.413-.613.176-.193.382-.32.619-.423.236-.09.487-.143.75-.143s.514.053.75.143c.237.103.442.23.619.423.176.165.314.37.413.613.099.233.149.475.149.743,0,.27-.051.513-.149.756-.098.233-.237.45-.413.616-.176.18-.382.308-.619.41s-.487.153-.75.153-.515-.05-.75-.153c-.237-.103-.443-.23-.619-.41-.175-.165-.313-.383-.413-.616-.1-.243-.149-.485-.149-.756Z" fill="#fff"></path> <path d="M75.876,202.444c.297,0,.577-.04.841-.128.264-.078.492-.193.685-.335.192-.14.343-.32.453-.523.109-.205.165-.438.165-.668,0-.333-.11-.613-.331-.858-.22-.243-.517-.358-.891-.358-.341,0-.614.115-.816.333-.123.14-.208.308-.257.501-.061.243-.267.41-.515.41h-2.339c-.249,0-.451-.193-.451-.45,0-.255.168-.793.312-1.089.226-.46.538-.871.94-1.229.401-.333.874-.616,1.419-.796.544-.193,1.135-.295,1.773-.295.649,0,1.24.118,1.773.32.533.218.992.513,1.377.873.385.358.682.768.891,1.254.209.475.313.948.313,1.462,0,1.654-.996,2.818-2.985,3.524v.731c0,.255-.202.448-.451.448h-2.134c-.249,0-.451-.193-.451-.448v-2.23c.001-.255.203-.448.452-.448h.227Z" fill="#fff"></path> </g> </g> <g> <path d="M255.574,241.088H29.106c-5.667,0-10.302-4.64-10.302-10.303s4.636-10.301,10.302-10.301h226.467c5.667,0,10.302,4.637,10.302,10.301.001,5.663-4.635,10.303-10.301,10.303Z" fill="#ee7219"></path> <text transform="translate(41.373 235.001)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">People with polycystic kidney disease</tspan></text> <g> <path d="M28.425,235.18c0-.268.049-.511.149-.743.099-.243.237-.448.413-.613.176-.193.382-.32.619-.423.236-.09.487-.143.75-.143s.514.053.75.143c.237.103.442.23.619.423.176.165.314.37.413.613.099.233.149.475.149.743,0,.27-.051.513-.149.756-.098.233-.237.45-.413.616-.176.18-.382.308-.619.41s-.487.153-.75.153-.515-.05-.75-.153c-.237-.103-.443-.23-.619-.41-.175-.165-.313-.383-.413-.616-.1-.243-.149-.485-.149-.756Z" fill="#fff"></path> <path d="M29.431,229.466c.297,0,.577-.04.841-.128.264-.078.492-.193.685-.335.192-.14.343-.32.453-.523.109-.205.165-.438.165-.668,0-.333-.11-.613-.331-.858-.22-.243-.517-.358-.891-.358-.341,0-.614.115-.816.333-.123.14-.208.308-.257.501-.061.243-.267.41-.515.41h-2.339c-.249,0-.451-.193-.451-.45,0-.255.168-.793.312-1.089.226-.46.538-.871.94-1.229.401-.333.874-.616,1.419-.796.544-.193,1.135-.295,1.773-.295.649,0,1.24.118,1.773.32.533.218.992.513,1.377.873.385.358.682.768.891,1.254.209.475.313.948.313,1.462,0,1.654-.996,2.818-2.985,3.524v.731c0,.255-.202.448-.451.448h-2.134c-.249,0-.451-.193-.451-.448v-2.23c.001-.255.203-.448.452-.448h.227Z" fill="#fff"></path> </g> </g> <g> <path d="M37.908,257.785c0-5.663,4.636-10.301,10.302-10.301h267.539c5.667,0,10.302,4.637,10.302,10.301v20c.001,5.663-4.635,10.303-10.301,10.303H48.211c-5.667,0-10.302-4.64-10.302-10.303v-20Z" fill="#ee7219"></path> <text transform="translate(60.478 262.001)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">People with low estimated GFR not receiving </tspan><tspan x="0" y="16.8">kidney replacement therapy</tspan></text> <g> <path d="M47.53,262.18c0-.268.049-.511.149-.743.099-.243.237-.448.413-.613.176-.193.382-.32.619-.423.236-.09.487-.143.75-.143s.514.053.75.143c.237.103.442.23.619.423.176.165.314.37.413.613.099.233.149.475.149.743,0,.27-.051.513-.149.756-.098.233-.237.45-.413.616-.176.18-.382.308-.619.41s-.487.153-.75.153-.515-.05-.75-.153c-.237-.103-.443-.23-.619-.41-.175-.165-.313-.383-.413-.616-.1-.243-.149-.485-.149-.756Z" fill="#fff"></path> <path d="M48.536,256.466c.297,0,.577-.04.841-.128.264-.078.492-.193.685-.335.192-.14.343-.32.453-.523.109-.205.165-.438.165-.668,0-.333-.11-.613-.331-.858-.22-.243-.517-.358-.891-.358-.341,0-.614.115-.816.333-.123.14-.208.308-.257.501-.061.243-.267.41-.515.41h-2.339c-.249,0-.451-.193-.451-.45,0-.255.168-.793.312-1.089.226-.46.538-.871.94-1.229.401-.333.874-.616,1.419-.796.544-.193,1.135-.295,1.773-.295.649,0,1.24.118,1.773.32.533.218.992.513,1.377.873.385.358.682.768.891,1.254.209.475.313.948.313,1.462,0,1.654-.996,2.818-2.985,3.524v.731c0,.255-.202.448-.451.448h-2.134c-.249,0-.451-.193-.451-.448v-2.23c.001-.255.203-.448.452-.448h.227Z" fill="#fff"></path> </g> </g> <g> <path d="M478.903,241.088h-196.468c-5.667,0-10.302-4.64-10.302-10.303s4.636-10.301,10.302-10.301h196.467c5.667,0,10.302,4.637,10.302,10.301.001,5.663-4.635,10.303-10.301,10.303Z" fill="#ee7219"></path> <text transform="translate(294.702 235.001)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">People with rare kidney diseases</tspan></text> <g> <path d="M281.754,235.18c0-.268.049-.511.149-.743.099-.243.237-.448.413-.613.176-.193.382-.32.619-.423.236-.09.487-.143.75-.143s.514.053.75.143c.237.103.442.23.619.423.176.165.314.37.413.613.099.233.149.475.149.743,0,.27-.051.513-.149.756-.098.233-.237.45-.413.616-.176.18-.382.308-.619.41s-.487.153-.75.153-.515-.05-.75-.153c-.237-.103-.443-.23-.619-.41-.175-.165-.313-.383-.413-.616-.1-.243-.149-.485-.149-.756Z" fill="#fff"></path> <path d="M282.761,229.466c.297,0,.577-.04.841-.128.264-.078.492-.193.685-.335.192-.14.343-.32.453-.523.109-.205.165-.438.165-.668,0-.333-.11-.613-.331-.858-.22-.243-.517-.358-.891-.358-.341,0-.614.115-.816.333-.123.14-.208.308-.257.501-.061.243-.267.41-.515.41h-2.339c-.249,0-.451-.193-.451-.45,0-.255.168-.793.312-1.089.226-.46.538-.871.94-1.229.401-.333.874-.616,1.419-.796.544-.193,1.135-.295,1.773-.295.649,0,1.24.118,1.773.32.533.218.992.513,1.377.873.385.358.682.768.891,1.254.209.475.313.948.313,1.462,0,1.654-.996,2.818-2.985,3.524v.731c0,.255-.202.448-.451.448h-2.134c-.249,0-.451-.193-.451-.448v-2.23c.001-.255.203-.448.452-.448h.227Z" fill="#fff"></path> </g> </g> <rect x="140.246" y="363.976" width="541.744" height="102.322" rx="6.258" ry="6.258" fill="#ccc"></rect> <g> <rect x="153.251" y="292.71" width="153.329" height="22.023" rx="11.012" ry="11.012" fill="#fcd8bb"></rect> <polygon points="265.33 298.522 252.177 311.674 239.024 298.522 231.096 267.613 265.33 298.522" fill="#fcd8bb"></polygon> <g> <text transform="translate(164.125 308.091)" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">&lt; 20 mL/min/1.73 m</tspan></text> <text transform="translate(286.33 303.429) scale(.583)" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">2</tspan></text> </g> </g> <g> <line x1="344.171" y1="447.898" x2="344.171" y2="528.023" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="336.692 525.835 344.17 538.787 351.65 525.835 336.692 525.835" fill="#777"></polygon> </g> <g> <line x1="479.004" y1="447.898" x2="479.004" y2="528.023" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="471.525 525.835 479.003 538.787 486.483 525.835 471.525 525.835" fill="#777"></polygon> </g> <g> <line x1="613.836" y1="447.898" x2="613.836" y2="528.023" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="606.358 525.835 613.836 538.787 621.315 525.835 606.358 525.835" fill="#777"></polygon> </g> <g> <line x1="209.339" y1="447.898" x2="209.339" y2="528.023" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="201.86 525.835 209.338 538.787 216.817 525.835 201.86 525.835" fill="#777"></polygon> </g> <g> <path d="M149.878,412.437c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <g> <path d="M193.517,427.051v-1.206h8.604v1.206h-8.604ZM194.11,424.566l-.504-1.296,5.814-2.25-5.58-2.088.468-1.242,7.398,2.845v1.044l-7.596,2.987Z"></path> <path d="M213.892,416.106c-.516.097-1.014.259-1.494.486-.48.229-.921.513-1.323.855-.402.342-.753.726-1.053,1.151-.3.426-.534.886-.702,1.377.312-.204.654-.365,1.026-.485s.768-.181,1.188-.181c.564,0,1.065.108,1.503.324s.807.51,1.107.882c.3.372.528.799.684,1.278.156.479.234.99.234,1.53s-.084,1.05-.252,1.529c-.168.48-.412.9-.729,1.261-.318.359-.705.645-1.161.854s-.966.315-1.53.315c-.684,0-1.272-.136-1.764-.405-.492-.271-.894-.627-1.206-1.071-.312-.443-.543-.951-.693-1.521-.15-.57-.225-1.155-.225-1.755,0-.973.141-1.884.423-2.736.282-.852.69-1.608,1.224-2.269.534-.659,1.176-1.212,1.926-1.655.75-.444,1.593-.744,2.529-.9l.288,1.134ZM210.058,420.751c-.36.132-.684.306-.972.521-.072.421-.108.841-.108,1.261,0,.384.039.786.117,1.206s.21.804.396,1.151c.186.349.435.633.747.855.312.222.702.333,1.17.333.372,0,.699-.078.981-.234.282-.155.516-.362.702-.621.186-.258.324-.549.414-.873s.135-.653.135-.99c0-.371-.051-.729-.153-1.07s-.252-.642-.45-.9c-.198-.258-.447-.462-.747-.612-.3-.149-.648-.225-1.044-.225-.42,0-.816.066-1.188.198Z"></path> <path d="M218.932,426.763c-.528-.36-.969-.831-1.323-1.413s-.615-1.242-.783-1.979c-.168-.738-.252-1.491-.252-2.26s.083-1.521.252-2.259c.168-.737.429-1.397.783-1.979s.798-1.05,1.332-1.404c.534-.354,1.173-.531,1.917-.531.732,0,1.368.178,1.908.531.54.354.987.822,1.341,1.404s.615,1.242.783,1.979c.168.738.252,1.491.252,2.259s-.087,1.521-.261,2.26c-.174.737-.435,1.397-.783,1.979-.348.582-.792,1.053-1.332,1.413s-1.176.54-1.908.54c-.744,0-1.386-.18-1.926-.54ZM218.734,424.459c.228.468.516.846.864,1.134.348.288.768.432,1.26.432.48,0,.894-.144,1.242-.432.348-.288.633-.666.855-1.134.222-.468.387-.996.495-1.584s.162-1.182.162-1.782-.051-1.19-.153-1.773c-.102-.581-.267-1.101-.495-1.557s-.516-.825-.864-1.106c-.348-.282-.762-.424-1.242-.424-.492,0-.912.142-1.26.424-.348.281-.636.65-.864,1.106s-.393.976-.495,1.557c-.103.583-.153,1.174-.153,1.773s.054,1.194.162,1.782.27,1.116.486,1.584Z"></path> <path d="M161.495,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M173.255,443.851v-9.338h1.12v8.372h4.326v.966h-5.446Z"></path> <path d="M178.981,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M185.953,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M198.091,436.108c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM197.544,443.851v-6.678h1.092v6.678h-1.092Z"></path> <path d="M200.568,443.851v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.561.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z"></path> <path d="M207.176,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M217.648,443.851v-7.966l-2.1,1.344-.546-.77,2.8-1.849h.98v9.24h-1.134Z"></path> <path d="M222.843,444.005c-.215,0-.395-.082-.539-.245-.145-.163-.217-.361-.217-.595s.072-.432.217-.596c.145-.163.324-.245.539-.245s.394.082.539.245c.145.164.217.362.217.596s-.072.432-.217.595c-.145.163-.324.245-.539.245Z"></path> <path d="M226.468,443.851l3.416-8.274h-5.124v-.951h6.398v.756l-3.514,8.47h-1.176Z"></path> <path d="M233.202,441.82c.243.43.543.742.903.938.359.195.726.294,1.099.294.252,0,.497-.042.735-.126.238-.084.448-.203.63-.357.182-.153.327-.341.434-.56.107-.22.161-.465.161-.735,0-.289-.056-.543-.168-.763s-.259-.403-.441-.553-.397-.264-.644-.344c-.248-.079-.502-.128-.763-.146v-.84c.233-.019.462-.065.686-.141.224-.074.425-.182.602-.321.177-.141.317-.309.42-.505.103-.195.154-.424.154-.686,0-.233-.047-.445-.14-.637s-.219-.353-.378-.483-.341-.23-.546-.301c-.206-.07-.42-.105-.644-.105-.392,0-.749.105-1.071.315-.322.21-.572.492-.749.847l-.882-.546c.271-.532.663-.938,1.176-1.218s1.064-.42,1.652-.42c.354,0,.697.059,1.029.175.331.116.625.279.882.489s.462.466.616.769.231.641.231,1.014c0,.54-.128.99-.385,1.349-.257.359-.581.617-.973.776.205.084.399.187.581.308.182.122.343.271.483.449s.25.39.329.638c.079.248.119.535.119.862,0,.448-.088.844-.266,1.185-.178.341-.411.631-.7.869-.29.238-.621.418-.994.54-.373.121-.756.182-1.148.182-.289,0-.574-.032-.854-.098-.28-.065-.548-.168-.805-.308-.257-.141-.493-.315-.707-.525-.215-.21-.397-.455-.546-.735l.882-.546Z"></path> <path d="M243.114,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M254.352,439.188v-.384c.299-.343.584-.672.857-.987.272-.315.522-.62.751-.914.13-.169.248-.325.351-.47.104-.144.19-.282.261-.416s.124-.264.159-.392c.036-.128.053-.263.053-.404,0-.311-.081-.545-.241-.706-.161-.16-.372-.24-.633-.24-.495,0-.9.271-1.216.815l-.514-.302c.19-.348.43-.617.718-.808.288-.19.639-.286,1.053-.286.234,0,.445.035.632.106.188.07.348.17.482.298.133.128.236.28.31.457.073.177.11.371.11.583,0,.354-.087.688-.261,1-.174.313-.381.622-.621.927-.212.277-.433.546-.661.804-.229.259-.457.513-.686.764h2.367v.555h-3.273Z"></path> </g> </g> <g> <path d="M284.711,412.437c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <g> <path d="M322.671,423.36v-1.277l5.904-6.895h.918v6.966h1.296v1.206h-1.296v3.69h-1.35v-3.69h-5.472ZM324.201,422.154h3.942v-4.535l-3.942,4.535Z"></path> <path d="M333.957,424.711c.492.852,1.314,1.278,2.466,1.278.756,0,1.371-.223,1.845-.666.474-.444.711-1.086.711-1.927,0-.936-.369-1.652-1.107-2.15-.738-.498-1.779-.747-3.123-.747h-1.314v-5.311h6.39v1.225h-5.04v2.861h.144c.756,0,1.464.072,2.124.217.66.144,1.233.378,1.719.701.486.324.87.751,1.152,1.278.282.528.423,1.176.423,1.944,0,.636-.103,1.194-.306,1.674-.204.48-.486.882-.846,1.206-.36.324-.78.57-1.26.738-.48.168-.99.252-1.53.252-.756,0-1.452-.153-2.088-.459-.636-.307-1.128-.771-1.476-1.396l1.116-.72Z"></path> <path d="M342.219,423.001v-1.278h3.906v1.278h-3.906Z"></path> <path d="M349.202,424.711c.492.852,1.314,1.278,2.466,1.278.757,0,1.371-.223,1.846-.666.474-.444.711-1.086.711-1.927,0-.936-.369-1.652-1.107-2.15s-1.779-.747-3.123-.747h-1.313v-5.311h6.39v1.225h-5.04v2.861h.145c.756,0,1.464.072,2.123.217.66.144,1.233.378,1.72.701.485.324.87.751,1.151,1.278.282.528.424,1.176.424,1.944,0,.636-.103,1.194-.307,1.674-.204.48-.485.882-.846,1.206s-.78.57-1.26.738c-.48.168-.99.252-1.53.252-.756,0-1.452-.153-2.088-.459-.637-.307-1.128-.771-1.477-1.396l1.116-.72Z"></path> <path d="M358.796,426.115c.54-.12,1.056-.294,1.548-.522.492-.228.939-.504,1.341-.828.402-.324.76-.692,1.071-1.106.312-.414.559-.867.738-1.359-.312.204-.648.363-1.008.477-.36.114-.756.172-1.188.172-.564,0-1.062-.111-1.494-.333-.432-.223-.798-.522-1.098-.9s-.528-.807-.684-1.287c-.156-.479-.234-.983-.234-1.512,0-.552.084-1.068.252-1.548.168-.48.411-.9.729-1.261.317-.359.701-.645,1.151-.854s.957-.315,1.521-.315c.659,0,1.235.136,1.728.405s.897.63,1.215,1.08c.318.45.556.96.711,1.53.156.569.234,1.154.234,1.755,0,.96-.15,1.862-.45,2.709-.3.846-.723,1.602-1.269,2.268-.547.666-1.203,1.222-1.972,1.665-.768.444-1.619.744-2.556.9l-.288-1.134ZM362.702,421.543c.372-.145.714-.33,1.026-.559.071-.407.107-.84.107-1.296,0-.384-.036-.782-.107-1.196-.072-.414-.201-.795-.388-1.144-.186-.348-.435-.633-.747-.854-.312-.223-.702-.333-1.17-.333-.384,0-.717.078-.999.233-.282.156-.516.363-.702.621-.186.259-.327.549-.423.873s-.144.654-.144.99c0,.384.051.747.152,1.089.103.342.253.646.45.909.198.264.45.474.756.63.307.156.663.234,1.071.234.384,0,.756-.066,1.116-.198Z"></path> <path d="M296.328,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M308.088,443.851v-9.338h1.12v8.372h4.326v.966h-5.446Z"></path> <path d="M313.814,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M320.786,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M332.924,436.108c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM332.377,443.851v-6.678h1.092v6.678h-1.092Z"></path> <path d="M335.401,443.851v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.561.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z"></path> <path d="M342.009,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M352.481,443.851v-7.966l-2.101,1.344-.546-.77,2.8-1.849h.98v9.24h-1.134Z"></path> <path d="M357.676,444.005c-.215,0-.395-.082-.539-.245-.146-.163-.218-.361-.218-.595s.072-.432.218-.596c.145-.163.324-.245.539-.245s.394.082.538.245c.146.164.218.362.218.596s-.072.432-.218.595c-.145.163-.324.245-.538.245Z"></path> <path d="M361.301,443.851l3.416-8.274h-5.124v-.951h6.398v.756l-3.515,8.47h-1.176Z"></path> <path d="M368.035,441.82c.242.43.543.742.902.938.359.195.726.294,1.1.294.252,0,.497-.042.734-.126.238-.084.448-.203.63-.357.183-.153.327-.341.435-.56.107-.22.161-.465.161-.735,0-.289-.057-.543-.168-.763-.112-.22-.259-.403-.441-.553-.182-.149-.396-.264-.644-.344-.248-.079-.502-.128-.764-.146v-.84c.233-.019.462-.065.687-.141.224-.074.425-.182.602-.321.178-.141.317-.309.42-.505.103-.195.154-.424.154-.686,0-.233-.047-.445-.14-.637-.094-.191-.22-.353-.378-.483-.159-.131-.341-.23-.546-.301-.206-.07-.421-.105-.645-.105-.392,0-.749.105-1.071.315-.321.21-.571.492-.749.847l-.882-.546c.271-.532.663-.938,1.176-1.218.514-.28,1.064-.42,1.652-.42.354,0,.697.059,1.029.175.331.116.625.279.882.489s.462.466.616.769c.153.303.23.641.23,1.014,0,.54-.128.99-.385,1.349-.257.359-.581.617-.973.776.205.084.398.187.581.308.182.122.343.271.482.449.141.178.25.39.329.638s.119.535.119.862c0,.448-.089.844-.266,1.185-.178.341-.411.631-.7.869-.29.238-.621.418-.994.54-.373.121-.756.182-1.148.182-.289,0-.573-.032-.854-.098s-.549-.168-.805-.308c-.257-.141-.493-.315-.707-.525-.215-.21-.397-.455-.546-.735l.882-.546Z"></path> <path d="M377.946,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.697.061,1.028.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.315-.252c.467,0,.856.062,1.17.188.312.126.56.309.741.546.183.238.311.532.386.883.074.35.111.748.111,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.56.077-.188.052-.362.114-.525.189-.163.074-.312.153-.448.237-.135.084-.249.164-.343.238.047.159.082.324.105.497.022.173.034.399.034.679v4.032h-1.077v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.428-.385-.177-.094-.405-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.848.497v5.208h-1.078Z"></path> <path d="M389.185,439.188v-.384c.299-.343.585-.672.857-.987.271-.315.522-.62.751-.914.13-.169.247-.325.351-.47.104-.144.19-.282.261-.416.071-.134.124-.264.159-.392.036-.128.054-.263.054-.404,0-.311-.081-.545-.241-.706-.16-.16-.371-.24-.633-.24-.495,0-.9.271-1.216.815l-.514-.302c.19-.348.43-.617.718-.808s.64-.286,1.053-.286c.234,0,.445.035.633.106.188.07.348.17.481.298s.236.28.311.457c.073.177.11.371.11.583,0,.354-.088.688-.262,1-.174.313-.381.622-.62.927-.212.277-.433.546-.661.804-.229.259-.457.513-.686.764h2.367v.555h-3.273Z"></path> </g> </g> <g> <path d="M419.543,412.437c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <g> <path d="M458.619,424.44c.312.553.699.954,1.161,1.206s.933.378,1.413.378c.323,0,.639-.054.944-.162.307-.107.576-.261.811-.459.233-.197.42-.438.558-.72.138-.281.207-.597.207-.944,0-.372-.072-.699-.216-.981-.145-.282-.333-.519-.567-.711-.233-.192-.51-.339-.828-.441-.317-.102-.645-.164-.98-.188v-1.08c.3-.024.594-.084.882-.18.288-.097.546-.234.774-.414.228-.181.407-.396.54-.648.132-.252.197-.546.197-.882,0-.3-.06-.573-.18-.819-.12-.245-.282-.452-.486-.621-.204-.168-.438-.297-.701-.387-.265-.09-.54-.135-.828-.135-.504,0-.963.135-1.377.405-.414.27-.735.633-.963,1.089l-1.135-.702c.349-.685.853-1.206,1.513-1.566.659-.359,1.367-.54,2.124-.54.455,0,.896.075,1.322.225.426.15.804.36,1.135.63.329.27.594.599.792.988.197.39.297.823.297,1.303,0,.695-.165,1.273-.495,1.734s-.747.794-1.251.997c.264.108.513.241.747.396.233.157.44.349.621.577.18.229.32.502.423.82.102.318.152.688.152,1.108,0,.577-.114,1.085-.342,1.523s-.528.811-.899,1.117c-.372.307-.799.538-1.278.694-.48.156-.972.234-1.476.234-.373,0-.738-.043-1.099-.126-.359-.085-.705-.217-1.035-.396s-.633-.405-.908-.675c-.276-.271-.511-.585-.702-.945l1.134-.702Z"></path> <path d="M469.455,426.763c-.528-.36-.97-.831-1.323-1.413-.354-.582-.615-1.242-.783-1.979-.168-.738-.252-1.491-.252-2.26s.084-1.521.252-2.259c.168-.737.429-1.397.783-1.979.354-.582.798-1.05,1.332-1.404.534-.354,1.173-.531,1.917-.531.731,0,1.368.178,1.908.531.54.354.986.822,1.341,1.404.354.582.614,1.242.783,1.979.168.738.252,1.491.252,2.259s-.088,1.521-.262,2.26c-.174.737-.435,1.397-.782,1.979-.349.582-.792,1.053-1.332,1.413s-1.177.54-1.908.54c-.744,0-1.386-.18-1.926-.54ZM469.257,424.459c.228.468.516.846.864,1.134.348.288.768.432,1.26.432.479,0,.894-.144,1.242-.432.348-.288.633-.666.854-1.134s.388-.996.495-1.584c.108-.588.162-1.182.162-1.782s-.051-1.19-.153-1.773c-.102-.581-.267-1.101-.495-1.557-.228-.456-.516-.825-.863-1.106-.349-.282-.763-.424-1.242-.424-.492,0-.912.142-1.26.424-.349.281-.637.65-.864,1.106-.229.456-.394.976-.495,1.557-.103.583-.153,1.174-.153,1.773s.055,1.194.162,1.782c.108.588.271,1.116.486,1.584Z"></path> <path d="M477.051,423.001v-1.278h3.906v1.278h-3.906Z"></path> <path d="M482.469,423.36v-1.277l5.904-6.895h.918v6.966h1.296v1.206h-1.296v3.69h-1.351v-3.69h-5.472ZM483.999,422.154h3.941v-4.535l-3.941,4.535Z"></path> <path d="M492.188,423.36v-1.277l5.904-6.895h.918v6.966h1.296v1.206h-1.296v3.69h-1.351v-3.69h-5.472ZM493.719,422.154h3.941v-4.535l-3.941,4.535Z"></path> <path d="M431.16,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.697.061,1.028.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.315-.252c.467,0,.856.062,1.17.188.312.126.56.309.741.546.183.238.311.532.386.883.074.35.111.748.111,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.56.077-.188.052-.362.114-.525.189-.163.074-.312.153-.448.237-.135.084-.249.164-.343.238.047.159.082.324.105.497.022.173.034.399.034.679v4.032h-1.077v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.428-.385-.177-.094-.405-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.848.497v5.208h-1.078Z"></path> <path d="M442.92,443.851v-9.338h1.12v8.372h4.326v.966h-5.446Z"></path> <path d="M448.646,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M455.618,443.851v-6.678h.994l.069.531c.225-.158.514-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182s.609.346.833.672c.28-.233.62-.434,1.021-.602s.841-.252,1.316-.252c.467,0,.856.062,1.169.188s.56.309.742.546c.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.188,0-.374.026-.561.077-.187.052-.361.114-.524.189-.164.074-.313.153-.448.237-.136.084-.25.164-.343.238.046.159.081.324.104.497s.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.062-.687-.042-.214-.117-.403-.225-.566s-.25-.292-.427-.385c-.178-.094-.406-.141-.687-.141-.326,0-.65.082-.973.245s-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M467.756,436.108c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM467.21,443.851v-6.678h1.092v6.678h-1.092Z"></path> <path d="M470.233,443.851v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.754-.195,1.155-.195.914,0,1.561.227,1.938.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z"></path> <path d="M476.842,443.669l5.894-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M487.313,443.851v-7.966l-2.1,1.344-.546-.77,2.8-1.849h.98v9.24h-1.135Z"></path> <path d="M492.508,444.005c-.215,0-.395-.082-.539-.245s-.217-.361-.217-.595.072-.432.217-.596c.145-.163.324-.245.539-.245s.395.082.539.245c.145.164.217.362.217.596s-.072.432-.217.595-.324.245-.539.245Z"></path> <path d="M496.134,443.851l3.415-8.274h-5.123v-.951h6.397v.756l-3.514,8.47h-1.176Z"></path> <path d="M502.867,441.82c.243.43.544.742.903.938.359.195.726.294,1.099.294.252,0,.497-.042.735-.126s.448-.203.63-.357c.182-.153.326-.341.434-.56.107-.22.161-.465.161-.735,0-.289-.056-.543-.168-.763-.111-.22-.259-.403-.44-.553-.183-.149-.397-.264-.645-.344-.247-.079-.502-.128-.763-.146v-.84c.233-.019.462-.065.686-.141.225-.074.425-.182.603-.321.177-.141.317-.309.42-.505.103-.195.154-.424.154-.686,0-.233-.047-.445-.141-.637-.093-.191-.219-.353-.378-.483-.158-.131-.341-.23-.546-.301s-.42-.105-.644-.105c-.393,0-.749.105-1.071.315s-.572.492-.749.847l-.882-.546c.271-.532.662-.938,1.176-1.218.513-.28,1.063-.42,1.652-.42.354,0,.697.059,1.028.175s.625.279.882.489.463.466.616.769c.154.303.231.641.231,1.014,0,.54-.129.99-.385,1.349-.257.359-.581.617-.974.776.205.084.399.187.581.308.183.122.343.271.483.449.14.178.249.39.329.638.079.248.118.535.118.862,0,.448-.088.844-.266,1.185s-.411.631-.7.869-.62.418-.994.54c-.373.121-.756.182-1.147.182-.289,0-.574-.032-.854-.098-.279-.065-.548-.168-.805-.308-.257-.141-.492-.315-.707-.525s-.396-.455-.546-.735l.882-.546Z"></path> <path d="M512.779,443.851v-6.678h.994l.069.531c.225-.158.514-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182s.609.346.833.672c.28-.233.62-.434,1.021-.602s.841-.252,1.316-.252c.467,0,.856.062,1.169.188s.56.309.742.546c.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.188,0-.374.026-.561.077-.187.052-.361.114-.524.189-.164.074-.313.153-.448.237-.136.084-.25.164-.343.238.046.159.081.324.104.497s.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.062-.687-.042-.214-.117-.403-.225-.566s-.25-.292-.427-.385c-.178-.094-.406-.141-.687-.141-.326,0-.65.082-.973.245s-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M524.018,439.188v-.384c.299-.343.584-.672.856-.987s.522-.62.751-.914c.131-.169.248-.325.351-.47.104-.144.19-.282.262-.416.07-.134.124-.264.159-.392s.053-.263.053-.404c0-.311-.08-.545-.24-.706-.161-.16-.372-.24-.633-.24-.495,0-.9.271-1.216.815l-.515-.302c.19-.348.43-.617.719-.808.288-.19.639-.286,1.053-.286.233,0,.444.035.632.106.188.07.349.17.482.298.133.128.236.28.31.457s.11.371.11.583c0,.354-.087.688-.261,1-.175.313-.382.622-.621.927-.212.277-.433.546-.661.804-.229.259-.457.513-.686.764h2.367v.555h-3.272Z"></path> </g> </g> <path d="M554.376,412.437c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#f8c6b4" stroke="#fff" stroke-miterlimit="10"></path> <g> <path d="M554.376,412.437c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <g> <path d="M596.629,421.579v-1.044l7.397-2.845.468,1.242-5.58,2.088,5.814,2.25-.504,1.296-7.596-2.987Z"></path> <path d="M610.794,424.44c.312.553.699.954,1.161,1.206s.934.378,1.413.378c.324,0,.639-.054.945-.162.306-.107.576-.261.81-.459.234-.197.42-.438.559-.72.138-.281.207-.597.207-.944,0-.372-.072-.699-.217-.981-.144-.282-.333-.519-.566-.711-.234-.192-.511-.339-.828-.441-.318-.102-.646-.164-.981-.188v-1.08c.3-.024.595-.084.883-.18.288-.097.546-.234.773-.414.228-.181.408-.396.54-.648s.198-.546.198-.882c0-.3-.061-.573-.18-.819-.12-.245-.282-.452-.486-.621-.204-.168-.438-.297-.702-.387s-.54-.135-.828-.135c-.504,0-.963.135-1.377.405-.414.27-.735.633-.963,1.089l-1.134-.702c.348-.685.852-1.206,1.512-1.566.66-.359,1.368-.54,2.124-.54.456,0,.897.075,1.323.225.426.15.804.36,1.134.63s.594.599.792.988.297.823.297,1.303c0,.695-.165,1.273-.495,1.734s-.747.794-1.251.997c.264.108.514.241.747.396.234.157.441.349.621.577s.321.502.423.82c.103.318.153.688.153,1.108,0,.577-.114,1.085-.342,1.523-.229.438-.528.811-.9,1.117s-.798.538-1.278.694c-.479.156-.972.234-1.476.234-.372,0-.738-.043-1.098-.126-.36-.085-.705-.217-1.035-.396s-.633-.405-.909-.675c-.276-.271-.51-.585-.702-.945l1.134-.702Z"></path> <path d="M621.63,426.763c-.528-.36-.969-.831-1.323-1.413-.354-.582-.614-1.242-.782-1.979-.169-.738-.252-1.491-.252-2.26s.083-1.521.252-2.259c.168-.737.429-1.397.782-1.979.354-.582.798-1.05,1.332-1.404.534-.354,1.173-.531,1.917-.531.732,0,1.368.178,1.908.531.54.354.987.822,1.341,1.404.354.582.615,1.242.783,1.979.168.738.252,1.491.252,2.259s-.087,1.521-.261,2.26c-.174.737-.436,1.397-.783,1.979s-.792,1.053-1.332,1.413-1.176.54-1.908.54c-.744,0-1.386-.18-1.926-.54ZM621.432,424.459c.229.468.517.846.864,1.134s.768.432,1.26.432c.48,0,.895-.144,1.242-.432s.633-.666.855-1.134c.222-.468.387-.996.495-1.584.107-.588.161-1.182.161-1.782s-.051-1.19-.152-1.773c-.103-.581-.268-1.101-.495-1.557-.229-.456-.517-.825-.864-1.106-.348-.282-.762-.424-1.242-.424-.492,0-.912.142-1.26.424-.348.281-.636.65-.864,1.106-.228.456-.393.976-.494,1.557-.103.583-.153,1.174-.153,1.773s.054,1.194.162,1.782c.107.588.27,1.116.485,1.584Z"></path> <path d="M565.993,443.851v-6.678h.994l.069.531c.225-.158.514-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182s.609.346.833.672c.28-.233.62-.434,1.021-.602s.841-.252,1.316-.252c.467,0,.856.062,1.169.188s.56.309.742.546c.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.188,0-.374.026-.561.077-.187.052-.361.114-.524.189-.164.074-.313.153-.448.237-.136.084-.25.164-.343.238.046.159.081.324.104.497s.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.062-.687-.042-.214-.117-.403-.225-.566s-.25-.292-.427-.385c-.178-.094-.406-.141-.687-.141-.326,0-.65.082-.973.245s-.604.329-.847.497v5.208h-1.078Z"></path> <path d="M577.753,443.851v-9.338h1.12v8.372h4.326v.966h-5.446Z"></path> <path d="M583.479,443.669l5.895-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M590.45,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.697.061,1.028.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.315-.252c.467,0,.856.062,1.17.188.312.126.56.309.741.546.183.238.311.532.386.883.074.35.111.748.111,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.56.077-.188.052-.362.114-.525.189-.163.074-.312.153-.448.237-.135.084-.249.164-.343.238.047.159.082.324.105.497.022.173.034.399.034.679v4.032h-1.077v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.428-.385-.177-.094-.405-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.848.497v5.208h-1.078Z"></path> <path d="M602.589,436.108c-.196,0-.364-.077-.505-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.505-.238s.363.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.141.153-.309.23-.504.23ZM602.042,443.851v-6.678h1.093v6.678h-1.093Z"></path> <path d="M605.066,443.851v-6.678h.994l.069.531c.271-.205.591-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.562.227,1.939.679.378.453.566,1.122.566,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.662-.476-1.231-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z"></path> <path d="M611.674,443.669l5.895-10.431.826.462-5.866,10.473-.854-.504Z"></path> <path d="M622.146,443.851v-7.966l-2.101,1.344-.546-.77,2.8-1.849h.98v9.24h-1.134Z"></path> <path d="M627.341,444.005c-.215,0-.395-.082-.539-.245-.146-.163-.218-.361-.218-.595s.072-.432.218-.596c.145-.163.324-.245.539-.245s.394.082.538.245c.146.164.218.362.218.596s-.072.432-.218.595c-.145.163-.324.245-.538.245Z"></path> <path d="M630.966,443.851l3.416-8.274h-5.124v-.951h6.398v.756l-3.515,8.47h-1.176Z"></path> <path d="M637.7,441.82c.242.43.543.742.902.938.359.195.726.294,1.1.294.252,0,.497-.042.734-.126.238-.084.448-.203.63-.357.183-.153.327-.341.435-.56.107-.22.161-.465.161-.735,0-.289-.057-.543-.168-.763-.112-.22-.259-.403-.441-.553-.182-.149-.396-.264-.644-.344-.248-.079-.502-.128-.764-.146v-.84c.233-.019.462-.065.687-.141.224-.074.425-.182.602-.321.178-.141.317-.309.42-.505.103-.195.154-.424.154-.686,0-.233-.047-.445-.14-.637-.094-.191-.22-.353-.378-.483-.159-.131-.341-.23-.546-.301-.206-.07-.421-.105-.645-.105-.392,0-.749.105-1.071.315-.321.21-.571.492-.749.847l-.882-.546c.271-.532.663-.938,1.176-1.218.514-.28,1.064-.42,1.652-.42.354,0,.697.059,1.029.175.331.116.625.279.882.489s.462.466.616.769c.153.303.23.641.23,1.014,0,.54-.128.99-.385,1.349-.257.359-.581.617-.973.776.205.084.398.187.581.308.182.122.343.271.482.449.141.178.25.39.329.638s.119.535.119.862c0,.448-.089.844-.266,1.185-.178.341-.411.631-.7.869-.29.238-.621.418-.994.54-.373.121-.756.182-1.148.182-.289,0-.573-.032-.854-.098s-.549-.168-.805-.308c-.257-.141-.493-.315-.707-.525-.215-.21-.397-.455-.546-.735l.882-.546Z"></path> <path d="M647.611,443.851v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.697.061,1.028.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.315-.252c.467,0,.856.062,1.17.188.312.126.56.309.741.546.183.238.311.532.386.883.074.35.111.748.111,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.56.077-.188.052-.362.114-.525.189-.163.074-.312.153-.448.237-.135.084-.249.164-.343.238.047.159.082.324.105.497.022.173.034.399.034.679v4.032h-1.077v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.428-.385-.177-.094-.405-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.848.497v5.208h-1.078Z"></path> <path d="M658.85,439.188v-.384c.299-.343.585-.672.857-.987.271-.315.522-.62.751-.914.13-.169.247-.325.351-.47.104-.144.19-.282.261-.416.071-.134.124-.264.159-.392.036-.128.054-.263.054-.404,0-.311-.081-.545-.241-.706-.16-.16-.371-.24-.633-.24-.495,0-.9.271-1.216.815l-.514-.302c.19-.348.43-.617.718-.808s.64-.286,1.053-.286c.234,0,.445.035.633.106.188.07.348.17.481.298s.236.28.311.457c.073.177.11.371.11.583,0,.354-.088.688-.262,1-.174.313-.381.622-.62.927-.212.277-.433.546-.661.804-.229.259-.457.513-.686.764h2.367v.555h-3.273Z"></path> </g> </g> <text transform="translate(403.452 278.41)" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Age is not accounted for in the risk </tspan><tspan x="0" y="16.8">stratification approach, leading to possible </tspan><tspan x="0" y="33.6">overestimation of risk in older adults and </tspan><tspan x="0" y="50.4">underestimation of risk in younger individuals</tspan></text> <rect x="540.066" y="330.678" width="18.601" height="18.601" transform="translate(-79.496 488.038) rotate(-45)" fill="#ccc"></rect> <circle cx="377.347" cy="285.422" r="18.556" fill="#fff"></circle> <g> <path d="M386.649,281.992h-.904v-2.932c0-.98-.797-1.777-1.777-1.777h-1.478v-.904h1.478c1.478,0,2.68,1.202,2.68,2.68v2.932Z" fill="#848a99"></path> <path d="M372.786,274.783v3.906c0,.25.202.452.452.452s.452-.202.452-.452v-3.906c0-.25-.202-.452-.452-.452s-.452.202-.452.452Z" fill="#848a99"></path> <rect x="374.593" y="276.38" width="5.186" height=".904" fill="#848a99"></rect> <path d="M368.803,281.992h-.904v-2.932c0-1.478,1.203-2.68,2.681-2.68h1.302v.904h-1.302c-.981,0-1.777.797-1.777,1.777v2.932Z" fill="#848a99"></path> <path d="M380.683,274.783v3.906c0,.25.202.452.452.452s.452-.202.452-.452v-3.906c0-.25-.202-.452-.452-.452s-.452.202-.452.452Z" fill="#848a99"></path> <path d="M383.969,294.563h-13.389c-1.478,0-2.681-1.202-2.681-2.68v-10.343h18.75v10.343c0,1.478-1.202,2.68-2.68,2.68ZM368.803,282.444v9.439c0,.98.797,1.777,1.777,1.777h13.389c.98,0,1.777-.797,1.777-1.777v-9.439h-16.943Z" fill="#848a99"></path> <path d="M378.684,284.713h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M383.596,284.713h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M378.684,287.424h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M373.773,287.424h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M383.596,287.424h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M378.684,290.135h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> <path d="M373.773,290.135h-3.002c-.25,0-.452.202-.452.452s.202.452.452.452h3.002c.25,0,.452-.202.452-.452s-.202-.452-.452-.452Z" fill="#848a99"></path> </g> <g> <rect x="13.143" y="461.251" width="113.504" height="255.938" rx="6.258" ry="6.258" fill="#ccc"></rect> <rect x="22.144" y="470.22" width="95.952" height="59.887" rx="6.258" ry="6.258" fill="#333"></rect> <text transform="translate(29.411 485.096)" fill="#fff" font-family="InterFace-Bold, InterFace" font-size="14" font-weight="700"><tspan x="0" y="0">Albuminuria</tspan></text> <g> <path d="M43.17,502.524l3.598-9.338h.686l3.668,9.338h-1.218l-1.106-2.884h-3.388l-1.064,2.884h-1.176ZM45.774,498.646h2.66l-1.358-3.57-1.302,3.57Z" fill="#fff"></path> <path d="M52.088,502.524v-9.338h1.078v9.338h-1.078Z" fill="#fff"></path> <path d="M56.176,496.057c.289-.131.567-.225.833-.28s.53-.084.791-.084c.429,0,.831.077,1.204.231.373.153.693.378.959.672s.476.657.63,1.092c.154.434.231.936.231,1.505,0,.532-.084,1.013-.252,1.442-.168.429-.401.796-.7,1.099-.299.304-.651.537-1.057.7-.406.163-.847.245-1.323.245-.513,0-.973-.054-1.379-.161-.406-.107-.744-.222-1.015-.343v-8.988h1.078v2.87ZM56.176,501.572c.177.075.369.136.574.183.205.046.401.069.588.069.373,0,.711-.062,1.015-.188.303-.126.56-.306.77-.539.21-.233.371-.514.483-.84.112-.327.168-.691.168-1.093s-.056-.763-.168-1.085c-.112-.321-.266-.595-.462-.818-.196-.225-.425-.395-.686-.512-.262-.116-.546-.175-.854-.175-.224,0-.458.03-.7.091-.243.062-.485.171-.728.329v4.578Z" fill="#fff"></path> <path d="M63.47,500.131c0,.588.135,1.015.406,1.28.271.267.672.399,1.204.399.345,0,.688-.072,1.029-.217.34-.145.618-.32.833-.525v-5.222h1.092v6.678h-.994l-.07-.518c-.271.205-.565.368-.882.489-.317.121-.714.183-1.19.183-.877,0-1.515-.215-1.911-.645-.397-.429-.595-1.082-.595-1.96v-4.228h1.078v4.284Z" fill="#fff"></path> <path d="M69.965,502.524v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.742-.23,1.162-.23.354,0,.698.061,1.029.182.332.121.609.346.833.672.28-.233.621-.434,1.022-.602s.84-.252,1.316-.252c.467,0,.856.062,1.169.188.312.126.56.309.742.546.182.238.31.532.385.883.074.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.607-.469-1.176-.469-.187,0-.374.026-.56.077-.187.052-.362.114-.525.189-.164.074-.313.153-.448.237s-.25.164-.343.238c.046.159.082.324.105.497.023.173.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.063-.687-.042-.214-.117-.403-.224-.566-.107-.163-.25-.292-.427-.385-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.973.245-.322.163-.604.329-.847.497v5.208h-1.078Z" fill="#fff"></path> <path d="M82.104,494.782c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM81.557,502.524v-6.678h1.092v6.678h-1.092Z" fill="#fff"></path> <path d="M84.581,502.524v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.561.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z" fill="#fff"></path> <path d="M91.819,499.374v-.993h3.038v.993h-3.038Z" fill="#fff"></path> <path d="M32.369,517.896c-.261.541-.618.94-1.071,1.196-.453.257-.931.386-1.435.386-.392,0-.777-.07-1.155-.21-.378-.141-.711-.354-1.001-.645-.289-.289-.522-.65-.7-1.085-.178-.434-.266-.945-.266-1.533,0-.625.088-1.162.266-1.609.177-.448.411-.814.7-1.1.29-.284.616-.492.98-.623.364-.13.728-.195,1.092-.195.373,0,.702.056.987.168.285.111.527.252.728.42s.364.346.49.532.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.495.058-.728.175-.233.116-.443.287-.63.511-.187.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.53.175.819.175.327,0,.642-.094.945-.28.303-.187.553-.49.749-.91l.756.477Z" fill="#fff"></path> <path d="M33.699,519.324v-6.678h.98l.084.588c.177-.187.406-.359.686-.519.28-.158.565-.237.854-.237.206,0,.395.014.567.042.172.027.305.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224-.248.149-.46.304-.637.462v5.194h-1.078Z" fill="#fff"></path> <path d="M38.809,515.922c0,.841.191,1.498.574,1.975.382.476.938.714,1.666.714.42,0,.774-.103,1.064-.309.289-.205.522-.457.7-.756l.714.477c-.243.42-.558.768-.945,1.043s-.908.413-1.561.413c-.504,0-.957-.077-1.358-.231s-.745-.378-1.029-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.217-1.435s.345-.789.602-1.093c.257-.303.569-.536.938-.699.369-.164.777-.245,1.225-.245.495,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092.122.425.182.889.182,1.393h-4.858ZM42.449,515.068c-.01-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.322.266-.544.712-.665,1.337h3.542Z" fill="#fff"></path> <path d="M48.889,519.324l-.056-.574c-.233.233-.502.413-.805.539s-.637.189-1.001.189c-.29,0-.572-.045-.847-.133-.275-.089-.518-.22-.728-.393-.21-.173-.38-.39-.511-.651-.131-.261-.196-.564-.196-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.392-.183.826-.311,1.302-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.238-.242-.581-.364-1.029-.364-.308,0-.59.068-.847.203-.257.136-.474.315-.651.539l-.756-.532c.271-.364.59-.632.959-.805s.833-.259,1.393-.259c.747,0,1.328.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM48.791,515.838c-.308.01-.635.033-.98.07-.346.037-.665.109-.959.217s-.537.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.154.042.306.063.455.063.327,0,.627-.068.903-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff"></path> <path d="M53.271,517.798c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.159-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.506.141-.889.141-.504,0-.891-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.764v4.27Z" fill="#fff"></path> <path d="M56.896,511.582c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM56.35,519.324v-6.678h1.092v6.678h-1.092Z" fill="#fff"></path> <path d="M59.374,519.324v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.561.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z" fill="#fff"></path> <path d="M67.494,511.582c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM66.948,519.324v-6.678h1.092v6.678h-1.092Z" fill="#fff"></path> <path d="M69.972,519.324v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.369-.13.754-.195,1.155-.195.915,0,1.561.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.632.324-.875.511v5.236h-1.078Z" fill="#fff"></path> <path d="M78.288,515.922c0,.841.191,1.498.574,1.975.382.476.938.714,1.666.714.42,0,.774-.103,1.064-.309.289-.205.522-.457.7-.756l.714.477c-.243.42-.558.768-.945,1.043s-.908.413-1.561.413c-.504,0-.957-.077-1.358-.231s-.745-.378-1.029-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.217-1.435s.345-.789.602-1.093c.257-.303.569-.536.938-.699.369-.164.777-.245,1.225-.245.495,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092.122.425.182.889.182,1.393h-4.858ZM81.928,515.068c-.01-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.322.266-.544.712-.665,1.337h3.542Z" fill="#fff"></path> <path d="M87.457,519.324v-6.678h.98l.084.588c.177-.187.406-.359.686-.519.28-.158.565-.237.854-.237.206,0,.395.014.567.042.172.027.305.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224-.248.149-.46.304-.637.462v5.194h-1.078Z" fill="#fff"></path> <path d="M95.535,519.324l-.056-.574c-.233.233-.502.413-.805.539s-.637.189-1.001.189c-.29,0-.572-.045-.847-.133-.275-.089-.518-.22-.728-.393-.21-.173-.38-.39-.511-.651-.131-.261-.196-.564-.196-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.392-.183.826-.311,1.302-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.238-.242-.581-.364-1.029-.364-.308,0-.59.068-.847.203-.257.136-.474.315-.651.539l-.756-.532c.271-.364.59-.632.959-.805s.833-.259,1.393-.259c.747,0,1.328.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM95.438,515.838c-.308.01-.635.033-.98.07-.346.037-.665.109-.959.217s-.537.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.154.042.306.063.455.063.327,0,.627-.068.903-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff"></path> <path d="M99.917,517.798c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.159-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.506.141-.889.141-.504,0-.891-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.764v4.27Z" fill="#fff"></path> <path d="M103.543,511.582c-.196,0-.364-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.14-.159.308-.238.504-.238s.364.079.504.238c.14.158.21.345.21.56,0,.224-.07.413-.21.567-.14.153-.308.23-.504.23ZM102.997,519.324v-6.678h1.092v6.678h-1.092Z" fill="#fff"></path> <path d="M107.449,519.185c-.383-.205-.705-.474-.966-.806-.262-.331-.458-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.32-.786.581-1.112.261-.327.585-.589.973-.784.387-.196.842-.294,1.365-.294.513,0,.966.101,1.358.301.392.201.716.464.973.791.256.327.45.7.581,1.12.13.42.196.85.196,1.288s-.065.868-.196,1.288c-.131.42-.325.793-.581,1.119-.257.327-.581.591-.973.791-.392.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM107.267,517.784c.177.243.394.441.651.595.257.154.553.231.889.231.345,0,.646-.077.903-.231.257-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.387-.445-.644-.595-.558-.225-.903-.225-.646.075-.903.225c-.257.149-.469.348-.637.595s-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff"></path> </g> </g> <g> <line x1="55.517" y1="564.056" x2="137.643" y2="564.056" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="135.454 571.535 148.406 564.056 135.454 556.577 135.454 571.535" fill="#777"></polygon> </g> <g> <line x1="55.517" y1="622.049" x2="137.643" y2="622.049" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="135.454 629.527 148.406 622.049 135.454 614.57 135.454 629.527" fill="#777"></polygon> </g> <g> <path d="M21.919,546.379c0-3.456,3.339-6.258,7.457-6.258h81.038c4.118,0,7.457,2.802,7.457,6.258v34.734c0,3.456-3.339,6.258-7.457,6.258H29.376c-4.118,0-7.457-2.802-7.457-6.258v-34.734Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(57.809 561.504)" font-family="InterFace-Regular, InterFace"><tspan font-size="18"><tspan x="0" y="0">&lt; 3</tspan></tspan><tspan font-size="14"><tspan x="-18.125" y="16.8">mg/mmol</tspan></tspan></text> </g> <g> <path d="M21.919,604.682c0-3.456,3.339-6.258,7.457-6.258h81.038c4.118,0,7.457,2.802,7.457,6.258v34.734c0,3.456-3.339,6.258-7.457,6.258H29.376c-4.118,0-7.457-2.802-7.457-6.258v-34.734Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(51.987 619.807)" font-family="InterFace-Regular, InterFace"><tspan font-size="18"><tspan x="0" y="0">3-30</tspan></tspan><tspan font-size="14"><tspan x="-12.302" y="16.8">mg/mmol</tspan></tspan></text> </g> <text></text> <g> <path d="M149.878,545.89c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#006ab3" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(194.156 561.504)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Low</tspan></text> <text transform="translate(160.566 577.75)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 1</tspan></text> </g> <g> <path d="M284.711,545.89c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#495284" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(308.721 561.504)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Moderate</tspan></text> <text transform="translate(295.398 577.75)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 2</tspan></text> </g> <g> <path d="M419.543,545.89c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#973851" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(461.635 561.504)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">High</tspan></text> <text transform="translate(430.231 577.75)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 3</tspan></text> </g> <g> <path d="M149.878,604.193c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#495284" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(173.889 619.807)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Moderate</tspan></text> <text transform="translate(160.566 636.053)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 2</tspan></text> </g> <g> <path d="M284.711,604.193c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#973851" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(326.802 619.807)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">High</tspan></text> <text transform="translate(295.398 636.053)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 3</tspan></text> </g> <g> <path d="M419.543,604.193c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(444.337 619.806)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(430.23 636.053)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M554.376,604.193c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(579.17 619.806)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(565.063 636.053)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M554.376,664.472c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(579.17 680.919)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(565.063 696.332)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M419.543,664.472c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(444.337 680.919)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(430.231 696.332)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M284.711,664.472c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(309.504 680.919)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(295.398 696.332)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M554.376,545.89c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#e11f21" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(579.17 561.504)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">Very high</tspan></text> <text transform="translate(565.063 577.75)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 4</tspan></text> </g> <g> <path d="M149.878,664.472c0-3.186,2.802-5.77,6.258-5.77h106.405c3.456,0,6.258,2.583,6.258,5.77v35.711c0,3.186-2.802,5.77-6.258,5.77h-106.405c-3.456,0-6.258-2.583-6.258-5.77v-35.711Z" fill="#973851" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(191.969 680.919)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="18"><tspan x="0" y="0">High</tspan></text> <text transform="translate(160.565 696.332)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="12"><tspan x="0" y="0">Recommendation 3</tspan></text> </g> <g> <line x1="55.517" y1="682.328" x2="137.643" y2="682.328" fill="none" stroke="#777" stroke-miterlimit="10" stroke-width="3"></line> <polygon points="135.454 689.806 148.406 682.328 135.454 674.849 135.454 689.806" fill="#777"></polygon> </g> <g> <path d="M21.919,664.961c0-3.456,3.339-6.258,7.457-6.258h81.038c4.118,0,7.457,2.802,7.457,6.258v34.734c0,3.456-3.339,6.258-7.457,6.258H29.376c-4.118,0-7.457-2.802-7.457-6.258v-34.734Z" fill="#fff" stroke="#fff" stroke-miterlimit="10"></path> <text transform="translate(52.16 680.086)" font-family="InterFace-Regular, InterFace"><tspan font-size="17"><tspan x="0" y="0">&gt; 30 </tspan></tspan><tspan font-size="14"><tspan x="-12.475" y="16.8">mg/mmol</tspan></tspan></text> </g> <g> <rect x="228.592" y="489.218" width="365.052" height="26.669" rx="6.258" ry="6.258" fill="#333"></rect> <text transform="translate(246.809 505.563)" fill="#fff" font-family="InterFace-Bold, InterFace" font-size="14" font-weight="700"><tspan x="0" y="0">Risk of kidney disease progression and complications</tspan></text> </g> <g> <rect x="299.015" y="372.6" width="224.206" height="26.669" rx="5.579" ry="5.579" fill="#333"></rect> <text transform="translate(318.642 388.946)" fill="#fff" font-size="14"><tspan x="0" y="0" xml:space="preserve" font-family="InterFace-Bold, InterFace" font-weight="700">GFR </tspan><tspan x="44.602" y="0" font-family="InterFace-Regular, InterFace">Glomerular filtration rate</tspan></text> </g> </svg></div></div></div><div id="image1"><div class="whiteBox" style="margin:15px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 35.868058238955705%; margin: 0px auto 0px auto;"><svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" version="1.1" viewBox="0 0 695 249.283"> <rect x="234.964" y="53.556" width="411.097" height="172.874" rx="11.856" ry="11.856" fill="#6f4f9b" stroke-width="0"></rect> <g> <text transform="translate(51.066 37.167)" fill="#2f6eb5" font-family="InterFace-Bold, InterFace" font-size="21" font-weight="700" isolation="isolate"><tspan x="0" y="0">Interventions compared</tspan></text> <path d="M43.787,27.488l-.007.003c-.045,2.878-2.387,5.198-5.273,5.198s-5.228-2.32-5.273-5.198l-.007-.003.006-.013c0-.022-.004-.044-.004-.067h.034l3.99-8.752-.121-.024-4.955.697c-.179.675-.631,1.232-1.234,1.554v16.146h5.476v3.174h-13.329v-3.174h5.476v-16.177c-.377-.213-.69-.517-.912-.888l-5.595.787,4.251,9.284h.033c0,.022-.003.044-.003.067l.006.013-.007.003c-.045,2.878-2.387,5.198-5.273,5.198s-5.228-2.32-5.273-5.198l-.007-.003.006-.013c0-.022-.004-.044-.004-.067h.034l4.095-8.983v-2.149l7.517-1.004c.332-.984,1.252-1.697,2.347-1.697.863,0,1.622.44,2.068,1.107l7.741-1.034v2.01l4.159,9.122h.034c0,.022-.003.044-.004.067l.008.014ZM35.007,27.408h7.001l-3.501-7.678-3.5,7.678ZM17.492,29.94h7.001l-3.501-7.678-3.5,7.678Z" fill="#2f6eb5" stroke-width="0"></path> </g> <g> <g> <path d="M259.104,65.556c-4.993,0-9.079,4.085-9.079,9.079s4.085,9.079,9.079,9.079h18.552v-18.157h-18.552Z" fill="#b3a4d0" stroke-width="0"></path> <path d="M296.208,65.556h-18.552v18.157h18.552c4.993,0,9.079-4.085,9.079-9.079s-4.085-9.079-9.079-9.079Z" fill="#d8dbdf" stroke-width="0"></path> </g> <rect x="255.592" y="68.166" width="44.129" height="3.464" rx="1.244" ry="1.244" fill="#fff" opacity=".3" stroke-width="0"></rect> </g> <g isolation="isolate"> <text transform="translate(314.232 80.918)" fill="#fff" font-family="InterFace-Bold, InterFace" font-size="18.507" font-weight="700" isolation="isolate"><tspan x="0" y="0">SGLT-2 inhibitors</tspan></text> </g> <rect x="18.585" y="53.556" width="200.212" height="172.874" rx="11.715" ry="11.715" fill="#00a9ab" stroke-width="0"></rect> <g isolation="isolate"> <text transform="translate(30.953 80.918)" fill="#fff" font-family="InterFace-Bold, InterFace" font-size="18.507" font-weight="700" isolation="isolate"><tspan x="0" y="0">No SGLT-2 inhibitors</tspan></text> </g> <g> <path d="M252.882,105.796c-.495-.28-.903-.646-1.226-1.099s-.56-.971-.714-1.554c-.154-.583-.231-1.178-.231-1.785s.077-1.199.231-1.778c.154-.579.392-1.097.714-1.554.322-.458.73-.824,1.226-1.099.494-.275,1.087-.413,1.777-.413.682,0,1.27.138,1.765.413.494.275.902.642,1.225,1.099.322.457.56.975.714,1.554.154.579.231,1.171.231,1.778s-.077,1.202-.231,1.785c-.154.583-.392,1.102-.714,1.554s-.73.819-1.225,1.099c-.495.28-1.083.419-1.765.419-.69,0-1.283-.14-1.777-.419ZM252.56,104.017c.233.364.522.656.868.875.345.22.756.329,1.231.329s.887-.109,1.232-.329c.345-.219.63-.511.854-.875.225-.364.393-.777.504-1.239.112-.462.168-.936.168-1.421,0-.476-.054-.945-.16-1.407-.107-.462-.273-.875-.497-1.239-.225-.364-.512-.656-.861-.875s-.763-.329-1.239-.329-.889.11-1.239.329c-.35.219-.639.511-.867.875-.229.364-.397.777-.504,1.239-.107.462-.161.931-.161,1.407,0,.485.056.959.168,1.421.111.462.279.875.504,1.239Z" fill="#fff" stroke-width="0"></path> <path d="M260.245,106.033v-6.678h.98l.084.588c.177-.187.405-.359.686-.518s.564-.238.854-.238c.205,0,.394.014.566.042.173.028.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.075-.777.224-.247.149-.46.303-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M268.463,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM268.365,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M271.333,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M280.853,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM280.755,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M288.734,100.055c.169.187.304.399.406.637.103.238.154.506.154.805,0,.392-.082.735-.245,1.029s-.381.539-.651.735-.583.341-.938.434-.719.14-1.092.14c-.122,0-.273-.009-.455-.028-.183-.019-.324-.037-.427-.056-.149.019-.29.068-.421.147-.131.079-.195.184-.195.315,0,.149.109.259.329.329.219.07.618.11,1.196.119.561.009,1.055.047,1.484.112.429.065.793.172,1.092.322s.525.353.679.609c.154.257.231.581.231.973,0,.364-.084.682-.252.952s-.396.497-.686.68c-.29.182-.628.319-1.016.413-.388.093-.796.14-1.225.14-1.073,0-1.906-.163-2.499-.49s-.89-.84-.89-1.54c0-.719.327-1.25.98-1.596-.168-.075-.308-.177-.42-.308s-.168-.299-.168-.504c0-.261.1-.476.301-.644.2-.168.45-.289.749-.364-.112-.056-.24-.135-.385-.238s-.28-.233-.406-.392-.23-.343-.314-.553c-.085-.21-.127-.455-.127-.735,0-.392.082-.732.245-1.022.163-.289.381-.529.651-.721s.576-.334.917-.427.688-.14,1.043-.14c.28,0,.553.026.819.077.266.051.52.133.763.245l.994-.994.686.63-.91.91ZM286.383,105.585c-.625-.019-1.055-.046-1.288-.084-.243.122-.438.28-.588.476s-.224.448-.224.756c0,.215.061.401.182.56.121.159.289.292.504.399s.469.188.763.245c.294.056.618.084.974.084.644,0,1.169-.117,1.575-.351.405-.233.608-.546.608-.938,0-.196-.037-.364-.112-.504-.074-.141-.207-.257-.398-.35s-.448-.164-.771-.21c-.321-.047-.73-.075-1.225-.084ZM284.703,102.057c.084.177.203.336.356.476.154.14.339.252.554.336.214.084.457.126.728.126.224,0,.445-.025.665-.077.219-.051.42-.135.602-.252.183-.116.329-.273.441-.469.112-.196.168-.434.168-.714,0-.233-.052-.441-.154-.623-.103-.182-.237-.332-.405-.448s-.362-.205-.581-.266c-.22-.061-.446-.091-.68-.091-.224,0-.445.03-.665.091-.219.061-.413.149-.581.266s-.303.266-.405.448c-.104.182-.154.394-.154.637,0,.196.037.383.112.56Z" fill="#fff" stroke-width="0"></path> <path d="M291.745,102.632c0,.84.191,1.498.574,1.974.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.308.289-.205.522-.457.7-.756l.714.476c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231-.401-.154-.744-.378-1.028-.672-.285-.294-.504-.66-.658-1.099-.154-.438-.231-.947-.231-1.526,0-.532.072-1.01.218-1.435.145-.424.345-.789.602-1.092s.569-.537.938-.7c.368-.163.776-.245,1.225-.245.494,0,.926.084,1.295.252.369.168.674.404.917.707.243.304.425.667.546,1.092s.183.889.183,1.393h-4.858ZM295.385,101.778c-.009-.29-.065-.544-.168-.763s-.233-.401-.392-.546c-.159-.145-.341-.252-.546-.322-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.711-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M298.115,106.033v-6.678h.994l.07.532c.271-.205.59-.373.959-.504.368-.131.753-.196,1.154-.196.915,0,1.562.227,1.939.679s.567,1.123.567,2.009v4.158h-1.078v-4.186c0-.56-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.077-1.043.231-.341.154-.633.325-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M307.201,104.508c0,.327.063.543.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.377-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.385-.271-.257-.406-.651-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M310.646,104.382c.158.299.361.53.609.693.247.164.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.196-.03-.362-.091-.497s-.158-.257-.294-.364c-.135-.107-.311-.21-.524-.308-.215-.098-.477-.203-.784-.315-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.542.198-.966.595-1.274.397-.308.922-.462,1.575-.462.541,0,.994.091,1.358.273.364.182.672.441.924.777l-.756.602c-.187-.224-.406-.411-.658-.56s-.537-.224-.854-.224c-.393,0-.685.077-.875.231-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.206.272.294.131.089.301.178.511.266.21.089.479.189.806.301.615.215,1.082.486,1.399.812.317.327.477.761.477,1.302,0,.317-.062.6-.183.847-.121.247-.287.455-.497.623-.21.168-.459.296-.749.385-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364-.373-.243-.672-.551-.896-.924l.84-.518Z" fill="#fff" stroke-width="0"></path> <path d="M320.36,104.508c0,.327.063.543.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.377-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.385-.271-.257-.406-.651-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M322.824,107.797c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.442c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M329.782,108.68v-9.325h.98l.084.49c.289-.233.595-.401.917-.504.321-.103.66-.154,1.015-.154.495,0,.915.094,1.26.28.346.187.628.439.848.756.219.317.378.684.476,1.099.098.416.147.847.147,1.295,0,.542-.084,1.031-.252,1.47-.168.438-.399.814-.693,1.127-.294.312-.646.553-1.057.721-.411.168-.854.252-1.33.252-.523,0-.962-.075-1.316-.224v2.716h-1.078ZM330.86,105.026c.103.075.252.142.448.203.196.061.415.091.658.091.354,0,.684-.061.986-.182.304-.121.564-.294.784-.518s.39-.501.511-.833c.121-.331.183-.707.183-1.127,0-.308-.033-.618-.099-.931-.065-.312-.173-.592-.321-.84-.149-.247-.349-.448-.596-.602-.247-.154-.553-.231-.917-.231-.299,0-.588.065-.867.196-.28.131-.537.304-.771.518v4.256Z" fill="#fff" stroke-width="0"></path> <path d="M337.664,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM337.118,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M345.448,104.605c-.262.542-.619.94-1.071,1.197-.453.256-.932.385-1.436.385-.392,0-.776-.07-1.154-.21-.378-.14-.712-.354-1.001-.644-.29-.289-.523-.651-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.61.177-.448.41-.814.7-1.099.289-.285.615-.492.979-.623s.729-.196,1.092-.196c.374,0,.702.056.987.168.284.112.527.252.729.42.2.168.363.345.489.532.126.187.217.355.273.504l-.798.504c-.196-.448-.443-.77-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.059-.728.175-.233.117-.443.287-.63.511-.188.224-.336.5-.448.826s-.168.7-.168,1.12.056.793.168,1.12.264.602.455.826.415.395.672.511c.257.117.529.175.819.175.326,0,.642-.093.944-.28.304-.187.554-.49.749-.91l.757.476Z" fill="#fff" stroke-width="0"></path> <path d="M350.487,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM350.39,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M353.357,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M356.367,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M358.761,107.797c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.442c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M372.229,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM372.131,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M379.551,106.033l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749-.252-.317-.443-.693-.574-1.127s-.196-.903-.196-1.407c0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.322.6-.581,1.001-.777.401-.196.868-.294,1.399-.294.336,0,.626.026.868.077.243.051.448.11.616.175v-2.744h1.078v9.338h-.994ZM379.467,100.378c-.056-.038-.133-.075-.231-.112-.098-.037-.207-.072-.328-.105-.122-.033-.248-.058-.378-.077-.131-.019-.257-.028-.379-.028-.392,0-.732.075-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.847-.093.317-.14.64-.14.966,0,.374.042.721.126,1.043.084.322.212.6.385.833.173.233.388.418.645.553.256.135.562.203.917.203.279,0,.555-.058.826-.175.271-.116.513-.31.728-.581v-4.186Z" fill="#fff" stroke-width="0"></path> <path d="M382.435,106.033v-6.678h.994l.07.532c.224-.159.513-.315.868-.469.354-.154.741-.231,1.161-.231.355,0,.698.061,1.029.182.331.122.609.346.833.672.28-.233.621-.434,1.022-.602.4-.168.84-.252,1.315-.252.467,0,.856.063,1.169.189.312.126.561.308.742.546.182.238.311.532.385.882.075.35.112.749.112,1.197v4.032h-1.092v-4.172c0-.56-.107-.996-.322-1.309-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.561.077-.187.051-.361.114-.524.189s-.312.154-.448.238-.25.163-.343.238c.047.159.081.324.104.497s.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.471-.062-.686s-.117-.404-.225-.567c-.107-.164-.249-.292-.427-.385-.177-.093-.406-.14-.686-.14-.327,0-.651.082-.974.245-.321.164-.604.329-.847.497v5.208h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M394.572,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM394.026,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M397.05,106.033v-6.678h.994l.07.532c.271-.205.59-.373.959-.504.368-.131.753-.196,1.154-.196.915,0,1.562.227,1.939.679s.567,1.123.567,2.009v4.158h-1.078v-4.186c0-.56-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.077-1.043.231-.341.154-.633.325-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M405.17,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM404.624,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M408.012,104.382c.158.299.361.53.609.693.247.164.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.196-.03-.362-.091-.497s-.158-.257-.294-.364c-.135-.107-.311-.21-.524-.308-.215-.098-.477-.203-.784-.315-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.542.198-.966.595-1.274.397-.308.922-.462,1.575-.462.541,0,.994.091,1.358.273.364.182.672.441.924.777l-.756.602c-.187-.224-.406-.411-.658-.56s-.537-.224-.854-.224c-.393,0-.685.077-.875.231-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.206.272.294.131.089.301.178.511.266.21.089.479.189.806.301.615.215,1.082.486,1.399.812.317.327.477.761.477,1.302,0,.317-.062.6-.183.847-.121.247-.287.455-.497.623-.21.168-.459.296-.749.385-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364-.373-.243-.672-.551-.896-.924l.84-.518Z" fill="#fff" stroke-width="0"></path> <path d="M414.927,104.508c0,.327.063.543.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.377-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.385-.271-.257-.406-.651-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M418.749,102.632c0,.84.191,1.498.574,1.974.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.308.289-.205.522-.457.7-.756l.714.476c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231-.401-.154-.744-.378-1.028-.672-.285-.294-.504-.66-.658-1.099-.154-.438-.231-.947-.231-1.526,0-.532.072-1.01.218-1.435.145-.424.345-.789.602-1.092s.569-.537.938-.7c.368-.163.776-.245,1.225-.245.494,0,.926.084,1.295.252.369.168.674.404.917.707.243.304.425.667.546,1.092s.183.889.183,1.393h-4.858ZM422.389,101.778c-.009-.29-.065-.544-.168-.763s-.233-.401-.392-.546c-.159-.145-.341-.252-.546-.322-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.711-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M425.119,106.033v-6.678h.98l.084.588c.177-.187.405-.359.686-.518s.564-.238.854-.238c.205,0,.394.014.566.042.173.028.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.075-.777.224-.247.149-.46.303-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M430.369,102.632c0,.84.191,1.498.574,1.974.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.308.289-.205.522-.457.7-.756l.714.476c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231-.401-.154-.744-.378-1.028-.672-.285-.294-.504-.66-.658-1.099-.154-.438-.231-.947-.231-1.526,0-.532.072-1.01.218-1.435.145-.424.345-.789.602-1.092s.569-.537.938-.7c.368-.163.776-.245,1.225-.245.494,0,.926.084,1.295.252.369.168.674.404.917.707.243.304.425.667.546,1.092s.183.889.183,1.393h-4.858ZM434.009,101.778c-.009-.29-.065-.544-.168-.763s-.233-.401-.392-.546c-.159-.145-.341-.252-.546-.322-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.711-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M441.191,106.033l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749-.252-.317-.443-.693-.574-1.127s-.196-.903-.196-1.407c0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.322.6-.581,1.001-.777.401-.196.868-.294,1.399-.294.336,0,.626.026.868.077.243.051.448.11.616.175v-2.744h1.078v9.338h-.994ZM441.107,100.378c-.056-.038-.133-.075-.231-.112-.098-.037-.207-.072-.328-.105-.122-.033-.248-.058-.378-.077-.131-.019-.257-.028-.379-.028-.392,0-.732.075-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.847-.093.317-.14.64-.14.966,0,.374.042.721.126,1.043.084.322.212.6.385.833.173.233.388.418.645.553.256.135.562.203.917.203.279,0,.555-.058.826-.175.271-.116.513-.31.728-.581v-4.186Z" fill="#fff" stroke-width="0"></path> <path d="M448.303,105.893c-.383-.205-.704-.474-.966-.805-.261-.332-.457-.709-.588-1.134-.131-.424-.196-.856-.196-1.295s.063-.866.189-1.281c.126-.416.319-.787.581-1.113.261-.327.586-.588.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12c.131.42.196.849.196,1.288s-.065.868-.196,1.288-.324.793-.581,1.12-.581.59-.973.791c-.393.201-.845.301-1.358.301s-.966-.099-1.358-.294ZM448.121,104.493c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.154.471-.355.644-.602s.301-.53.385-.847.126-.639.126-.966-.042-.649-.126-.966c-.084-.317-.212-.6-.385-.847-.173-.248-.388-.446-.644-.595-.257-.149-.558-.224-.903-.224s-.646.075-.903.224c-.257.149-.469.348-.637.595-.168.247-.294.527-.378.84-.084.313-.126.632-.126.959,0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M454.379,106.033v-6.678h.994l.07.532c.271-.205.59-.373.959-.504.368-.131.753-.196,1.154-.196.915,0,1.562.227,1.939.679s.567,1.123.567,2.009v4.158h-1.078v-4.186c0-.56-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.077-1.043.231-.341.154-.633.325-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M467.26,104.605c-.262.542-.619.94-1.071,1.197-.453.256-.932.385-1.436.385-.392,0-.776-.07-1.154-.21-.378-.14-.712-.354-1.001-.644-.29-.289-.523-.651-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.61.177-.448.41-.814.7-1.099.289-.285.615-.492.979-.623s.729-.196,1.092-.196c.374,0,.702.056.987.168.284.112.527.252.729.42.2.168.363.345.489.532.126.187.217.355.273.504l-.798.504c-.196-.448-.443-.77-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.059-.728.175-.233.117-.443.287-.63.511-.188.224-.336.5-.448.826s-.168.7-.168,1.12.056.793.168,1.12.264.602.455.826.415.395.672.511c.257.117.529.175.819.175.326,0,.642-.093.944-.28.304-.187.554-.49.749-.91l.757.476Z" fill="#fff" stroke-width="0"></path> <path d="M469.331,102.632c0,.84.191,1.498.574,1.974.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.308.289-.205.522-.457.7-.756l.714.476c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231-.401-.154-.744-.378-1.028-.672-.285-.294-.504-.66-.658-1.099-.154-.438-.231-.947-.231-1.526,0-.532.072-1.01.218-1.435.145-.424.345-.789.602-1.092s.569-.537.938-.7c.368-.163.776-.245,1.225-.245.494,0,.926.084,1.295.252.369.168.674.404.917.707.243.304.425.667.546,1.092s.183.889.183,1.393h-4.858ZM472.971,101.778c-.009-.29-.065-.544-.168-.763s-.233-.401-.392-.546c-.159-.145-.341-.252-.546-.322-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.711-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M482.953,106.033l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749-.252-.317-.443-.693-.574-1.127s-.196-.903-.196-1.407c0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.322.6-.581,1.001-.777.401-.196.868-.294,1.399-.294.336,0,.626.026.868.077.243.051.448.11.616.175v-2.744h1.078v9.338h-.994ZM482.869,100.378c-.056-.038-.133-.075-.231-.112-.098-.037-.207-.072-.328-.105-.122-.033-.248-.058-.378-.077-.131-.019-.257-.028-.379-.028-.392,0-.732.075-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.847-.093.317-.14.64-.14.966,0,.374.042.721.126,1.043.084.322.212.6.385.833.173.233.388.418.645.553.256.135.562.203.917.203.279,0,.555-.058.826-.175.271-.116.513-.31.728-.581v-4.186Z" fill="#fff" stroke-width="0"></path> <path d="M489.547,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM489.449,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M492.963,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM492.417,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M495.44,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M497.834,107.797c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.442c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M504.008,106.957c.168-.047.357-.143.567-.287s.353-.301.427-.469c-.111-.047-.217-.143-.314-.287-.099-.145-.147-.343-.147-.595,0-.233.07-.439.21-.616.141-.177.317-.266.532-.266.224,0,.408.091.553.273.145.182.217.423.217.721,0,.233-.058.455-.175.666-.116.21-.269.403-.455.58-.187.178-.392.329-.615.455-.225.126-.448.222-.673.287l-.126-.462Z" fill="#fff" stroke-width="0"></path> <path d="M510.993,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM510.447,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M513.471,106.033v-6.678h.994l.07.532c.271-.205.59-.373.959-.504.368-.131.753-.196,1.154-.196.915,0,1.562.227,1.939.679s.567,1.123.567,2.009v4.158h-1.078v-4.186c0-.56-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.077-1.043.231-.341.154-.633.325-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M521.591,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM521.045,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M525.58,104.508c0,.327.063.543.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.377-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.385-.271-.257-.406-.651-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M529.206,98.291c-.195,0-.363-.077-.504-.231-.14-.154-.21-.343-.21-.567,0-.214.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.159.21.346.21.56,0,.224-.069.413-.21.567-.14.154-.308.231-.504.231ZM528.66,106.033v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M535.394,106.033l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393-.21-.172-.381-.39-.512-.651-.13-.261-.195-.564-.195-.91,0-.476.128-.868.385-1.176s.581-.553.973-.735c.393-.182.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.56-.119-.961-.357-1.204-.237-.243-.581-.364-1.028-.364-.309,0-.591.068-.848.203s-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.574.415.383.623,1.022.623,1.918v4.354h-.98ZM535.296,102.548c-.309.009-.635.033-.98.07-.345.038-.665.11-.959.217-.294.107-.536.264-.728.469-.191.206-.287.476-.287.812,0,.215.042.397.126.546.084.149.189.273.315.371s.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.067.902-.203.275-.135.521-.296.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M538.264,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M541.273,106.033v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M543.667,107.797c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.442c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M554.461,103.639c0,.588.135,1.015.406,1.281.271.266.672.399,1.204.399.345,0,.688-.072,1.028-.217.341-.145.618-.319.833-.525v-5.222h1.093v6.678h-.994l-.07-.518c-.271.206-.564.369-.882.49-.317.121-.714.182-1.19.182-.877,0-1.514-.215-1.911-.645-.396-.429-.595-1.083-.595-1.96v-4.228h1.078v4.284Z" fill="#fff" stroke-width="0"></path> <path d="M561.321,104.382c.158.299.361.53.609.693.247.164.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.196-.03-.362-.091-.497s-.158-.257-.294-.364c-.135-.107-.311-.21-.524-.308-.215-.098-.477-.203-.784-.315-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.542.198-.966.595-1.274.397-.308.922-.462,1.575-.462.541,0,.994.091,1.358.273.364.182.672.441.924.777l-.756.602c-.187-.224-.406-.411-.658-.56s-.537-.224-.854-.224c-.393,0-.685.077-.875.231-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.206.272.294.131.089.301.178.511.266.21.089.479.189.806.301.615.215,1.082.486,1.399.812.317.327.477.761.477,1.302,0,.317-.062.6-.183.847-.121.247-.287.455-.497.623-.21.168-.459.296-.749.385-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364-.373-.243-.672-.551-.896-.924l.84-.518Z" fill="#fff" stroke-width="0"></path> <path d="M567.467,102.632c0,.84.191,1.498.574,1.974.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.308.289-.205.522-.457.7-.756l.714.476c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231-.401-.154-.744-.378-1.028-.672-.285-.294-.504-.66-.658-1.099-.154-.438-.231-.947-.231-1.526,0-.532.072-1.01.218-1.435.145-.424.345-.789.602-1.092s.569-.537.938-.7c.368-.163.776-.245,1.225-.245.494,0,.926.084,1.295.252.369.168.674.404.917.707.243.304.425.667.546,1.092s.183.889.183,1.393h-4.858ZM571.106,101.778c-.009-.29-.065-.544-.168-.763s-.233-.401-.392-.546c-.159-.145-.341-.252-.546-.322-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.711-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M578.289,106.033l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749-.252-.317-.443-.693-.574-1.127s-.196-.903-.196-1.407c0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.322.6-.581,1.001-.777.401-.196.868-.294,1.399-.294.336,0,.626.026.868.077.243.051.448.11.616.175v-2.744h1.078v9.338h-.994ZM578.205,100.378c-.056-.038-.133-.075-.231-.112-.098-.037-.207-.072-.328-.105-.122-.033-.248-.058-.378-.077-.131-.019-.257-.028-.379-.028-.392,0-.732.075-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.847-.093.317-.14.64-.14.966,0,.374.042.721.126,1.043.084.322.212.6.385.833.173.233.388.418.645.553.256.135.562.203.917.203.279,0,.555-.058.826-.175.271-.116.513-.31.728-.581v-4.186Z" fill="#fff" stroke-width="0"></path> <path d="M250.991,125.48v-9.324h.98l.084.489c.289-.232.595-.4.917-.504.321-.103.66-.153,1.015-.153.495,0,.915.093,1.26.279.346.188.628.439.848.757.219.317.378.684.476,1.099s.147.847.147,1.295c0,.541-.084,1.031-.252,1.47-.168.439-.399.814-.693,1.127-.294.313-.646.554-1.057.722-.411.168-.854.252-1.33.252-.523,0-.962-.075-1.316-.225v2.717h-1.078ZM252.069,121.825c.103.074.252.143.448.203s.415.091.658.091c.354,0,.684-.061.986-.183.304-.121.564-.294.784-.518s.39-.502.511-.833.183-.707.183-1.127c0-.308-.033-.618-.099-.931s-.173-.593-.321-.84c-.149-.248-.349-.448-.596-.603s-.553-.23-.917-.23c-.299,0-.588.065-.867.195-.28.131-.537.304-.771.519v4.256Z" fill="#fff" stroke-width="0"></path> <path d="M258.327,122.833v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M263.381,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM262.835,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M265.858,122.833v-6.678h.994l.07.531c.224-.158.513-.314.868-.469.354-.153.741-.23,1.161-.23.355,0,.698.061,1.029.182s.609.346.833.672c.28-.233.621-.434,1.022-.602.4-.168.84-.252,1.315-.252.467,0,.856.062,1.169.188s.561.309.742.546c.182.238.311.532.385.883.075.35.112.748.112,1.196v4.032h-1.092v-4.172c0-.561-.107-.996-.322-1.31-.215-.312-.606-.469-1.176-.469-.187,0-.373.026-.561.077-.187.052-.361.114-.524.189-.163.074-.312.153-.448.237s-.25.164-.343.238c.047.159.081.324.104.497s.035.399.035.679v4.032h-1.078v-4.172c0-.243-.021-.472-.062-.687-.042-.214-.117-.403-.225-.566s-.249-.292-.427-.385c-.177-.094-.406-.141-.686-.141-.327,0-.651.082-.974.245-.321.163-.604.329-.847.497v5.208h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M281.16,122.833l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM281.062,119.347c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M284.03,122.833v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M289.084,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM288.538,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M291.562,122.833v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M293.955,124.597c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.441c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M304.007,122.833v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h1.596v.882h-1.582v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M309.242,122.694c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM309.061,121.293c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M315.318,122.833v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M324.138,121.307c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M326.602,124.597c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.441c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M333.56,125.48v-9.324h.98l.084.489c.289-.232.595-.4.917-.504.321-.103.66-.153,1.015-.153.495,0,.915.093,1.26.279.346.188.628.439.848.757.219.317.378.684.476,1.099s.147.847.147,1.295c0,.541-.084,1.031-.252,1.47-.168.439-.399.814-.693,1.127-.294.313-.646.554-1.057.722-.411.168-.854.252-1.33.252-.523,0-.962-.075-1.316-.225v2.717h-1.078ZM334.638,121.825c.103.074.252.143.448.203s.415.091.658.091c.354,0,.684-.061.986-.183.304-.121.564-.294.784-.518s.39-.502.511-.833.183-.707.183-1.127c0-.308-.033-.618-.099-.931s-.173-.593-.321-.84c-.149-.248-.349-.448-.596-.603s-.553-.23-.917-.23c-.299,0-.588.065-.867.195-.28.131-.537.304-.771.519v4.256Z" fill="#fff" stroke-width="0"></path> <path d="M341.638,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM345.277,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M350.892,122.833v-.658c.514-.588,1.003-1.152,1.47-1.693.467-.542.896-1.064,1.288-1.568.225-.289.425-.558.603-.805.177-.248.326-.485.448-.715.121-.229.212-.452.272-.672.061-.219.091-.45.091-.692,0-.532-.138-.936-.413-1.211s-.637-.413-1.085-.413c-.849,0-1.545.467-2.086,1.399l-.882-.518c.327-.598.737-1.06,1.232-1.386.494-.327,1.097-.49,1.806-.49.401,0,.763.061,1.085.182.322.122.598.292.826.512.229.219.406.48.532.783.126.304.188.638.188,1.001,0,.607-.149,1.179-.448,1.716-.299.536-.653,1.066-1.063,1.589-.364.476-.742.936-1.134,1.379-.393.443-.784.88-1.177,1.309h4.061v.952h-5.614Z" fill="#fff" stroke-width="0"></path> <path d="M365.619,122.833l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM365.535,117.177c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M369.049,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM368.503,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M375.236,122.833l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM375.139,119.347c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M379.185,116.365c.289-.131.567-.225.833-.28s.529-.084.791-.084c.43,0,.831.077,1.204.231.373.153.693.378.959.672s.476.657.63,1.092c.154.434.231.936.231,1.505,0,.532-.084,1.013-.252,1.442-.168.429-.401.796-.7,1.099-.299.304-.651.537-1.058.7-.405.163-.847.245-1.322.245-.514,0-.974-.054-1.379-.161-.406-.107-.745-.222-1.016-.343v-8.988h1.078v2.87ZM379.185,121.881c.177.075.368.136.574.183.205.046.401.069.588.069.373,0,.712-.062,1.015-.188.304-.126.561-.306.771-.539s.371-.514.482-.84c.112-.327.168-.691.168-1.093s-.056-.763-.168-1.085c-.111-.321-.266-.595-.462-.818-.195-.225-.425-.395-.686-.512-.262-.116-.546-.175-.854-.175-.224,0-.457.03-.699.091-.243.062-.486.171-.729.329v4.578Z" fill="#fff" stroke-width="0"></path> <path d="M386.185,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM389.824,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M394.066,121.307c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M397.889,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM401.528,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M404.623,121.181c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M409.242,123.757c.168-.047.357-.143.567-.287s.353-.301.427-.469c-.111-.047-.217-.143-.314-.287-.099-.145-.147-.343-.147-.595,0-.233.07-.438.21-.616.141-.177.317-.266.532-.266.224,0,.408.091.553.272.145.183.217.423.217.722,0,.233-.058.454-.175.665-.116.21-.269.403-.455.58-.187.178-.392.329-.615.455-.225.126-.448.222-.673.287l-.126-.462Z" fill="#fff" stroke-width="0"></path> <path d="M416.928,122.833l-2.212-6.678h1.162l1.512,5.025,1.638-5.025h.616l1.652,5.025,1.512-5.025h1.162l-2.212,6.678h-.84l-1.582-4.816-1.568,4.816h-.84Z" fill="#fff" stroke-width="0"></path> <path d="M425.481,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM424.936,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M429.471,121.307c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M432.551,122.833v-9.338h1.078v3.191c.271-.195.579-.361.924-.496.346-.136.732-.203,1.162-.203.905,0,1.547.229,1.925.686.378.458.567,1.125.567,2.002v4.158h-1.092v-4.172c0-.616-.126-1.071-.378-1.365s-.658-.44-1.219-.44c-.354,0-.697.081-1.028.244-.332.164-.619.334-.861.512v5.222h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M446.606,122.833l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM446.509,119.347c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M457.288,116.856c.169.187.304.398.406.637s.154.506.154.805c0,.393-.082.735-.245,1.029s-.381.539-.651.734c-.271.196-.583.341-.938.435s-.719.14-1.092.14c-.122,0-.273-.009-.455-.027-.183-.019-.324-.038-.427-.057-.149.019-.29.068-.421.147s-.195.185-.195.314c0,.149.109.26.329.329.219.07.618.11,1.196.119.561.01,1.055.047,1.484.112.429.065.793.173,1.092.321.299.149.525.353.679.609.154.257.231.581.231.973,0,.364-.084.682-.252.952s-.396.497-.686.68c-.29.182-.628.319-1.016.413-.388.093-.796.14-1.225.14-1.073,0-1.906-.163-2.499-.49s-.89-.84-.89-1.54c0-.719.327-1.25.98-1.596-.168-.075-.308-.178-.42-.309-.112-.13-.168-.298-.168-.504,0-.261.1-.476.301-.644.2-.168.45-.289.749-.364-.112-.056-.24-.135-.385-.238-.145-.103-.28-.232-.406-.392-.126-.158-.23-.343-.314-.553-.085-.21-.127-.455-.127-.735,0-.392.082-.732.245-1.021.163-.29.381-.53.651-.722.271-.19.576-.333.917-.427.341-.093.688-.14,1.043-.14.28,0,.553.025.819.077.266.051.52.133.763.244l.994-.993.686.63-.91.91ZM454.937,122.385c-.625-.019-1.055-.046-1.288-.084-.243.122-.438.28-.588.477-.149.195-.224.447-.224.756,0,.215.061.401.182.56.121.159.289.292.504.399s.469.188.763.245c.294.056.618.084.974.084.644,0,1.169-.117,1.575-.351.405-.233.608-.546.608-.938,0-.196-.037-.364-.112-.504-.074-.141-.207-.257-.398-.351-.191-.093-.448-.163-.771-.21-.321-.046-.73-.074-1.225-.084ZM453.257,118.858c.084.177.203.336.356.476.154.14.339.252.554.336.214.084.457.126.728.126.224,0,.445-.025.665-.077.219-.051.42-.135.602-.252.183-.116.329-.272.441-.469s.168-.434.168-.714c0-.233-.052-.441-.154-.623-.103-.183-.237-.331-.405-.448-.168-.116-.362-.205-.581-.266-.22-.061-.446-.091-.68-.091-.224,0-.445.03-.665.091-.219.061-.413.149-.581.266-.168.117-.303.266-.405.448-.104.182-.154.395-.154.637,0,.196.037.383.112.561Z" fill="#fff" stroke-width="0"></path> <path d="M459.557,122.833v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M465.492,122.694c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM465.311,121.293c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M472.814,122.833l-2.212-6.678h1.162l1.512,5.025,1.638-5.025h.616l1.652,5.025,1.512-5.025h1.162l-2.212,6.678h-.84l-1.582-4.816-1.568,4.816h-.84Z" fill="#fff" stroke-width="0"></path> <path d="M481.368,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM480.822,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M483.846,122.833v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M496.432,116.856c.169.187.304.398.406.637s.154.506.154.805c0,.393-.082.735-.245,1.029s-.381.539-.651.734c-.271.196-.583.341-.938.435s-.719.14-1.092.14c-.122,0-.273-.009-.455-.027-.183-.019-.324-.038-.427-.057-.149.019-.29.068-.421.147s-.195.185-.195.314c0,.149.109.26.329.329.219.07.618.11,1.196.119.561.01,1.055.047,1.484.112.429.065.793.173,1.092.321.299.149.525.353.679.609.154.257.231.581.231.973,0,.364-.084.682-.252.952s-.396.497-.686.68c-.29.182-.628.319-1.016.413-.388.093-.796.14-1.225.14-1.073,0-1.906-.163-2.499-.49s-.89-.84-.89-1.54c0-.719.327-1.25.98-1.596-.168-.075-.308-.178-.42-.309-.112-.13-.168-.298-.168-.504,0-.261.1-.476.301-.644.2-.168.45-.289.749-.364-.112-.056-.24-.135-.385-.238-.145-.103-.28-.232-.406-.392-.126-.158-.23-.343-.314-.553-.085-.21-.127-.455-.127-.735,0-.392.082-.732.245-1.021.163-.29.381-.53.651-.722.271-.19.576-.333.917-.427.341-.093.688-.14,1.043-.14.28,0,.553.025.819.077.266.051.52.133.763.244l.994-.993.686.63-.91.91ZM494.08,122.385c-.625-.019-1.055-.046-1.288-.084-.243.122-.438.28-.588.477-.149.195-.224.447-.224.756,0,.215.061.401.182.56.121.159.289.292.504.399s.469.188.763.245c.294.056.618.084.974.084.644,0,1.169-.117,1.575-.351.405-.233.608-.546.608-.938,0-.196-.037-.364-.112-.504-.074-.141-.207-.257-.398-.351-.191-.093-.448-.163-.771-.21-.321-.046-.73-.074-1.225-.084ZM492.4,118.858c.084.177.203.336.356.476.154.14.339.252.554.336.214.084.457.126.728.126.224,0,.445-.025.665-.077.219-.051.42-.135.602-.252.183-.116.329-.272.441-.469s.168-.434.168-.714c0-.233-.052-.441-.154-.623-.103-.183-.237-.331-.405-.448-.168-.116-.362-.205-.581-.266-.22-.061-.446-.091-.68-.091-.224,0-.445.03-.665.091-.219.061-.413.149-.581.266-.168.117-.303.266-.405.448-.104.182-.154.395-.154.637,0,.196.037.383.112.561Z" fill="#fff" stroke-width="0"></path> <path d="M502.578,116.365c.289-.131.567-.225.833-.28s.529-.084.791-.084c.43,0,.831.077,1.204.231.373.153.693.378.959.672s.476.657.63,1.092c.154.434.231.936.231,1.505,0,.532-.084,1.013-.252,1.442-.168.429-.401.796-.7,1.099-.299.304-.651.537-1.058.7-.405.163-.847.245-1.322.245-.514,0-.974-.054-1.379-.161-.406-.107-.745-.222-1.016-.343v-8.988h1.078v2.87ZM502.578,121.881c.177.075.368.136.574.183.205.046.401.069.588.069.373,0,.712-.062,1.015-.188.304-.126.561-.306.771-.539s.371-.514.482-.84c.112-.327.168-.691.168-1.093s-.056-.763-.168-1.085c-.111-.321-.266-.595-.462-.818-.195-.225-.425-.395-.686-.512-.262-.116-.546-.175-.854-.175-.224,0-.457.03-.699.091-.243.062-.486.171-.729.329v4.578Z" fill="#fff" stroke-width="0"></path> <path d="M510.264,122.694c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM510.082,121.293c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M520.792,122.833l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM520.708,117.177c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M523.06,124.597c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.441c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M534.245,122.694c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM534.063,121.293c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M540.615,122.833v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h1.596v.882h-1.582v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M547.965,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM551.604,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M555.875,122.833l-2.506-6.678h1.162l1.988,5.445,2.002-5.445h1.092l-2.506,6.678h-1.232Z" fill="#fff" stroke-width="0"></path> <path d="M561.125,115.091c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM560.579,122.833v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M568.055,122.833l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM567.971,117.177c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M571.681,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM575.32,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M578.051,122.833v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M590.932,121.405c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M593.003,119.431c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM596.643,118.577c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M250.991,139.633v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M256.241,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM259.881,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M267.623,133.655c.169.187.304.398.406.637s.154.506.154.805c0,.393-.082.735-.245,1.029s-.381.539-.651.734c-.271.196-.583.341-.938.435s-.719.14-1.092.14c-.122,0-.273-.009-.455-.027-.183-.019-.324-.038-.427-.057-.149.019-.29.068-.421.147s-.195.185-.195.314c0,.149.109.26.329.329.219.07.618.11,1.196.119.561.01,1.055.047,1.484.112.429.065.793.173,1.092.321.299.149.525.353.679.609.154.257.231.581.231.973,0,.364-.084.682-.252.952s-.396.497-.686.68c-.29.182-.628.319-1.016.413-.388.093-.796.14-1.225.14-1.073,0-1.906-.163-2.499-.49s-.89-.84-.89-1.54c0-.719.327-1.25.98-1.596-.168-.075-.308-.178-.42-.309-.112-.13-.168-.298-.168-.504,0-.261.1-.476.301-.644.2-.168.45-.289.749-.364-.112-.056-.24-.135-.385-.238-.145-.103-.28-.232-.406-.392-.126-.158-.23-.343-.314-.553-.085-.21-.127-.455-.127-.735,0-.392.082-.732.245-1.021.163-.29.381-.53.651-.722.271-.19.576-.333.917-.427.341-.093.688-.14,1.043-.14.28,0,.553.025.819.077.266.051.52.133.763.244l.994-.993.686.63-.91.91ZM265.271,139.185c-.625-.019-1.055-.046-1.288-.084-.243.122-.438.28-.588.477-.149.195-.224.447-.224.756,0,.215.061.401.182.56.121.159.289.292.504.399s.469.188.763.245c.294.056.618.084.974.084.644,0,1.169-.117,1.575-.351.405-.233.608-.546.608-.938,0-.196-.037-.364-.112-.504-.074-.141-.207-.257-.398-.351-.191-.093-.448-.163-.771-.21-.321-.046-.73-.074-1.225-.084ZM263.592,135.657c.084.177.203.336.356.476.154.14.339.252.554.336.214.084.457.126.728.126.224,0,.445-.025.665-.077.219-.051.42-.135.602-.252.183-.116.329-.272.441-.469s.168-.434.168-.714c0-.233-.052-.441-.154-.623-.103-.183-.237-.331-.405-.448-.168-.116-.362-.205-.581-.266-.22-.061-.446-.091-.68-.091-.224,0-.445.03-.665.091-.219.061-.413.149-.581.266-.168.117-.303.266-.405.448-.104.182-.154.395-.154.637,0,.196.037.383.112.561Z" fill="#fff" stroke-width="0"></path> <path d="M273.602,139.633l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM273.504,136.147c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M276.472,139.633v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M285.432,139.633l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM285.348,133.977c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M288.861,131.891c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM288.315,139.633v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M291.339,139.633v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M303.925,133.655c.169.187.304.398.406.637s.154.506.154.805c0,.393-.082.735-.245,1.029s-.381.539-.651.734c-.271.196-.583.341-.938.435s-.719.14-1.092.14c-.122,0-.273-.009-.455-.027-.183-.019-.324-.038-.427-.057-.149.019-.29.068-.421.147s-.195.185-.195.314c0,.149.109.26.329.329.219.07.618.11,1.196.119.561.01,1.055.047,1.484.112.429.065.793.173,1.092.321.299.149.525.353.679.609.154.257.231.581.231.973,0,.364-.084.682-.252.952s-.396.497-.686.68c-.29.182-.628.319-1.016.413-.388.093-.796.14-1.225.14-1.073,0-1.906-.163-2.499-.49s-.89-.84-.89-1.54c0-.719.327-1.25.98-1.596-.168-.075-.308-.178-.42-.309-.112-.13-.168-.298-.168-.504,0-.261.1-.476.301-.644.2-.168.45-.289.749-.364-.112-.056-.24-.135-.385-.238-.145-.103-.28-.232-.406-.392-.126-.158-.23-.343-.314-.553-.085-.21-.127-.455-.127-.735,0-.392.082-.732.245-1.021.163-.29.381-.53.651-.722.271-.19.576-.333.917-.427.341-.093.688-.14,1.043-.14.28,0,.553.025.819.077.266.051.52.133.763.244l.994-.993.686.63-.91.91ZM301.573,139.185c-.625-.019-1.055-.046-1.288-.084-.243.122-.438.28-.588.477-.149.195-.224.447-.224.756,0,.215.061.401.182.56.121.159.289.292.504.399s.469.188.763.245c.294.056.618.084.974.084.644,0,1.169-.117,1.575-.351.405-.233.608-.546.608-.938,0-.196-.037-.364-.112-.504-.074-.141-.207-.257-.398-.351-.191-.093-.448-.163-.771-.21-.321-.046-.73-.074-1.225-.084ZM299.894,135.657c.084.177.203.336.356.476.154.14.339.252.554.336.214.084.457.126.728.126.224,0,.445-.025.665-.077.219-.051.42-.135.602-.252.183-.116.329-.272.441-.469s.168-.434.168-.714c0-.233-.052-.441-.154-.623-.103-.183-.237-.331-.405-.448-.168-.116-.362-.205-.581-.266-.22-.061-.446-.091-.68-.091-.224,0-.445.03-.665.091-.219.061-.413.149-.581.266-.168.117-.303.266-.405.448-.104.182-.154.395-.154.637,0,.196.037.383.112.561Z" fill="#fff" stroke-width="0"></path> <path d="M314.3,138.205c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M319.339,139.633l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM319.241,136.147c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M322.209,139.633v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M331.169,139.633l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM331.085,133.977c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M334.599,131.891c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM334.053,139.633v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M338.504,139.493c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM338.322,138.093c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M346.12,139.633l-2.506-6.678h1.162l1.988,5.445,2.002-5.445h1.092l-2.506,6.678h-1.232Z" fill="#fff" stroke-width="0"></path> <path d="M354.534,139.633l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM354.437,136.147c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M357.769,137.981c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M368.479,138.205c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M370.844,137.239c0,.588.135,1.015.406,1.28.271.267.672.399,1.204.399.345,0,.688-.072,1.028-.217s.618-.32.833-.525v-5.222h1.093v6.678h-.994l-.07-.518c-.271.205-.564.368-.882.489s-.714.183-1.19.183c-.877,0-1.514-.215-1.911-.645-.396-.429-.595-1.082-.595-1.96v-4.228h1.078v4.284Z" fill="#fff" stroke-width="0"></path> <path d="M377.34,139.633v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M384.06,139.633l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM383.962,136.147c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M386.93,139.633v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M397.947,139.633l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM397.85,136.147c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M400.817,139.633v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M412.844,139.633l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM412.76,133.977c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M418.527,139.633v-9.338h1.078v5.194l2.702-2.534h1.372l-2.282,2.155,2.87,4.522h-1.246l-2.422-3.78-.994.91v2.87h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M425.751,131.891c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM425.205,139.633v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M432.681,139.633l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM432.597,133.977c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M435.564,139.633v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M443.881,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM447.521,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M449.635,141.397c.103.037.231.072.386.105.153.032.31.049.469.049.215,0,.383-.052.504-.154s.247-.303.378-.602l.546-1.33-2.632-6.51h1.232l1.974,5.138,1.974-5.138h1.162l-3.416,8.441c-.168.411-.403.691-.707.84-.303.149-.618.225-.944.225-.215,0-.441-.03-.68-.091-.237-.062-.422-.119-.553-.176l.308-.798Z" fill="#fff" stroke-width="0"></path> <path d="M459.393,142.279v-9.324h.98l.084.489c.289-.232.595-.4.917-.504.321-.103.66-.153,1.015-.153.495,0,.915.093,1.26.279.346.188.628.439.848.757.219.317.378.684.476,1.099s.147.847.147,1.295c0,.541-.084,1.031-.252,1.47-.168.439-.399.814-.693,1.127-.294.313-.646.554-1.057.722-.411.168-.854.252-1.33.252-.523,0-.962-.075-1.316-.225v2.717h-1.078ZM460.471,138.625c.103.074.252.143.448.203s.415.091.658.091c.354,0,.684-.061.986-.183.304-.121.564-.294.784-.518s.39-.502.511-.833.183-.707.183-1.127c0-.308-.033-.618-.099-.931s-.173-.593-.321-.84c-.149-.248-.349-.448-.596-.603s-.553-.23-.917-.23c-.299,0-.588.065-.867.195-.28.131-.537.304-.771.519v4.256Z" fill="#fff" stroke-width="0"></path> <path d="M466.729,139.633v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M472.664,139.493c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM472.482,138.093c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M480.252,138.107c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M484.074,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM487.714,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M495.751,138.205c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M498.592,138.107c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M502.218,131.891c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM501.672,139.633v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M506.235,139.633l-2.506-6.678h1.162l1.988,5.445,2.002-5.445h1.092l-2.506,6.678h-1.232Z" fill="#fff" stroke-width="0"></path> <path d="M511.682,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM515.321,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M521.594,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM525.233,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M528.258,139.633v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h3.038v-.49c0-.43.049-.793.147-1.092.098-.299.235-.541.412-.729.178-.187.388-.321.631-.405.242-.084.513-.126.812-.126.354,0,.655.034.903.104.247.07.464.156.65.259l-.321.826c-.159-.074-.334-.143-.525-.203s-.408-.091-.651-.091c-.158,0-.299.019-.42.056-.121.038-.224.11-.308.218s-.149.257-.196.447c-.047.191-.069.441-.069.749v.477h1.596v.882h-1.582v5.796h-1.092v-5.796h-3.011v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M536.91,136.231c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM540.55,135.377c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M548.587,138.205c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M551.428,138.107c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M554.872,137.981c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M560.695,139.787c-.215,0-.395-.082-.539-.245s-.217-.361-.217-.595.072-.432.217-.596c.145-.163.324-.245.539-.245s.395.082.539.245c.145.164.217.362.217.596s-.072.432-.217.595-.324.245-.539.245Z" fill="#fff" stroke-width="0"></path> <path d="M251.159,156.434v-9.338h2.66c.934,0,1.638.214,2.114.643.476.429.714,1.007.714,1.733,0,.597-.171,1.056-.511,1.377-.341.321-.777.528-1.31.622.262.028.53.089.806.182.274.094.522.231.741.414.22.183.399.416.539.701.141.285.21.638.21,1.059,0,.401-.067.764-.203,1.086-.135.322-.321.596-.56.82s-.525.397-.861.519c-.336.122-.699.183-1.092.183h-3.248ZM252.279,151.058h1.442c.56,0,.991-.149,1.295-.448.303-.299.455-.69.455-1.176,0-.915-.537-1.372-1.61-1.372h-1.582v2.996ZM252.279,155.468h2.072c.476,0,.858-.138,1.147-.413.29-.275.435-.693.435-1.253,0-1.186-.724-1.778-2.17-1.778h-1.484v3.444Z" fill="#fff" stroke-width="0"></path> <path d="M259.251,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM262.891,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M265.621,156.434v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M273.938,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM277.577,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M280.602,156.434v-5.796h-.979v-.882h.994v-.49c0-.401.062-.751.188-1.05s.294-.544.504-.735.455-.333.735-.427.574-.14.882-.14c.514,0,.922.072,1.225.217.304.145.558.306.764.482l-.519.714c-.158-.13-.359-.256-.602-.378-.243-.121-.527-.182-.854-.182-.392,0-.699.112-.924.336-.224.224-.336.616-.336,1.176v.477h1.596v.882h-1.582v5.796h-1.092ZM284.158,156.434v-6.678h1.077v6.678h-1.077Z" fill="#fff" stroke-width="0"></path> <path d="M292.474,155.006c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M294.349,148.692c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM293.803,156.434v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M300.536,156.434l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM300.438,152.947c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M303.406,156.434v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M309.958,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM313.598,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M316.622,156.434v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h3.038v-.49c0-.43.049-.793.147-1.092.098-.299.235-.541.412-.729.178-.187.388-.321.631-.405.242-.084.513-.126.812-.126.354,0,.655.034.903.104.247.07.464.156.65.259l-.321.826c-.159-.074-.334-.143-.525-.203s-.408-.091-.651-.091c-.158,0-.299.019-.42.056-.121.038-.224.11-.308.218s-.149.257-.196.447c-.047.191-.069.441-.069.749v.477h1.596v.882h-1.582v5.796h-1.092v-5.796h-3.011v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M325.274,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM328.914,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M336.951,155.006c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M339.792,154.907c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M343.236,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M352.867,156.294c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM352.686,154.894c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M359.237,156.434v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h1.596v.882h-1.582v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M366.181,154.432c.271.392.625.686,1.064.882.438.196.887.294,1.344.294.242,0,.474-.03.693-.091.219-.061.41-.154.573-.28.164-.126.295-.291.393-.497.098-.205.146-.447.146-.728,0-.262-.061-.492-.182-.693-.121-.2-.285-.38-.49-.539-.205-.158-.438-.301-.7-.427-.261-.126-.531-.25-.812-.371-.317-.14-.63-.282-.938-.427-.308-.145-.585-.319-.833-.525-.247-.205-.447-.443-.602-.714s-.231-.602-.231-.994c0-.401.082-.753.245-1.057s.383-.556.658-.756c.275-.201.588-.351.938-.448.35-.098.716-.146,1.099-.146.588,0,1.152.116,1.694.35.541.233.979.602,1.315,1.105l-.854.673c-.243-.336-.553-.609-.932-.819-.378-.21-.791-.315-1.238-.315-.551,0-.979.124-1.281.371-.304.248-.455.577-.455.987,0,.233.054.432.161.595.107.164.257.313.448.448.19.136.422.264.692.385.271.122.574.257.91.406.317.14.63.289.938.448.308.158.583.345.825.56.243.215.439.467.589.756.148.29.224.635.224,1.036,0,.477-.082.887-.245,1.232-.163.345-.385.63-.665.854-.28.225-.604.388-.973.49-.369.103-.764.154-1.184.154-.317,0-.632-.035-.944-.105-.313-.069-.611-.17-.896-.301-.284-.131-.546-.292-.784-.483-.237-.19-.437-.408-.595-.65l.882-.658Z" fill="#fff" stroke-width="0"></path> <path d="M379.761,156.084c-.141.056-.313.116-.519.182s-.438.124-.699.175c-.262.052-.542.094-.841.126-.299.033-.606.049-.924.049-.551,0-1.066-.091-1.547-.272-.48-.183-.903-.467-1.267-.854-.364-.387-.651-.884-.861-1.49-.21-.607-.315-1.34-.315-2.198,0-.877.105-1.624.315-2.24s.49-1.12.84-1.512c.351-.393.751-.68,1.204-.861s.922-.272,1.407-.272c.42,0,.788.042,1.105.126s.598.205.841.363c.242.159.452.351.63.574.177.224.336.476.476.756l-.896.546c-.215-.42-.488-.753-.819-1.001-.331-.247-.777-.371-1.337-.371-.327,0-.646.075-.959.225s-.588.383-.826.7-.43.723-.574,1.218c-.145.494-.217,1.083-.217,1.764,0,.606.074,1.148.224,1.624.149.477.353.878.609,1.204.257.327.556.574.896.742.34.168.702.252,1.085.252.42,0,.783-.025,1.092-.077.308-.051.56-.109.756-.175v-2.437h-1.54v-.979h2.66v4.116Z" fill="#fff" stroke-width="0"></path> <path d="M381.594,156.434v-9.338h1.12v8.372h4.326v.966h-5.446Z" fill="#fff" stroke-width="0"></path> <path d="M390.345,156.434v-8.372h-2.898v-.966h6.902v.966h-2.898v8.372h-1.105Z" fill="#fff" stroke-width="0"></path> <path d="M395.104,153.283v-.993h3.038v.993h-3.038Z" fill="#fff" stroke-width="0"></path> <path d="M399.822,156.434v-.658c.514-.588,1.003-1.152,1.47-1.693.467-.542.896-1.064,1.288-1.568.225-.289.425-.558.603-.805.177-.248.326-.485.448-.715.121-.229.212-.452.272-.672.061-.219.091-.45.091-.692,0-.532-.138-.936-.413-1.211s-.637-.413-1.085-.413c-.849,0-1.545.467-2.086,1.399l-.882-.518c.327-.598.737-1.06,1.232-1.386.494-.327,1.097-.49,1.806-.49.401,0,.763.061,1.085.182.322.122.598.292.826.512.229.219.406.48.532.783.126.304.188.638.188,1.001,0,.607-.149,1.179-.448,1.716-.299.536-.653,1.066-1.063,1.589-.364.476-.742.936-1.134,1.379-.393.443-.784.88-1.177,1.309h4.061v.952h-5.614Z" fill="#fff" stroke-width="0"></path> <path d="M410.644,148.692c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM410.098,156.434v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M413.121,156.434v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M420.695,156.434v-9.338h1.078v3.191c.271-.195.579-.361.924-.496.346-.136.732-.203,1.162-.203.905,0,1.547.229,1.925.686.378.458.567,1.125.567,2.002v4.158h-1.092v-4.172c0-.616-.126-1.071-.378-1.365s-.658-.44-1.219-.44c-.354,0-.697.081-1.028.244-.332.164-.619.334-.861.512v5.222h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M428.787,148.692c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM428.241,156.434v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M432.343,149.966c.289-.131.567-.225.833-.28s.529-.084.791-.084c.43,0,.831.077,1.204.231.373.153.693.378.959.672s.476.657.63,1.092c.154.434.231.936.231,1.505,0,.532-.084,1.013-.252,1.442-.168.429-.401.796-.7,1.099-.299.304-.651.537-1.058.7-.405.163-.847.245-1.322.245-.514,0-.974-.054-1.379-.161-.406-.107-.745-.222-1.016-.343v-8.988h1.078v2.87ZM432.343,155.482c.177.075.368.136.574.183.205.046.401.069.588.069.373,0,.712-.062,1.015-.188.304-.126.561-.306.771-.539s.371-.514.482-.84c.112-.327.168-.691.168-1.093s-.056-.763-.168-1.085c-.111-.321-.266-.595-.462-.818-.195-.225-.425-.395-.686-.512-.262-.116-.546-.175-.854-.175-.224,0-.457.03-.699.091-.243.062-.486.171-.729.329v4.578Z" fill="#fff" stroke-width="0"></path> <path d="M439.146,148.692c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM438.601,156.434v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M443.136,154.907c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M447.644,156.294c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM447.462,154.894c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M453.72,156.434v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M458.592,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M470.505,156.434l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM470.407,152.947c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M473.375,156.434v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M478.625,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM482.265,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M493.102,155.006c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M495.858,156.294c-.383-.205-.704-.474-.966-.806-.261-.331-.457-.709-.588-1.134s-.196-.856-.196-1.295.063-.865.189-1.281c.126-.415.319-.786.581-1.112.261-.327.586-.589.973-.784.388-.196.843-.294,1.365-.294.514,0,.966.101,1.358.301.392.201.716.464.973.791s.45.7.581,1.12.196.85.196,1.288-.065.868-.196,1.288-.324.793-.581,1.119c-.257.327-.581.591-.973.791-.393.201-.845.302-1.358.302s-.966-.099-1.358-.294ZM495.677,154.894c.178.243.395.441.651.595.256.154.553.231.889.231.346,0,.646-.077.903-.231.256-.153.471-.354.644-.602s.301-.529.385-.847.126-.64.126-.967-.042-.648-.126-.966-.212-.6-.385-.847-.388-.445-.644-.595c-.257-.149-.558-.225-.903-.225s-.646.075-.903.225-.469.348-.637.595-.294.527-.378.84-.126.633-.126.959c0,.336.042.663.126.98s.21.602.378.854Z" fill="#fff" stroke-width="0"></path> <path d="M501.935,156.434v-6.678h.994l.07.531c.271-.205.59-.373.959-.504.368-.13.753-.195,1.154-.195.915,0,1.562.227,1.939.679.378.453.567,1.122.567,2.009v4.158h-1.078v-4.186c0-.561-.126-.999-.378-1.316s-.663-.476-1.232-.476c-.354,0-.702.076-1.043.23s-.633.324-.875.511v5.236h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M509.873,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M515.822,148.692c-.195,0-.363-.077-.504-.23-.14-.154-.21-.344-.21-.567,0-.215.07-.401.21-.56.141-.159.309-.238.504-.238.196,0,.364.079.504.238.141.158.21.345.21.56,0,.224-.069.413-.21.567-.14.153-.308.23-.504.23ZM515.276,156.434v-6.678h1.092v6.678h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M522.752,156.434l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM522.668,150.778c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M526.378,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM530.018,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M532.748,156.434v-6.678h.98l.084.588c.177-.187.405-.359.686-.519.28-.158.564-.237.854-.237.205,0,.394.014.566.042.173.027.306.056.399.084l-.196.994c-.233-.103-.527-.154-.882-.154-.271,0-.53.074-.777.224s-.46.304-.637.462v5.194h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M537.998,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM541.638,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M548.82,156.434l-.084-.546c-.243.252-.507.432-.791.539-.285.107-.595.161-.931.161-.477,0-.898-.091-1.268-.273-.368-.182-.679-.432-.931-.749s-.443-.692-.574-1.127c-.131-.434-.196-.903-.196-1.407,0-.429.068-.852.203-1.267.136-.415.336-.784.603-1.106.266-.321.6-.581,1.001-.776.401-.196.868-.294,1.399-.294.336,0,.626.025.868.077.243.051.448.109.616.175v-2.744h1.078v9.338h-.994ZM548.736,150.778c-.056-.037-.133-.074-.231-.111-.098-.038-.207-.072-.328-.105-.122-.032-.248-.059-.378-.077-.131-.019-.257-.027-.379-.027-.392,0-.732.074-1.021.224s-.53.348-.721.595c-.191.248-.334.53-.428.848-.093.317-.14.639-.14.966,0,.373.042.721.126,1.043.084.321.212.6.385.833s.388.418.645.553c.256.136.562.203.917.203.279,0,.555-.059.826-.175.271-.117.513-.311.728-.581v-4.187Z" fill="#fff" stroke-width="0"></path> <path d="M559.811,155.006c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M561.14,156.434v-9.338h1.078v9.338h-1.078Z" fill="#fff" stroke-width="0"></path> <path d="M567.859,156.434l-.056-.574c-.233.233-.502.413-.805.539-.304.126-.638.189-1.001.189-.29,0-.572-.045-.848-.133-.275-.089-.518-.22-.728-.393s-.381-.39-.512-.651c-.13-.261-.195-.564-.195-.909,0-.477.128-.868.385-1.177.257-.308.581-.553.973-.734.393-.183.826-.311,1.303-.385.476-.075.938-.112,1.386-.112v-.084c0-.561-.119-.961-.357-1.204-.237-.242-.581-.364-1.028-.364-.309,0-.591.068-.848.203-.257.136-.474.315-.65.539l-.756-.532c.271-.364.59-.632.959-.805.368-.173.833-.259,1.393-.259.746,0,1.327.191,1.743.573.415.383.623,1.022.623,1.919v4.354h-.98ZM567.762,152.947c-.309.01-.635.033-.98.07-.345.037-.665.109-.959.217s-.536.264-.728.469c-.191.206-.287.477-.287.812,0,.215.042.396.126.546s.189.273.315.371.266.168.42.21c.153.042.306.063.455.063.326,0,.627-.068.902-.203.275-.136.521-.297.735-.483v-2.072Z" fill="#fff" stroke-width="0"></path> <path d="M571.094,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M576.861,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> <path d="M585.807,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM589.446,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M592.471,156.434v-5.796h-.979v-.882h.994v-.49c0-.43.049-.793.146-1.092s.235-.541.413-.729c.177-.187.387-.321.63-.405s.514-.126.812-.126c.354,0,.655.034.902.104s.465.156.651.259l-.322.826c-.158-.074-.334-.143-.524-.203-.191-.061-.409-.091-.651-.091-.159,0-.299.019-.42.056-.121.038-.224.11-.309.218-.084.107-.148.257-.195.447-.047.191-.07.441-.07.749v.477h3.038v-.49c0-.43.049-.793.147-1.092.098-.299.235-.541.412-.729.178-.187.388-.321.631-.405.242-.084.513-.126.812-.126.354,0,.655.034.903.104.247.07.464.156.65.259l-.321.826c-.159-.074-.334-.143-.525-.203s-.408-.091-.651-.091c-.158,0-.299.019-.42.056-.121.038-.224.11-.308.218s-.149.257-.196.447c-.047.191-.069.441-.069.749v.477h1.596v.882h-1.582v5.796h-1.092v-5.796h-3.011v5.796h-1.092Z" fill="#fff" stroke-width="0"></path> <path d="M601.123,153.031c0,.841.191,1.498.574,1.975.383.476.938.714,1.666.714.42,0,.774-.103,1.063-.309.289-.205.522-.457.7-.756l.714.477c-.242.42-.558.768-.944,1.043-.388.275-.908.413-1.562.413-.504,0-.957-.077-1.358-.231s-.744-.378-1.028-.672c-.285-.294-.504-.66-.658-1.099s-.231-.947-.231-1.526c0-.532.072-1.01.218-1.435.145-.425.345-.789.602-1.093.257-.303.569-.536.938-.699.368-.164.776-.245,1.225-.245.494,0,.926.084,1.295.252s.674.403.917.707c.243.303.425.667.546,1.092s.183.889.183,1.393h-4.858ZM604.763,152.178c-.009-.289-.065-.544-.168-.763-.103-.22-.233-.401-.392-.547-.159-.145-.341-.252-.546-.321-.206-.07-.411-.105-.616-.105-.448,0-.833.133-1.155.399-.321.266-.544.712-.665,1.337h3.542Z" fill="#fff" stroke-width="0"></path> <path d="M612.8,155.006c-.262.541-.619.94-1.071,1.196-.453.257-.932.386-1.436.386-.392,0-.776-.07-1.154-.21-.378-.141-.712-.354-1.001-.645-.29-.289-.523-.65-.7-1.085-.178-.434-.267-.945-.267-1.533,0-.625.089-1.162.267-1.609.177-.448.41-.814.7-1.1.289-.284.615-.492.979-.623.364-.13.729-.195,1.092-.195.374,0,.702.056.987.168.284.111.527.252.729.42.2.168.363.346.489.532s.217.354.273.504l-.798.504c-.196-.448-.443-.771-.742-.966-.299-.196-.611-.294-.938-.294-.252,0-.494.058-.728.175-.233.116-.443.287-.63.511-.188.224-.336.499-.448.826-.112.326-.168.7-.168,1.12s.056.793.168,1.12c.112.326.264.602.455.825.191.225.415.395.672.512.257.116.529.175.819.175.326,0,.642-.094.944-.28.304-.187.554-.49.749-.91l.757.477Z" fill="#fff" stroke-width="0"></path> <path d="M615.641,154.907c0,.327.063.544.189.651s.287.161.483.161c.177,0,.345-.037.504-.112.158-.074.303-.163.434-.266l.42.728c-.215.159-.427.285-.637.378-.21.094-.507.141-.889.141-.505,0-.892-.129-1.162-.386-.271-.256-.406-.65-.406-1.183v-4.382h-1.148v-.882h1.148v-1.82h1.078v1.82h1.75v.882h-1.765v4.27Z" fill="#fff" stroke-width="0"></path> <path d="M619.085,154.781c.158.299.361.53.609.693.247.163.58.245,1.001.245.914,0,1.371-.327,1.371-.98,0-.195-.03-.361-.091-.497-.061-.135-.158-.256-.294-.363-.135-.107-.311-.21-.524-.309-.215-.098-.477-.203-.784-.314-.336-.112-.621-.231-.854-.357s-.425-.264-.573-.413c-.149-.149-.26-.317-.329-.504-.07-.187-.105-.406-.105-.658,0-.541.198-.966.595-1.273.397-.309.922-.462,1.575-.462.541,0,.994.091,1.358.272.364.183.672.441.924.777l-.756.602c-.187-.224-.406-.41-.658-.56s-.537-.224-.854-.224c-.393,0-.685.076-.875.23-.191.154-.287.343-.287.567,0,.14.025.264.077.371.051.107.142.205.272.294s.301.177.511.266.479.189.806.301c.615.215,1.082.485,1.399.812.317.326.477.761.477,1.302,0,.317-.062.6-.183.847-.121.248-.287.455-.497.623s-.459.297-.749.386c-.289.088-.606.133-.951.133-.663,0-1.182-.122-1.555-.364s-.672-.551-.896-.924l.84-.519Z" fill="#fff" stroke-width="0"></path> </g> <text transform="translate(250.025 181.135)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Medications:</tspan></text> <text transform="translate(30.953 106.033)" fill="#fff" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Usual care without </tspan><tspan x="0" y="16.8">SGLT-2 inhibitors </tspan></text> <g> <rect x="250.502" y="190.46" width="95.354" height="21.081" rx="10.541" ry="10.541" fill="#fff" stroke-width="0"></rect> <text transform="translate(258.933 204.852)" fill="#000" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Empagliflozin</tspan></text> </g> <g> <rect x="352.614" y="190.46" width="91.708" height="21.081" rx="10.541" ry="10.541" fill="#fff" stroke-width="0"></rect> <text transform="translate(361.045 204.852)" fill="#000" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Dapagliflozin</tspan></text> </g> <g> <rect x="451.432" y="190.46" width="91.708" height="21.081" rx="10.541" ry="10.541" fill="#fff" stroke-width="0"></rect> <text transform="translate(459.863 204.852)" fill="#000" font-family="InterFace-Regular, InterFace" font-size="14"><tspan x="0" y="0">Canagliflozin</tspan></text> </g> </svg></div></div></div><div class="whiteBox" style="margin:15px; padding:10px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 11.223%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 78" enable-background="0 0 695 78" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 55.1034 36.7349)" fill="#333333" font-family="'InterFace-Bold'" font-size="21px">Recommendation 1</text><path fill="#7C8696" d="M33.809,20.915c-7.32,0-13.254,3.258-13.254,7.277c0,2.436,2.187,4.586,5.534,5.907l-1.029,7.434l6.421-6.183c0.757,0.074,1.533,0.119,2.328,0.119c7.32,0,13.254-3.258,13.254-7.277S41.129,20.915,33.809,20.915z"></path></svg></div><div class="scaling-svg-container" style="padding-bottom: 24.89208633093525%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 173" enable-background="0 0 695 173" xml:space="preserve" style="width: 100%;"><path fill="#D8DBDF" d="M34.5,0 h626 a20,20 0 0 1 20,20 v120 a20,20 0 0 1 -20,20 h-626 a20,20 0 0 1 -20,-20 v-120 a20,20 0 0 1 20,-20"></path><path fill="#00B2A9" d="M34.5,0 h313 v90 h-333 v-70 a20,20 0 0 1 20,-20"></path><path fill="#765FA8" d="M347.5,0 h313 a20,20 0 0 1 20,20 v70 h-333 z"></path><text transform="matrix(1 0 0 1 184 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">No SGLT-2 inhibitors</text><text transform="matrix(1 0 0 1 511 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">SGLT-2 inhibitors</text><line fill="none" stroke="#FFFFFF" stroke-width="3" stroke-miterlimit="10" x1="347.5" y1="0" x2="347.5" y2="90"></line><circle fill="#FFFFFF" cx="347.776" cy="46.175" r="15.575"></circle><text transform="matrix(1 0 0 1 339.7538 50.7762)" font-family="'InterFace-Regular'" font-size="18px">or</text><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M252.351,158.478H42.009c-8.182,0-14.876-6.694-14.876-14.876v-23.514c0-4.28,3.502-7.781,7.781-7.781h217.438c4.28,0,7.781,3.502,7.781,7.781v30.609C260.132,154.976,256.631,158.478,252.351,158.478z"></path><g transform="translate(0,0)"><path fill="#7C8696" d="M36.955,126.089c0-1.686,1.395-3.052,3.116-3.052c1.721,0,3.117,1.366,3.117,3.052c0,1.685-1.396,3.052-3.117,3.052C38.351,129.141,36.955,127.774,36.955,126.089z"></path><path fill="#7C8696" d="M40.236,130.024h-0.328c-2.174,0-3.936,0.456-3.936,3.855v2.209c0,1.474,0.531,2.295,1.368,2.737l0.602,6.887h4.182l0.6-6.855c0.883-0.439,1.449-1.27,1.449-2.769v-2.209C44.173,130.425,42.41,130.024,40.236,130.024z"></path><path fill="#7C8696" d="M46.749,124.235c0-1.931,1.598-3.496,3.57-3.496c1.971,0,3.57,1.565,3.57,3.496c0,1.93-1.599,3.496-3.57,3.496C48.347,127.731,46.749,126.166,46.749,124.235z"></path><path fill="#7C8696" d="M50.507,128.742h-0.376c-2.49,0-4.509,0.522-4.509,4.415v2.53c0,1.689,0.609,2.629,1.567,3.136l0.69,7.888h4.791l0.687-7.852c1.012-0.503,1.659-1.455,1.659-3.171v-2.53C55.016,129.202,52.997,128.742,50.507,128.742z"></path><path fill="#7C8696" d="M57.363,126.826c0-1.537,1.272-2.782,2.84-2.782c1.569,0,2.841,1.245,2.841,2.782c0,1.536-1.272,2.782-2.841,2.782C58.634,129.608,57.363,128.362,57.363,126.826z"></path><path fill="#7C8696" d="M60.353,130.412h-0.299c-1.982,0-3.588,0.415-3.588,3.514v2.013c0,1.344,0.484,2.092,1.247,2.495l0.549,6.277h3.812l0.547-6.248c0.805-0.4,1.32-1.157,1.32-2.524v-2.013C63.941,130.778,62.334,130.412,60.353,130.412z"></path></g><text transform="matrix(1 0 0 1 74.466 138.498)" font-family="'InterFace-Regular'" font-size="14px">Low risk</text></g><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M276.914,158.478h375.71c8.182,0,14.876-6.694,14.876-14.876v-23.514c0-4.28-3.502-7.781-7.781-7.781H276.914c-4.28,0-7.781,3.502-7.781,7.781v30.609C269.132,154.976,272.634,158.478,276.914,158.478z"></path><path fill="#7C8696" d="M277.498,123.473c1.013-1.118,2.563-1.802,4.651-2.052c0.822-0.099,1.548,0.492,1.548,1.225v1.42c0,0.521-0.365,1.008-0.929,1.159c-0.667,0.179-1.158,0.473-1.474,0.881c-0.449,0.581-0.673,1.452-0.673,2.613v0.522h1.682c0.77,0,1.393,0.551,1.393,1.231v5.9c0,0.68-0.624,1.231-1.393,1.231h-5.286c-0.77,0-1.393-0.551-1.393-1.231v-6.608C275.624,126.95,276.249,124.852,277.498,123.473z M289.724,119.879c1.271-1.402,3.215-2.26,5.834-2.574c1.032-0.124,1.942,0.617,1.942,1.537v1.782c0,0.654-0.457,1.264-1.165,1.454c-0.836,0.224-1.452,0.593-1.848,1.106c-0.563,0.729-0.844,1.821-0.844,3.278v0.655h2.11c0.965,0,1.748,0.691,1.748,1.544v7.401c0,0.853-0.783,1.544-1.748,1.544h-6.631c-0.965,0-1.748-0.691-1.748-1.544v-8.288C287.374,124.24,288.157,121.609,289.724,119.879z"></path><path fill="#7C8696" d="M657.626,145.424c-1.013,1.118-2.563,1.802-4.651,2.052c-0.822,0.099-1.548-0.492-1.548-1.225v-1.42c0-0.521,0.365-1.008,0.929-1.159c0.667-0.179,1.158-0.473,1.474-0.882c0.449-0.581,0.673-1.452,0.673-2.613v-0.522h-1.682c-0.77,0-1.393-0.551-1.393-1.231v-5.9c0-0.68,0.624-1.231,1.393-1.231h5.286c0.77,0,1.393,0.551,1.393,1.231v6.608C659.5,141.947,658.875,144.045,657.626,145.424z M645.4,149.018c-1.271,1.402-3.215,2.26-5.834,2.574c-1.032,0.124-1.942-0.617-1.942-1.537v-1.782c0-0.654,0.457-1.264,1.166-1.454c0.836-0.224,1.452-0.593,1.848-1.106c0.563-0.729,0.844-1.821,0.844-3.278v-0.655h-2.11c-0.965,0-1.748-0.691-1.748-1.544v-7.401c0-0.853,0.783-1.544,1.748-1.544h6.631c0.965,0,1.748,0.691,1.748,1.544v8.288C647.751,144.657,646.967,147.289,645.4,149.018z"></path><text transform="matrix(1 0 0 1 467.816 138.6864)" font-family="'InterFace-Regular'" font-size="14px" text-anchor="middle">We suggest administering SGLT-2 inhibitors</text></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="164.011,117.552 66.011,117.552 56.011,102.552 66.011,87.552 164.011,87.552 154.011,102.552"></polygon><text transform="matrix(1 0 0 1 84.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="160.139" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M160.648,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L160.648,91.629z M160.896,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C161.774,86.635,161.382,87.026,160.896,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M251.153,185.394h-229.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h108.9l6-6l6,6h109.001c3.2,0,5.5,2.6,5.5,5.7v45.754C256.653,183.194,254.353,185.394,251.153,185.394z"></path><text transform="matrix(1 0 0 1 24.9805 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the left. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="274.011,117.552 176.011,117.552 166.011,102.552 176.011,87.552 274.011,87.552 264.011,102.552"></polygon><text transform="matrix(1 0 0 1 198.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="271.472" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M271.981,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L271.981,91.629z M272.229,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C273.107,86.635,272.715,87.026,272.229,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M348.293,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C353.793,183.194,351.493,185.394,348.293,185.394z"></path><text transform="matrix(1 0 0 1 107.1205 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the left. Benefits would outweigh harms for</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="1" fill="#FFFFFF" points="390.511,117.552 488.511,117.552 498.511,102.552 488.511,87.552 390.511,87.552 400.511,102.552"></polygon><text transform="matrix(1 0 0 1 425.6487 107.8645)" fill="#7D5CC6" font-family="'InterFace-Bold'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="487.595" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M488.104,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L488.104,91.629z M488.352,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C489.23,86.635,488.838,87.026,488.352,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M573.214,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C578.714,183.194,576.413,185.394,573.214,185.394z"></path><text transform="matrix(1 0 0 1 332.041 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the right. Benefits would outweigh harms</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">for the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="500.511,117.552 598.511,117.552 608.511,102.552 598.511,87.552 500.511,87.552 510.511,102.552"></polygon><text transform="matrix(1 0 0 1 530.6486 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="597.928" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M598.437,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L598.437,91.629z M598.685,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C599.563,86.635,599.171,87.026,598.685,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M649.787,185.394h-231.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h107.9l6-6l6,6h112.001c3.2,0,5.5,2.6,5.5,5.7v45.754C655.287,183.194,652.987,185.394,649.787,185.394z"></path><text transform="matrix(1 0 0 1 421.6153 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the right. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g></svg></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 315.4078 21.7755)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Rationale</text><circle fill="#FFFFFF" cx="298.537" cy="16.747" r="10.974"></circle><path fill="#2A6EBB" d="M297.269,19.248v-0.967c0-0.307,0.05-0.605,0.149-0.896s0.226-0.563,0.38-0.816c0.153-0.253,0.318-0.487,0.494-0.702c0.176-0.214,0.341-0.398,0.495-0.552c0.215-0.229,0.433-0.444,0.656-0.644c0.222-0.199,0.421-0.406,0.598-0.621s0.322-0.438,0.437-0.667c0.115-0.23,0.173-0.491,0.173-0.782c0-0.536-0.161-0.95-0.483-1.242c-0.322-0.291-0.782-0.437-1.38-0.437c-0.445,0-0.889,0.126-1.334,0.379s-0.913,0.748-1.403,1.483l-2.208-1.472c0.537-0.843,1.223-1.533,2.059-2.07c0.835-0.536,1.859-0.805,3.07-0.805c1.533,0,2.703,0.384,3.507,1.15c0.805,0.767,1.208,1.802,1.208,3.104c0,0.384-0.057,0.736-0.172,1.059c-0.115,0.321-0.265,0.629-0.449,0.92c-0.184,0.291-0.391,0.563-0.621,0.816s-0.46,0.494-0.69,0.725c-0.399,0.429-0.759,0.839-1.081,1.23c-0.322,0.391-0.483,0.809-0.483,1.253v0.553H297.269z M297.959,24.192c-0.215-0.092-0.406-0.226-0.575-0.402c-0.169-0.176-0.299-0.376-0.391-0.598c-0.092-0.223-0.138-0.456-0.138-0.702c0-0.245,0.046-0.479,0.138-0.701c0.092-0.222,0.222-0.418,0.391-0.587c0.168-0.168,0.364-0.306,0.586-0.413c0.222-0.107,0.472-0.161,0.748-0.161c0.552,0,1.004,0.188,1.357,0.563c0.353,0.376,0.529,0.809,0.529,1.299c0,0.491-0.176,0.924-0.529,1.3c-0.353,0.376-0.805,0.563-1.357,0.563C298.442,24.354,298.189,24.3,297.959,24.192z"></path></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 14.144144144144144%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 94.2" enable-background="0 0 666 94.2" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 109.7213 21.7755)" font-family="'InterFace-Regular'" font-size="14px">Moderate certainty of small but important reductions in risks of</text><text transform="matrix(1 0 0 1 109.7213 38.575500000000005)" font-family="'InterFace-Regular'" font-size="14px">all-cause mortality and non-fatal stroke, balanced against moderate</text><text transform="matrix(1 0 0 1 109.7213 55.3755)" font-family="'InterFace-Regular'" font-size="14px">certainty of no important increase in the risk of harms led to a weak</text><text transform="matrix(1 0 0 1 109.7213 72.1755)" font-family="'InterFace-Regular'" font-size="14px">recommendation in favour of treatment</text></svg></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Potential benefits</text></svg></div></h2><div class="pane-content" style="padding: 0px 0px 10px 0px; max-width: 666px; margin: 0px auto 0px auto;"><div style="clear: both;"></div><div class="scaling-svg-container" style="padding-bottom: 11.562%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 60" enable-background="0 0 666 60" xml:space="preserve" style="width: 100%;"><polygon fill="#00B2A9" points="256.718,43.109 66.888,43.109 54.888,30.943 66.888,18.776 256.718,18.776 243.718,30.943"></polygon><text transform="matrix(1 0 0 1 157.389 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No SGLT-2 inhibitors</text><polygon fill="#765FA8" points="407.721,18.776 597.551,18.776 609.551,30.943 597.551,43.109 407.721,43.109 419.721,30.943"></polygon><text transform="matrix(1 0 0 1 511.128 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">SGLT-2 inhibitors</text><g class="thishasatooltip"><polygon fill="#7C8696" points="403.351,43.109 260.522,43.109 248.522,30.943 260.522,18.776 403.351,18.776 415.351,30.943"></polygon><text transform="matrix(1 0 0 1 332.32 34.4258)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No important difference</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="395.241" cy="18.088" r="6"></circle><path fill="#FFFFFF" d="M395.751,20.48c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L395.751,20.48z M395.999,15.877c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C396.877,15.486,396.484,15.877,395.999,15.877z"></path><g transform="matrix(1 0 0 1 365 5)" class="thisisthetooltip"><path opacity="0.8" enable-background="new " d="M-349.979,51.675c-5.6,0-10.1-4.5-10.1-10.1V10.211c0-5.6,4.5-10.1,10.1-10.1H11.135c5.6,0,10.1,4.5,10.1,10.1v5.2l10,10l-10,10v6.264c0,5.6-4.5,10.1-10.1,10.1L-349.979,51.675z"></path><text transform="matrix(1 0 0 1 -353.0981 16.7624)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">The panel found that this difference was not important for most patients,</tspan><tspan x="0" y="13" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">because the intervention effects were negligible and/or very imprecise, for</tspan><tspan x="0" y="26" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">example confidence intervals that include both important benefit and harm</tspan></text></g></g></svg></div><div class="scaling-svg-container" style="padding-bottom: 3.003%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 20" enable-background="0 0 666 20" xml:space="preserve" style="width: 100%;"><text transform="matrix(0.9746 0 0 1 14.0746 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Benefits</text><path fill="none" stroke="#7C8696" stroke-miterlimit="10" d="M441.083,17.13c0,0,0-1.791,0-3.98s-2.122-3.98-4.716-3.98H189.049c-2.594,0-4.716,1.791-4.716,3.98s0,3.98,0,3.98"></path><rect x="210.591642578125" y="5" fill="#C1D3E9" width="204.03271484375" height="8"></rect><text transform="matrix(0.9746 0 0 1 312.608 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">Events per 1000 people over 5 years</text><text transform="matrix(0.9746 0 0 1 488.304 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Evidence quality</text></svg></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">All-cause mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">7 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">44</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">37</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 981 patients in 11 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">all-cause mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Cardiovascular mortality</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">11</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">9</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 27 429 patients in 7 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on cardiovascular death</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Kidney failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">1</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">1</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 221 patients in 9 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on kidney failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal myocardial infarction</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">61</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">46</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on non-fatal myocardial</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">infarction</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal stroke</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">10 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">38</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">28</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal stroke</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Admission for heart failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">14</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">10</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 962 patients in 6 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on hospital admission for heart</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/pico/?gId=EezrQj&amp;picoId=noR8wa&amp;tab=outcome','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 206.71409106445313px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 206.71409106445313 18" enable-background="0 0 206.71409106445313 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="197.71409106445313" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="188.71409106445313"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">See all outcomes</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(2.014434814453125,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/recommendation/?gId=EezrQj&amp;recId=j1Og5V&amp;open=1&amp;tab=da&amp;org=1&amp;m=1&amp;lb=1','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 223.80849719238282px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 223.80849719238282 18" enable-background="0 0 223.80849719238282 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="214.80849719238282" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="205.80849719238282"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">Patient decision aids</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(19.108840942382812,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><div class="scaling-svg-container" style="padding-bottom: 5.045045045045046%; max-width: 666px; margin: 15px auto 0px auto; clear: both;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 33.6" enable-background="0 0 666 33.6" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 15.0713 20.0906)" fill="#000000" font-family="'InterFace-Regular'" font-size="14px">See below for summary of harms</text></svg></div><div style="clear:both;"></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Individual considerations</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 22.16216216216216%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 147.6" enable-background="0 0 666 147.6" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="125.6" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Values and preferences</text><text transform="matrix(1 0 0 1 125 70)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">The panel inferred that the majority of individuals would be inclined to receive</text><text transform="matrix(1 0 0 1 125 84.4)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors, though acknowledged that a substantial proportion may be</text><text transform="matrix(1 0 0 1 125 98.80000000000001)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">disinclined to do so when faced with marginal benefits, increased pill burden,</text><text transform="matrix(1 0 0 1 125 113.20000000000002)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">medication costs and a residual risk of harms</text></svg></div></div></div></div></div><div class="whiteBox" style="margin:15px; padding:10px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 11.223%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 78" enable-background="0 0 695 78" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 55.1034 36.7349)" fill="#333333" font-family="'InterFace-Bold'" font-size="21px">Recommendation 2</text><path fill="#7C8696" d="M33.809,20.915c-7.32,0-13.254,3.258-13.254,7.277c0,2.436,2.187,4.586,5.534,5.907l-1.029,7.434l6.421-6.183c0.757,0.074,1.533,0.119,2.328,0.119c7.32,0,13.254-3.258,13.254-7.277S41.129,20.915,33.809,20.915z"></path></svg></div><div class="scaling-svg-container" style="padding-bottom: 24.89208633093525%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 173" enable-background="0 0 695 173" xml:space="preserve" style="width: 100%;"><path fill="#D8DBDF" d="M34.5,0 h626 a20,20 0 0 1 20,20 v120 a20,20 0 0 1 -20,20 h-626 a20,20 0 0 1 -20,-20 v-120 a20,20 0 0 1 20,-20"></path><path fill="#00B2A9" d="M34.5,0 h313 v90 h-333 v-70 a20,20 0 0 1 20,-20"></path><path fill="#765FA8" d="M347.5,0 h313 a20,20 0 0 1 20,20 v70 h-333 z"></path><text transform="matrix(1 0 0 1 184 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">No SGLT-2 inhibitors</text><text transform="matrix(1 0 0 1 511 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">SGLT-2 inhibitors</text><line fill="none" stroke="#FFFFFF" stroke-width="3" stroke-miterlimit="10" x1="347.5" y1="0" x2="347.5" y2="90"></line><circle fill="#FFFFFF" cx="347.776" cy="46.175" r="15.575"></circle><text transform="matrix(1 0 0 1 339.7538 50.7762)" font-family="'InterFace-Regular'" font-size="18px">or</text><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M252.351,158.478H42.009c-8.182,0-14.876-6.694-14.876-14.876v-23.514c0-4.28,3.502-7.781,7.781-7.781h217.438c4.28,0,7.781,3.502,7.781,7.781v30.609C260.132,154.976,256.631,158.478,252.351,158.478z"></path><g transform="translate(0,0)"><path fill="#7C8696" d="M36.955,126.089c0-1.686,1.395-3.052,3.116-3.052c1.721,0,3.117,1.366,3.117,3.052c0,1.685-1.396,3.052-3.117,3.052C38.351,129.141,36.955,127.774,36.955,126.089z"></path><path fill="#7C8696" d="M40.236,130.024h-0.328c-2.174,0-3.936,0.456-3.936,3.855v2.209c0,1.474,0.531,2.295,1.368,2.737l0.602,6.887h4.182l0.6-6.855c0.883-0.439,1.449-1.27,1.449-2.769v-2.209C44.173,130.425,42.41,130.024,40.236,130.024z"></path><path fill="#7C8696" d="M46.749,124.235c0-1.931,1.598-3.496,3.57-3.496c1.971,0,3.57,1.565,3.57,3.496c0,1.93-1.599,3.496-3.57,3.496C48.347,127.731,46.749,126.166,46.749,124.235z"></path><path fill="#7C8696" d="M50.507,128.742h-0.376c-2.49,0-4.509,0.522-4.509,4.415v2.53c0,1.689,0.609,2.629,1.567,3.136l0.69,7.888h4.791l0.687-7.852c1.012-0.503,1.659-1.455,1.659-3.171v-2.53C55.016,129.202,52.997,128.742,50.507,128.742z"></path><path fill="#7C8696" d="M57.363,126.826c0-1.537,1.272-2.782,2.84-2.782c1.569,0,2.841,1.245,2.841,2.782c0,1.536-1.272,2.782-2.841,2.782C58.634,129.608,57.363,128.362,57.363,126.826z"></path><path fill="#7C8696" d="M60.353,130.412h-0.299c-1.982,0-3.588,0.415-3.588,3.514v2.013c0,1.344,0.484,2.092,1.247,2.495l0.549,6.277h3.812l0.547-6.248c0.805-0.4,1.32-1.157,1.32-2.524v-2.013C63.941,130.778,62.334,130.412,60.353,130.412z"></path></g><text transform="matrix(1 0 0 1 74.466 138.498)" font-family="'InterFace-Regular'" font-size="14px">Moderate risk</text></g><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M276.914,158.478h375.71c8.182,0,14.876-6.694,14.876-14.876v-23.514c0-4.28-3.502-7.781-7.781-7.781H276.914c-4.28,0-7.781,3.502-7.781,7.781v30.609C269.132,154.976,272.634,158.478,276.914,158.478z"></path><path fill="#7C8696" d="M277.498,123.473c1.013-1.118,2.563-1.802,4.651-2.052c0.822-0.099,1.548,0.492,1.548,1.225v1.42c0,0.521-0.365,1.008-0.929,1.159c-0.667,0.179-1.158,0.473-1.474,0.881c-0.449,0.581-0.673,1.452-0.673,2.613v0.522h1.682c0.77,0,1.393,0.551,1.393,1.231v5.9c0,0.68-0.624,1.231-1.393,1.231h-5.286c-0.77,0-1.393-0.551-1.393-1.231v-6.608C275.624,126.95,276.249,124.852,277.498,123.473z M289.724,119.879c1.271-1.402,3.215-2.26,5.834-2.574c1.032-0.124,1.942,0.617,1.942,1.537v1.782c0,0.654-0.457,1.264-1.165,1.454c-0.836,0.224-1.452,0.593-1.848,1.106c-0.563,0.729-0.844,1.821-0.844,3.278v0.655h2.11c0.965,0,1.748,0.691,1.748,1.544v7.401c0,0.853-0.783,1.544-1.748,1.544h-6.631c-0.965,0-1.748-0.691-1.748-1.544v-8.288C287.374,124.24,288.157,121.609,289.724,119.879z"></path><path fill="#7C8696" d="M657.626,145.424c-1.013,1.118-2.563,1.802-4.651,2.052c-0.822,0.099-1.548-0.492-1.548-1.225v-1.42c0-0.521,0.365-1.008,0.929-1.159c0.667-0.179,1.158-0.473,1.474-0.882c0.449-0.581,0.673-1.452,0.673-2.613v-0.522h-1.682c-0.77,0-1.393-0.551-1.393-1.231v-5.9c0-0.68,0.624-1.231,1.393-1.231h5.286c0.77,0,1.393,0.551,1.393,1.231v6.608C659.5,141.947,658.875,144.045,657.626,145.424z M645.4,149.018c-1.271,1.402-3.215,2.26-5.834,2.574c-1.032,0.124-1.942-0.617-1.942-1.537v-1.782c0-0.654,0.457-1.264,1.166-1.454c0.836-0.224,1.452-0.593,1.848-1.106c0.563-0.729,0.844-1.821,0.844-3.278v-0.655h-2.11c-0.965,0-1.748-0.691-1.748-1.544v-7.401c0-0.853,0.783-1.544,1.748-1.544h6.631c0.965,0,1.748,0.691,1.748,1.544v8.288C647.751,144.657,646.967,147.289,645.4,149.018z"></path><text transform="matrix(1 0 0 1 467.816 138.6864)" font-family="'InterFace-Regular'" font-size="14px" text-anchor="middle">We suggest administering SGLT-2 inhibitors</text></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="164.011,117.552 66.011,117.552 56.011,102.552 66.011,87.552 164.011,87.552 154.011,102.552"></polygon><text transform="matrix(1 0 0 1 84.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="160.139" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M160.648,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L160.648,91.629z M160.896,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C161.774,86.635,161.382,87.026,160.896,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M251.153,185.394h-229.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h108.9l6-6l6,6h109.001c3.2,0,5.5,2.6,5.5,5.7v45.754C256.653,183.194,254.353,185.394,251.153,185.394z"></path><text transform="matrix(1 0 0 1 24.9805 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the left. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="274.011,117.552 176.011,117.552 166.011,102.552 176.011,87.552 274.011,87.552 264.011,102.552"></polygon><text transform="matrix(1 0 0 1 198.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="271.472" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M271.981,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L271.981,91.629z M272.229,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C273.107,86.635,272.715,87.026,272.229,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M348.293,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C353.793,183.194,351.493,185.394,348.293,185.394z"></path><text transform="matrix(1 0 0 1 107.1205 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the left. Benefits would outweigh harms for</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="1" fill="#FFFFFF" points="390.511,117.552 488.511,117.552 498.511,102.552 488.511,87.552 390.511,87.552 400.511,102.552"></polygon><text transform="matrix(1 0 0 1 425.6487 107.8645)" fill="#7D5CC6" font-family="'InterFace-Bold'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="487.595" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M488.104,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L488.104,91.629z M488.352,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C489.23,86.635,488.838,87.026,488.352,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M573.214,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C578.714,183.194,576.413,185.394,573.214,185.394z"></path><text transform="matrix(1 0 0 1 332.041 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the right. Benefits would outweigh harms</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">for the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="500.511,117.552 598.511,117.552 608.511,102.552 598.511,87.552 500.511,87.552 510.511,102.552"></polygon><text transform="matrix(1 0 0 1 530.6486 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="597.928" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M598.437,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L598.437,91.629z M598.685,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C599.563,86.635,599.171,87.026,598.685,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M649.787,185.394h-231.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h107.9l6-6l6,6h112.001c3.2,0,5.5,2.6,5.5,5.7v45.754C655.287,183.194,652.987,185.394,649.787,185.394z"></path><text transform="matrix(1 0 0 1 421.6153 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the right. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g></svg></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 315.4078 21.7755)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Rationale</text><circle fill="#FFFFFF" cx="298.537" cy="16.747" r="10.974"></circle><path fill="#2A6EBB" d="M297.269,19.248v-0.967c0-0.307,0.05-0.605,0.149-0.896s0.226-0.563,0.38-0.816c0.153-0.253,0.318-0.487,0.494-0.702c0.176-0.214,0.341-0.398,0.495-0.552c0.215-0.229,0.433-0.444,0.656-0.644c0.222-0.199,0.421-0.406,0.598-0.621s0.322-0.438,0.437-0.667c0.115-0.23,0.173-0.491,0.173-0.782c0-0.536-0.161-0.95-0.483-1.242c-0.322-0.291-0.782-0.437-1.38-0.437c-0.445,0-0.889,0.126-1.334,0.379s-0.913,0.748-1.403,1.483l-2.208-1.472c0.537-0.843,1.223-1.533,2.059-2.07c0.835-0.536,1.859-0.805,3.07-0.805c1.533,0,2.703,0.384,3.507,1.15c0.805,0.767,1.208,1.802,1.208,3.104c0,0.384-0.057,0.736-0.172,1.059c-0.115,0.321-0.265,0.629-0.449,0.92c-0.184,0.291-0.391,0.563-0.621,0.816s-0.46,0.494-0.69,0.725c-0.399,0.429-0.759,0.839-1.081,1.23c-0.322,0.391-0.483,0.809-0.483,1.253v0.553H297.269z M297.959,24.192c-0.215-0.092-0.406-0.226-0.575-0.402c-0.169-0.176-0.299-0.376-0.391-0.598c-0.092-0.223-0.138-0.456-0.138-0.702c0-0.245,0.046-0.479,0.138-0.701c0.092-0.222,0.222-0.418,0.391-0.587c0.168-0.168,0.364-0.306,0.586-0.413c0.222-0.107,0.472-0.161,0.748-0.161c0.552,0,1.004,0.188,1.357,0.563c0.353,0.376,0.529,0.809,0.529,1.299c0,0.491-0.176,0.924-0.529,1.3c-0.353,0.376-0.805,0.563-1.357,0.563C298.442,24.354,298.189,24.3,297.959,24.192z"></path></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 14.144144144144144%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 94.2" enable-background="0 0 666 94.2" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 109.7213 21.7755)" font-family="'InterFace-Regular'" font-size="14px">Moderate certainty of important reductions in risks of all-cause</text><text transform="matrix(1 0 0 1 109.7213 38.575500000000005)" font-family="'InterFace-Regular'" font-size="14px">mortality and non-fatal stroke, balanced against moderate certainty of</text><text transform="matrix(1 0 0 1 109.7213 55.3755)" font-family="'InterFace-Regular'" font-size="14px">no important increase in the risk of harms led to a weak</text><text transform="matrix(1 0 0 1 109.7213 72.1755)" font-family="'InterFace-Regular'" font-size="14px">recommendation in favour</text></svg></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Potential benefits</text></svg></div></h2><div class="pane-content" style="padding: 0px 0px 10px 0px; max-width: 666px; margin: 0px auto 0px auto;"><div style="clear: both;"></div><div class="scaling-svg-container" style="padding-bottom: 11.562%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 60" enable-background="0 0 666 60" xml:space="preserve" style="width: 100%;"><polygon fill="#00B2A9" points="256.718,43.109 66.888,43.109 54.888,30.943 66.888,18.776 256.718,18.776 243.718,30.943"></polygon><text transform="matrix(1 0 0 1 157.389 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No SGLT-2 inhibitors</text><polygon fill="#765FA8" points="407.721,18.776 597.551,18.776 609.551,30.943 597.551,43.109 407.721,43.109 419.721,30.943"></polygon><text transform="matrix(1 0 0 1 511.128 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">SGLT-2 inhibitors</text><g class="thishasatooltip"><polygon fill="#7C8696" points="403.351,43.109 260.522,43.109 248.522,30.943 260.522,18.776 403.351,18.776 415.351,30.943"></polygon><text transform="matrix(1 0 0 1 332.32 34.4258)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No important difference</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="395.241" cy="18.088" r="6"></circle><path fill="#FFFFFF" d="M395.751,20.48c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L395.751,20.48z M395.999,15.877c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C396.877,15.486,396.484,15.877,395.999,15.877z"></path><g transform="matrix(1 0 0 1 365 5)" class="thisisthetooltip"><path opacity="0.8" enable-background="new " d="M-349.979,51.675c-5.6,0-10.1-4.5-10.1-10.1V10.211c0-5.6,4.5-10.1,10.1-10.1H11.135c5.6,0,10.1,4.5,10.1,10.1v5.2l10,10l-10,10v6.264c0,5.6-4.5,10.1-10.1,10.1L-349.979,51.675z"></path><text transform="matrix(1 0 0 1 -353.0981 16.7624)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">The panel found that this difference was not important for most patients,</tspan><tspan x="0" y="13" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">because the intervention effects were negligible and/or very imprecise, for</tspan><tspan x="0" y="26" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">example confidence intervals that include both important benefit and harm</tspan></text></g></g></svg></div><div class="scaling-svg-container" style="padding-bottom: 3.003%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 20" enable-background="0 0 666 20" xml:space="preserve" style="width: 100%;"><text transform="matrix(0.9746 0 0 1 14.0746 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Benefits</text><path fill="none" stroke="#7C8696" stroke-miterlimit="10" d="M441.083,17.13c0,0,0-1.791,0-3.98s-2.122-3.98-4.716-3.98H189.049c-2.594,0-4.716,1.791-4.716,3.98s0,3.98,0,3.98"></path><rect x="210.591642578125" y="5" fill="#C1D3E9" width="204.03271484375" height="8"></rect><text transform="matrix(0.9746 0 0 1 312.608 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">Events per 1000 people over 5 years</text><text transform="matrix(0.9746 0 0 1 488.304 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Evidence quality</text></svg></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">All-cause mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">13 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">84</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">71</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 981 patients in 11 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">all-cause mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Cardiovascular mortality</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">20</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">17</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 27 429 patients in 7 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on cardiovascular mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Kidney failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">1</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">1</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 221 patients in 9 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on kidney failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal myocardial infarction</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">73</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">55</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on non-fatal myocardial</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">infarction</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal stroke</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">13 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">49</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">36</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal stroke</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Admission for heart failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">27</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">18</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 962 patients in 6 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on hospital admission for heart</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/pico/?gId=EezrQj&amp;picoId=nJBaqe&amp;tab=outcome','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 206.71409106445313px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 206.71409106445313 18" enable-background="0 0 206.71409106445313 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="197.71409106445313" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="188.71409106445313"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">See all outcomes</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(2.014434814453125,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/recommendation/?gId=EezrQj&amp;recId=Egapbw&amp;open=1&amp;tab=da&amp;org=1&amp;m=1&amp;lb=1','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 223.80849719238282px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 223.80849719238282 18" enable-background="0 0 223.80849719238282 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="214.80849719238282" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="205.80849719238282"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">Patient decision aids</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(19.108840942382812,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><div class="scaling-svg-container" style="padding-bottom: 5.045045045045046%; max-width: 666px; margin: 15px auto 0px auto; clear: both;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 33.6" enable-background="0 0 666 33.6" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 15.0713 20.0906)" fill="#000000" font-family="'InterFace-Regular'" font-size="14px">See below for summary of harms</text></svg></div><div style="clear:both;"></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Individual considerations</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 22.16216216216216%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 147.6" enable-background="0 0 666 147.6" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="125.6" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Values and preferences</text><text transform="matrix(1 0 0 1 125 70)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">The panel inferred that the majority of individuals would be inclined to receive</text><text transform="matrix(1 0 0 1 125 84.4)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors, though a substantial proportion may be disinclined to do the</text><text transform="matrix(1 0 0 1 125 98.80000000000001)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">same, given the degree of benefits, increased pill burden, medication costs and a</text><text transform="matrix(1 0 0 1 125 113.20000000000002)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">residual risk of harms</text></svg></div></div></div></div></div><div class="whiteBox" style="margin:15px; padding:10px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 11.223%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 78" enable-background="0 0 695 78" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 55.1034 36.7349)" fill="#333333" font-family="'InterFace-Bold'" font-size="21px">Recommendation 3</text><path fill="#7C8696" d="M33.809,20.915c-7.32,0-13.254,3.258-13.254,7.277c0,2.436,2.187,4.586,5.534,5.907l-1.029,7.434l6.421-6.183c0.757,0.074,1.533,0.119,2.328,0.119c7.32,0,13.254-3.258,13.254-7.277S41.129,20.915,33.809,20.915z"></path></svg></div><div class="scaling-svg-container" style="padding-bottom: 24.89208633093525%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 173" enable-background="0 0 695 173" xml:space="preserve" style="width: 100%;"><path fill="#D8DBDF" d="M34.5,0 h626 a20,20 0 0 1 20,20 v120 a20,20 0 0 1 -20,20 h-626 a20,20 0 0 1 -20,-20 v-120 a20,20 0 0 1 20,-20"></path><path fill="#00B2A9" d="M34.5,0 h313 v90 h-333 v-70 a20,20 0 0 1 20,-20"></path><path fill="#765FA8" d="M347.5,0 h313 a20,20 0 0 1 20,20 v70 h-333 z"></path><text transform="matrix(1 0 0 1 184 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">No SGLT-2 inhibitors</text><text transform="matrix(1 0 0 1 511 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">SGLT-2 inhibitors</text><line fill="none" stroke="#FFFFFF" stroke-width="3" stroke-miterlimit="10" x1="347.5" y1="0" x2="347.5" y2="90"></line><circle fill="#FFFFFF" cx="347.776" cy="46.175" r="15.575"></circle><text transform="matrix(1 0 0 1 339.7538 50.7762)" font-family="'InterFace-Regular'" font-size="18px">or</text><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M252.351,158.478H42.009c-8.182,0-14.876-6.694-14.876-14.876v-23.514c0-4.28,3.502-7.781,7.781-7.781h217.438c4.28,0,7.781,3.502,7.781,7.781v30.609C260.132,154.976,256.631,158.478,252.351,158.478z"></path><g transform="translate(0,0)"><path fill="#7C8696" d="M36.955,126.089c0-1.686,1.395-3.052,3.116-3.052c1.721,0,3.117,1.366,3.117,3.052c0,1.685-1.396,3.052-3.117,3.052C38.351,129.141,36.955,127.774,36.955,126.089z"></path><path fill="#7C8696" d="M40.236,130.024h-0.328c-2.174,0-3.936,0.456-3.936,3.855v2.209c0,1.474,0.531,2.295,1.368,2.737l0.602,6.887h4.182l0.6-6.855c0.883-0.439,1.449-1.27,1.449-2.769v-2.209C44.173,130.425,42.41,130.024,40.236,130.024z"></path><path fill="#7C8696" d="M46.749,124.235c0-1.931,1.598-3.496,3.57-3.496c1.971,0,3.57,1.565,3.57,3.496c0,1.93-1.599,3.496-3.57,3.496C48.347,127.731,46.749,126.166,46.749,124.235z"></path><path fill="#7C8696" d="M50.507,128.742h-0.376c-2.49,0-4.509,0.522-4.509,4.415v2.53c0,1.689,0.609,2.629,1.567,3.136l0.69,7.888h4.791l0.687-7.852c1.012-0.503,1.659-1.455,1.659-3.171v-2.53C55.016,129.202,52.997,128.742,50.507,128.742z"></path><path fill="#7C8696" d="M57.363,126.826c0-1.537,1.272-2.782,2.84-2.782c1.569,0,2.841,1.245,2.841,2.782c0,1.536-1.272,2.782-2.841,2.782C58.634,129.608,57.363,128.362,57.363,126.826z"></path><path fill="#7C8696" d="M60.353,130.412h-0.299c-1.982,0-3.588,0.415-3.588,3.514v2.013c0,1.344,0.484,2.092,1.247,2.495l0.549,6.277h3.812l0.547-6.248c0.805-0.4,1.32-1.157,1.32-2.524v-2.013C63.941,130.778,62.334,130.412,60.353,130.412z"></path></g><text transform="matrix(1 0 0 1 74.466 138.498)" font-family="'InterFace-Regular'" font-size="14px">High risk</text></g><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M276.914,158.478h375.71c8.182,0,14.876-6.694,14.876-14.876v-23.514c0-4.28-3.502-7.781-7.781-7.781H276.914c-4.28,0-7.781,3.502-7.781,7.781v30.609C269.132,154.976,272.634,158.478,276.914,158.478z"></path><path fill="#7C8696" d="M277.498,123.473c1.013-1.118,2.563-1.802,4.651-2.052c0.822-0.099,1.548,0.492,1.548,1.225v1.42c0,0.521-0.365,1.008-0.929,1.159c-0.667,0.179-1.158,0.473-1.474,0.881c-0.449,0.581-0.673,1.452-0.673,2.613v0.522h1.682c0.77,0,1.393,0.551,1.393,1.231v5.9c0,0.68-0.624,1.231-1.393,1.231h-5.286c-0.77,0-1.393-0.551-1.393-1.231v-6.608C275.624,126.95,276.249,124.852,277.498,123.473z M289.724,119.879c1.271-1.402,3.215-2.26,5.834-2.574c1.032-0.124,1.942,0.617,1.942,1.537v1.782c0,0.654-0.457,1.264-1.165,1.454c-0.836,0.224-1.452,0.593-1.848,1.106c-0.563,0.729-0.844,1.821-0.844,3.278v0.655h2.11c0.965,0,1.748,0.691,1.748,1.544v7.401c0,0.853-0.783,1.544-1.748,1.544h-6.631c-0.965,0-1.748-0.691-1.748-1.544v-8.288C287.374,124.24,288.157,121.609,289.724,119.879z"></path><path fill="#7C8696" d="M657.626,145.424c-1.013,1.118-2.563,1.802-4.651,2.052c-0.822,0.099-1.548-0.492-1.548-1.225v-1.42c0-0.521,0.365-1.008,0.929-1.159c0.667-0.179,1.158-0.473,1.474-0.882c0.449-0.581,0.673-1.452,0.673-2.613v-0.522h-1.682c-0.77,0-1.393-0.551-1.393-1.231v-5.9c0-0.68,0.624-1.231,1.393-1.231h5.286c0.77,0,1.393,0.551,1.393,1.231v6.608C659.5,141.947,658.875,144.045,657.626,145.424z M645.4,149.018c-1.271,1.402-3.215,2.26-5.834,2.574c-1.032,0.124-1.942-0.617-1.942-1.537v-1.782c0-0.654,0.457-1.264,1.166-1.454c0.836-0.224,1.452-0.593,1.848-1.106c0.563-0.729,0.844-1.821,0.844-3.278v-0.655h-2.11c-0.965,0-1.748-0.691-1.748-1.544v-7.401c0-0.853,0.783-1.544,1.748-1.544h6.631c0.965,0,1.748,0.691,1.748,1.544v8.288C647.751,144.657,646.967,147.289,645.4,149.018z"></path><text transform="matrix(1 0 0 1 467.816 138.6864)" font-family="'InterFace-Regular'" font-size="14px" text-anchor="middle">We recommend administering SGLT-2 inhibitors</text></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="164.011,117.552 66.011,117.552 56.011,102.552 66.011,87.552 164.011,87.552 154.011,102.552"></polygon><text transform="matrix(1 0 0 1 81.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="160.139" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M160.648,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L160.648,91.629z M160.896,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C161.774,86.635,161.382,87.026,160.896,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M251.153,185.394h-229.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h108.9l6-6l6,6h109.001c3.2,0,5.5,2.6,5.5,5.7v45.754C256.653,183.194,254.353,185.394,251.153,185.394z"></path><text transform="matrix(1 0 0 1 24.9805 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the left. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="274.011,117.552 176.011,117.552 166.011,102.552 176.011,87.552 274.011,87.552 264.011,102.552"></polygon><text transform="matrix(1 0 0 1 198.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="271.472" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M271.981,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L271.981,91.629z M272.229,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C273.107,86.635,272.715,87.026,272.229,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M348.293,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C353.793,183.194,351.493,185.394,348.293,185.394z"></path><text transform="matrix(1 0 0 1 107.1205 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the left. Benefits would outweigh harms for</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="390.511,117.552 488.511,117.552 498.511,102.552 488.511,87.552 390.511,87.552 400.511,102.552"></polygon><text transform="matrix(1 0 0 1 425.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="487.595" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M488.104,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L488.104,91.629z M488.352,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C489.23,86.635,488.838,87.026,488.352,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M573.214,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C578.714,183.194,576.413,185.394,573.214,185.394z"></path><text transform="matrix(1 0 0 1 332.041 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the right. Benefits would outweigh harms</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">for the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="1" fill="#FFFFFF" points="500.511,117.552 598.511,117.552 608.511,102.552 598.511,87.552 500.511,87.552 510.511,102.552"></polygon><text transform="matrix(1 0 0 1 527.6486 107.8645)" fill="#7D5CC6" font-family="'InterFace-Bold'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="597.928" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M598.437,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L598.437,91.629z M598.685,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C599.563,86.635,599.171,87.026,598.685,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M649.787,185.394h-231.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h107.9l6-6l6,6h112.001c3.2,0,5.5,2.6,5.5,5.7v45.754C655.287,183.194,652.987,185.394,649.787,185.394z"></path><text transform="matrix(1 0 0 1 421.6153 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the right. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g></svg></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 315.4078 21.7755)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Rationale</text><circle fill="#FFFFFF" cx="298.537" cy="16.747" r="10.974"></circle><path fill="#2A6EBB" d="M297.269,19.248v-0.967c0-0.307,0.05-0.605,0.149-0.896s0.226-0.563,0.38-0.816c0.153-0.253,0.318-0.487,0.494-0.702c0.176-0.214,0.341-0.398,0.495-0.552c0.215-0.229,0.433-0.444,0.656-0.644c0.222-0.199,0.421-0.406,0.598-0.621s0.322-0.438,0.437-0.667c0.115-0.23,0.173-0.491,0.173-0.782c0-0.536-0.161-0.95-0.483-1.242c-0.322-0.291-0.782-0.437-1.38-0.437c-0.445,0-0.889,0.126-1.334,0.379s-0.913,0.748-1.403,1.483l-2.208-1.472c0.537-0.843,1.223-1.533,2.059-2.07c0.835-0.536,1.859-0.805,3.07-0.805c1.533,0,2.703,0.384,3.507,1.15c0.805,0.767,1.208,1.802,1.208,3.104c0,0.384-0.057,0.736-0.172,1.059c-0.115,0.321-0.265,0.629-0.449,0.92c-0.184,0.291-0.391,0.563-0.621,0.816s-0.46,0.494-0.69,0.725c-0.399,0.429-0.759,0.839-1.081,1.23c-0.322,0.391-0.483,0.809-0.483,1.253v0.553H297.269z M297.959,24.192c-0.215-0.092-0.406-0.226-0.575-0.402c-0.169-0.176-0.299-0.376-0.391-0.598c-0.092-0.223-0.138-0.456-0.138-0.702c0-0.245,0.046-0.479,0.138-0.701c0.092-0.222,0.222-0.418,0.391-0.587c0.168-0.168,0.364-0.306,0.586-0.413c0.222-0.107,0.472-0.161,0.748-0.161c0.552,0,1.004,0.188,1.357,0.563c0.353,0.376,0.529,0.809,0.529,1.299c0,0.491-0.176,0.924-0.529,1.3c-0.353,0.376-0.805,0.563-1.357,0.563C298.442,24.354,298.189,24.3,297.959,24.192z"></path></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 14.144144144144144%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 94.2" enable-background="0 0 666 94.2" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 109.7213 21.7755)" font-family="'InterFace-Regular'" font-size="14px">Moderate certainty of important reductions in risks of mortality and</text><text transform="matrix(1 0 0 1 109.7213 38.575500000000005)" font-family="'InterFace-Regular'" font-size="14px">most cardiovascular and kidney outcomes, combined with moderate</text><text transform="matrix(1 0 0 1 109.7213 55.3755)" font-family="'InterFace-Regular'" font-size="14px">certainty of no important increase in the risk of harms led to a</text><text transform="matrix(1 0 0 1 109.7213 72.1755)" font-family="'InterFace-Regular'" font-size="14px">strong recommendation in favour of treatment</text></svg></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Potential benefits</text></svg></div></h2><div class="pane-content" style="padding: 0px 0px 10px 0px; max-width: 666px; margin: 0px auto 0px auto;"><div style="clear: both;"></div><div class="scaling-svg-container" style="padding-bottom: 11.562%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 60" enable-background="0 0 666 60" xml:space="preserve" style="width: 100%;"><polygon fill="#00B2A9" points="256.718,43.109 66.888,43.109 54.888,30.943 66.888,18.776 256.718,18.776 243.718,30.943"></polygon><text transform="matrix(1 0 0 1 157.389 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No SGLT-2 inhibitors</text><polygon fill="#765FA8" points="407.721,18.776 597.551,18.776 609.551,30.943 597.551,43.109 407.721,43.109 419.721,30.943"></polygon><text transform="matrix(1 0 0 1 511.128 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">SGLT-2 inhibitors</text><g class="thishasatooltip"><polygon fill="#7C8696" points="403.351,43.109 260.522,43.109 248.522,30.943 260.522,18.776 403.351,18.776 415.351,30.943"></polygon><text transform="matrix(1 0 0 1 332.32 34.4258)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No important difference</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="395.241" cy="18.088" r="6"></circle><path fill="#FFFFFF" d="M395.751,20.48c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L395.751,20.48z M395.999,15.877c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C396.877,15.486,396.484,15.877,395.999,15.877z"></path><g transform="matrix(1 0 0 1 365 5)" class="thisisthetooltip"><path opacity="0.8" enable-background="new " d="M-349.979,51.675c-5.6,0-10.1-4.5-10.1-10.1V10.211c0-5.6,4.5-10.1,10.1-10.1H11.135c5.6,0,10.1,4.5,10.1,10.1v5.2l10,10l-10,10v6.264c0,5.6-4.5,10.1-10.1,10.1L-349.979,51.675z"></path><text transform="matrix(1 0 0 1 -353.0981 16.7624)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">The panel found that this difference was not important for most patients,</tspan><tspan x="0" y="13" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">because the intervention effects were negligible and/or very imprecise, for</tspan><tspan x="0" y="26" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">example confidence intervals that include both important benefit and harm</tspan></text></g></g></svg></div><div class="scaling-svg-container" style="padding-bottom: 3.003%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 20" enable-background="0 0 666 20" xml:space="preserve" style="width: 100%;"><text transform="matrix(0.9746 0 0 1 14.0746 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Benefits</text><path fill="none" stroke="#7C8696" stroke-miterlimit="10" d="M441.083,17.13c0,0,0-1.791,0-3.98s-2.122-3.98-4.716-3.98H189.049c-2.594,0-4.716,1.791-4.716,3.98s0,3.98,0,3.98"></path><rect x="210.591642578125" y="5" fill="#C1D3E9" width="204.03271484375" height="8"></rect><text transform="matrix(0.9746 0 0 1 312.608 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">Events per 1000 people over 5 years</text><text transform="matrix(0.9746 0 0 1 488.304 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Evidence quality</text></svg></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">All-cause mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">24 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">159</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">135</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 981 patients in 11 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">all-cause mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Cardiovascular mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">6 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">37</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">31</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 27 429 patients in 7 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">cardiovascular mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Kidney failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">9</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">6</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 221 patients in 9 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on kidney failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal myocardial infarction</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">21 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">85</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">64</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal myocardial infarction</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal stroke</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">21 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">78</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">57</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal stroke</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Admission for heart failure</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">40</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">27</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 962 patients in 6 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on hospital admission for heart</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/pico/?gId=EezrQj&amp;picoId=L48om5&amp;tab=outcome','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 206.71409106445313px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 206.71409106445313 18" enable-background="0 0 206.71409106445313 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="197.71409106445313" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="188.71409106445313"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">See all outcomes</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(2.014434814453125,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/recommendation/?gId=EezrQj&amp;recId=LwrBb6&amp;open=1&amp;tab=da&amp;org=1&amp;m=1&amp;lb=1','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 223.80849719238282px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 223.80849719238282 18" enable-background="0 0 223.80849719238282 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="214.80849719238282" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="205.80849719238282"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">Patient decision aids</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(19.108840942382812,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><div class="scaling-svg-container" style="padding-bottom: 5.045045045045046%; max-width: 666px; margin: 15px auto 0px auto; clear: both;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 33.6" enable-background="0 0 666 33.6" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 15.0713 20.0906)" fill="#000000" font-family="'InterFace-Regular'" font-size="14px">See below for summary of harms</text></svg></div><div style="clear:both;"></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Individual considerations</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 20%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 133.2" enable-background="0 0 666 133.2" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="111.19999999999999" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Values and preferences</text><text transform="matrix(1 0 0 1 125 70)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">The panel inferred that all or almost all individuals would be inclined to receive</text><text transform="matrix(1 0 0 1 125 84.4)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors, given benefits substantially outweigh possible harms. No</text><text transform="matrix(1 0 0 1 125 98.80000000000001)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">significant variability in patient preference was anticipated</text></svg></div></div></div></div></div><div class="whiteBox" style="margin:15px; padding:10px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 11.223%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 78" enable-background="0 0 695 78" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 55.1034 36.7349)" fill="#333333" font-family="'InterFace-Bold'" font-size="21px">Recommendation 4</text><path fill="#7C8696" d="M33.809,20.915c-7.32,0-13.254,3.258-13.254,7.277c0,2.436,2.187,4.586,5.534,5.907l-1.029,7.434l6.421-6.183c0.757,0.074,1.533,0.119,2.328,0.119c7.32,0,13.254-3.258,13.254-7.277S41.129,20.915,33.809,20.915z"></path></svg></div><div class="scaling-svg-container" style="padding-bottom: 24.89208633093525%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 173" enable-background="0 0 695 173" xml:space="preserve" style="width: 100%;"><path fill="#D8DBDF" d="M34.5,0 h626 a20,20 0 0 1 20,20 v120 a20,20 0 0 1 -20,20 h-626 a20,20 0 0 1 -20,-20 v-120 a20,20 0 0 1 20,-20"></path><path fill="#00B2A9" d="M34.5,0 h313 v90 h-333 v-70 a20,20 0 0 1 20,-20"></path><path fill="#765FA8" d="M347.5,0 h313 a20,20 0 0 1 20,20 v70 h-333 z"></path><text transform="matrix(1 0 0 1 184 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">No SGLT-2 inhibitors</text><text transform="matrix(1 0 0 1 511 28)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="18px" text-anchor="middle">SGLT-2 inhibitors</text><line fill="none" stroke="#FFFFFF" stroke-width="3" stroke-miterlimit="10" x1="347.5" y1="0" x2="347.5" y2="90"></line><circle fill="#FFFFFF" cx="347.776" cy="46.175" r="15.575"></circle><text transform="matrix(1 0 0 1 339.7538 50.7762)" font-family="'InterFace-Regular'" font-size="18px">or</text><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M252.351,158.478H42.009c-8.182,0-14.876-6.694-14.876-14.876v-23.514c0-4.28,3.502-7.781,7.781-7.781h217.438c4.28,0,7.781,3.502,7.781,7.781v30.609C260.132,154.976,256.631,158.478,252.351,158.478z"></path><g transform="translate(0,0)"><path fill="#7C8696" d="M36.955,126.089c0-1.686,1.395-3.052,3.116-3.052c1.721,0,3.117,1.366,3.117,3.052c0,1.685-1.396,3.052-3.117,3.052C38.351,129.141,36.955,127.774,36.955,126.089z"></path><path fill="#7C8696" d="M40.236,130.024h-0.328c-2.174,0-3.936,0.456-3.936,3.855v2.209c0,1.474,0.531,2.295,1.368,2.737l0.602,6.887h4.182l0.6-6.855c0.883-0.439,1.449-1.27,1.449-2.769v-2.209C44.173,130.425,42.41,130.024,40.236,130.024z"></path><path fill="#7C8696" d="M46.749,124.235c0-1.931,1.598-3.496,3.57-3.496c1.971,0,3.57,1.565,3.57,3.496c0,1.93-1.599,3.496-3.57,3.496C48.347,127.731,46.749,126.166,46.749,124.235z"></path><path fill="#7C8696" d="M50.507,128.742h-0.376c-2.49,0-4.509,0.522-4.509,4.415v2.53c0,1.689,0.609,2.629,1.567,3.136l0.69,7.888h4.791l0.687-7.852c1.012-0.503,1.659-1.455,1.659-3.171v-2.53C55.016,129.202,52.997,128.742,50.507,128.742z"></path><path fill="#7C8696" d="M57.363,126.826c0-1.537,1.272-2.782,2.84-2.782c1.569,0,2.841,1.245,2.841,2.782c0,1.536-1.272,2.782-2.841,2.782C58.634,129.608,57.363,128.362,57.363,126.826z"></path><path fill="#7C8696" d="M60.353,130.412h-0.299c-1.982,0-3.588,0.415-3.588,3.514v2.013c0,1.344,0.484,2.092,1.247,2.495l0.549,6.277h3.812l0.547-6.248c0.805-0.4,1.32-1.157,1.32-2.524v-2.013C63.941,130.778,62.334,130.412,60.353,130.412z"></path></g><text transform="matrix(1 0 0 1 74.466 138.498)" font-family="'InterFace-Regular'" font-size="14px">Very high risk</text></g><g transform="translate(0,-10.598800000000011)"><path fill="#FFFFFF" d="M276.914,158.478h375.71c8.182,0,14.876-6.694,14.876-14.876v-23.514c0-4.28-3.502-7.781-7.781-7.781H276.914c-4.28,0-7.781,3.502-7.781,7.781v30.609C269.132,154.976,272.634,158.478,276.914,158.478z"></path><path fill="#7C8696" d="M277.498,123.473c1.013-1.118,2.563-1.802,4.651-2.052c0.822-0.099,1.548,0.492,1.548,1.225v1.42c0,0.521-0.365,1.008-0.929,1.159c-0.667,0.179-1.158,0.473-1.474,0.881c-0.449,0.581-0.673,1.452-0.673,2.613v0.522h1.682c0.77,0,1.393,0.551,1.393,1.231v5.9c0,0.68-0.624,1.231-1.393,1.231h-5.286c-0.77,0-1.393-0.551-1.393-1.231v-6.608C275.624,126.95,276.249,124.852,277.498,123.473z M289.724,119.879c1.271-1.402,3.215-2.26,5.834-2.574c1.032-0.124,1.942,0.617,1.942,1.537v1.782c0,0.654-0.457,1.264-1.165,1.454c-0.836,0.224-1.452,0.593-1.848,1.106c-0.563,0.729-0.844,1.821-0.844,3.278v0.655h2.11c0.965,0,1.748,0.691,1.748,1.544v7.401c0,0.853-0.783,1.544-1.748,1.544h-6.631c-0.965,0-1.748-0.691-1.748-1.544v-8.288C287.374,124.24,288.157,121.609,289.724,119.879z"></path><path fill="#7C8696" d="M657.626,145.424c-1.013,1.118-2.563,1.802-4.651,2.052c-0.822,0.099-1.548-0.492-1.548-1.225v-1.42c0-0.521,0.365-1.008,0.929-1.159c0.667-0.179,1.158-0.473,1.474-0.882c0.449-0.581,0.673-1.452,0.673-2.613v-0.522h-1.682c-0.77,0-1.393-0.551-1.393-1.231v-5.9c0-0.68,0.624-1.231,1.393-1.231h5.286c0.77,0,1.393,0.551,1.393,1.231v6.608C659.5,141.947,658.875,144.045,657.626,145.424z M645.4,149.018c-1.271,1.402-3.215,2.26-5.834,2.574c-1.032,0.124-1.942-0.617-1.942-1.537v-1.782c0-0.654,0.457-1.264,1.166-1.454c0.836-0.224,1.452-0.593,1.848-1.106c0.563-0.729,0.844-1.821,0.844-3.278v-0.655h-2.11c-0.965,0-1.748-0.691-1.748-1.544v-7.401c0-0.853,0.783-1.544,1.748-1.544h6.631c0.965,0,1.748,0.691,1.748,1.544v8.288C647.751,144.657,646.967,147.289,645.4,149.018z"></path><text transform="matrix(1 0 0 1 467.816 138.6864)" font-family="'InterFace-Regular'" font-size="14px" text-anchor="middle">We recommend administering SGLT-2 inhibitors</text></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="164.011,117.552 66.011,117.552 56.011,102.552 66.011,87.552 164.011,87.552 154.011,102.552"></polygon><text transform="matrix(1 0 0 1 81.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="160.139" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M160.648,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L160.648,91.629z M160.896,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C161.774,86.635,161.382,87.026,160.896,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M251.153,185.394h-229.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h108.9l6-6l6,6h109.001c3.2,0,5.5,2.6,5.5,5.7v45.754C256.653,183.194,254.353,185.394,251.153,185.394z"></path><text transform="matrix(1 0 0 1 24.9805 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the left. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="274.011,117.552 176.011,117.552 166.011,102.552 176.011,87.552 274.011,87.552 264.011,102.552"></polygon><text transform="matrix(1 0 0 1 198.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="271.472" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M271.981,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L271.981,91.629z M272.229,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C273.107,86.635,272.715,87.026,272.229,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M348.293,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C353.793,183.194,351.493,185.394,348.293,185.394z"></path><text transform="matrix(1 0 0 1 107.1205 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the left. Benefits would outweigh harms for</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="0.2" fill="#FFFFFF" points="390.511,117.552 488.511,117.552 498.511,102.552 488.511,87.552 390.511,87.552 400.511,102.552"></polygon><text transform="matrix(1 0 0 1 425.6487 107.8645)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="18px">Weak</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="487.595" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M488.104,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L488.104,91.629z M488.352,87.026c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C489.23,86.635,488.838,87.026,488.352,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M573.214,185.394h-244.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h115.9l6-6l6,6h117.001c3.2,0,5.5,2.6,5.5,5.7v45.754C578.714,183.194,576.413,185.394,573.214,185.394z"></path><text transform="matrix(1 0 0 1 332.041 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">Most people would likely want the intervention</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">to the right. Benefits would outweigh harms</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">for the majority, but not for everyone</tspan></text></g></g><g class="thishasatooltip" transform="translate(14.4892, -42.398799999999994)"><polygon opacity="1" fill="#FFFFFF" points="500.511,117.552 598.511,117.552 608.511,102.552 598.511,87.552 500.511,87.552 510.511,102.552"></polygon><text transform="matrix(1 0 0 1 527.6486 107.8645)" fill="#7D5CC6" font-family="'InterFace-Bold'" font-size="18px">Strong</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="597.928" cy="89.237" r="6"></circle><path fill="#FFFFFF" d="M598.437,91.629c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.041,0.436c-0.465,0.243-0.898,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.548-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.578,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L598.437,91.629z M598.685,87.026c-0.476,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.476,0,0.857,0.403,0.857,0.891C599.563,86.635,599.171,87.026,598.685,87.026z"></path><g class="thisisthetooltip" transform="matrix(1 0 0 1 0 0)"><path opacity="0.8" enable-background="new " d="M649.787,185.394h-231.9c-3.2,0-6.1-2.2-6.1-5.4V134.14c0-3.1,2.9-5.7,6.1-5.7h107.9l6-6l6,6h112.001c3.2,0,5.5,2.6,5.5,5.7v45.754C655.287,183.194,652.987,185.394,649.787,185.394z"></path><text transform="matrix(1 0 0 1 421.6153 145.54)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">All or nearly all informed people would likely</tspan><tspan x="0" y="13.8" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">want the intervention to the right. Benefits</tspan><tspan x="0" y="27.6" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">would outweigh harms for almost everyone</tspan></text></g></g></svg></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 315.4078 21.7755)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Rationale</text><circle fill="#FFFFFF" cx="298.537" cy="16.747" r="10.974"></circle><path fill="#2A6EBB" d="M297.269,19.248v-0.967c0-0.307,0.05-0.605,0.149-0.896s0.226-0.563,0.38-0.816c0.153-0.253,0.318-0.487,0.494-0.702c0.176-0.214,0.341-0.398,0.495-0.552c0.215-0.229,0.433-0.444,0.656-0.644c0.222-0.199,0.421-0.406,0.598-0.621s0.322-0.438,0.437-0.667c0.115-0.23,0.173-0.491,0.173-0.782c0-0.536-0.161-0.95-0.483-1.242c-0.322-0.291-0.782-0.437-1.38-0.437c-0.445,0-0.889,0.126-1.334,0.379s-0.913,0.748-1.403,1.483l-2.208-1.472c0.537-0.843,1.223-1.533,2.059-2.07c0.835-0.536,1.859-0.805,3.07-0.805c1.533,0,2.703,0.384,3.507,1.15c0.805,0.767,1.208,1.802,1.208,3.104c0,0.384-0.057,0.736-0.172,1.059c-0.115,0.321-0.265,0.629-0.449,0.92c-0.184,0.291-0.391,0.563-0.621,0.816s-0.46,0.494-0.69,0.725c-0.399,0.429-0.759,0.839-1.081,1.23c-0.322,0.391-0.483,0.809-0.483,1.253v0.553H297.269z M297.959,24.192c-0.215-0.092-0.406-0.226-0.575-0.402c-0.169-0.176-0.299-0.376-0.391-0.598c-0.092-0.223-0.138-0.456-0.138-0.702c0-0.245,0.046-0.479,0.138-0.701c0.092-0.222,0.222-0.418,0.391-0.587c0.168-0.168,0.364-0.306,0.586-0.413c0.222-0.107,0.472-0.161,0.748-0.161c0.552,0,1.004,0.188,1.357,0.563c0.353,0.376,0.529,0.809,0.529,1.299c0,0.491-0.176,0.924-0.529,1.3c-0.353,0.376-0.805,0.563-1.357,0.563C298.442,24.354,298.189,24.3,297.959,24.192z"></path></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 16.666666666666664%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 111" enable-background="0 0 666 111" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 109.7213 21.7755)" font-family="'InterFace-Regular'" font-size="14px">High certainty of an overall survival benefit and reduced risk of</text><text transform="matrix(1 0 0 1 109.7213 38.575500000000005)" font-family="'InterFace-Regular'" font-size="14px">kidney failure, moderate certainty of important reductions in</text><text transform="matrix(1 0 0 1 109.7213 55.3755)" font-family="'InterFace-Regular'" font-size="14px">cardiovascular mortality and outcomes, and moderate certainty of no</text><text transform="matrix(1 0 0 1 109.7213 72.1755)" font-family="'InterFace-Regular'" font-size="14px">important increase in the risk of harms led to a strong recommendation</text><text transform="matrix(1 0 0 1 109.7213 88.97550000000001)" font-family="'InterFace-Regular'" font-size="14px">in favour</text></svg></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Potential benefits</text></svg></div></h2><div class="pane-content" style="padding: 0px 0px 10px 0px; max-width: 666px; margin: 0px auto 0px auto;"><div style="clear: both;"></div><div class="scaling-svg-container" style="padding-bottom: 11.562%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 60" enable-background="0 0 666 60" xml:space="preserve" style="width: 100%;"><polygon fill="#00B2A9" points="256.718,43.109 66.888,43.109 54.888,30.943 66.888,18.776 256.718,18.776 243.718,30.943"></polygon><text transform="matrix(1 0 0 1 157.389 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No SGLT-2 inhibitors</text><polygon fill="#765FA8" points="407.721,18.776 597.551,18.776 609.551,30.943 597.551,43.109 407.721,43.109 419.721,30.943"></polygon><text transform="matrix(1 0 0 1 511.128 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">SGLT-2 inhibitors</text><g class="thishasatooltip"><polygon fill="#7C8696" points="403.351,43.109 260.522,43.109 248.522,30.943 260.522,18.776 403.351,18.776 415.351,30.943"></polygon><text transform="matrix(1 0 0 1 332.32 34.4258)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No important difference</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="395.241" cy="18.088" r="6"></circle><path fill="#FFFFFF" d="M395.751,20.48c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L395.751,20.48z M395.999,15.877c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C396.877,15.486,396.484,15.877,395.999,15.877z"></path><g transform="matrix(1 0 0 1 365 5)" class="thisisthetooltip"><path opacity="0.8" enable-background="new " d="M-349.979,51.675c-5.6,0-10.1-4.5-10.1-10.1V10.211c0-5.6,4.5-10.1,10.1-10.1H11.135c5.6,0,10.1,4.5,10.1,10.1v5.2l10,10l-10,10v6.264c0,5.6-4.5,10.1-10.1,10.1L-349.979,51.675z"></path><text transform="matrix(1 0 0 1 -353.0981 16.7624)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">The panel found that this difference was not important for most patients,</tspan><tspan x="0" y="13" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">because the intervention effects were negligible and/or very imprecise, for</tspan><tspan x="0" y="26" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">example confidence intervals that include both important benefit and harm</tspan></text></g></g></svg></div><div class="scaling-svg-container" style="padding-bottom: 3.003%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 20" enable-background="0 0 666 20" xml:space="preserve" style="width: 100%;"><text transform="matrix(0.9746 0 0 1 14.0746 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Benefits</text><path fill="none" stroke="#7C8696" stroke-miterlimit="10" d="M441.083,17.13c0,0,0-1.791,0-3.98s-2.122-3.98-4.716-3.98H189.049c-2.594,0-4.716,1.791-4.716,3.98s0,3.98,0,3.98"></path><rect x="210.591642578125" y="5" fill="#C1D3E9" width="204.03271484375" height="8"></rect><text transform="matrix(0.9746 0 0 1 312.608 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">Events per 1000 people over 5 years</text><text transform="matrix(0.9746 0 0 1 488.304 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Evidence quality</text></svg></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">All-cause mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">48 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">323</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">275</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 981 patients in 11 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors decrease all-cause</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Cardiovascular mortality</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">10 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">64</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">54</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 27 429 patients in 7 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">cardiovascular mortality</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Kidney failure</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">58 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">181</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">123</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">High</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#EEAA1F" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 28 221 patients in 9 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors decrease kidney</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">High</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(390.29061698913574,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(475.29061698913574,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-23.709383010864258,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal myocardial infarction</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">32 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">127</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">95</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal myocardial infarction</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Non-fatal stroke</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">25 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">93</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">68</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 16 049 patients in 4 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">non-fatal stroke</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Admission for heart failure</text><polygon fill="#765FA8" points="318.227,15 440.227,15 447.227,7.5 440.227,0 318.227,0"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 323.2949 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="start">25 fewer</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">79</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#FFFFFF">54</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 962 patients in 6 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably decrease</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">hospital admission for heart failure</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/pico/?gId=EezrQj&amp;picoId=Ea05q8&amp;tab=outcome','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 206.71409106445313px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 206.71409106445313 18" enable-background="0 0 206.71409106445313 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="197.71409106445313" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="188.71409106445313"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">See all outcomes</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(2.014434814453125,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><a xlink:href="javascript:void(0)" onclick="window.open('https://app.magicapp.org/widget/recommendation/?gId=EezrQj&amp;recId=Lrv1GW&amp;open=1&amp;tab=da&amp;org=1&amp;m=1&amp;lb=1','PICO','width=800,height=600,left=0,top=0')"><div class="magicLink1" style="margin: 10px 5px 5px 10px; height: 18px; max-width: 223.80849719238282px; float: left;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 223.80849719238282 18" enable-background="0 0 223.80849719238282 18" xml:space="preserve" style="width: 100%;"><circle fill="#FFFFFF" cx="9" cy="9" r="9"></circle><circle fill="#FFFFFF" cx="214.80849719238282" cy="9" r="9"></circle><rect fill="#FFFFFF" x="9" height="18" width="205.80849719238282"></rect><path fill="#FFFFFF" d="M195.3,35.176H9.3c-5.1,0-9.3-3.9-9.3-9l0,0c0-5.1,4.2-9,9.3-9h186.1c5.1,0,9.3,3.9,9.3,9l0,0C204.7,31.276,200.5,35.176,195.3,35.176z"></path><text transform="matrix(1 0 0 1 20.0713 12.0906)" fill="#417283" font-family="'InterFace-Regular'" font-size="12.2883px">Patient decision aids</text><circle fill="#057482" cx="9.6" cy="8.867" r="6.9"></circle><polygon fill="#FFFFFF" points="7.687,12.367 7.687,5.267 13.887,8.767 "></polygon><g transform="translate(19.108840942382812,-17.15)"><rect x="174.277" y="20.171" fill="#057482" width="20.823" height="11.301"></rect><path fill="#057482" d="M128.215,26.947c0.094,0.208,0.184,0.422,0.27,0.641c0.086-0.224,0.178-0.441,0.274-0.652c0.096-0.211,0.195-0.416,0.297-0.614l2.849-5.613c0.051-0.097,0.103-0.172,0.156-0.225c0.053-0.053,0.113-0.093,0.179-0.118s0.141-0.038,0.225-0.038s0.182,0,0.293,0h1.965V31.42h-2.27v-6.384c0-0.31,0.015-0.645,0.046-1.006l-2.941,5.706c-0.091,0.178-0.215,0.312-0.369,0.404c-0.155,0.091-0.331,0.137-0.529,0.137h-0.35c-0.198,0-0.375-0.046-0.529-0.137c-0.155-0.091-0.278-0.226-0.369-0.404l-2.956-5.714c0.02,0.178,0.035,0.354,0.046,0.529c0.01,0.175,0.015,0.336,0.015,0.484v6.384h-2.27V20.327h1.965c0.112,0,0.209,0,0.293,0s0.159,0.013,0.225,0.038s0.126,0.065,0.179,0.118s0.105,0.128,0.156,0.225l2.857,5.636C128.024,26.537,128.121,26.738,128.215,26.947z"></path><path fill="#057482" d="M146.883,31.419h-1.996c-0.224,0-0.408-0.052-0.552-0.156c-0.145-0.104-0.245-0.237-0.301-0.4l-0.655-1.935h-4.22l-0.655,1.935c-0.051,0.142-0.15,0.27-0.297,0.385c-0.147,0.114-0.328,0.171-0.541,0.171h-2.011l4.297-11.099h2.636L146.883,31.419z M139.753,27.176h3.032l-1.021-3.04c-0.066-0.193-0.144-0.42-0.232-0.682c-0.089-0.262-0.177-0.545-0.263-0.849c-0.081,0.31-0.165,0.597-0.251,0.861c-0.086,0.264-0.168,0.493-0.244,0.686L139.753,27.176z"></path><path fill="#057482" d="M152.551,29.56c0.355,0,0.67-0.03,0.945-0.091c0.274-0.061,0.533-0.142,0.777-0.244v-1.684h-1.097c-0.163,0-0.29-0.043-0.381-0.13c-0.091-0.086-0.137-0.195-0.137-0.328v-1.417h3.946v4.685c-0.285,0.208-0.58,0.387-0.888,0.537c-0.307,0.15-0.635,0.273-0.983,0.369c-0.348,0.097-0.719,0.168-1.112,0.213c-0.394,0.046-0.816,0.069-1.268,0.069c-0.813,0-1.564-0.143-2.255-0.43c-0.691-0.287-1.289-0.683-1.794-1.188s-0.902-1.105-1.188-1.798c-0.287-0.693-0.43-1.446-0.43-2.259c0-0.828,0.137-1.588,0.411-2.282c0.274-0.693,0.667-1.291,1.177-1.794s1.128-0.894,1.851-1.173c0.724-0.279,1.532-0.419,2.426-0.419c0.462,0,0.896,0.038,1.303,0.114c0.406,0.076,0.781,0.18,1.124,0.312c0.343,0.132,0.656,0.289,0.941,0.472c0.284,0.183,0.538,0.381,0.762,0.594l-0.747,1.135c-0.071,0.107-0.156,0.19-0.255,0.251c-0.099,0.061-0.207,0.091-0.324,0.091c-0.152,0-0.31-0.051-0.472-0.152c-0.203-0.122-0.395-0.227-0.575-0.316s-0.364-0.161-0.552-0.217s-0.386-0.096-0.594-0.122c-0.208-0.025-0.442-0.038-0.701-0.038c-0.482,0-0.917,0.085-1.303,0.255c-0.386,0.17-0.715,0.41-0.987,0.72s-0.481,0.682-0.628,1.116s-0.221,0.918-0.221,1.451c0,0.589,0.081,1.112,0.244,1.569c0.162,0.457,0.387,0.843,0.674,1.158c0.287,0.315,0.627,0.555,1.021,0.72C151.654,29.478,152.084,29.56,152.551,29.56z"></path><path fill="#057482" d="M160.992,31.419h-2.59v-11.1h2.59V31.419z"></path><path fill="#057482" d="M170.507,28.547c0.061,0,0.122,0.011,0.183,0.034s0.119,0.062,0.175,0.118l1.021,1.074c-0.447,0.584-1.007,1.025-1.68,1.322c-0.673,0.297-1.469,0.446-2.388,0.446c-0.843,0-1.599-0.143-2.266-0.43c-0.668-0.287-1.234-0.683-1.699-1.188c-0.465-0.505-0.822-1.105-1.07-1.798c-0.249-0.693-0.373-1.446-0.373-2.259c0-0.828,0.142-1.588,0.427-2.282c0.284-0.693,0.682-1.291,1.192-1.794s1.121-0.894,1.832-1.173c0.711-0.279,1.496-0.419,2.354-0.419c0.416,0,0.809,0.037,1.177,0.11c0.368,0.074,0.712,0.175,1.032,0.305c0.32,0.13,0.614,0.284,0.884,0.465c0.269,0.18,0.508,0.38,0.716,0.598l-0.869,1.166c-0.056,0.071-0.122,0.136-0.198,0.194s-0.183,0.088-0.32,0.088c-0.091,0-0.178-0.02-0.259-0.061c-0.081-0.041-0.168-0.09-0.259-0.149c-0.091-0.058-0.192-0.122-0.301-0.19c-0.109-0.069-0.239-0.132-0.388-0.19c-0.15-0.058-0.325-0.108-0.526-0.149s-0.435-0.061-0.705-0.061c-0.467,0-0.894,0.083-1.28,0.248c-0.386,0.165-0.717,0.401-0.994,0.708c-0.277,0.307-0.493,0.679-0.648,1.116c-0.155,0.437-0.232,0.927-0.232,1.47c0,0.569,0.077,1.074,0.232,1.516c0.155,0.442,0.366,0.814,0.632,1.116c0.267,0.302,0.578,0.532,0.933,0.689s0.736,0.236,1.143,0.236c0.234,0,0.447-0.011,0.64-0.034s0.372-0.062,0.537-0.118c0.165-0.056,0.322-0.128,0.472-0.217c0.15-0.089,0.301-0.199,0.453-0.331c0.061-0.051,0.127-0.093,0.198-0.126C170.357,28.563,170.43,28.547,170.507,28.547z"></path><path fill="#FFFFFF" d="M186.463,26.7c-0.08,0.359-0.209,0.648-0.385,0.866c-0.178,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.643,0.139-1.06,0.139h-0.173c-0.058,0-0.117-0.003-0.172-0.008v1.562h-1.284v-6.002c0,0,0.632-0.541,2.322-0.541c0.265,0,0.496,0.036,0.696,0.112c0.198,0.072,0.363,0.195,0.491,0.362c0.128,0.167,0.225,0.39,0.289,0.668s0.095,0.629,0.095,1.047C186.583,25.898,186.544,26.341,186.463,26.7z M185.155,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.077-0.034-0.173-0.048-0.29-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.069,0.006,0.139,0.012,0.211,0.014c0.07,0.006,0.136,0.006,0.2,0.006c0.181,0,0.329-0.02,0.445-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.07-0.12,0.114-0.284,0.139-0.493c0.029-0.206,0.039-0.479,0.039-0.813c0-0.242-0.008-0.443-0.028-0.596C185.236,24.715,185.202,24.596,185.155,24.509z"></path><path fill="#FFFFFF" d="M181.393,27.772c0,0-0.682,0.37-1.974,0.37c-0.893,0-1.782-0.543-1.782-1.534c0-0.576,0.187-1.612,2.019-1.612h0.389V24.84c0-0.184-0.025-0.326-0.117-0.423c-0.092-0.097-0.242-0.147-0.481-0.147c-0.273,0-0.526,0.019-0.758,0.061c-0.128,0.022-0.259,0.05-0.387,0.081c-0.056,0.014-0.162,0.028-0.162,0.042v-1.081c0,0,0.023-0.005,0.034-0.008c0.038-0.008,0.078-0.017,0.12-0.022c0.122-0.023,0.248-0.045,0.378-0.064c0.128-0.017,0.262-0.033,0.401-0.042c0.133-0.008,0.262-0.014,0.376-0.014c0.406,0,0.734,0.033,0.983,0.1c0.248,0.067,0.445,0.17,0.582,0.309s0.24,0.317,0.287,0.532c0.047,0.217,0.091,0.47,0.091,0.762L181.393,27.772L181.393,27.772z M178.748,26.606c0,0.365,0.301,0.565,0.699,0.565c0.376,0,0.585-0.095,0.593-0.1l0.005-0.012v-1.041c0,0-0.342-0.044-0.579-0.044C179.063,25.974,178.748,26.193,178.748,26.606z"></path><path fill="#FFFFFF" d="M191.45,26.7c-0.078,0.359-0.209,0.648-0.385,0.866c-0.175,0.22-0.409,0.376-0.699,0.468c-0.289,0.095-0.642,0.139-1.06,0.139h-0.173c-0.058,0-0.114-0.003-0.172-0.008v1.562h-1.281v-6.002c0,0,0.632-0.541,2.323-0.541c0.262,0,0.492,0.036,0.692,0.112c0.198,0.072,0.362,0.195,0.491,0.362c0.127,0.167,0.225,0.39,0.289,0.668s0.098,0.629,0.098,1.047C191.572,25.898,191.53,26.341,191.45,26.7z M190.141,24.509c-0.05-0.086-0.111-0.147-0.19-0.178c-0.076-0.034-0.173-0.048-0.289-0.048c-0.211,0-0.701,0.095-0.701,0.268v2.505c0.07,0.006,0.142,0.012,0.211,0.014c0.07,0.006,0.14,0.006,0.203,0.006c0.178,0,0.326-0.02,0.443-0.064c0.114-0.039,0.206-0.12,0.273-0.239c0.069-0.12,0.114-0.284,0.142-0.493c0.025-0.206,0.039-0.479,0.039-0.813c0-0.242-0.011-0.443-0.03-0.596C190.222,24.715,190.189,24.596,190.141,24.509z"></path></g></svg></div></a><div class="scaling-svg-container" style="padding-bottom: 5.045045045045046%; max-width: 666px; margin: 15px auto 0px auto; clear: both;"><svg version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 33.6" enable-background="0 0 666 33.6" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 15.0713 20.0906)" fill="#000000" font-family="'InterFace-Regular'" font-size="14px">See below for summary of harms</text></svg></div><div style="clear:both;"></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Individual considerations</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 20%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 133.2" enable-background="0 0 666 133.2" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="111.19999999999999" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Values and preferences</text><text transform="matrix(1 0 0 1 125 70)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">The panel inferred that all or almost all individuals would be inclined to receive</text><text transform="matrix(1 0 0 1 125 84.4)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors, given benefits substantially outweigh possible harms. No</text><text transform="matrix(1 0 0 1 125 98.80000000000001)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">significant variability in patient preference was anticipated</text></svg></div></div></div></div></div><div class="whiteBox" style="margin:15px; padding:10px; background-color: #FFF; border-radius: 12px;"><div class="scaling-svg-container" style="padding-bottom: 11.223%; max-width: 695px; margin: 0px auto 0px auto"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 695 78" enable-background="0 0 695 78" xml:space="preserve" style="width: 100%;"><text transform="matrix(1 0 0 1 55.1034 36.7349)" fill="#333333" font-family="'InterFace-Bold'" font-size="21px">Harms (all patients)</text><path fill="#eb6467" stroke-width="0" d="M33.409,17.725c.609-1.055,1.605-1.055,2.214,0l11.517,19.947c.609,1.055.111,1.917-1.107,1.917h-23.033c-1.218,0-1.716-.863-1.107-1.917l11.517-19.947Z"></path><polygon fill="#fff" stroke-width="0" points="24.875 37.228 34.516 20.531 44.156 37.228 24.875 37.228"></polygon><path fill="#454444" stroke-width="0" d="M33.771,29.832c-.145-1.039-.261-1.916-.349-2.629-.088-.713-.132-1.233-.132-1.559s.111-.605.333-.838c.222-.233.52-.349.892-.349s.669.116.892.349c.222.233.333.512.333.838s-.044.845-.132,1.559c-.088.713-.204,1.59-.349,2.629-.145,1.039-.253,1.895-.326,2.567h-.838c-.072-.672-.181-1.528-.326-2.567ZM33.671,35.431c-.233-.233-.349-.514-.349-.845s.116-.613.349-.845c.233-.233.514-.349.845-.349s.613.116.845.349c.233.233.349.515.349.845s-.116.613-.349.845c-.233.233-.515.349-.845.349s-.613-.116-.845-.349Z"></path></svg></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Applicable across risk levels</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 14.03903903903904%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 93.5" enable-background="0 0 666 93.5" xml:space="preserve" style="width: 100%;"><rect x="125" y="10" fill="#FFFFFF" width="400" height="63.5" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 135 33)" fill="#000000" font-family="'InterFace-Regular'" font-size="12px">Harm outcomes were not risk-stratified. To reflect the uncertainty in</text><text transform="matrix(1 0 0 1 135 47.5)" fill="#000000" font-family="'InterFace-Regular'" font-size="12px">using unstratified absolute effect estimates, certainty in evidence was</text><text transform="matrix(1 0 0 1 135 62)" fill="#000000" font-family="'InterFace-Regular'" font-size="12px">rated down for indirectness in baseline risks</text></svg></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Potential harms</text></svg></div></h2><div class="pane-content" style="padding: 0px 0px 10px 0px; max-width: 666px; margin: 0px auto 0px auto;"><div style="clear: both;"></div><div class="scaling-svg-container" style="padding-bottom: 11.562%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 60" enable-background="0 0 666 60" xml:space="preserve" style="width: 100%;"><polygon fill="#00B2A9" points="256.718,43.109 66.888,43.109 54.888,30.943 66.888,18.776 256.718,18.776 243.718,30.943"></polygon><text transform="matrix(1 0 0 1 157.389 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No SGLT-2 inhibitors</text><polygon fill="#765FA8" points="407.721,18.776 597.551,18.776 609.551,30.943 597.551,43.109 407.721,43.109 419.721,30.943"></polygon><text transform="matrix(1 0 0 1 511.128 33.5013)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">SGLT-2 inhibitors</text><g class="thishasatooltip"><polygon fill="#7C8696" points="403.351,43.109 260.522,43.109 248.522,30.943 260.522,18.776 403.351,18.776 415.351,30.943"></polygon><text transform="matrix(1 0 0 1 332.32 34.4258)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">No important difference</text><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="395.241" cy="18.088" r="6"></circle><path fill="#FFFFFF" d="M395.751,20.48c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L395.751,20.48z M395.999,15.877c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C396.877,15.486,396.484,15.877,395.999,15.877z"></path><g transform="matrix(1 0 0 1 365 5)" class="thisisthetooltip"><path opacity="0.8" enable-background="new " d="M-349.979,51.675c-5.6,0-10.1-4.5-10.1-10.1V10.211c0-5.6,4.5-10.1,10.1-10.1H11.135c5.6,0,10.1,4.5,10.1,10.1v5.2l10,10l-10,10v6.264c0,5.6-4.5,10.1-10.1,10.1L-349.979,51.675z"></path><text transform="matrix(1 0 0 1 -353.0981 16.7624)" enable-background="new "><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">The panel found that this difference was not important for most patients,</tspan><tspan x="0" y="13" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">because the intervention effects were negligible and/or very imprecise, for</tspan><tspan x="0" y="26" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">example confidence intervals that include both important benefit and harm</tspan></text></g></g></svg></div><div class="scaling-svg-container" style="padding-bottom: 3.003%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 20" enable-background="0 0 666 20" xml:space="preserve" style="width: 100%;"><text transform="matrix(0.9746 0 0 1 14.0746 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Harms</text><path fill="none" stroke="#7C8696" stroke-miterlimit="10" d="M441.083,17.13c0,0,0-1.791,0-3.98s-2.122-3.98-4.716-3.98H189.049c-2.594,0-4.716,1.791-4.716,3.98s0,3.98,0,3.98"></path><rect x="210.591642578125" y="5" fill="#C1D3E9" width="204.03271484375" height="8"></rect><text transform="matrix(0.9746 0 0 1 312.608 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">Events per 1000 people over 5 years</text><text transform="matrix(0.9746 0 0 1 488.304 13.5564)" font-family="'InterFace-Bold'" font-size="12.2883px">Evidence quality</text></svg></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Kidney injury requiring dialysis</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">23</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">14</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="255.65357971191406" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 8701 patients in 2 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on acute kidney injury</tspan><tspan x="0" y="29.492" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">requiring dialysis</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Lower limb amputation</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">29</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">31</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Low</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#FAE5BC" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 763 patients in 7 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors may have little or no</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">effect on lower limb amputation</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Low</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(387.4285469055176,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(472.4285469055176,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(-26.571453094482422,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Ketoacidosis</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">3</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">7</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 26 912 patients in 6 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on ketoacidosis</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Fracture</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">91</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">93</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 29 276 patients in 12 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on fracture</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Genital infection</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">16</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">43</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="271.0919494628906" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 29 597 patients in 13 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on genital infections</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div class="accordion-group" style="padding: 1px 10px 1px 10px;"><h2 class="accord-title rr-graphic-title"><div class="scaling-svg-container" style="padding-bottom: 2.392%; max-width: 627px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 627 15" enable-background="0 0 627 15" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M619.867,15H7.133C3.21,15,0,11.79,0,7.867l0-0.735C0,3.21,3.21,0,7.133,0l612.735,0C623.79,0,627,3.21,627,7.133v0.735C627,11.79,623.79,15,619.867,15z"></path><text transform="matrix(1 0 0 1 8.2104 11.2426)" font-family="'InterFace-Regular'" font-size="12.2883px">Symptomatic hypovolemia</text><polygon fill="#7C8696" points="399.412,15 228.588,15 221.588,7.5 228.588,0 399.412,0 405.412,7.5"></polygon><text fill="#FFFFFF" transform="matrix(1 0 0 1 315.11 11.1465)" font-family="'InterFace-Bold'" font-size="12.2883px" text-anchor="middle">No important difference</text><text transform="matrix(1 0 0 1 183.4097 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#00B2A9">111</text><text transform="matrix(1 0 0 1 439.877 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px" text-anchor="end" fill="#765FA8">143</text><text transform="matrix(1 0 0 1 514.752 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">Moderate</text><path fill="#EEAA1F" d="M469.116,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C469.287,11.862,469.048,11.689,469.116,11.482z"></path><path fill="#EEAA1F" d="M479.953,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C480.124,11.862,479.885,11.689,479.953,11.482z"></path><path fill="#EEAA1F" d="M490.79,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C490.96,11.862,490.722,11.689,490.79,11.482z"></path><path fill="#FAE5BC" d="M501.627,11.482l2.641-8.073c0.068-0.207,0.36-0.207,0.427,0l2.633,8.06c0.068,0.207-0.17,0.38-0.346,0.251l-6.86-5.005c-0.176-0.128-0.085-0.406,0.133-0.406h8.418c0.217,0,0.308,0.277,0.133,0.406l-6.831,5.019C501.797,11.862,501.559,11.689,501.627,11.482z"></path><text transform="matrix(1 0 0 1 582.915 11.1465)" font-family="'InterFace-Regular'" font-size="12.2883px">More</text><path d="M616.91,11.58c-0.155,0.155-0.402,0.155-0.556,0l-4.585-4.579c-0.155-0.155-0.155-0.408,0-0.563l1.026-1.019c0.155-0.155,0.402-0.155,0.557,0l3.281,3.281l3.281-3.281c0.155-0.155,0.402-0.155,0.557,0l1.026,1.019c0.155,0.155,0.155,0.408,0,0.563L616.91,11.58z"></path></svg></div></h2><div class="pane-content rr-outcome-pane" style="max-width: 601px; margin: 1px auto 10px auto; "><div class="scaling-svg-container" style="padding-bottom: 25.124792013311147%; max-width: 601px; margin: 1px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 601 151" enable-background="0 0 601 151" xml:space="preserve" style="width: 100%;"><rect x="21.128" y="14.34" fill="#B2E8E5" width="264.4617919921875" height="27.492"></rect><rect x="35.39" y="9.891" transform="matrix(0.7071 -0.7071 0.7071 0.7071 0.0658 35.9028)" fill="#B2E8E5" width="15.962" height="15.962"></rect><text transform="matrix(1 0 0 1 29.7787 31.3985)" font-family="'InterFace-Regular'" font-size="12.2883px">Based on data from 27 550 patients in 8 studies</text><g transform="translate(0,20)"><path fill="#C8CCD3" d="M308.8,33.9c6.1,0,11,4.9,11,11v31c0,6.1-4.9,11-11,11H33.1c-6.1,0-11-4.9-11-11v-31c0-6.1,4.9-11,11-11H308.8 M308.8,32.9H33.1c-6.6,0-12,5.4-12,12v31c0,6.6,5.4,12,12,12h275.7c6.6,0,12-5.4,12-12v-31C320.8,38.3,315.4,32.9,308.8,32.9L308.8,32.9z"></path><path fill="#A2A9B4" d="M84.1,87.9h-51c-6.6,0-12-5.4-12-12v-31c0-6.6,5.4-12,12-12h51"></path><ellipse fill="#FFFFFF" cx="53.544" cy="56.4" rx="17.417" ry="9.562"></ellipse><polygon fill="#FFFFFF" points="44.1,59.2 42,74 54.3,62.1"></polygon><text transform="translate(94.5221 48.6479)"><tspan x="0" y="0" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">SGLT-2 inhibitors probably have little</tspan><tspan x="0" y="14.746" fill="#1D1D1B" font-family="'InterFace-Regular'" font-size="12.2883px">or no effect on symptomatic hypovolemia</tspan></text></g><path fill="#F0AB00" opacity="0.3" d="M348.097,24.626v105.058c0,5.145,4.171,9.316,9.316,9.316h222.72c5.654,0,10.28-4.626,10.28-10.28V25.141c0-5.578-4.564-10.141-10.141-10.141h-67.026l-10-11.333l-10,11.333H357.723C352.429,15,348.097,19.332,348.097,24.626z"></path><text font-family="'InterFace-Bold'" font-size="12.2883px" transform="translate(361.0023 31.08)">Moderate</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(416.85326385498047,31.08)">GRADE rating,</text><text font-family="'InterFace-Regular'" font-size="12.2883px" transform="translate(501.85326385498047,31.08)">because of:</text><g transform="translate(0,0)"><path fill="#FFFFFF" d="M575.618,53.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,50.049,579.539,53.257,575.618,53.257z"></path><path fill="#EEAA1F" d="M447.413,53.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.9483" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Risk of bias</text><text x="452.58" y="49.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,72.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,69.049,579.539,72.257,575.618,72.257z"></path><path fill="#EEAA1F" d="M447.413,72.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.3677" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Imprecision</text><text x="452.58" y="68.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#7C8696" d="M575.618,91.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,88.049,579.539,91.257,575.618,91.257z"></path><path fill="#EEAA1F" d="M447.413,91.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.8648" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Indirectness</text><text x="452.58" y="87.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF">Serious</text><path fill="#FFFFFF" d="M575.618,110.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,107.049,579.539,110.257,575.618,110.257z"></path><path fill="#EEAA1F" d="M447.413,110.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.0801" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Inconsistency</text><text x="452.58" y="106.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text><path fill="#FFFFFF" d="M575.618,129.257h-210.66c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h210.66c3.921,0,7.128,3.208,7.128,7.128v0C582.747,126.049,579.539,129.257,575.618,129.257z"></path><path fill="#EEAA1F" d="M447.413,129.257h-82.455c-3.921,0-7.128-3.208-7.128-7.128v0c0-3.921,3.208-7.128,7.128-7.128h82.455"></path><text x="443.1461" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#FFFFFF" text-anchor="end">Publication bias</text><text x="452.58" y="125.6665" font-family="'InterFace-Regular'" font-size="12.2883px" fill="#1D1D1B">No serious concerns</text></g><g transform="translate(2.8532638549804688,0)" class="thishasatooltip"><circle fill="#2A6EBB" stroke="#FFFFFF" stroke-miterlimit="10" cx="488.795" cy="24.562" r="6"></circle><path fill="#FFFFFF" d="M489.304,26.954c-0.041,0.181-0.072,0.318-0.072,0.436c0,0.243,0.134,0.339,0.424,0.339c0.124,0,0.227-0.011,0.361-0.021l0.042,0.436c-0.465,0.243-0.899,0.371-1.395,0.371c-0.661,0-0.961-0.34-0.961-0.955c0-0.19,0.031-0.402,0.083-0.636l0.547-2.28c0.041-0.159,0.062-0.308,0.062-0.403c0-0.371-0.228-0.52-0.733-0.52l0.093-0.413c0.32-0.17,0.806-0.351,1.312-0.351c0.579,0,0.888,0.266,0.888,0.859c0,0.17-0.021,0.35-0.072,0.572L489.304,26.954z M489.552,22.351c-0.475,0-0.868-0.392-0.868-0.88c0-0.487,0.393-0.891,0.889-0.891c0.475,0,0.857,0.403,0.857,0.891C490.431,21.96,490.038,22.351,489.552,22.351z"></path><g class="thisisthetooltip" transform="translate(355,8)"><path opacity="0.8" enable-background="new " d="M-355.7,43.6c0-5.6,4.5-10.1,10.1-10.1H123l10-10l10,10h49.5c5.6,0,10.1,4.5,10.1,10.1v82.2c0,5.6-4.5,10.1-10.1,10.1h-538c-5.6,0-10.1-4.5-10.1-10.1L-355.7,43.6z"></path><text transform="matrix(0.9746 0 0 1 -134.5737 47.909)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">GRADE certainty ratings</text><text transform="matrix(0.9746 0 0 1 -297.9473 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">High</text><text transform="matrix(0.9746 0 0 1 -344.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors have a lot of</text><text transform="matrix(0.9746 0 0 1 -344.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">confidence that the true</text><text transform="matrix(0.9746 0 0 1 -344.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">effect is similar to the</text><text transform="matrix(0.9746 0 0 1 -344.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -156.0044 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Moderate</text><text transform="matrix(0.9746 0 0 1 -202.6631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The authors believe that</text><text transform="matrix(0.9746 0 0 1 -202.6631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the true effect is probably</text><text transform="matrix(0.9746 0 0 1 -202.6631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">close to the</text><text transform="matrix(0.9746 0 0 1 -202.6631 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><text transform="matrix(0.9746 0 0 1 -5.6768 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Low</text><text transform="matrix(0.9746 0 0 1 -53.1631 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect might be</text><text transform="matrix(0.9746 0 0 1 -53.1631 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">markedly different from</text><text transform="matrix(0.9746 0 0 1 -53.1631 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">the estimated effect</text><text transform="matrix(0.9746 0 0 1 137.7656 68.6673)" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12.2883px">Very low</text><text transform="matrix(0.9746 0 0 1 91.3369 84.9095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">The true effect is</text><text transform="matrix(0.9746 0 0 1 91.3369 98.1097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">probably markedly</text><text transform="matrix(0.9746 0 0 1 91.3369 111.4095)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">different from the</text><text transform="matrix(0.9746 0 0 1 91.3369 124.6097)" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12.2883px">estimated effect</text><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-213.5" y1="59.9" x2="-213.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="-66.5" y1="59.9" x2="-66.5" y2="126.4"></line><line fill="none" stroke="#FFFFFF" stroke-miterlimit="10" x1="78" y1="59.9" x2="78" y2="126.4"></line><path fill="#FFFFFF" d="M-342.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-342.3,69-342.5,68.9-342.4,68.7z"></path><path fill="#FFFFFF" d="M-331.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-331.4,69-331.7,68.9-331.6,68.7z"></path><path fill="#FFFFFF" d="M-320.8,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-320.6,69-320.8,68.9-320.8,68.7z"></path><path fill="#FFFFFF" d="M-309.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-309.8,69-310,68.9-309.9,68.7z"></path><path fill="#FFFFFF" d="M-201,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-200.9,69-201.1,68.9-201,68.7z"></path><path fill="#FFFFFF" d="M-190.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-190,69-190.3,68.9-190.2,68.7z"></path><path fill="#FFFFFF" d="M-179.4,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-179.2,69-179.4,68.9-179.4,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-168.5,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-168.4,69-168.6,68.9-168.5,68.7z"></path><path fill="#FFFFFF" d="M-50.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-50.5,69-50.8,68.9-50.7,68.7z"></path><path fill="#FFFFFF" d="M-39.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-39.7,69-39.9,68.9-39.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-29,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.5c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-28.9,69-29.1,68.9-29,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M-18.2,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C-18,69-18.3,68.9-18.2,68.7z"></path><path fill="#FFFFFF" d="M93,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C93.2,69,93,68.9,93,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M103.9,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C104.1,69,103.8,68.9,103.9,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M114.7,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C114.9,69,114.7,68.9,114.7,68.7z"></path><path opacity="0.3" fill="#FFFFFF" enable-background="new " d="M125.6,68.7l2.6-8.1c0.1-0.2,0.4-0.2,0.4,0l2.6,8.1c0.1,0.2-0.2,0.4-0.3,0.3l-6.9-5c-0.2-0.1-0.1-0.4,0.1-0.4h8.4c0.2,0,0.3,0.3,0.1,0.4l-6.8,5C125.7,69,125.5,68.9,125.6,68.7z"></path></g></g></svg></div></div></div><div style="clear:both;"></div></div></div></div><div class="dropdown-background" style="border-radius: 20px; max-width: 666px; margin: 0px auto 10px auto;"><div class="accordion-group"><h2 class="dropdown-title accord-title" style="border-radius: 20px; margin:0px;"><div class="scaling-svg-container" style="padding-bottom: 5.105%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 34" enable-background="0 0 666 34" xml:space="preserve" style="width: 100%;"><path fill="#FFFFFF" d="M643.96,21.985c-0.25,0.25-0.65,0.25-0.901,0l-7.42-7.41c-0.25-0.25-0.25-0.66,0-0.911l1.66-1.649c0.25-0.25,0.65-0.25,0.901,0l5.31,5.31l5.31-5.31c0.25-0.25,0.65-0.25,0.901,0l1.66,1.649c0.25,0.25,0.25,0.66,0,0.911L643.96,21.985z"></path><text transform="matrix(1 0 0 1 333 21.7755)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Individual considerations</text></svg></div></h2><div class="pane-content" style="padding: 10px; max-width: 666px; margin: 0px auto 0px auto;"><div class="scaling-svg-container" style="padding-bottom: 84.08408408408408%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 560" enable-background="0 0 666 560" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="538" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Key practical issues</text><text transform="matrix(1 0 0 1 330 67)" text-anchor="middle" font-family="'InterFace-Bold'" font-size="15px">SGLT-2 inhibitors</text><rect x="16.5" y="79" fill="#5a8ac7" width="633" height="17.846"></rect><text transform="matrix(1 0 0 1 333 92)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12px">Practical considerations</text><rect x="130" y="102" fill="#765FA8" width="400" height="33" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 115)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors may be initiated at the highest possible dose and do not</text><text transform="matrix(1 0 0 1 330 128)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">require dose titration</text><rect x="130" y="140" fill="#765FA8" width="400" height="33" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 153)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors may be initiated in adults with estimated GFR ≥ 20 ml/min</text><text transform="matrix(1 0 0 1 330 166)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">per 1.73 m²</text><rect x="130" y="178" fill="#765FA8" width="400" height="33" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 191)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">Once initiated, SGLT-2 inhibitors may be continued even if estimated GFR &lt;</text><text transform="matrix(1 0 0 1 330 204)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">20 ml/min per 1.73 m² until dialysis initiation</text><rect x="130" y="216" fill="#765FA8" width="400" height="59" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 229)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">While SGLT-2 inhibitors are likely to cause a transient decline in GFR shortly</text><text transform="matrix(1 0 0 1 330 242)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">after initiation, routine kidney function monitoring is not warranted except in</text><text transform="matrix(1 0 0 1 330 255)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">higher risk individuals (for example people with prior acute kidney injury or</text><text transform="matrix(1 0 0 1 330 268)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">risk of volume depletion)</text><rect x="130" y="280" fill="#765FA8" width="400" height="46" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 293)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">A transient decline in GFR should not be a reason to discontinue therapy</text><text transform="matrix(1 0 0 1 330 306)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">unless it exceeds 25% from baseline. If discontinued, therapy should be</text><text transform="matrix(1 0 0 1 330 319)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">re-initiated after recovery of kidney function</text><rect x="130" y="331" fill="#765FA8" width="400" height="46" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 344)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">Individuals taking diuretics or otherwise at risk of volume depletion may</text><text transform="matrix(1 0 0 1 330 357)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">require closer monitoring and diuretic titration when initiating SGLT-2</text><text transform="matrix(1 0 0 1 330 370)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">inhibitors</text><rect x="130" y="382" fill="#765FA8" width="400" height="33" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 395)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors are recommended in individuals with concomitant heart</text><text transform="matrix(1 0 0 1 330 408)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">failure, irrespective of kidney function and degree of albuminuria</text><rect x="16.5" y="425" fill="#5a8ac7" width="633" height="17.846"></rect><text transform="matrix(1 0 0 1 333 438)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="12px">Counselling to patients</text><rect x="130" y="448" fill="#765FA8" width="400" height="46" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 461)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">Advise patients about potential adverse events, including genital mycotic</text><text transform="matrix(1 0 0 1 330 474)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">infections, acute kidney injury, fractures, euglycaemic ketoacidosis, volume</text><text transform="matrix(1 0 0 1 330 487)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">depletion, Fournier's gangrene and amputations</text><rect x="130" y="499" fill="#765FA8" width="400" height="46" rx="8" ry="8"></rect><text transform="matrix(1 0 0 1 330 512)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">Advise patients about temporarily stopping medication when unwell,</text><text transform="matrix(1 0 0 1 330 525)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">engaging in prolonged fasting, undergoing surgery or suffering from severe</text><text transform="matrix(1 0 0 1 330 538)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="12px">gastrointestinal losses such as diarrhoea or vomiting (sick day counselling)</text></svg></div><div class="scaling-svg-container" style="padding-bottom: 22.16216216216216%; max-width: 666px; margin: 0px auto 0px auto;"><svg class="scaling-svg" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 666 147.6" enable-background="0 0 666 147.6" xml:space="preserve" style="width: 100%;"><rect fill="#FFFFFF" x="16.5" y="16.471" width="633" height="125.6" rx="12" ry="12"></rect><path fill="#2A6EBB" d="M16.5,46.419V28.471c0-6.6,5.4-12,12-12h609c6.6,0,12,5.4,12,12v17.948"></path><text transform="matrix(1 0 0 1 333 36)" text-anchor="middle" fill="#FFFFFF" font-family="'InterFace-Bold'" font-size="15px">Resources and availability</text><text transform="matrix(1 0 0 1 125 70)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">SGLT-2 inhibitors are widely available internationally. Most SGLT-2 inhibitors are</text><text transform="matrix(1 0 0 1 125 84.4)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">available as once-daily oral regimens. Individuals initiating SGLT-2 inhibitors</text><text transform="matrix(1 0 0 1 125 98.80000000000001)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">require counselling regarding possibility of adverse events and sick day</text><text transform="matrix(1 0 0 1 125 113.20000000000002)" text-anchor="start" font-family="'InterFace-Regular'" font-size="12px">counselling</text></svg></div></div></div></div></div></div> <p style="margin: 15px 0px 0px 0px;">©BMJ Publishing Group Limited.</p> <p style="font-size:10px;">Disclaimer: This infographic is not a validated clinical decision aid. This information is provided without any representations, conditions or warranties that it is accurate or up to date. BMJ and its licensors assume no responsibility for any aspect of treatment administered with the aid of this information. Any reliance placed on this information is strictly at the user's own risk. For the full disclaimer wording see BMJ's terms and conditions: <a href="https://www.bmj.com/company/legal-information">https://www.bmj.com/company/legal-information/</a></p> <!-- magic app link --> <a id="magicLink" href="https://app.magicapp.org/#/guideline/EezrQj" target="new"> <svg version="1.1" id="Layer_1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 500 55" enable-background="new 0 0 500 55" xml:space="preserve" style="max-width: 500; margin: 0 0 10 0;"> <path fill="#057482" d="M484.7,0H15.3C6.9,0,0,6.9,0,15.3v24.3C0,48.1,6.9,55,15.3,55h469.3c8.5,0,15.3-6.9,15.3-15.3 V15.3C500,6.9,493.1,0,484.7,0z"></path> <circle fill="#FFFFFF" cx="24.2" cy="26.9" r="12.4"></circle> <polygon fill="#057482" points="20.2,33.2 20.2,20.4 31.4,26.7 "></polygon> <g> <g> <g> <path fill="#FFFFFF" d="M359.1,29.1c0.2,0.4,0.3,0.8,0.5,1.1c0.2-0.4,0.3-0.8,0.5-1.2c0.2-0.4,0.3-0.7,0.5-1.1 l5.1-10c0.1-0.2,0.2-0.3,0.3-0.4c0.1-0.1,0.2-0.2,0.3-0.2c0.1,0,0.3-0.1,0.4-0.1c0.1,0,0.3,0,0.5,0h3.5v19.8h-4.1V25.7 c0-0.6,0-1.2,0.1-1.8l-5.3,10.2c-0.2,0.3-0.4,0.6-0.7,0.7c-0.3,0.2-0.6,0.2-0.9,0.2h-0.6c-0.4,0-0.7-0.1-0.9-0.2 c-0.3-0.2-0.5-0.4-0.7-0.7l-5.3-10.2c0,0.3,0.1,0.6,0.1,0.9c0,0.3,0,0.6,0,0.9v11.4h-4.1V17.3h3.5c0.2,0,0.4,0,0.5,0 c0.1,0,0.3,0,0.4,0.1c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.2,0.2,0.3,0.4l5.1,10.1C358.7,28.4,358.9,28.8,359.1,29.1z"></path> <path fill="#FFFFFF" d="M392.5,37.1h-3.6c-0.4,0-0.7-0.1-1-0.3c-0.3-0.2-0.4-0.4-0.5-0.7l-1.2-3.5h-7.6l-1.2,3.5 c-0.1,0.3-0.3,0.5-0.5,0.7c-0.3,0.2-0.6,0.3-1,0.3h-3.6l7.7-19.9h4.7L392.5,37.1z M379.7,29.5h5.4l-1.8-5.4 c-0.1-0.3-0.3-0.8-0.4-1.2c-0.2-0.5-0.3-1-0.5-1.5c-0.1,0.6-0.3,1.1-0.4,1.5c-0.2,0.5-0.3,0.9-0.4,1.2L379.7,29.5z"></path> <path fill="#FFFFFF" d="M402.6,33.8c0.6,0,1.2-0.1,1.7-0.2c0.5-0.1,1-0.3,1.4-0.4v-3h-2c-0.3,0-0.5-0.1-0.7-0.2 c-0.2-0.2-0.2-0.3-0.2-0.6v-2.5h7.1v8.4c-0.5,0.4-1,0.7-1.6,1c-0.5,0.3-1.1,0.5-1.8,0.7c-0.6,0.2-1.3,0.3-2,0.4 c-0.7,0.1-1.5,0.1-2.3,0.1c-1.5,0-2.8-0.3-4-0.8c-1.2-0.5-2.3-1.2-3.2-2.1c-0.9-0.9-1.6-2-2.1-3.2c-0.5-1.2-0.8-2.6-0.8-4 c0-1.5,0.2-2.8,0.7-4.1c0.5-1.2,1.2-2.3,2.1-3.2c0.9-0.9,2-1.6,3.3-2.1c1.3-0.5,2.7-0.7,4.3-0.7c0.8,0,1.6,0.1,2.3,0.2 c0.7,0.1,1.4,0.3,2,0.6c0.6,0.2,1.2,0.5,1.7,0.8c0.5,0.3,1,0.7,1.4,1.1l-1.3,2c-0.1,0.2-0.3,0.3-0.5,0.4 c-0.2,0.1-0.4,0.2-0.6,0.2c-0.3,0-0.6-0.1-0.8-0.3c-0.4-0.2-0.7-0.4-1-0.6c-0.3-0.2-0.7-0.3-1-0.4c-0.3-0.1-0.7-0.2-1.1-0.2 c-0.4,0-0.8-0.1-1.3-0.1c-0.9,0-1.6,0.2-2.3,0.5c-0.7,0.3-1.3,0.7-1.8,1.3c-0.5,0.6-0.9,1.2-1.1,2c-0.3,0.8-0.4,1.6-0.4,2.6 c0,1.1,0.1,2,0.4,2.8c0.3,0.8,0.7,1.5,1.2,2.1c0.5,0.6,1.1,1,1.8,1.3C401,33.7,401.8,33.8,402.6,33.8z"></path> <path fill="#FFFFFF" d="M417.7,37.1h-4.6V17.3h4.6V37.1z"></path> <path fill="#FFFFFF" d="M434.7,32c0.1,0,0.2,0,0.3,0.1c0.1,0,0.2,0.1,0.3,0.2l1.8,1.9c-0.8,1-1.8,1.8-3,2.4 c-1.2,0.5-2.6,0.8-4.3,0.8c-1.5,0-2.9-0.3-4.1-0.8c-1.2-0.5-2.2-1.2-3-2.1c-0.8-0.9-1.5-2-1.9-3.2c-0.4-1.2-0.7-2.6-0.7-4 c0-1.5,0.3-2.8,0.8-4.1c0.5-1.2,1.2-2.3,2.1-3.2c0.9-0.9,2-1.6,3.3-2.1c1.3-0.5,2.7-0.7,4.2-0.7c0.7,0,1.4,0.1,2.1,0.2 c0.7,0.1,1.3,0.3,1.8,0.5c0.6,0.2,1.1,0.5,1.6,0.8c0.5,0.3,0.9,0.7,1.3,1.1l-1.6,2.1c-0.1,0.1-0.2,0.2-0.4,0.3 c-0.1,0.1-0.3,0.2-0.6,0.2c-0.2,0-0.3,0-0.5-0.1c-0.1-0.1-0.3-0.2-0.5-0.3c-0.2-0.1-0.3-0.2-0.5-0.3c-0.2-0.1-0.4-0.2-0.7-0.3 c-0.3-0.1-0.6-0.2-0.9-0.3c-0.4-0.1-0.8-0.1-1.3-0.1c-0.8,0-1.6,0.1-2.3,0.4c-0.7,0.3-1.3,0.7-1.8,1.3c-0.5,0.5-0.9,1.2-1.2,2 c-0.3,0.8-0.4,1.7-0.4,2.6c0,1,0.1,1.9,0.4,2.7c0.3,0.8,0.7,1.5,1.1,2c0.5,0.5,1,1,1.7,1.2s1.3,0.4,2,0.4c0.4,0,0.8,0,1.1-0.1 c0.3,0,0.7-0.1,1-0.2c0.3-0.1,0.6-0.2,0.8-0.4c0.3-0.2,0.5-0.4,0.8-0.6c0.1-0.1,0.2-0.2,0.4-0.2C434.5,32,434.6,32,434.7,32z"></path> </g> </g> <rect x="441.5" y="17" fill="#FFFFFF" width="37.3" height="20.2"></rect> <g> <path fill="#057482" d="M463.3,28.7c-0.1,0.6-0.4,1.2-0.7,1.5c-0.3,0.4-0.7,0.7-1.2,0.8c-0.5,0.2-1.1,0.2-1.9,0.2 h-0.3c-0.1,0-0.2,0-0.3,0v2.8h-2.3V23.4c0,0,1.1-1,4.2-1c0.5,0,0.9,0.1,1.2,0.2c0.4,0.1,0.6,0.3,0.9,0.6c0.2,0.3,0.4,0.7,0.5,1.2 c0.1,0.5,0.2,1.1,0.2,1.9C463.5,27.2,463.4,28,463.3,28.7z M460.9,24.8c-0.1-0.2-0.2-0.3-0.3-0.3c-0.1-0.1-0.3-0.1-0.5-0.1 c-0.4,0-1.3,0.2-1.3,0.5v4.5c0.1,0,0.2,0,0.4,0c0.1,0,0.2,0,0.4,0c0.3,0,0.6,0,0.8-0.1c0.2-0.1,0.4-0.2,0.5-0.4 c0.1-0.2,0.2-0.5,0.2-0.9c0.1-0.4,0.1-0.9,0.1-1.5c0-0.4,0-0.8,0-1.1C461.1,25.1,461,24.9,460.9,24.8z"></path> <path fill="#057482" d="M454.2,30.6c0,0-1.2,0.7-3.5,0.7c-1.6,0-3.2-1-3.2-2.7c0-1,0.3-2.9,3.6-2.9h0.7v-0.3 c0-0.3,0-0.6-0.2-0.8c-0.2-0.2-0.4-0.3-0.9-0.3c-0.5,0-0.9,0-1.4,0.1c-0.2,0-0.5,0.1-0.7,0.1c-0.1,0-0.3,0-0.3,0.1v-1.9 c0,0,0,0,0.1,0c0.1,0,0.1,0,0.2,0c0.2,0,0.4-0.1,0.7-0.1c0.2,0,0.5-0.1,0.7-0.1c0.2,0,0.5,0,0.7,0c0.7,0,1.3,0.1,1.8,0.2 c0.4,0.1,0.8,0.3,1,0.6c0.2,0.2,0.4,0.6,0.5,1c0.1,0.4,0.2,0.8,0.2,1.4V30.6z M449.5,28.5c0,0.7,0.5,1,1.3,1c0.7,0,1-0.2,1.1-0.2 l0,0v-1.9c0,0-0.6-0.1-1-0.1C450,27.4,449.5,27.8,449.5,28.5z"></path> <path fill="#057482" d="M472.2,28.7c-0.1,0.6-0.4,1.2-0.7,1.5c-0.3,0.4-0.7,0.7-1.3,0.8c-0.5,0.2-1.1,0.2-1.9,0.2 h-0.3c-0.1,0-0.2,0-0.3,0v2.8h-2.3V23.4c0,0,1.1-1,4.2-1c0.5,0,0.9,0.1,1.2,0.2c0.4,0.1,0.6,0.3,0.9,0.6c0.2,0.3,0.4,0.7,0.5,1.2 c0.1,0.5,0.2,1.1,0.2,1.9C472.4,27.2,472.3,28,472.2,28.7z M469.9,24.8c-0.1-0.2-0.2-0.3-0.3-0.3c-0.1-0.1-0.3-0.1-0.5-0.1 c-0.4,0-1.3,0.2-1.3,0.5v4.5c0.1,0,0.3,0,0.4,0c0.1,0,0.2,0,0.4,0c0.3,0,0.6,0,0.8-0.1c0.2-0.1,0.4-0.2,0.5-0.4 c0.1-0.2,0.2-0.5,0.3-0.9c0-0.4,0.1-0.9,0.1-1.5c0-0.4,0-0.8-0.1-1.1C470,25.1,469.9,24.9,469.9,24.8z"></path> </g> </g> <g> <polygon fill="none" points="46.7,12 341,12 340.2,47.1 46.7,47.1 "></polygon> <text transform="matrix(1 0 0 1 46.6667 23.7046)"><tspan x="0" y="0" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="14px">Find recommendations, evidence summaries and </tspan><tspan x="0" y="16" fill="#FFFFFF" font-family="'InterFace-Regular'" font-size="14px">consultation decision aids for use in your practice</tspan></text> </g> </svg> </a> </span> </cite> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" > <div class="pane-content"> <ul class="tabs inline panels-ajax-tab"><li class="first"><a title="Article Tab - Article" href="/content/387/bmj-2024-080257" class="panels-ajax-tab-tab" data-panel-name="jnl_bmj_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="" data-url-enabled="1"><span>Article</span></a><a title="Article Tab - Article" href="/panels_ajax_tab/jnl_bmj_tab_art/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> <li><a title="Article Tab - Related Articles" href="/content/387/bmj-2024-080257/related" class="panels-ajax-tab-tab" data-panel-name="jnl_bmj_tab_related_art" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="related" data-url-enabled="1"><span>Related content</span></a><a title="Article Tab - Related Articles" href="/panels_ajax_tab/jnl_bmj_tab_related_art/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> <li><a title="Article Tab - Info & Metrics" href="/content/387/bmj-2024-080257/article-info" class="panels-ajax-tab-tab" data-panel-name="jnl_bmj_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="article-info" data-url-enabled="1"><span>Metrics</span></a><a title="Article Tab - Info & Metrics" href="/panels_ajax_tab/jnl_bmj_tab_info/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> <li><a title="BMJ Article Related Rapid Responses" href="/content/387/bmj-2024-080257/rapid-responses" class="panels-ajax-tab-tab" data-panel-name="bmj_related_rapid_responses" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="rapid-responses" data-url-enabled="1"><span>Responses</span></a><a title="BMJ Article Related Rapid Responses" href="/panels_ajax_tab/bmj_related_rapid_responses/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> <li><a title="Article Tab - Peer review" href="/content/387/bmj-2024-080257/peer-review" class="panels-ajax-tab-tab" data-panel-name="jnl_bmj_tab_peer_review" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="peer-review" data-url-enabled="1"><span>Peer review</span></a><a title="Article Tab - Peer review" href="/panels_ajax_tab/jnl_bmj_tab_peer_review/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> <li class="last"><a title="BMJ Rapid Responses Form" href="/content/387/bmj-2024-080257/submit-a-rapid-response" class="panels-ajax-tab-tab" data-panel-name="bmj_rapid_responses_form" data-target-id="highwire_article_tabs" data-entity-context="node:1101485" data-trigger="submit-a-rapid-response" data-url-enabled="1"><i class="fa fa-edit"></i></a><a title="BMJ Rapid Responses Form" href="/panels_ajax_tab/bmj_rapid_responses_form/node:1101485/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li> </ul> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" > <div class="pane-content"> <div data-panels-ajax-tab-preloaded="jnl_bmj_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.bmj.com/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-jnl_bmj_tab_art"><div class="panel-display panel-1col clearfix" > <div class="panel-panel panel-col"> <div><div class="panel-pane pane-highwire-corrections" > <div class="pane-content"> <div class="messages highwire-corrections highwire-correction-type-correction"><h3 class="highwire-corrections-title">This article has a correction. Please see:</h3><ul class="highwire-corrections-list"><li class="relation-2661027 first last"><a href="/content/387/bmj.q2605">Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline - November 21, 2024</a></li> </ul></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-highwire-markup" > <div class="pane-content"> <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" class="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="contributors"><ol class="contributor-list" id="contrib-group-1"><li class="contributor" id="contrib-1"><span class="name">Arnav Agarwal</span><span class="contrib-role">, internist, methods co-chair</span><a id="xref-aff-2-1" class="xref-aff" href="#aff-2">2</a><a id="xref-aff-3-1" class="xref-aff" href="#aff-3">3</a><a id="xref-aff-4-1" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-22-1" class="xref-aff" href="#aff-22">*</a>, </li><li class="contributor" id="contrib-2"><span class="name">Xiaoxi Zeng</span><span class="contrib-role">, nephrologist, methods co-chair trainee</span><a id="xref-aff-1-1" class="xref-aff" href="#aff-1">1</a><a id="xref-aff-4-2" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-22-2" class="xref-aff" href="#aff-22">*</a>, </li><li class="contributor" id="contrib-3"><span class="name">Sheyu Li</span><span class="contrib-role">, endocrinologist, methodologist</span><a id="xref-aff-5-1" class="xref-aff" href="#aff-5">5</a><a id="xref-aff-6-1" class="xref-aff" href="#aff-6">6</a>, </li><li class="contributor" id="contrib-4"><span class="name">Daniel Rayner</span><span class="contrib-role">, methodologist</span><a id="xref-aff-3-2" class="xref-aff" href="#aff-3">3</a>, </li><li class="contributor" id="contrib-5"><span class="name">Farid Foroutan</span><span class="contrib-role">, methodologist</span><a id="xref-aff-3-3" class="xref-aff" href="#aff-3">3</a><a id="xref-aff-4-3" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-7-1" class="xref-aff" href="#aff-7">7</a>, </li><li class="contributor" id="contrib-6"><span class="name">Bert Aertgeerts</span><span class="contrib-role">, primary care physician</span><a id="xref-aff-8-1" class="xref-aff" href="#aff-8">8</a><a id="xref-aff-9-1" class="xref-aff" href="#aff-9">9</a>, </li><li class="contributor" id="contrib-7"><span class="name">Frederic Coyac</span><span class="contrib-role">, patient partner</span><a id="xref-aff-10-1" class="xref-aff" href="#aff-10">10</a>, </li><li class="contributor" id="contrib-8"><span class="name">Pauline Darbellay Farhoumand</span><span class="contrib-role">, internist</span><a id="xref-aff-11-1" class="xref-aff" href="#aff-11">11</a>, </li><li class="contributor" id="contrib-9"><span class="name">Andrew Demaine</span><span class="contrib-role">, patient partner</span><a id="xref-aff-12-1" class="xref-aff" href="#aff-12">12</a>, </li><li class="contributor" id="contrib-10"><span class="name">Anja Fog Heen</span><span class="contrib-role">, endocrinologist, methodologist</span><a id="xref-aff-4-4" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-13-1" class="xref-aff" href="#aff-13">13</a>, </li><li class="contributor" id="contrib-11"><span class="name">Vivekanand Jha</span><span class="contrib-role">, nephrologist</span><a id="xref-aff-14-1" class="xref-aff" href="#aff-14">14</a><a id="xref-aff-15-1" class="xref-aff" href="#aff-15">15</a><a id="xref-aff-16-1" class="xref-aff" href="#aff-16">16</a>, </li><li class="contributor" id="contrib-12"><span class="name">Edward Machuve</span><span class="contrib-role">, patient partner</span><a id="xref-aff-10-2" class="xref-aff" href="#aff-10">10</a>, </li><li class="contributor" id="contrib-13"><span class="name">Evi Nagler</span><span class="contrib-role">, nephrologist</span><a id="xref-aff-17-1" class="xref-aff" href="#aff-17">17</a>, </li><li class="contributor" id="contrib-14"><span class="name">David J Tunnicliffe</span><span class="contrib-role">, methodologist</span><a id="xref-aff-18-1" class="xref-aff" href="#aff-18">18</a><a id="xref-aff-19-1" class="xref-aff" href="#aff-19">19</a>, </li><li class="contributor" id="contrib-15"><span class="name">Gordon H Guyatt</span><span class="contrib-role">, internist, methodologist</span><a id="xref-aff-2-2" class="xref-aff" href="#aff-2">2</a><a id="xref-aff-3-4" class="xref-aff" href="#aff-3">3</a><a id="xref-aff-4-5" class="xref-aff" href="#aff-4">4</a>, </li><li class="contributor" id="contrib-16"><span class="name">Per Olav Vandvik</span><span class="contrib-role">, internist, methodologist</span><a id="xref-aff-4-6" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-20-1" class="xref-aff" href="#aff-20">20</a>, </li><li class="contributor" id="contrib-17"><span class="name">Belen Ponte</span><span class="contrib-role">, nephrologist, clinical co-chair</span><a id="xref-aff-21-1" class="xref-aff" href="#aff-21">21</a><a id="xref-aff-23-1" class="xref-aff" href="#aff-23">†</a>, </li><li class="last" id="contrib-18"><span class="name">Thomas Agoritsas</span><span class="contrib-role">, internist, methodologist</span><a id="xref-aff-3-5" class="xref-aff" href="#aff-3">3</a><a id="xref-aff-4-7" class="xref-aff" href="#aff-4">4</a><a id="xref-aff-11-2" class="xref-aff" href="#aff-11">11</a><a id="xref-aff-23-2" class="xref-aff" href="#aff-23">†</a></li></ol><ol class="affiliation-list"><li class="aff"><a id="aff-1" name="aff-1"></a><address><sup>1</sup>Department of Nephrology, West China Hospital, Sichuan University, Chengdu, China, 610041</address></li><li class="aff"><a id="aff-2" name="aff-2"></a><address><sup>2</sup>Department of Medicine, McMaster University, Hamilton, Ontario, Canada, L8N 3Z5</address></li><li class="aff"><a id="aff-3" name="aff-3"></a><address><sup>3</sup>Department of Health Research Methods, Evidence and Impact, HSC 2C, Hamilton, Ontario, Canada, L8S 4L8</address></li><li class="aff"><a id="aff-4" name="aff-4"></a><address><sup>4</sup>MAGIC Evidence Ecosystem Foundation, Oslo, Norway, 0282</address></li><li class="aff"><a id="aff-5" name="aff-5"></a><address><sup>5</sup>Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China, 610041</address></li><li class="aff"><a id="aff-6" name="aff-6"></a><address><sup>6</sup>Chinese Evidence-Based Medicine Center, Cochrane China Center and MAGIC China Center, West China Hospital, Sichuan University, Chengdu, China, 610041</address></li><li class="aff"><a id="aff-7" name="aff-7"></a><address><sup>7</sup>Ted Rogers Center for Heart Research, Toronto, Ontario, Canada, M5G 1X8</address></li><li class="aff"><a id="aff-8" name="aff-8"></a><address><sup>8</sup>Academic Centre for General Practice, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium, 3000</address></li><li class="aff"><a id="aff-9" name="aff-9"></a><address><sup>9</sup>CEBAM, Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, Leuven, Belgium, 3000.</address></li><li class="aff"><a id="aff-10" name="aff-10"></a><address><sup>10</sup>Geneva, Switzerland.</address></li><li class="aff"><a id="aff-11" name="aff-11"></a><address><sup>11</sup>Division of General Internal Medicine, Department of Medicine, Hôpitaux Universitaire de Genève and University of Geneva, Geneva, Switzerland, 1205</address></li><li class="aff"><a id="aff-12" name="aff-12"></a><address><sup>12</sup>Plymouth, United Kingdom.</address></li><li class="aff"><a id="aff-13" name="aff-13"></a><address><sup>13</sup>Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway, 0456</address></li><li class="aff"><a id="aff-14" name="aff-14"></a><address><sup>14</sup>George Institute for Global Health, Elegance Tower, Jasola District Centre, New Delhi, India, 110025.</address></li><li class="aff"><a id="aff-15" name="aff-15"></a><address><sup>15</sup>School of Public Health, Imperial College London, London, UK, SW7 2AZ</address></li><li class="aff"><a id="aff-16" name="aff-16"></a><address><sup>16</sup>Prasanna School of Public Health, Manipal Academy of Higher Education, Madhav Nagar, Eshwar Nagar, Manipal, Karnataka, India, 576104</address></li><li class="aff"><a id="aff-17" name="aff-17"></a><address><sup>17</sup>Department of Nephrology, Ghent University Hospital, Ghent, Belgium, 9000</address></li><li class="aff"><a id="aff-18" name="aff-18"></a><address><sup>18</sup>Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia, 2006</address></li><li class="aff"><a id="aff-19" name="aff-19"></a><address><sup>19</sup>Centre for Kidney Research, The Children’s Hospital at Westmead, Westmead, New South Wales, Australia, 2145</address></li><li class="aff"><a id="aff-20" name="aff-20"></a><address><sup>20</sup>Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway, 2819</address></li><li class="aff"><a id="aff-21" name="aff-21"></a><address><sup>21</sup>Division of Nephrology and Hypertension, Department of Medicine, University of Geneva, University Hospitals of Geneva, Geneva, Switzerland, 1205</address></li><li class="aff"><a id="aff-22" name="aff-22"></a><address><sup>*</sup>. Both authors contributed equally (co-first authors)</address></li><li class="aff"><a id="aff-23" name="aff-23"></a><address><sup>†</sup>. Both authors contributed equally (co-last authors)</address></li></ol><ol class="corresp-list"><li class="corresp" id="corresp-1">Correspondence to: S Li <span class="em-link"><span class="em-addr">lisheyu{at}gmail.com</span></span>, B Ponte <span class="em-link"><span class="em-addr">belen.ponte{at}hug.ch</span></span>, T Agoritsas <span class="em-link"><span class="em-addr">thomas.agoritsas{at}unige.ch</span></span></li></ol></div><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><div id="sec-1" class="subsection"><p id="p-1"><strong>Clinical question</strong> What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidney outcomes for adults living with chronic kidney disease (CKD)?</p></div><div id="sec-2" class="subsection"><p id="p-2"><strong>Current practice</strong> Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors have demonstrated cardiovascular and kidney benefits in adults with CKD with and without type 2 diabetes. Existing guidance for SGLT-2 inhibitors does not account for the totality of current best evidence for adults with CKD and does not provide fully stratified treatment effects and recommendations across all risk groups based on risk of CKD progression and complications.</p></div><div id="sec-3" class="subsection"><p id="p-3"><strong>Recommendations</strong> The guideline panel considered evidence regarding benefits and harms of SGLT-2 inhibitor therapy for adults with CKD over a five year period, along with contextual factors, and provided the following recommendations:</p><p id="p-4">1. For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)</p><p id="p-5">2. For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)</p><p id="p-6">3. For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour)</p><p id="p-7">4. For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour).</p><p id="p-8">Recommendations are applicable to all adults with CKD, irrespective of type 2 diabetes status.</p></div><div id="sec-4" class="subsection"><p id="p-9"><strong>How this guideline was created</strong> An international panel including patients, clinicians, and methodologists produced these recommendations following standards for trustworthy guidelines and using the GRADE approach. The panel identified typical risk strata of adults with CKD (from low to very high risk of CKD progression and related complications) using the classification system developed by Kidney Disease Improving Global Outcomes (KDIGO), and applied an individual patient perspective in moving from evidence to recommendations. Effects of SGLT-2 inhibitors were interpreted in absolute terms applicable to different risk strata with varying baseline risks for outcomes of benefit over a five year period. The panel explicitly considered the balance of benefits, harms, and burdens of starting an SGLT-2 inhibitor, incorporating the values and preferences of adults with different risk profiles. Interactive evidence summaries and decision aids accompany multilayered recommendations, developed in an online authoring and publication platform (<a href="http://www.magicapp.org">www.magicapp.org</a>) that allows reuse and adaptation.</p></div><div id="sec-5" class="subsection"><p id="p-10"><strong>The evidence</strong> A linked systematic review and pairwise meta-analysis (13 trials including 29 614 participants) of benefits and harms associated with SGLT-2 inhibitors in adults with CKD with or without type 2 diabetes informed guidance. Among individuals at very high risk of CKD progression and complications, moderate to high certainty evidence shows SGLT-2 inhibitors (relative to placebo or standard care without SGLT-2 inhibitors) decrease all-cause and cardiovascular mortality, hospitalisation for heart failure, kidney failure, non-fatal myocardial infarction, and non-fatal stroke. Among individuals at high risk, moderate to high certainty evidence shows SGLT-2 inhibitors result in similar benefits across outcomes except demonstrating little or no effect on hospitalisation for heart failure and kidney failure. Among individuals at moderate and low risk, moderate to high certainty evidence shows SGLT-2 inhibitors probably reduce all-cause mortality and non-fatal stroke, with little or no effect for other outcomes of benefit. Risk-stratified estimates were unavailable for outcomes of harm; the panel therefore considered absolute effects summarised across risk strata. SGLT-2 inhibitors are associated with little or no effect on acute kidney injury requiring dialysis, bone fractures, lower limb amputations, ketoacidosis, genital infections, or symptomatic hypovolaemia, although a residual possibility of harms at the individual patient level remains.</p></div><div id="sec-6" class="subsection"><p id="p-11"><strong>Understanding the recommendation</strong> In order to apply recommendations, clinicians must appropriately identify adults with CKD, consider the underlying aetiology, and risk stratify them based on glomerular filtration rate (estimated or measured) and degree of albuminuria. In addition to classifying individuals into risk strata, further estimation of a given patient’s risk based on the extent of their kidney disease and other comorbidities may be warranted to inform individual-level decisions and shared decision making. Available risk calculators may help estimate a given patient’s risk of CKD progression and complications.</p></div></div><div class="section other1" id="sec-7"><h2 class="">Why is the guideline needed?</h2><p id="p-12">Chronic kidney disease (CKD) is characterised by abnormalities of kidney structure or function, present for a minimum of three months, and is classified based on aetiology, glomerular filtration rate (GFR), and degree of albuminuria.<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a> CKD affects approximately 850 million individuals internationally, is the tenth leading cause of death, and is projected to be the fifth leading cause by 2050.<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a><a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a><a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a> Although clinical trajectories vary across individuals, CKD is generally progressive, with declining GFR and progressive albuminuria associated with an increasing risk of cardiovascular complications, kidney failure, and premature death.<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a><a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a></p><p id="p-13">For a long time, therapies to slow progression of kidney disease and improve long term prognosis of adults living with CKD were lacking. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have emerged—alongside renin-angiotensin system inhibitors, glucagon-like peptide 1 agonists, and non-steroidal mineralocorticoid receptor antagonists—as therapies with potential cardiovascular and kidney protective effects among individuals with type 2 diabetes and CKD.<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a> Recently, two randomised trials have demonstrated similar cardiovascular and kidney benefits with the use of SGLT-2 inhibitors among non-diabetic individuals with CKD at varying GFRs and degrees of albuminuria.<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a><a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a></p><p id="p-14">Previous guidelines from Kidney Disease: Improving Global Outcomes (KDIGO) recommended the use of SGLT-2 inhibitors for patients with type 2 diabetes, CKD, and an estimated GFR of ≥20 mL/min per 1.73 m<sup>2</sup>.<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a> Their more recent guidance provide recommendations for SGLT-2 inhibitors more broadly for adults with CKD irrespective of diabetes status; however, recommendations are limited to specific risk groups (that is, an estimated GFR ≥20 mL/min per 1.73 m<sup>2</sup> with urine albumin to creatinine ratio (ACR) ≥20 mg/mmol (≥200 mg/g) with concurrent heart failure; or with an estimated GFR 20-45 mL/min per 1.73 m<sup>2</sup> with urine ACR &lt;20 mg/mmol).<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a> Moreover, these recommendations are primarily informed by a systematic review and meta-analysis of large double-blind, placebo-controlled trials of at least six months duration evaluating SGLT-2 inhibitors across disease populations including CKD. The review included only four large trials including adults with CKD and did not account for the entirety of existing randomised trial evidence applicable to the CKD population. The review and practice guideline did not take into account treatment effects in absolute terms based on varying prognoses and baseline risks (that is, likelihood of events occurring without treatment), therefore failing to provide risk-stratified interpretations of the evidence and risk-stratified recommendations.<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a><a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a></p><p id="p-15">We need trustworthy and actionable guidelines that consider all available randomised trial evidence regarding benefits and harms, translate evidence into absolute effects for patient-important outcomes over a reasonable timeframe, and provide risk-stratified recommendations that account for the variable prognoses of adults living with CKD. An international guideline panel involving diverse healthcare professionals, patient partners, and methodologists experienced in guideline development provides the basis for practice guidance that can be used, adapted, and widely implemented.<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a></p><div class="boxed-text" id="boxed-text-1"><h3>Linked resources in this <em>BMJ</em> Rapid Recommendations cluster</h3><p id="p-16">Recommendations are informed by a systematic review and meta-analysis evaluating SGLT-2 inhibitors for adults with CKD, including individuals with and without type 2 diabetes. Summary of findings tables included in the guideline are directly informed by the systematic review.</p><p id="p-17">This guideline on SGLT-2 inhibitors for individuals with CKD parallels an ongoing living <em>BMJ</em> Rapid Recommendation on drugs for type 2 diabetes, informed by a living systematic review and network meta-analysis. The living diabetes guideline provides recommendations across varying degrees of cardiovascular and kidney risk profiles, and includes recommendations for SGLT-2 inhibitors in individuals with type 2 diabetes. Approaches to risk stratification and recommendations provided are harmonised between the two guidelines by the MAGIC Evidence Ecosystem Foundation (<a href="http://www.magicevidence.org">www.magicevidence.org</a>).</p><p id="p-18">This guideline, as well as the parallel living guideline on drugs for diabetes, contribute to the <em>BMJ</em> Rapid Recommendations series, focused on providing clinicians with trustworthy recommendations for potentially practice changing evidence. <em>BMJ</em> Rapid Recommendations represent a collaborative effort between MAGIC and <em>The BMJ</em>.<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a> MAGICapp (<a href="http://www.magicapp.org">www.magicapp.org</a>) houses the full version of the guideline, including interactive decision aids, and is accessible across all devices in multilayered formats.<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a> Readers can access an interactive version of this guideline with associated evidence summaries and interactive decision aids via MAGICapp (link below).</p><div id="sec-8" class="subsection"><h4>Linked resouces</h4><ul class="list-unord " id="list-1"><li id="list-item-1"><p id="p-19">Zou X, Shi Q, Vandvik P, et al. Sodium glucose co-transporter-2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes: a systematic review and meta-analysis. <em>BMJ Med</em> 2024;3:e001009, doi:<a href="/lookup/doi/10.1136/bmjmed-2024-001009">10.1136/bmjmed-2024-001009</a>.</p></li><li id="list-item-2"><p id="p-20">Agarwal A, Zeng X, Li S, et al. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline. <em>BMJ</em> 2024;386:e080257, doi:<a href="/lookup/doi/10.1136/bmj-2024-080257">10.1136/bmj-2024-080257</a></p></li><li id="list-item-3"><p id="p-21">MAGICapp: <a href="https://app.magicapp.org/#/guideline/EezrQj">https://app.magicapp.org/#/guideline/EezrQj</a></p></li></ul></div></div></div><div class="section other2" id="sec-9"><h2 class="">Context for recommendations</h2><p id="p-22">This practice guidance is intended to facilitate evidence-informed decision making for nephrologists, endocrinologists, internal medicine physicians, general practitioners, and patients with established CKD regardless of degree of kidney dysfunction and albuminuria. The recommendations take into account all available evidence regarding SGLT-2 inhibitors for adults with CKD; the expertise and experience of healthcare professionals, researchers, guideline methodologists, and people living with CKD; and the values and preferences of people with CKD when making treatment decisions, informed directly by patient partners on the guideline panel. The recommendations also take into account other factors such as practical issues, affordability, and health equity; follow standards for trustworthy guidelines; and use the GRADE approach.<a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a><a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a></p><div id="sec-10" class="subsection"><h3>Approach to risk stratification</h3><p id="p-23">Risks of death, adverse cardiovascular outcomes, and progression to kidney failure vary across GFRs and degrees of albuminuria. No single prognostic model was identified that accurately risk-stratifies individuals with varying CKD profiles and produces reliable estimates for all prioritised cardiovascular and kidney outcomes and harms. Ultimately, the panel agreed to use the CGA classification, which incorporates underlying cause of CKD (C), GFR (G), and degree of albuminuria (A), initially introduced in 2012 by KDIGO and maintained in its most recent practice guidance.<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a><a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a><a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">11</a> Data from a United Kingdom-based primary care database of records collected as part of routine care with general practitioners (99 129 patients) informed baseline risks and absolute effects across cardiovascular and kidney outcomes—specifically, all-cause and cardiovascular mortality, hospitalisation for heart failure, non-fatal myocardial infarction, non-fatal stroke, and kidney failure (see “How this guideline was created” below for more details). <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a> Absolute effects were estimated over a five year time-frame.</p><p id="p-24"><a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a> summarises the four risk strata, adopting KDIGO’s classification system based on GFR and albuminuria categories; users may refer to reference materials from KDIGO for a visual representation of the risk stratification approach. </p><div id="T1" class="table pos-float"><div class="table"><div class="table-caption"><span class="table-label">Table 1</span> <p id="p-25" class="first-child">Chronic kidney disease (CKD) prognosis classification system used by KDIGO (adopted from the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD<a id="xref-ref-11-4" class="xref-bibr" href="#ref-11">11</a>) </p><div class="sb-div caption-clear"></div></div><div class="table-inline"><div class="callout"><span>View this table:</span><ul class="callout-links"><li><a href="/highwire/markup/1101486/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_figures%2Chighwire_math" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables">View popup</a></li><li><a href="" class="table-expand-inline" data-table-url="/highwire/markup/1101486/expansion?postprocessors=highwire_figures%2Chighwire_math">View inline</a></li></ul></div></div></div><div></div></div><p id="p-27">Beyond accounting for GFR and degree of albuminuria, risk needs to be further stratified in order to tailor care to a given individual. To accomplish this, clinicians may choose to consider other comorbidities, and may use one of several available prognostic models (see appendix).</p></div><div id="sec-11" class="subsection"><h3>Applicability of recommendations</h3><p id="p-28">Recommendations apply to most adults with established CKD irrespective of type 2 diabetes status, heart failure status, sex, gender, or ethnicity. In line with internationally accepted definitions, CKD is defined as abnormalities in kidney structure or function for a minimum of three months, with health implications. Either decreased GFR (&lt;60 mL/min per 1.73 m<sup>2</sup>) or one or more markers of kidney damage (such as albuminuria with an albumin to creatinine ratio ≥3 mg/mmol) must be present to establish the diagnosis. This guideline does not apply to adults meeting neither criterion and therefore not having CKD.</p><p id="p-29">Recommendations may not be applicable to certain other groups based on specific clinical considerations and lack of representation in included studies:</p><ul class="list-unord " id="list-2"><li id="list-item-4"><p id="p-30">Individuals receiving kidney replacement therapy</p></li><li id="list-item-5"><p id="p-31">Individuals who have received a kidney transplant</p></li><li id="list-item-6"><p id="p-32">Individuals with polycystic kidney disease</p></li><li id="list-item-7"><p id="p-33">Individuals with rare kidney diseases</p></li><li id="list-item-8"><p id="p-34">Individuals with estimated GFR &lt;20 mL/min per 1.73 m<sup>2</sup> and not receiving kidney replacement therapy.</p></li></ul><p id="p-35">Age is not accounted for in the definition and classification system published by KDIGO in 2012 and maintained in its most recent practice guidelines. This may result in possible overestimation of risk in older adults (such as ≥65 years) and underestimation of risk in younger individuals (such as &lt;40 years),<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a> making recommendations less applicable to these groups.</p><p id="p-36">Moreover, individuals with rare kidney diseases (encompassing over 150 conditions as defined by KDIGO) can have higher rates of kidney failure but higher rates of survival relative to the general population of adults with CKD. Evidence regarding SGLT-2 inhibitors in such cases is either low certainty or non-existent. Recommendations may therefore be less applicable to these individuals.<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a></p><div class="boxed-text" id="boxed-text-2"><h3>How this guideline was created</h3><div id="sec-12" class="subsection"><h4>Standards, methods, and processes for trustworthy guidance</h4><p id="p-37">This <em>BMJ Rapid Recommendation</em> was developed in accordance with standards for trustworthy guidance from the Institute of Medicine,<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a> and strives to meet criteria for methodological rigour as per AGREE-II.<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a></p></div><div id="sec-13" class="subsection"><h4>Who was involved?</h4><p id="p-38">We recruited an international guideline panel including patient partners (individuals living with CKD irrespective of disease stage and with or without a history of cardiovascular and kidney complications), general practitioners, internal medicine physicians, endocrinologists, nephrologists, and methodologists. Panel members were diverse in geography, sex, and expertise. The panel collectively determined the scope of this guideline and formulated recommendations. Methods and clinical co-chairs were selected by the MAGIC Evidence Ecosystem Foundation to lead panel deliberations.</p><p id="p-39">No panel member reported financial conflicts of interest. Intellectual conflicts of interest were minimised and managed in accordance with established policies for <em>The BMJ</em> and MAGIC.</p></div><div id="sec-14" class="subsection"><h4>What research did the guideline panel request and review?</h4><p id="p-40">The panel defined the clinical question and related population, intervention, outcomes and subgroups of interest to be addressed by the guideline. To fully address the specified question, an independent team of clinical epidemiologists, clinical experts, and biostatisticians conducted a pairwise systematic review to examine benefits and harms addressing the clinical question. Team members had expertise in GRADE methods.<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">14</a></p><p id="p-41">A second independent team of epidemiologists, clinical experts, and biostatisticians conducted a review of existing literature to identify prognostic models and classification systems to guide risk stratification of adults across different degrees of CKD severity. Identified prognostic models and classifications were reviewed by a core team of methodologists, and informed the strategy used for risk stratification in the guideline.</p><p id="p-42">The panel did not prioritise a separate systematic review on the values and preferences of adults with CKD and instead relied on input from patient partners and clinical experts on the panel to inform their judgments.</p></div><div id="sec-15" class="subsection"><h4>What outcomes did the guideline panel request and review?</h4><p id="p-43">Twelve patient-important outcomes were selected in the systematic review summarising benefits and harms of SGLT-2 inhibitor therapy. Panel members completed a survey to prioritise these outcomes from the perspective of an average adult with CKD.</p><p id="p-44">The following outcomes were deemed as being of critical importance (rated 7 to 9 on a 9-point ordinal scale): all-cause mortality, cardiovascular mortality, kidney failure, non-fatal stroke, hospitalisation for heart failure, non-fatal myocardial infarction, acute kidney injury requiring dialysis, and lower limb amputation.</p><p id="p-45">The following outcomes were deemed as being of importance (rated as 4 to 6 on the scale): ketoacidosis, bone fracture, genital infection, and symptomatic hypovolaemia.</p><p id="p-46">All 12 outcomes—six addressing benefit and six addressing harm (adverse events)—were retained as being patient-important.</p></div><div id="sec-16" class="subsection"><h4>How did the panel formulate recommendations?</h4><p id="p-47">Pre-established standards, methods, and processes for the <em>BMJ </em>Rapid Recommendations for developing trustworthy guidelines were adopted.<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a><a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">20</a> The GRADE approach provided the framework for evaluating certainty of available evidence and determining the strength and direction of recommendations. With GRADE, recommendations can be strong or weak, and for or against a treatment or course of action.<a id="xref-ref-14-3" class="xref-bibr" href="#ref-14">14</a></p><p id="p-48">To facilitate panel deliberations regarding interpretation of effects associated with SGLT-2 inhibitors, a survey was conducted asking panel members to rate the relative importance to patients of identified outcomes on an ordinal scale from 1 (not patient-important) to 9 (of critical importance). </p><p id="p-49">The panel adopted a consensus based approach to establish thresholds for minimal important differences for each prioritised outcome. The minimal important difference is the smallest treatment effect that a patient would deem as being important. Established thresholds facilitated interpretation of absolute effects (differentiating important from unimportant (that is, little or no difference) effects) and directly influenced ratings of precision when evaluating certainty of evidence using GRADE. Thresholds were generally inversely proportional to the relative patient importance of outcomes (that is, more patient-important outcomes were assigned lower thresholds whereby a treatment effect was deemed important). The minimal important difference thresholds used are summarised in the Summary of Findings tables provided in MAGICapp and in the linked systematic review and meta-analysis.</p><p id="p-50">Panel meetings were facilitated by methods and clinical co-chairs, and were conducted in July 2023 via web conference. The panel reviewed survey results regarding outcome prioritisation; reached agreement regarding an approach to risk stratification, patient values and preferences, and minimal important difference thresholds for interpreting treatment effects in absolute terms; and reviewed Summary of Findings tables, providing risk-stratified summaries of evidence across prioritised outcomes and their respective certainty ratings. A consensus based approach was adopted to move from evidence to recommendations, with informal voting used to anchor discussions and facilitate consensus. When the panel was unable to reach a consensus by discussion, a priori voting rules were established; voting was limited to panel members with clinical expertise and patient partners, excluding methodologists.</p><p id="p-51">In addition to consideration of absolute benefits and harms for prioritised patient-important outcomes and associated certainty of the evidence, several other factors were considered in moving from evidence to recommendations. Decisional domains included values and preferences of individuals living with CKD, feasibility, and acceptability. Issues related to equity were discussed but did not weigh heavily on deliberations when making recommendations. The panel also provided input regarding practicalities of administering SGLT-2 inhibitors, and issues related to applicability of recommendations to specific groups.</p><p id="p-52">Guidance was drafted by the methods chair with input from the clinical chair and methods trainee co-chair, and was circulated for review to the panel. Internal feedback was incorporated, and the panel approved the final version of the guidance prior to submission.</p></div><div id="sec-17" class="subsection"><h4>What is the approach to prognosis and risk prediction for outcomes?</h4><p id="p-53">The methods team conducted a review of existing prognostic models for risk stratification of individuals with CKD and establishing risk-stratified prognoses (that is, baseline risks) for cardiovascular and kidney outcomes. Evaluation of identified prognostic models, including those reported by the CKD Prognosis Consortium, yielded no models that provided accurate risk stratification (that is, adequate discrimination and calibration) across the majority of prioritised cardiovascular and kidney outcomes.</p><p id="p-54">The KDIGO classification was considered as an alternate approach to risk stratification of individuals with CKD based on a combined assessment of GFR (measured or estimated) and albuminuria levels.<a id="xref-ref-1-3" class="xref-bibr" href="#ref-1">1</a> This classification system was adopted due to its widespread use and practicality of application in clinical practice, requiring only GFR and albuminuria inputs to estimate risk. Data from a large retrospective cohort study including a primary care database—the United Kingdom Clinical Practice Research Datalink (CPRD)—was used to inform baseline risks and absolute effects across cardiovascular and kidney outcomes using this classification. The United Kingdom CPRD uses medical records collected as part of routine care with general practitioners, and was deemed appropriately representative of a community based population with CKD. Data were used to inform risk-stratified estimates for all-cause and cardiovascular mortality, hospitalisation for heart failure, non-fatal myocardial infarction, non-fatal stroke, and kidney failure.<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a> Absolute effects were estimated over a five year time-frame for all outcomes.</p><p id="p-55">The methods team and panel acknowledged several limitations with adopting the KDIGO classification for risk stratification. The classification uses fixed thresholds for GFR and albuminuria without stratifying for age. Among younger individuals, a small GFR decline with or without albuminuria may represent pathological CKD with a higher risk of mortality and cardiovascular and kidney-related sequelae. On the contrary, among older individuals, an isolated decline in GFR may represent a physiological process without similar increases in these risks.<a id="xref-ref-16-2" class="xref-bibr" href="#ref-16">16</a> Therefore, universal thresholds for both variables could lead to a misleading incidence of CKD without proportionally increased or decreased risks of kidney failure and mortality, and with a risk of underestimating risk in younger individuals and overestimating it in older individuals.<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a> The panel also noted issues related to GFR being either estimated or measured in the classification system and that different equations may be used to estimate GFR.</p><p id="p-56">The panel acknowledged that, although risk stratification was made possible for outcomes of benefit with this strategy, harm outcomes were not able to be similarly risk-stratified. Treatment effects were anticipated to be similar irrespective of baseline kidney function.<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a> However, possible variation in baseline risks of harms across risk strata was anticipated (such as higher risk CKD groups are at higher risk of developing acute kidney injury). Certainty in evidence was therefore downgraded for indirectness in baseline risks to reflect the uncertainty in using the unstratified absolute effect estimates for these outcomes to inform decision making.</p></div><div id="sec-18" class="subsection"><h4>How were values and preferences of patients incorporated?</h4><p id="p-57">In the absence of a systematic review regarding the values and preferences of adults with CKD as they apply to SGLT-2 inhibitors, the panel relied on their own judgments of what well informed adults would value after carefully balancing benefits, harms, and burdens of therapy. Input from three patient partners who live with CKD informed judgments. The following values and preferences were deemed to be typical of well informed adults with CKD:</p><ul class="list-unord " id="list-3"><li id="list-item-9"><p id="p-58">Most adults living with CKD would be inclined to accept SGLT-2 inhibitor therapy when faced with moderate or high certainty of potential benefit and moderate or high certainty of little or no increased risk of harms. The larger the benefit, the more individuals would be willing to accept therapy.</p></li><li id="list-item-10"><p id="p-59">Most adults living with CKD would be disinclined to accept SGLT-2 inhibitor when faced with moderate or high certainty of little or no benefit regardless of associated harms.</p></li></ul><p id="p-60">Even when faced with moderate or high certainty of unimportant harms, there remains a possibility for harm that may drive individuals to avoid therapy unless benefits are compelling. Moreover, the introduction of an additional medication for individuals who may already be taking numerous medications (increased pill burden) may be considered an important harm. These considerations were incorporated when making recommendations.</p></div></div></div></div><div class="section other3" id="sec-19"><h2 class="">The recommendations</h2><p id="p-61">Recommendations across risk strata were informed by 13 randomised trials including 29 614 participants.</p><div id="sec-20" class="subsection"><h3>Recommendation 1: For adults at low risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)</h3><p id="p-62"><em>Understanding the recommendation</em>—Moderate certainty of small but important reductions in risks of all-cause mortality and non-fatal stroke, balanced against moderate certainty of no important increase in the risk of harms, led to a weak recommendation in favour of treatment. The panel deliberated on whether treatment effects justified a weak recommendation in favour or against—given that benefits are more marginal than in higher risk groups and there remains a possibility of adverse events at the individual level (even in the absence of an important increase in risk per 1000 individuals)—and ultimately concluded that most patients would be inclined to accept treatment.</p><p id="p-63"><em>Benefits and harms</em>—In adults at low risk, SGLT-2 inhibitors probably decrease all-cause mortality (7 fewer per 1000 adults, 95% confidence interval 11 fewer to 1 fewer) and non-fatal stroke (10 fewer per 1000, 16 fewer to 2 fewer) (both moderate certainty) with little or no effect on cardiovascular mortality, hospitalisation for heart failure, kidney failure, and non-fatal myocardial infarction (all moderate to high certainty). Therapy is probably associated with little or no increased risk of harms, including acute kidney injury requiring dialysis (9 fewer per 1000, 14 fewer to 1 fewer), bone fracture (2 more per 1000, 10 fewer to 15 more), lower limb amputation (2 more per 1000, 4 fewer to 10 more), ketoacidosis (4 more per 1000, 1 more to 9 more), genital infection (27 more per 1000, 17 more to 39 more), and symptomatic hypovolaemia (32 more per 1000, 17 more to 49 more) (low certainty for lower limb amputation; moderate certainty for all other outcomes). Despite no effect estimates crossing the pre-established thresholds for minimal important differences across harm outcomes, the panel acknowledged adverse events remained plausible at the individual patient level.</p><p id="p-64"><em>Values and preferences</em>—Applying the values and preferences agreed on by the panel with patient partner input (see “How this guideline was created”), the majority of individuals would be expected to accept SGLT-2 inhibitors, though a reasonable proportion would likely decline, given the marginal benefits, increased pill burden, medication costs, and a residual possibility of harms.</p></div><div id="sec-21" class="subsection"><h3>Recommendation 2: For adults at moderate risk of CKD progression and complications, we suggest administering SGLT-2 inhibitors (weak recommendation in favour)</h3><p id="p-65"><em>Understanding the recommendation</em>—Moderate certainty of important reductions in risks of all-cause mortality and non-fatal stroke, balanced against moderate certainty of no important increase in the risk of harms, justified a weak recommendation in favour.</p><p id="p-66"><em>Benefits and harms</em>—In adults at moderate risk, SGLT-2 inhibitors probably decrease all-cause mortality (13 fewer per 1000, 95% CI 22 fewer to 2 fewer) and non-fatal stroke (13 fewer per 1000, 21 fewer to 3 fewer) (both moderate certainty), with little or no effect on cardiovascular mortality, non-fatal myocardial infarction (both moderate certainty), hospitalisation for heart failure, and kidney failure (both high certainty). Harms are the same as for adults in other risk strata, acknowledging uncertainty given lack of risk-stratified estimates and the residual possibility of adverse events at the individual patient level.</p><p id="p-67"><em>Values and preferences</em>—Same as for recommendation 1.</p></div><div id="sec-22" class="subsection"><h3>Recommendation 3: For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour)</h3><p id="p-68"><em>Understanding the recommendation</em>—Moderate certainty of important reductions in risks of mortality and most cardiovascular and kidney outcomes, combined with moderate certainty of no important increase in the risk of harms, motivated a strong recommendation in favour of treatment.</p><p id="p-69"><em>Benefits and harms</em>—In individuals at high risk, SGLT-2 inhibitors probably decrease all-cause mortality (24 fewer per 1000, 95% CI 41 fewer to 3 fewer) and cardiovascular mortality (6 fewer per 1000, 10 fewer to 1 fewer), non-fatal myocardial infarction (21 fewer per 1000, 34 fewer to 6 fewer), and non-fatal stroke (21 fewer per 1000, 34 fewer to 5 fewer) (all moderate certainty), with little or no effect on hospitalisation for heart failure and kidney failure (both high certainty). Harms are the same as for adults in other risk strata, acknowledging uncertainty given lack of risk-stratified estimates and the residual possibility of adverse events at the individual patient level.</p><p id="p-70"><em>Values and preferences</em>—Applying the values and preferences agreed on by the panel with patient partner input (see “How this guideline was created”), the panel inferred that all or almost all individuals would be inclined to receive SGLT-2 inhibitors in light of benefits substantially outweighing potential harms and treatment burdens, and did not anticipate substantial variability in preferences.</p></div><div id="sec-23" class="subsection"><h3>Recommendation 4: For adults at very high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation in favour)</h3><p id="p-71"><em>Understanding the recommendation</em>—High certainty of an overall survival benefit and reduced risk of kidney failure, moderate certainty of important reductions in cardiovascular mortality and outcomes, and moderate certainty of no important increase in the risk of harms, justified a strong recommendation in favour.</p><p id="p-72"><em>Benefits and harms</em>—In individuals at very high risk, SGLT-2 inhibitors decrease all-cause mortality (48 fewer per 1000, 95% CI 84 fewer to 6 fewer) and kidney failure (58 fewer per 1000, 72 fewer to 42 fewer) (both high certainty), and probably decrease cardiovascular mortality (10 fewer per 1000, 17 fewer to 3 fewer), hospitalisation for heart failure (25 fewer per 1000, 32 fewer to 17 fewer), non-fatal myocardial infarction (32 fewer per 1000, 51 fewer to 9 fewer), and non-fatal stroke (25 fewer per 1000, 40 fewer to 6 fewer) (all moderate certainty). Harms are the same as for adults in other risk strata, acknowledging uncertainty given lack of risk-stratified estimates and the residual possibility of adverse events at the individual patient level.</p><p id="p-73"><em>Values and preferences</em>—Same as recommendation 3.</p><div class="boxed-text" id="boxed-text-3"><h3>Resource, equity, acceptability, and feasibility considerations</h3><p id="p-74">SGLT-2 inhibitors are widely available internationally.<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a> Most SGLT-2 inhibitors are available as once-daily oral regimens. Individuals initiating SGLT-2 inhibitors require counselling regarding possibility of adverse events and sick day rules,<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a><a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a> but otherwise do not require intensive follow-up. These considerations are applicable across risk strata.</p></div><div class="boxed-text" id="boxed-text-4"><h3>Practical considerations</h3><ul class="list-simple " id="list-4"><li id="list-item-11"><p id="p-75">The following should be considered when prescribing SGLT-2 inhibitors to adults with CKD:</p><ul class="list-unord " id="list-5"><li id="list-item-12"><p id="p-76">SGLT-2 inhibitors may be initiated at the highest possible dose and do not require dose titration</p></li><li id="list-item-13"><p id="p-77">SGLT-2 inhibitors may be initiated in adults with estimated glomerular filtration rate (GFR) ≥20 mL/min per 1.73 m<sup>2</sup></p></li><li id="list-item-14"><p id="p-78">Once initiated, SGLT-2 inhibitors may be continued even if estimated GFR &lt;20 mL/min per 1.73 m<sup>2</sup> until dialysis initiation</p></li><li id="list-item-15"><p id="p-79">SGLT-2 inhibitors are likely to cause an acute transient decline in GFR within two to four weeks after initiation. However, it is not routinely necessary to check blood tests after initiating an SGLT-2 inhibitor in adults with CKD, except in high risk individuals such as those with prior acute kidney injury or at risk of volume depletion</p></li><li id="list-item-16"><p id="p-80">A transient decline in GFR should not be a reason to discontinue therapy unless it exceeds 25% from baseline. If treatment is discontinued, another attempt to initiate therapy may be pursued after recovery of kidney function</p></li><li id="list-item-17"><p id="p-81">Individuals who are taking diuretics at baseline or are otherwise at risk of volume depletion may require closer monitoring and diuretic titration when initiating SGLT-2 inhibitors. This may be particularly pertinent with exposure to hot weather</p></li><li id="list-item-18"><p id="p-82">In individuals with concomitant heart failure, SGLT-2 inhibitors should be initiated irrespective of kidney function and degree of albuminuria</p></li></ul></li><li id="list-item-19"><p id="p-83">Individuals should be counselled regarding the following:</p><ul class="list-unord " id="list-6"><li id="list-item-20"><p id="p-84">Potential adverse events, including genital mycotic infections, acute kidney injury, fractures, euglycaemic ketoacidosis, volume depletion, Fournier's gangrene, and amputations. Even for harm outcomes where important increases in risk are not evident, a residual risk of such events exists and warrants counselling</p></li><li id="list-item-21"><p id="p-85">The need to stop medication if unwell, engaging in prolonged fasting, undergoing surgery, or experiencing severe gastrointestinal losses such as diarrhoea or vomiting (that is, sick day counselling).</p></li></ul></li></ul><p id="p-86">The beneficial effects of SGLT-2 inhibitors are considered to be class effects. By extension, all SGLT-2 inhibitors are considered similarly. SGLT-2 inhibitors that may be considered for use in individuals with CKD include canagliflozin, dapagliflozin, and empagliflozin.</p></div></div></div><div class="section other4" id="sec-24"><h2 class="">Key uncertainties and future directions</h2><p id="p-87">We identified the following key uncertainties and areas for future research:</p><ul class="list-unord " id="list-7"><li id="list-item-22"><p id="p-88">Development of a prognostic model that estimates cardiovascular and kidney risk in adults with CKD (currently available models either do not provide accurate risk stratification or do not do so for the majority of key outcomes)</p></li><li id="list-item-23"><p id="p-89">Risk estimation for patient-important outcomes that incorporates age stratification (not currently incorporated into the KDIGO classification based on GFR and albuminuria)</p></li><li id="list-item-24"><p id="p-90">Risk-stratified estimates for patient-important harm outcomes (no robust evidence currently available to inform baseline risks across different risk strata)</p></li><li id="list-item-25"><p id="p-91">Safety of initiating SGLT-2 inhibitors with a baseline GFR &lt;20 mL/min per 1.73 m<sup>2</sup> (current evidence and guidance are less applicable to this group)</p></li><li id="list-item-26"><p id="p-92">Impact of initiating SGLT-2 inhibitors among adults receiving kidney replacement therapy (peritoneal or haemodialysis) or after kidney transplantation (current evidence and guidance are less applicable to these groups)</p></li><li id="list-item-27"><p id="p-93">Impact of continuing SGLT-2 inhibitors with low GFRs (particularly &lt;20 mL/min per 1.73 m<sup>2</sup>) or for adults who begin kidney replacement therapy (current evidence and guidance are more uncertain for or less applicable to these groups)</p></li><li id="list-item-28"><p id="p-94">Impact of initiating SGLT-2 inhibitors for adults with rare kidney diseases, particularly autosomal dominant polycystic kidney disease (current evidence and guidance are less applicable to these groups)</p></li><li id="list-item-29"><p id="p-95">Impact of initiating SGLT-2 inhibitors for adults with other diseases in which kidney disease is often implicated, such as antineutrophil cytoplasmic antibody (ANCA) associated vasculitis and lupus nephritis (current evidence and guidance are less applicable to these groups)<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a></p></li><li id="list-item-30"><p id="p-96">Evidence of values and preferences of adults with CKD regarding use of SGLT-2 inhibitors as it applies to different risk strata (more robust evidence incorporating input from a larger cohort of adults living with CKD is warranted).</p></li></ul><div class="boxed-text" id="boxed-text-5"><h3>How patients were involved in the creation of this article</h3><p id="p-97">The panel included three patients with CKD. Their perspectives informed judgments regarding values and preferences associated with decision-making related to SGLT-2 inhibitors.</p></div></div><div class="section ack" id="ack-1"><h2>Acknowledgments</h2><p id="p-98">We thank all the following panel members who contributed to this endeavour:</p><p id="p-99">• Patient partners: Frederic Coyac, Andrew Demaine, Edward Machuve.</p><p id="p-100">• Clinical experts: Bert Aertgeerts, Pauline Darbellay Farhoumand, Anja Fog Heen, Vivekanand Jha, Evi Nagler, Belen Ponte (clinical co-chair).</p><p id="p-101">• Methodologists: Arnav Agarwal (methods co-chair), Thomas Agoritsas (MAGIC lead and primary supervisor), Farid Foroutan, Gordon Guyatt, Sheyu Li, Daniel Rayner, David Tunnicliffe, Per Olav Vandvik, Xiaoxi Zeng (methods co-chair trainee).</p></div><div class="section fn-group" id="fn-group-1"><h2>Footnotes</h2><ul><li class="fn-financial-disclosure" id="fn-2"><p id="p-102">Funding: This guideline was funded by the West China Hospital, Sichuan University (ZYJC18010 and ZYYC24001). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. MAGIC provided oversight and methodological contributions and support throughout the guideline process.</p></li><li class="fn-conflict" id="fn-3"><p id="p-103">Competing interests: All authors have completed the <em>BMJ</em> Rapid Recommendations disclosure of interests form. <em>The BMJ</em> has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.</p></li><li class="fn-other" id="fn-4"><p id="p-104">Provenance and peer review: This publication was commissioned by <em>The BMJ</em> in partnership with the MAGIC Evidence Ecosystem Foundation, in the context of the <em>BMJ</em> Rapid Recommendations. Pre-publication internal and external peer review was managed by MAGIC, and internal review was managed by <em>The BMJ</em>. Post-publication review through rapid responses is facilitated on bmj.com and through MAGICapp.</p></li><li class="fn-other" id="fn-5"><p id="p-105">Copyright statement: The Corresponding Authors have the right to grant on behalf of all authors and do grant on behalf of all authors, an exclusive license on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence (<a href="https://authors.bmj.com/policies/#copyright">https://authors.bmj.com/policies/#copyright</a><span class="underline">).</span></p></li><li class="fn-other" id="fn-6"><p id="p-106"></p></li></ul></div><div class="section ref-list" id="ref-list-1"><h2>References</h2><ol class="cit-list"><li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.1" data-doi="10.1038/kisup.2012.73"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Work Group</span></li></ol><cite>. <span class="cit-article-title">KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">Kidney Int Suppl</abbr><span class="cit-pub-date">2013</span>;<span class="cit-vol">3</span>:<span class="cit-fpage">1</span>-<span class="cit-lpage">150</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%2BSuppl%26rft.volume%253D3%26rft.spage%253D1%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fkisup.2012.73%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/kisup.2012.73&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.2" data-doi="10.1016/j.kisu.2021.11.003"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Kovesdy</span> <span class="cit-name-given-names">CP</span></span></li></ol><cite>. <span class="cit-article-title">Epidemiology of chronic kidney disease: an update 2022</span>. <abbr class="cit-jnl-abbrev">Kidney Int Suppl</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">7</span>-<span class="cit-lpage">11</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/j.kisu.2021.11.003</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>35529086</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%2BSuppl%26rft.volume%253D12%26rft.spage%253D7%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.kisu.2021.11.003%26rft_id%253Dinfo%253Apmid%252F35529086%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.kisu.2021.11.003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=35529086&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.3" data-doi="10.1016/S0140-6736(24)00685-8"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">GBD 2021 Forecasting Collaborators</span></li></ol><cite>. <span class="cit-article-title">Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2024</span>;<span class="cit-vol">403</span>:<span class="cit-fpage">2204</span>-<span class="cit-lpage">56</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/S0140-6736(24)00685-8</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>38762325</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D403%26rft.spage%253D2204%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252824%252900685-8%26rft_id%253Dinfo%253Apmid%252F38762325%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(24)00685-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=38762325&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.4" data-doi="10.1016/S0140-6736(18)31694-5"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Foreman</span> <span class="cit-name-given-names">KJ</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Marquez</span> <span class="cit-name-given-names">N</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Dolgert</span> <span class="cit-name-given-names">A</span></span>, </li><li><span class="cit-etal">et al</span></li></ol><cite>. <span class="cit-article-title">Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2018</span>;<span class="cit-vol">392</span>:<span class="cit-fpage">2052</span>-<span class="cit-lpage">90</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/S0140-6736(18)31694-5</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>30340847</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D392%26rft.spage%253D2052%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252818%252931694-5%26rft_id%253Dinfo%253Apmid%252F30340847%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(18)31694-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=30340847&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.5" data-doi="10.1001/jama.286.4.421"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Gerstein</span> <span class="cit-name-given-names">HC</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Mann</span> <span class="cit-name-given-names">JF</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Yi</span> <span class="cit-name-given-names">Q</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">HOPE Study Investigators</span></li></ol><cite>. <span class="cit-article-title">Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals</span>. <abbr class="cit-jnl-abbrev">JAMA</abbr><span class="cit-pub-date">2001</span>;<span class="cit-vol">286</span>:<span class="cit-fpage">421</span>-<span class="cit-lpage">6</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1001/jama.286.4.421</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>11466120</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.aulast%253DGerstein%26rft.auinit1%253DH.%2BC.%26rft.volume%253D286%26rft.issue%253D4%26rft.spage%253D421%26rft.epage%253D426%26rft.atitle%253DAlbuminuria%2Band%2BRisk%2Bof%2BCardiovascular%2BEvents%252C%2BDeath%252C%2Band%2BHeart%2BFailure%2Bin%2BDiabetic%2Band%2BNondiabetic%2BIndividuals%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.286.4.421%26rft_id%253Dinfo%253Apmid%252F11466120%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1001/jama.286.4.421&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11466120&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000170069000013&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.6" data-doi="10.1056/NEJMoa041031"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Go</span> <span class="cit-name-given-names">AS</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Chertow</span> <span class="cit-name-given-names">GM</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Fan</span> <span class="cit-name-given-names">D</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">McCulloch</span> <span class="cit-name-given-names">CE</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Hsu</span> <span class="cit-name-given-names">CY</span></span></li></ol><cite>. <span class="cit-article-title">Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2004</span>;<span class="cit-vol">351</span>:<span class="cit-fpage">1296</span>-<span class="cit-lpage">305</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1056/NEJMoa041031</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>15385656</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DGo%26rft.auinit1%253DA.%2BS.%26rft.volume%253D351%26rft.issue%253D13%26rft.spage%253D1296%26rft.epage%253D1305%26rft.atitle%253DChronic%2BKidney%2BDisease%2Band%2Bthe%2BRisks%2Bof%2BDeath%252C%2BCardiovascular%2BEvents%252C%2Band%2BHospitalization%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa041031%26rft_id%253Dinfo%253Apmid%252F15385656%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa041031&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=15385656&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000223997700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.7" data-doi="10.1056/NEJMoa1811744"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Perkovic</span> <span class="cit-name-given-names">V</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Jardine</span> <span class="cit-name-given-names">MJ</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Neal</span> <span class="cit-name-given-names">B</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">CREDENCE Trial Investigators</span></li></ol><cite>. <span class="cit-article-title">Canagliflozin and renal outcomes in type 2 diabetes and nephropathy</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2019</span>;<span class="cit-vol">380</span>:<span class="cit-fpage">2295</span>-<span class="cit-lpage">306</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1056/NEJMoa1811744</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>30990260</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1811744%26rft_id%253Dinfo%253Apmid%252F30990260%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa1811744&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=30990260&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.8" data-doi="10.1056/NEJMoa2024816"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Heerspink</span> <span class="cit-name-given-names">HJL</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Stefánsson</span> <span class="cit-name-given-names">BV</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Correa-Rotter</span> <span class="cit-name-given-names">R</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">DAPA-CKD Trial Committees and Investigators</span></li></ol><cite>. <span class="cit-article-title">Dapagliflozin in patients with chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2020</span>;<span class="cit-vol">383</span>:<span class="cit-fpage">1436</span>-<span class="cit-lpage">46</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1056/NEJMoa2024816</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>32970396</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D383%26rft.spage%253D1436%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2024816%26rft_id%253Dinfo%253Apmid%252F32970396%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa2024816&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=32970396&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.9" data-doi="10.1056/NEJMoa2204233"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Herrington</span> <span class="cit-name-given-names">WG</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Staplin</span> <span class="cit-name-given-names">N</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Wanner</span> <span class="cit-name-given-names">C</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">The EMPA-KIDNEY Collaborative Group</span></li></ol><cite>. <span class="cit-article-title">Empagliflozin in patients with chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr><span class="cit-pub-date">2023</span>;<span class="cit-vol">388</span>:<span class="cit-fpage">117</span>-<span class="cit-lpage">27</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1056/NEJMoa2204233</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36331190</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D388%26rft.spage%253D117%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2204233%26rft_id%253Dinfo%253Apmid%252F36331190%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa2204233&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36331190&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.10" data-doi="10.1016/j.kint.2022.06.008"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group</span></li></ol><cite>. <span class="cit-article-title">KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">Kidney Int</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">102</span>(<span class="cit-supplement">5S</span>):<span class="cit-fpage">S1</span>-<span class="cit-lpage">127</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/j.kint.2022.06.008</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36272764</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%26rft.volume%253D102%26rft.spage%253DS1%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.kint.2022.06.008%26rft_id%253Dinfo%253Apmid%252F36272764%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.kint.2022.06.008&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36272764&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.11" data-doi="10.1016/j.kint.2023.10.018"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work Group</span></li></ol><cite>. <span class="cit-article-title">KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">Kidney Int</abbr><span class="cit-pub-date">2024</span>;<span class="cit-vol">105</span>(<span class="cit-supplement">4S</span>):<span class="cit-fpage">S117</span>-<span class="cit-lpage">314</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/j.kint.2023.10.018</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>38490803</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.kint.2023.10.018%26rft_id%253Dinfo%253Apmid%252F38490803%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.kint.2023.10.018&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=38490803&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.12" data-doi="10.1016/S0140-6736(22)02074-8"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Nuffield Department of Population Health Renal Studies Group</span>, </li><li><span class="cit-auth cit-collab">SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists’ Consortium</span></li></ol><cite>. <span class="cit-article-title">Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">400</span>:<span class="cit-fpage">1788</span>-<span class="cit-lpage">801</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/S0140-6736(22)02074-8</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36351458</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D400%26rft.spage%253D1788%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252822%252902074-8%26rft_id%253Dinfo%253Apmid%252F36351458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(22)02074-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36351458&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a><div class="cit ref-cit ref-book" id="cit-387.oct01_4.e080257.13"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Institute of Medicine (U.S.) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines</span></li></ol><cite>. <span class="cit-source">Clinical practice guidelines we can trust.</span><span class="cit-publ-name">National Academies Press (US)</span>, <span class="cit-pub-date">2011</span>.</cite></div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.14" data-doi="10.1136/bmj.39489.470347.AD"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Guyatt</span> <span class="cit-name-given-names">GH</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Oxman</span> <span class="cit-name-given-names">AD</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Vist</span> <span class="cit-name-given-names">GE</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">GRADE Working Group</span></li></ol><cite>. <span class="cit-article-title">GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2008</span>;<span class="cit-vol">336</span>:<span class="cit-fpage">924</span>-<span class="cit-lpage">6</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1136/bmj.39489.470347.AD</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>18436948</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.39489.470347.AD%26rft_id%253Dinfo%253Apmid%252F18436948%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjEyOiIzMzYvNzY1MC85MjQiO3M6NDoiYXRvbSI7czoyOToiL2Jtai8zODcvYm1qLTIwMjQtMDgwMjU3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.15" data-doi="10.1016/j.ekir.2022.05.033"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">James</span> <span class="cit-name-given-names">G</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Garcia Sanchez</span> <span class="cit-name-given-names">JJ</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Carrero</span> <span class="cit-name-given-names">JJ</span></span>, </li><li><span class="cit-etal">et al</span></li></ol><cite>. <span class="cit-article-title">Low adherence to Kidney Disease: Improving Global Outcomes 2012 CKD clinical practice guidelines despite clear evidence of utility</span>. <abbr class="cit-jnl-abbrev">Kidney Int Rep</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">2059</span>-<span class="cit-lpage">70</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/j.ekir.2022.05.033</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36090504</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%2BRep%26rft.volume%253D7%26rft.spage%253D2059%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.ekir.2022.05.033%26rft_id%253Dinfo%253Apmid%252F36090504%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.ekir.2022.05.033&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36090504&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.16" data-doi="10.1001/jamainternmed.2021.4813"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Liu</span> <span class="cit-name-given-names">P</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Quinn</span> <span class="cit-name-given-names">RR</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Lam</span> <span class="cit-name-given-names">NN</span></span>, </li><li><span class="cit-etal">et al</span></li></ol><cite>. <span class="cit-article-title">Accounting for age in the definition of chronic kidney disease</span>. <abbr class="cit-jnl-abbrev">JAMA Intern Med</abbr><span class="cit-pub-date">2021</span>;<span class="cit-vol">181</span>:<span class="cit-fpage">1359</span>-<span class="cit-lpage">66</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1001/jamainternmed.2021.4813</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>34459844</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJAMA%2BIntern%2BMed%26rft.volume%253D181%26rft.spage%253D1359%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjamainternmed.2021.4813%26rft_id%253Dinfo%253Apmid%252F34459844%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1001/jamainternmed.2021.4813&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=34459844&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.17" data-doi="10.1016/S0140-6736(23)02843-X"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Wong</span> <span class="cit-name-given-names">K</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Pitcher</span> <span class="cit-name-given-names">D</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Braddon</span> <span class="cit-name-given-names">F</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">RaDaR consortium</span></li></ol><cite>. <span class="cit-article-title">Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2024</span>;<span class="cit-vol">403</span>:<span class="cit-fpage">1279</span>-<span class="cit-lpage">89</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/S0140-6736(23)02843-X</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>38492578</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D403%26rft.spage%253D1279%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252823%252902843-X%26rft_id%253Dinfo%253Apmid%252F38492578%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(23)02843-X&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=38492578&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.18" data-doi="10.1136/annrheumdis-2021-221474"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Säemann</span> <span class="cit-name-given-names">M</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Kronbichler</span> <span class="cit-name-given-names">A</span></span></li></ol><cite>. <span class="cit-article-title">Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors</span>. <abbr class="cit-jnl-abbrev">Ann Rheum Dis</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">81</span>:<span class="cit-fpage">614</span>-<span class="cit-lpage">7</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1136/annrheumdis-2021-221474</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>34844933</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnn%2BRheum%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fannrheumdis-2021-221474%26rft_id%253Dinfo%253Apmid%252F34844933%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6ImFubnJoZXVtZGlzIjtzOjU6InJlc2lkIjtzOjg6IjgxLzUvNjE0IjtzOjQ6ImF0b20iO3M6Mjk6Ii9ibWovMzg3L2Jtai0yMDI0LTA4MDI1Ny5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a><div class="cit ref-cit ref-web" id="cit-387.oct01_4.e080257.19"><div class="cit-metadata unstructured">BMJ Rapid Recommendations. <em>BMJ</em> 2024. <a href="https://www.bmj.com/rapid-recommendations">https://www.bmj.com/rapid-recommendations</a>.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.20" data-doi="10.1136/bmj.i5191"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Siemieniuk</span> <span class="cit-name-given-names">RA</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Agoritsas</span> <span class="cit-name-given-names">T</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Macdonald</span> <span class="cit-name-given-names">H</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Guyatt</span> <span class="cit-name-given-names">GH</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Brandt</span> <span class="cit-name-given-names">L</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Vandvik</span> <span class="cit-name-given-names">PO</span></span></li></ol><cite>. <span class="cit-article-title">Introduction to BMJ Rapid Recommendations</span>. <abbr class="cit-jnl-abbrev">BMJ</abbr><span class="cit-pub-date">2016</span>;<span class="cit-vol">354</span>:<span class="cit-fpage">i5191</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1136/bmj.i5191</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>27680768</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.i5191%26rft_id%253Dinfo%253Apmid%252F27680768%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjE4OiIzNTQvc2VwMjhfMTIvaTUxOTEiO3M6NDoiYXRvbSI7czoyOToiL2Jtai8zODcvYm1qLTIwMjQtMDgwMjU3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.21" data-doi="10.1503/cmaj.090449"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Brouwers</span> <span class="cit-name-given-names">MC</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Kho</span> <span class="cit-name-given-names">ME</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Browman</span> <span class="cit-name-given-names">GP</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">AGREE Next Steps Consortium</span></li></ol><cite>. <span class="cit-article-title">AGREE II: advancing guideline development, reporting and evaluation in health care</span>. <abbr class="cit-jnl-abbrev">CMAJ</abbr><span class="cit-pub-date">2010</span>;<span class="cit-vol">182</span>:<span class="cit-fpage">E839</span>-<span class="cit-lpage">42</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1503/cmaj.090449</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>20603348</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCMAJ%26rft_id%253Dinfo%253Adoi%252F10.1503%252Fcmaj.090449%26rft_id%253Dinfo%253Apmid%252F20603348%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiY21haiI7czo1OiJyZXNpZCI7czoxMToiMTgyLzE4L0U4MzkiO3M6NDoiYXRvbSI7czoyOToiL2Jtai8zODcvYm1qLTIwMjQtMDgwMjU3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.22" data-doi="10.1016/S0140-6736(22)02074-8"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth cit-collab">Nuffield Department of Population Health Renal Studies Group</span>, </li><li><span class="cit-auth cit-collab">SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists’ Consortium</span></li></ol><cite>. <span class="cit-article-title">Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">400</span>:<span class="cit-fpage">1788</span>-<span class="cit-lpage">801</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1016/S0140-6736(22)02074-8</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36351458</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D400%26rft.spage%253D1788%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252822%252902074-8%26rft_id%253Dinfo%253Apmid%252F36351458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(22)02074-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36351458&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a><div class="cit ref-cit ref-web" id="cit-387.oct01_4.e080257.23"><div class="cit-metadata unstructured">World Health Organization. WHO model list of essential medicines – 23rd list, 2023. 2023. <a href="https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02">https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02</a>.</div><div class="cit-extra"></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.24" data-doi="10.1053/j.ajkd.2022.10.012"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Watson</span> <span class="cit-name-given-names">KE</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Dhaliwal</span> <span class="cit-name-given-names">K</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Robertshaw</span> <span class="cit-name-given-names">S</span></span>, </li><li><span class="cit-etal">et al.</span>, </li><li><span class="cit-auth cit-collab">PAUSE (Preventing Medication Complications During Acute Illness Through Symptom Evaluation and Sick Day Guidance) Medication Safety Advisory Panel</span></li></ol><cite>. <span class="cit-article-title">Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process</span>. <abbr class="cit-jnl-abbrev">Am J Kidney Dis</abbr><span class="cit-pub-date">2023</span>;<span class="cit-vol">81</span>:<span class="cit-fpage">564</span>-<span class="cit-lpage">74</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id cit-pub-id-doi"><span class="cit-pub-id-scheme-doi">doi:</span>10.1053/j.ajkd.2022.10.012</span> <span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>36470530</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAm%2BJ%2BKidney%2BDis%26rft.volume%253D81%26rft.spage%253D564%26rft_id%253Dinfo%253Adoi%252F10.1053%252Fj.ajkd.2022.10.012%26rft_id%253Dinfo%253Apmid%252F36470530%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1053/j.ajkd.2022.10.012&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=36470530&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-387.oct01_4.e080257.25" data-doi="10.1016/j.ekir.2022.04.094"><div class="cit-metadata"><ol class="cit-auth-list"><li><span class="cit-auth"><span class="cit-name-surname">Yau</span> <span class="cit-name-given-names">K</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Dharia</span> <span class="cit-name-given-names">A</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Alrowiyti</span> <span class="cit-name-given-names">I</span></span>, </li><li><span class="cit-auth"><span class="cit-name-surname">Cherney</span> <span class="cit-name-given-names">DZI</span></span></li></ol><cite>. <span class="cit-article-title">Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations</span>. <abbr class="cit-jnl-abbrev">Kidney Int Rep</abbr><span class="cit-pub-date">2022</span>;<span class="cit-vol">7</span>:<span class="cit-fpage">1463</span>-<span class="cit-lpage">76</span>.<span class="cit-pub-id cit-pub-id-pmid"><span class="cit-pub-id-scheme-pmid">pmid:</span>35812300</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DKidney%2BInt%2BRep%26rft.volume%253D7%26rft.spage%253D1463%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.ekir.2022.04.094%26rft_id%253Dinfo%253Apmid%252F35812300%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.ekir.2022.04.094&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=35812300&amp;link_type=MED&amp;atom=%2Fbmj%2F387%2Fbmj-2024-080257.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div></div> </div> </div> </div> </div> </div> </div></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-highwire-article-trendmd" > <div class="pane-content"> <div id="trendmd-suggestions"></div> </div> </div> </article> </div> <div class="right-nav col-xs-12 col-sm-4 col-md-4 col-lg-4"> <aside> <div class="panel-pane pane-service-links" > <div class="pane-content"> <div class="service-links"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.bmj.com/content/387/bmj-2024-080257&amp;count=horizontal&amp;via=&amp;text=Sodium-glucose%20cotransporter-2%20%28SGLT-2%29%20inhibitors%20for%20adults%20with%20chronic%20kidney%20disease%3A%20a%20clinical%20practice%20guideline&amp;counturl=https%3A//www.bmj.com/content/387/bmj-2024-080257" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow"><span class="element-invisible">Tweet Widget</span></a></li> <li class="last"><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.bmj.com/content/387/bmj-2024-080257&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow"><span class="element-invisible">Facebook Like</span></a></li> </ul></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet" > <div class="pane-content"> <div class="oas-ad-middle-1" id="oas-ad-middle-1"> <div class="snippet-content"> <div id="div-gpt-ad-7326006-2"><script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-7326006-2'); }); </script></div> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-issue-link" > <div class="pane-content"> <a href="/content/387/8445" class="btn btn-primary" target="_blank">See other articles in issue 8445</a> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-article-buttons" > <h2 class="pane-title"> Article tools </h2> <div class="pane-content"> <a href="/content/387/bmj-2024-080257.full.pdf" title="PDF" class="pdf-link"><span class="icon"><em class="bmj-icon blue-icon fa fa-file-text"></em>PDF</span></a><a href="/content/387/bmj-2024-080257/rapid-responses" class="citation-rr-link"><em class="bmj-icon blue-icon fa fa-comment"></em>3 responses</a> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-article-custom-meta" > <div class="pane-content"> <a href="//resources.bmj.com/bmj/authors/fast-track-publication" title="fast track"><img class="fast-track" title="fast track" src="https://www.bmj.com/sites/default/modules/jnl-bmj/jnl_bmj/plugins/content_types/bmj_article_custom_meta_images/fast-track.jpg" /></a> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-bmj-art-tools" > <div class="pane-content"> <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_bmj_art_tools"> <div class="panel-panel panel-col"> <div><ul><li class="first"><div class="panel-pane pane-custom pane-1" > <div class="pane-content"> <p><i class="bmj-icon fa fa-edit"></i><a href="/content/387/bmj-2024-080257/submit-a-rapid-response">Respond to this article</a></p> </div> </div> </li> <li><div class="panel-pane pane-bmj-article-fig-data-link" > <div class="pane-content"> <i class="bmj-icon fa fa-plus"></i><a href="/content/387/bmj-2024-080257/related#datasupp">Data supplement</a> </div> </div> </li> <li><div class="panel-pane pane-bmj-variant-link" > <div class="pane-content"> <i class="bmj-icon fa fa-print"></i><a href="/content/387/bmj-2024-080257.full-text.print" data-font-icon="fa fa-print">Print</a> </div> </div> </li> <li><div class="panel-pane pane-bmj-minipanel-model-link pane-jnl-bmj-article-page-alerts" > <div class="pane-content"> <div class='minipanel-model-wrapper'><div class='minipanel-model-link-link'><i class="bmj-icon fa fa-bullhorn"></i><a href="/#mini-panel-jnl-bmj-article-page-alerts-1" data-toggle="collapse" role="button" data-font-icon="fa fa-bullhorn">Alerts & updates</a></div><!-- Collapse --><div id="mini-panel-jnl-bmj-article-page-alerts-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Article alerts</h4><div class="short-description"><div class="alerts-marketing">Please note: your email address is provided to the journal, which may use this information for marketing purposes.</div></div></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-jnl_bmj_article_page_alerts"> <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12"> <div class="panel-pane pane-custom pane-2" > <div class="pane-content"> <h4 class="minipanel-label">Log in or register:</h4> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-alerts-login-form" > <div class="pane-content"> <form action="/content/387/bmj-2024-080257?tab=article-alert" method="post" id="user-login-form" accept-charset="UTF-8"><div><div class="form-type-textfield form-item-name form-item form-group"> <label for="edit-name">Username <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="text" id="edit-name" name="name" value="" size="15" maxlength="60" /> </div> <div class="form-type-password form-item-pass form-item form-group"> <label for="edit-pass">Password <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="password" id="edit-pass" name="pass" size="15" maxlength="128" /> </div> <input type="hidden" name="form_build_id" value="form--AzdWBkcJ8t_gMFszK9wleGF9Y4u7PIQ4rpjDgiNkgw" /> <input type="hidden" name="form_id" value="highwire_alerts_user_login" /> <input class="btn form-submit" type="submit" id="edit-submit" name="op" value="Log in" /></div></form> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-custom pane-3" id="register-for-alerts" > <div class="pane-content"> <p><a class="btn register-button" href="//myaccount.bmj.com/myaccount/registration.html?regService=bmj-registration&amp;fwdUrl=https://www.bmj.com/content/387/bmj-2024-080257?tab=article-alert&amp;itemId=pr1906">Register for alerts</a><br /> <div class="alerts-email"><i class="fa fa-info-circle"></i> If you have registered for alerts, you should use your registered email address as your username</div> </div> </div> </div> </div> </div></div></div> </div> </div> </li> <li><div class="panel-pane pane-bmj-minipanel-model-link pane-article-page-citation-download" > <div class="pane-content"> <div class='minipanel-model-wrapper'><div class='minipanel-model-link-link'><i class="bmj-icon fa fa-globe"></i><a href="/#mini-panel-article-page-citation-download-1" data-toggle="collapse" role="button" data-font-icon="fa fa-globe">Citation tools</a></div><!-- Collapse --><div id="mini-panel-article-page-citation-download-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Download this article to citation manager</h4></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-article_page_citation_download"> <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12"> <div class="panel-pane pane-bmj-citation-export" > <div class="pane-content"> <div> <div class="highwire-citation-info"> <div class="highwire-article-citation highwire-citation-type-highwire-article node1101485--3" data-node-nid="1101485" id="node-1101485--4250708328" data-pisa="bmj;387/oct01_4/e080257" data-pisa-master="bmj;bmj-2024-080257" data-apath="/bmj/387/bmj-2024-080257.atom"><div id="jnl_bmj_custom_authors" style="display: none;"><span data-delta="0"><span class="nlm-given-names">Arnav</span> <span class="nlm-surname">Agarwal</span> <span class="nlm-role">internist, methods co-chair</span></span>, <span data-delta="1"><span class="nlm-given-names">Xiaoxi</span> <span class="nlm-surname">Zeng</span> <span class="nlm-role">nephrologist, methods co-chair trainee</span></span>, <span data-delta="2"><span class="nlm-given-names">Sheyu</span> <span class="nlm-surname">Li</span> <span class="nlm-role">endocrinologist, methodologist</span></span>, <span data-delta="3"><span class="nlm-given-names">Daniel</span> <span class="nlm-surname">Rayner</span> <span class="nlm-role">methodologist</span></span>, <span data-delta="4"><span class="nlm-given-names">Farid</span> <span class="nlm-surname">Foroutan</span> <span class="nlm-role">methodologist</span></span>, <span data-delta="5"><span class="nlm-given-names">Bert</span> <span class="nlm-surname">Aertgeerts</span> <span class="nlm-role">primary care physician</span></span> et al</div> <div class="highwire-cite highwire-cite-highwire-article highwire-citation-bmj-article-citation-export clearfix" > <span class="highwire-cite-authors" ><!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd"> <html><body><span data-delta="0"><span class="nlm-surname">Agarwal</span> <span class="nlm-given-names">A</span></span>, <span data-delta="1"><span class="nlm-surname">Zeng</span> <span class="nlm-given-names">X</span></span>, <span data-delta="2"><span class="nlm-surname">Li</span> <span class="nlm-given-names">S</span></span>, <span data-delta="3"><span class="nlm-surname">Rayner</span> <span class="nlm-given-names">D</span></span>, <span data-delta="4"><span class="nlm-surname">Foroutan</span> <span class="nlm-given-names">F</span></span>, <span data-delta="5"><span class="nlm-surname">Aertgeerts</span> <span class="nlm-given-names">B</span></span> et al. </body></html> </span> <span class="highwire-cite-title article-title">Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline</span> <span class="highwire-cite-metadata" ><span class="highwire-cite-metadata-journal highwire-cite-metadata">BMJ </span><span class="highwire-cite-metadata-date highwire-cite-metadata">2024; </span><span class="highwire-cite-metadata-volume highwire-cite-metadata">387 </span><span class="highwire-cite-metadata-volume highwire-cite-metadata">:e080257 </span></span> <span class="article-doi" >doi:10.1136/bmj-2024-080257</span> </div> </div> </div> <div class="highwire-citation-formats"> <div class="highwire-citation-formats-links"> <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=Sodium-glucose%20cotransporter-2%20%28SGLT-2%29%20inhibitors%20for%20adults%20with%20chronic%20kidney%20disease%3A%20a%20clinical%20practice%20guideline&amp;rft.volume=387&amp;rft.issue&amp;rft.date=2024-10-01%2013%3A31%3A26&amp;rft.stitle&amp;rft.jtitle=BMJ&amp;rft.au=Agarwal%2C+Arnav&amp;rft.au=Zeng%2C+Xiaoxi&amp;rft.au=Li%2C+Sheyu&amp;rft.au=Rayner%2C+Daniel&amp;rft.au=Foroutan%2C+Farid&amp;rft.au=Aertgeerts%2C+Bert&amp;rft.au=Coyac%2C+Frederic&amp;rft.au=Farhoumand%2C+Pauline+Darbellay&amp;rft.au=Demaine%2C+Andrew&amp;rft.au=Heen%2C+Anja+Fog&amp;rft.au=Jha%2C+Vivekanand&amp;rft.au=Machuve%2C+Edward&amp;rft.au=Nagler%2C+Evi&amp;rft.au=Tunnicliffe%2C+David+J&amp;rft.au=Guyatt%2C+Gordon+H&amp;rft.au=Vandvik%2C+Per+Olav&amp;rft.au=Ponte%2C+Belen&amp;rft.au=Agoritsas%2C+Thomas"></span><h3></h3><ul class="bmj-citation-links"><li class="first">BibTeX (win & mac)<a href="/highwire/citation/1101485/bibtext" class="citation-link btn btn-primary pull-right">Download</a></li> <li>EndNote (tagged)<a href="/highwire/citation/1101485/endnote-tagged" class="citation-link btn btn-primary pull-right">Download</a></li> <li>EndNote 8 (xml)<a href="/highwire/citation/1101485/endnote-8-xml" class="citation-link btn btn-primary pull-right">Download</a></li> <li>RefWorks Tagged (win & mac)<a href="/highwire/citation/1101485/refworks-tagged" class="citation-link btn btn-primary pull-right">Download</a></li> <li>RIS (win only)<a href="/highwire/citation/1101485/ris" class="citation-link btn btn-primary pull-right">Download</a></li> <li class="last">Medlars<a href="/highwire/citation/1101485/medlars" class="citation-link btn btn-primary pull-right">Download</a></li> </ul> </div> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet" > <h2 class="pane-title"> Help </h2> <div class="pane-content"> <div class="jnl-bmj-citation-download-help" id="jnl-bmj-citation-download-help"> <div class="snippet-content"> <div class="citation-help"> <p class="citation-manager">If you are unable to import citations, please contact technical support for your product directly (links go to external sites):</p> <ul> <li><a href="http://www.endnote.com/support/ensupport.asp">EndNote</a></li> <li><a href="http://www.procite.com/support/pcsupport.asp">ProCite</a></li> <li><a href="http://www.refman.com/support/rmsupport.asp">Reference Manager</a></li> <li><a href= "http://www.refworks.com/content/products/content.asp">RefWorks</a></li> <li><a href="http://www.zotero.org/support">Zotero</a></li> </ul> </div> </div> </div> </div> </div> </div> </div> </div></div></div> </div> </div> </li> <li class="last"><div class="panel-pane pane-bmj-permission-link" > <div class="pane-content"> <i class="bmj-icon icon-copyright"></i><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=BMJ&amp;publication=bmj&amp;title=Sodium-glucose%20cotransporter-2%20%28SGLT-2%29%20inhibitors%20for%20adults%20with%20chronic%20kidney%20disease%3A%20a%20clinical%20practice%20guideline&amp;publicationDate=10/01/2024&amp;author=Arnav%20Agarwal%2C%20Xiaoxi%20Zeng%2C%20Sheyu%20Li%2C%20Daniel%20Rayner%2C%20Farid%20Foroutan%2C%20Bert%20Aertgeerts%2C%20Frederic%20Coyac%2C%20Pauline%20Darbellay%20Farhoumand%2C%20Andrew%20Demaine%2C%20Anja%20Fog%20Heen%2C%20Vivekanand%20Jha%2C%20Edward%20Machuve%2C%20Evi%20Nagler%2C%20David%20J%20Tunnicliffe%2C%20Gordon%20H%20Guyatt%2C%20Per%20Olav%20Vandvik%2C%20Belen%20Ponte%2C%20Thomas%20Agoritsas&amp;contentID=10.1136/bmj-2024-080257&amp;volumeNum=387&amp;issueNum=&amp;startPage=&amp;endPage=&amp;copyright=BMJ%20Publishing%20Group%20Ltd&amp;oa=n&amp;orderBeanReset=1&amp;link_type=PERMISSIONDIRECT&amp;atom=/bmj/387/bmj-2024-080257.atom" rel="external" class="bmj-permission-link request-permissions" target="_blank" data-font-icon="icon-copyright">Request permissions</a> </div> </div> </li> </ul></div> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-bmj-article-share-modal" > <div class="pane-content"> <div class="panel-display row bootstrap-onecol" id="mini-panel-bmj_article_share_modal"> <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12"> <div class="panel-pane pane-bmj-article-links" > <div class="pane-content"> <div class="bmj-article-links minipanel-model-wrapper"><ul class="links"><li><div class="minipanel-model-link-link"><i class="bmj-icon fa fa-user"></i><a data-font-icon="fa fa-bullhorn" role="button" data-toggle="collapse" href="/#mini-panel-jnl-bmj-article-page-citation" class="collapsed">Author citation</a></div></li></ul><div style="height: 0px;" id="mini-panel-jnl-bmj-article-page-citation" class="panel-collapse collapse"><ul class="links"><li class="0 first"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Agarwal%20Arnav%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Arnav Agarwal</a></li> <li class="1"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Zeng%20Xiaoxi%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Xiaoxi Zeng</a></li> <li class="2"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Li%20Sheyu%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Sheyu Li</a></li> <li class="3"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Rayner%20Daniel%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Daniel Rayner</a></li> <li class="4"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Foroutan%20Farid%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Farid Foroutan</a></li> <li class="5"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Aertgeerts%20Bert%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Bert Aertgeerts</a></li> <li class="6"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Coyac%20Frederic%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Frederic Coyac</a></li> <li class="7"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Farhoumand%20Pauline%20Darbellay%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Pauline Darbellay Farhoumand</a></li> <li class="8"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Demaine%20Andrew%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Andrew Demaine</a></li> <li class="9"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Heen%20Anja%20Fog%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Anja Fog Heen</a></li> <li class="10"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Jha%20Vivekanand%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Vivekanand Jha</a></li> <li class="11"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Machuve%20Edward%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Edward Machuve</a></li> <li class="12"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Nagler%20Evi%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Evi Nagler</a></li> <li class="13"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Tunnicliffe%20David%20J%5Bau%5D&amp;dispmax=50" target="_blank">Articles by David J Tunnicliffe</a></li> <li class="14"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Guyatt%20Gordon%20H%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Gordon H Guyatt</a></li> <li class="15"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Vandvik%20Per%20Olav%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Per Olav Vandvik</a></li> <li class="16"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Ponte%20Belen%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Belen Ponte</a></li> <li class="17 last"><a href="//www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;term=Agoritsas%20Thomas%5Bau%5D&amp;dispmax=50" target="_blank">Articles by Thomas Agoritsas</a></li> </ul></div></div><div class="bmj-article-links"><ul class="links"><li class="0 first last"><a href="//portfolio.bmj.com/portfolio/add-to-portfolio.html?t=Sodium-glucose%20cotransporter-2%20%28SGLT-2%29%20inhibitors%20for%20adults%20with%20chronic%20kidney%20disease%3A%20a%20clinical%20practice%20guideline&amp;u=https%3A//www.bmj.com/content/387/bmj-2024-080257" target="_blank" id="add-to-bmj-portfolio" class="bmj-portfolio" rel="nofollow">Add article to BMJ Portfolio</a></li> </ul></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-minipanel-model-link pane-jnl-bmj-article-button-email-to" > <div class="pane-content"> <div class='minipanel-model-wrapper'><div class='minipanel-model-link-link'><i class="bmj-icon icon-email"></i><a href="/#mini-panel-jnl-bmj-article-button-email-to-1" data-toggle="collapse" role="button" data-font-icon="icon-email">Email to a friend</a></div><!-- Collapse --><div id="mini-panel-jnl-bmj-article-button-email-to-1" class="panel-collapse collapse"><div class="minipanel-header"><h4 class="minipanel-label">Forward this page</h4></div><div class="minipanel-body"><div class="panel-display row bootstrap-onecol" id="mini-panel-jnl_bmj_article_button_email_to"> <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12"> <div class="panel-pane pane-block pane-forward-form" > <div class="pane-content"> <form action="/content/387/bmj-2024-080257" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-type-item form-item form-group"> <p>Thank you for your interest in spreading the word about The BMJ.</p><p>NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.</p> </div> <div class="form-type-textfield form-item-name form-item form-group"> <label for="edit-name--2">Username <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="text" id="edit-name--2" name="name" value="" size="58" maxlength="256" /> </div> <div class="form-type-textfield form-item-email form-item form-group"> <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label> <input class="form-control form-text required" type="text" id="edit-email" name="email" value="" size="58" maxlength="256" /> </div> <div class="form-type-textarea form-item-recipients form-item form-group"> <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label> <div class="form-textarea-wrapper"><textarea class="form-control form-textarea required" id="edit-recipients" name="recipients" cols="50" rows="3"></textarea></div> </div> <div id="edit-page" class="form-type-item form-item form-group"> <label for="edit-page">You are going to email the following </label> <a href="/content/387/bmj-2024-080257" class="active">Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline</a> </div> <div class="form-type-textarea form-item-message form-item form-group"> <label for="edit-message--2">Your Personal Message </label> <div class="form-textarea-wrapper"><textarea class="form-control form-textarea" id="edit-message--2" name="message" cols="50" rows="3"></textarea></div> </div> <input type="hidden" name="path" value="node/1101485" /> <input type="hidden" name="path_cid" value="" /> <input type="hidden" name="forward_footer" value=" " /> <input type="hidden" name="form_build_id" value="form-9upN70sRys9Hd2JfIgFCwIVcS4lf8DaYqtJkhuXZVq8" /> <input type="hidden" name="form_id" value="forward_form" /> <fieldset class="captcha panel panel-default form-wrapper"> <legend class="panel-heading"> <div class="panel-title fieldset-legend"> CAPTCHA </div> </legend> <div class="panel-body"> <p class="help-block"> This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. </p> <input type="hidden" name="captcha_sid" value="358799648" /> <input type="hidden" name="captcha_token" value="c4dcdd3b6be7f3774b73215f571a90f1" /> <input type="hidden" name="captcha_response" value="Google no captcha" /> <div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image"></div> </div> </fieldset> <input class="btn form-submit" type="submit" id="edit-submit--2" name="op" value="Send" /></div></form> </div> </div> </div> </div> </div></div></div> </div> </div> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-article-specialities" > <h2 class="pane-title"> Topics </h2> <div class="pane-content"> <div class="bmj-item-more-less-list bmj-item-list"><ul class="item-list-speciality"><li class="first last"><a href="/specialties/rapid-recommendation" class="article-speciality c-rapid-recommendation">Rapid Recommendation</a></li> </ul></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet" > <div class="pane-content"> <div class="altmertrics" id="altmertrics"> <div class="snippet-content"> <!-- Widget start --> <div id="altmetric"></div> <!-- Widget end --> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet" > <div class="pane-content"> <div class="oas-ad-middle-2" id="oas-ad-middle-2"> <div class="snippet-content"> <div id="div-gpt-ad-7326006-3"><script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-7326006-3'); }); </script></div> </div> </div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-custom pane-4" > <div class="pane-content"> <!-- Start CrossMark Snippet v1.5 --><p><a data-target="crossmark"><img src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg" width="150" /></a></p> <div id="crossmark-dialog" style="display: none;" title="Crossmark"> <!-- the external CrossMark data is loaded inside this iframe --><iframe id="crossmark-dialog-frame" frameborder="0"></iframe></div> <!-- End CrossMark Snippet --> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet pane-poll-international" id="poll-widget" > <h2 class="pane-title"> This week&#039;s poll </h2> <div class="pane-content"> <div class="poll-international" id="poll-international"> <div class="snippet-content"> <p><a class="anchor" id="this-weeks-poll"></a></p> <div id="PDI_container58250" class="PDS_Poll"></div> <div id="PD_superContainer"></div> <div class="poll-related"> <p><a href="https://www.bmj.com/content/385/bmj.q1429">Read</a> related article</p> <p><a href="/about-bmj/poll-archive">See</a> previous polls</p> </div> </div> </div> </div> </div> </aside> </div> </div> <!-- /row --> <div class="row"> <div class="panel-panel page-bottom col-md-12 col-lg-12"> <div class="panel-pane pane-highwire-back-to-top" > <div class="pane-content"> <a href="#page" class="back-to-top"><span class="icon-chevron-up"></span> Back to top</a> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-snippet pane-oas-ad-bottom" > <div class="pane-content"> <div class="oas-ad-bottom" id="oas-ad-bottom"> <div class="snippet-content"> <div id="div-gpt-ad-7326006-4"><script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-7326006-4'); }); </script></div> </div> </div> </div> </div> </div> </div> <!-- /row --> </div> <!-- /container --> </section> <!-- /.block --> </div> </section> </div><!-- /row --> </div><!-- /main-container --> <!-- ______________________ FOOTER _______________________ --> <div class="footer-wrapper"> <div class="container"> <footer id="footer"> <div class="region region-footer"> <section id="block-panels-mini-bmj-footer" class="block block-panels-mini clearfix"> <div class="panel-display bootstrap-footer" id="mini-panel-bmj_footer"> <div class="footer-top-row"> <div id="footer-social-media" class="footer-column panel-panel col-xs-12 col-sm-3 col-md-3 col-lg-3"> <div class="panel-pane pane-block pane-menu-block-2" > <h2 class="pane-title"> Follow us on </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-2 menu-name-menu-footer parent-mlid-1298 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-1299"><a href="http://twitter.com/bmj_latest" target="_blank">Twitter</a></li> <li class="leaf menu-mlid-1301"><a href="https://www.facebook.com/bmjdotcom" target="_blank">Facebook</a></li> <li class="leaf menu-mlid-1300"><a href="http://youtube.com/user/BMJmedia" target="_blank">YouTube</a></li> <li class="last leaf menu-mlid-1302"><a href="http://feeds.bmj.com/bmj/recent">RSS</a></li> </ul></div> </div> </div> </div> <div class="footer-content col-xs-12 col-sm-9 col-md-9 col-lg-9"> <div id="footer-top-row" class="row"> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-3" > <h2 class="pane-title"> Content links </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-3 menu-name-menu-footer parent-mlid-1303 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-125058"><a href="http://www.bmj.com/collections">Collections</a></li> <li class="leaf menu-mlid-125036"><a href="http://www.bmj.com/health-in-south-asia">Health in South Asia</a></li> <li class="leaf menu-mlid-125034"><a href="http://www.bmj.com/content/women%E2%80%99s-children%E2%80%99s-and-adolescents%E2%80%99-health-0">Women’s, children’s &amp; adolescents’ health</a></li> <li class="leaf menu-mlid-17959"><a href="http://www.bmj.com/freezikaresources">Zika virus</a></li> <li class="leaf menu-mlid-1305"><a href="/us/research">Research</a></li> <li class="leaf menu-mlid-1306"><a href="/us/education">Education</a></li> <li class="leaf menu-mlid-6506"><a href="/us/news">News and views</a></li> <li class="leaf menu-mlid-1310"><a href="http://blogs.bmj.com/bmj/">BMJ Opinion</a></li> <li class="leaf menu-mlid-7612"><a href="/rapid-responses">Rapid responses</a></li> <li class="last leaf menu-mlid-1309"><a href="/archive">Archive</a></li> </ul></div> </div> </div> </div> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-4" > <h2 class="pane-title"> About us </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-4 menu-name-menu-footer parent-mlid-1314 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-6487"><a href="/about-bmj">About us</a></li> <li class="leaf menu-mlid-1316"><a href="/about-bmj/editorial-staff">Editorial staff</a></li> <li class="leaf menu-mlid-1317"><a href="/about-bmj/editorial-staff/bmj-united-states">BMJ in the USA</a></li> <li class="leaf menu-mlid-127585"><a href="/health-in-latin-america">BMJ in Latin America</a></li> <li class="leaf menu-mlid-1318"><a href="/about-bmj/editorial-staff/bmj-south-asia">BMJ in South Asia</a></li> <li class="leaf menu-mlid-1319"><a href="/about-bmj/advisory-panels">Advisers</a></li> <li class="leaf menu-mlid-1320"><a href="/about-bmj/resources-authors/forms-policies-and-checklists">Policies</a></li> <li class="last leaf menu-mlid-1323"><a href="http://mc.manuscriptcentral.com/bmj">Submit your paper</a></li> </ul></div> </div> </div> </div> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-5" > <h2 class="pane-title"> Resources </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-5 menu-name-menu-footer parent-mlid-1324 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-1325"><a href="/about-bmj/resources-authors">Authors</a></li> <li class="leaf menu-mlid-1326"><a href="/about-bmj/resources-reviewers">Reviewers</a></li> <li class="leaf menu-mlid-1327"><a href="/about-bmj/resources-bma-members">BMA members</a></li> <li class="leaf menu-mlid-1329"><a href="/about-bmj/resources-readers">Readers</a></li> <li class="leaf menu-mlid-1328"><a href="/about-bmj/resources-subscribers">Subscribers</a></li> <li class="leaf menu-mlid-1330"><a href="/about-bmj/resources-advertisers-and-sponsors">Advertisers and sponsors</a></li> <li class="leaf menu-mlid-1331"><a href="/about-bmj/resources-media">Media</a></li> <li class="last leaf menu-mlid-7610"><a href="https://recruiter.bmj.com/">Recruiters</a></li> </ul></div> </div> </div> </div> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-6" > <h2 class="pane-title"> Explore BMJ </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-6 menu-name-menu-footer parent-mlid-1332 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-7613"><a href="https://www.bmj.com/company/?int_source=tbmj&amp;int_medium=footer&amp;int_campaign=URLswitch">Our company</a></li> <li class="leaf menu-mlid-7421"><a href="https://jobs.bmj.com/">BMJ Careers</a></li> <li class="leaf menu-mlid-7423"><a href="http://learning.bmj.com/">BMJ Learning</a></li> <li class="leaf menu-mlid-7424"><a href="http://masterclasses.bmj.com">BMJ Masterclasses</a></li> <li class="leaf menu-mlid-7425"><a href="http://journals.bmj.com">BMJ Journals</a></li> <li class="leaf menu-mlid-7422"><a href="/student">BMJ Student</a></li> <li class="leaf menu-mlid-7426"><a href="http://www.bmj.com/about-bmj/resources-readers">Academic edition of The BMJ</a></li> <li class="leaf menu-mlid-7427"><a href="http://bestpractice.bmj.com/">BMJ Best Practice</a></li> <li class="last leaf menu-mlid-17958"><a href="http://thebmjawards.bmj.com/home">The BMJ Awards</a></li> </ul></div> </div> </div> </div> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-7" > <h2 class="pane-title"> My account </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-7 menu-name-menu-footer parent-mlid-1343 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-1344"><a href="http://myaccount.bmj.com/myaccount/account/hw-registration.html">Email alerts</a></li> <li class="last leaf menu-mlid-1345"><a href="http://journals.bmj.com/cgi/activate">Activate subscription</a></li> </ul></div> </div> </div> </div> <div class="footer-column panel-panel col-xs-6 col-sm-4 col-md-4 col-lg-4"> <div class="panel-pane pane-block pane-menu-block-8" > <h2 class="pane-title"> Information </h2> <div class="pane-content"> <div class="menu-block-wrapper menu-block-8 menu-name-menu-footer parent-mlid-1346 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-1347"><a href="/about-bmj/contact-us">Contact us</a></li> <li class="last leaf menu-mlid-1321"><a href="/about-bmj/complaints-procedure">Complaints</a></li> </ul></div> </div> </div> </div> </div> </div> </div> <div id="footer-bottom-row" class="row"> <div class="panel-panel col-xs-12 col-sm-12 col-md-12 col-lg-12"> <div class="panel-pane pane-block pane-menu-block-9 hidden-phone" > <div class="pane-content"> <div class="menu-block-wrapper menu-block-9 menu-name-menu-footer parent-mlid-1349 menu-level-1"> <ul class="menu nav"><li class="first leaf menu-mlid-125888"><a id="ot-sdk-btn" class="ot-sdk-show-settings" clickable="false">Cookie settings</a></li> <li class="leaf menu-mlid-1350"><a href="https://www.bmj.com/company/your-privacy/cookies-policy/">Cookie Policy</a></li> <li class="leaf menu-mlid-125299"><a href="https://www.bmj.com/company/your-privacy/">Privacy policy</a></li> <li class="leaf menu-mlid-1351"><a href="http://www.bmj.com/company/legal-information/">Website T&amp;Cs</a></li> <li class="leaf menu-mlid-1352"><a href="http://group.bmj.com/group/about/revenue-sources">Revenue Sources</a></li> <li class="leaf menu-mlid-1353"><a href="http://home.highwire.org/">HighWire Press</a></li> <li class="last leaf menu-mlid-8093"><a href="/sitemap">Sitemap</a></li> </ul></div> </div> </div> <div class="panel-separator"></div><div class="panel-pane pane-bmj-copy-right" > <div class="pane-content"> <div class="copyright">Copyright © 2024 BMJ Publishing Group Ltd</div> </div> </div> </div> </div> </div> </section> <!-- /.block --> </div> </footer> <!-- /footer --> </div><!-- /footer-wrapper:container --> </div><!-- /footer-wrapper --> </div> <!-- /wrapper --> </div> <!-- /wrapper-outer --> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__uW7NyUocxI-7E_sL-GP7L5FYvHrfi0D8UkwaFa_jFUQ__ITpTmydBN18ujP4Nq9igNKs2_uPvSa_MMIGZilNH7xo__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__L2RNsEq1_BwrvVr4-XqL6HCM3TrId8FewyOD-ifl56Y__xFUWwD-CmrvIMpj7PKKOzG6M0u5x4a4YsfZcc7fa3qg__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__ADNpAJRqEZQTdJr17qFcuXkfatW9ULGGExiAh_zWtxs__Xan4DQzBMVgws81Yi1i-_1Amp0wkg5IKAA2fCWPVSwI__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__wteGLiD1wamodYGt1CPf350dgG_dnSPaybjTJJ4V8O0__tHSi0oVxXVY1K8dKSadgniknKfq0JO39EkwFnl-Qx3k__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script src="https://static.polldaddy.com/w/58250.js"></script> <script src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.8.7/jquery-ui.min.js"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script src="https://www.bmj.com/sites/default/files/advagg_js/js__SFoHIUTheqo0e4hxRINC0gFp_rO4LFMUUrC70xvOwtY__h5zRuwNt-m_fFPTyMKF2APwK7ArnJ2U3S4dW5Cp_p_o__a7Jq5VSqcMKMeR_gboGw1x4AC4g6SRpO1Geb_4xJjYc.js"></script> <script> setTimeout(function(){var a=document.createElement("script"); var b=document.getElementsByTagName("script")[0]; a.src=document.location.protocol+"//dnn506yrbagrg.cloudfront.net/pages/scripts/0014/4896.js?"+Math.floor(new Date().getTime()/3600000); a.async=true;a.type="text/javascript";b.parentNode.insertBefore(a,b)}, 1);</script> <script>jQuery(".page-search .pane-quick-search-results .search-snippet").text(function (_, old){ return old.replace(/\S+@\S+\.\S+/, "");});</script> <script type="text/javascript"> /* <![CDATA[ */ var google_conversion_id = 973817434; var google_custom_params = window.google_tag_params; var google_remarketing_only = true; /* ]]> */ </script> <script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js"> </script> <noscript> <div style="display:inline;"> <img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/973817434/?value=0&amp;guid=ON&amp;script=0"/> </div> </noscript> <script async src="https://cdn.pbgrd.com/core-bmj.js"></script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10